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peripherally-evoked action potentials in the spinal cord during a root compression to be at 6.6Â±3.0 minutes
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GLT-1 and upregulation of spinal GLAST at day 7. Additional studies examine the role of the spinal
glutamatergic system in mediating radicular pain by administering Riluzole to inhibit glutamate release at day
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and the associated neuronal hyperexcitability that is normally observed in the deep laminae of the dorsal horn.
Additionally, Riluzole mitigated the axonal neuropathology in the root that normally develops by day 7 while
ceftriaxone restored the spinal expression of GLAST. Together these studies identify how one aspect of nerve
root biomechanics, compression duration, modulates neuronal and glutamatergic responses in the nerve root
and spinal cord that are associated with cervical radicular pain. Day 1 was identified as a critical time-point
when inhibiting glutamate signaling in the central nervous system can prevent persistent nerve root-mediated
pain that is likely maintained by downregulation of spinal GLT-1. Finally, these studies suggest that primary
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Degree Type
Dissertation
Degree Name
Doctor of Philosophy (PhD)
Graduate Group
Bioengineering
First Advisor
Beth A. Winkelstein
This dissertation is available at ScholarlyCommons: http://repository.upenn.edu/edissertations/785
Keywords
electrophysiology, glutamate, glutamate transporter, injury, nerve root
Subject Categories
Biomechanics | Biomedical | Neuroscience and Neurobiology
This dissertation is available at ScholarlyCommons: http://repository.upenn.edu/edissertations/785
DEFINING THE ROLE OF MECHANICAL SIGNALS DURING NERVE ROOT 
COMPRESSION IN THE DEVELOPMENT OF SUSTAINED PAIN AND 
NEUROPHYSIOLOGICAL CORRELATES THAT DEVELOP IN THE  
INJURED TISSUE AND SPINAL CORD 
 
Kristen J. Nicholson 
 
A DISSERTATION 
in 
Bioengineering 
 
Presented to the Faculties of the University of Pennsylvania in  
Partial Fulfillment of the Requirements for the  
Degree of Doctor of Philosophy  
2013 
 
 
 
Supervisor of Dissertation 
 
________________________________________ 
Beth A. Winkelstein 
Professor of Bioengineering 
 
 
Graduate Group Chairperson 
 
________________________________________ 
Jason A. Burdick 
Professor of Bioengineering 
 
 
Dissertation Committee: 
 
Kristy Arbogast, Research Associate Professor of Pediatrics 
Kelly L. Jordan-Sciutto, Associate Professor of Pathology 
Brian Litt, Professor of Neurology and Bioengineering 
ii 
ACKNOWLEDGMENTS 
 
  I would first like to thank Dr. Kristy Arbogast, Dr. Kelly Jordan-Sciutto and Dr. 
Brian Litt for taking the time to sit on my thesis committee. I am particularly grateful for 
my advisor, Dr. Beth Winkelstein, for her commitment and time devoted to my training. 
Thank you to all the members of the Spine Pain Research Lab for the years of advice, 
support and friendship. Thank you especially to Christine, Jenn and Ling for always 
being there to discuss anything and everything. I would like to specifically acknowledge 
Taylor for her assistance in many aspects of the research presented in this thesis. I am 
also thankful for the support of Ben, Julia and Sijia who were instrumental in the 
completion of many studies presented here. 
  I would like to thank my family and friends for their encouragement and 
unconditional love. Thank you to my mom for always being there to listen to me and for 
always trusting in me and to Dave for taking such good care of Paco. Thank you to my 
dad for his constant belief in me and to Cindy for her encouraging words when I need 
them. I am especially thankful for Keri, Kyle, Alexis and Melena for being such amazing 
role models for me. I would like to thank Ben, Heather, Jason, Steve and Wei for their 
support and friendship over the years. Finally, I would like to thank my dog, Paco, for 
being the most loving and happy dog I could ask for. 
iii 
ABSTRACT 
 
DEFINING THE ROLE OF MECHANICAL SIGNALS DURING NERVE ROOT 
COMPRESSION IN THE DEVELOPMENT OF SUSTAINED PAIN AND 
NEUROPHYSIOLOGICAL CORRELATES THAT DEVELOP IN THE  
INJURED TISSUE AND SPINAL CORD 
 
 
Kristen J. Nicholson 
 
Beth A. Winkelstein 
 
Cervical nerve root injury commonly leads to pain. The duration of an applied 
compression has been shown to contribute to both the onset of persistent pain and also 
the degree of spinal cellular and molecular responses related to nociception that are 
produced. This thesis uses a rat model of a transient cervical nerve root compression to 
study how the duration of an applied compression modulates both peripherally-evoked 
activity in spinal cord neurons during a root compression and the resulting neuronal and 
glutamatergic responses in the nerve root and spinal cord. Studies define the compression 
duration threshold that inhibits peripherally-evoked action potentials in the spinal cord 
during a root compression to be at 6.6±3.0 minutes and this is similar to the threshold for 
eliciting persistent mechanical allodynia after a cervical root compression that lies 
between 3 and 10 minutes. Furthermore, neurotransmission remains inhibited for at least 
10 minutes after a painful nerve root compression and this may contribute to the 
subsequent development of neuropathology in the root, spinal neuronal hyperexcitability, 
downregulation of spinal GLT-1 and upregulation of spinal GLAST at day 7. Additional 
iv 
studies examine the role of the spinal glutamatergic system in mediating radicular pain by 
administering Riluzole to inhibit glutamate release at day 1 or ceftriaxone daily to 
upregulate spinal GLT-1, separately. Both treatments abolished behavioral sensitivity and 
the associated neuronal hyperexcitability that is normally observed in the deep laminae of 
the dorsal horn. Additionally, Riluzole mitigated the axonal neuropathology in the root 
that normally develops by day 7 while ceftriaxone restored the spinal expression of 
GLAST. Together these studies identify how one aspect of nerve root biomechanics, 
compression duration, modulates neuronal and glutamatergic responses in the nerve root 
and spinal cord that are associated with cervical radicular pain. Day 1 was identified as a 
critical time-point when inhibiting glutamate signaling in the central nervous system can 
prevent persistent nerve root-mediated pain that is likely maintained by downregulation 
of spinal GLT-1. Finally, these studies suggest that primary afferent regulation of spinal 
GLT-1 may have a critical role in transducing the biomechanics of a nerve root 
compression into radicular pain. 
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CHAPTER 1 
 
Introduction & Background 
 
 
 
 
1.1 Introduction 
 Studies in Europe and North America estimate the annual incidence of neck pain 
to range from 10-21% (Côté et al. 2004, Hoy et al. 2010) and that up to two-thirds of 
individuals will experience neck pain in their lives (Côté et al. 1998). As many as 35-
66% of those cases persist for at least one year (Hoy et al. 2010), and are defined as 
“chronic.” In the United States, health care costs for individuals with spine-related pain 
are as high as 70% greater for than those without; in 2005, total annual health care 
expenditures for individuals with spine-related pain in the United States was estimated to 
be $85 billion (Martin et al. 2008). Although neck pain can be attributed to a variety of 
spinal tissues, including the facet joints, ligaments, and surrounding musculature, the 
cervical nerve roots are particularly vulnerable to mechanical injury due to foraminal 
impingement, disc herniation, direct spinal trauma, and/or foraminal stenosis (Cornefjord 
et al. 1997, Krivickas & Wilbourn 2000, Nuckley et al. 2002, Olmarker et al. 1989a, 
Panjabi et al. 2006, Wainner & Gill 2000). 
Pain, as defined by the International Association for the Study of Pain (IASP) is 
“an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage” (Merskey & Bogduk 1994). 
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According to the IASP, pain is a psychological state and, as such, the pain field defines 
specific types of hypersensitivities that often accompany the sensation of pain, such as 
allodynia and hyperalgesia, to provide both clinicians and researchers with objective 
methods to assess the presence pain (DeLeo & Winkelstein 2002, Merskey & Bogduk 
1994, Mogil 2009, Sandkuhler 2009). Allodynia, defined by the IASP is “pain due to a 
stimulus that does not normally provoke pain,” while hyperalgesia is “increased pain 
from a stimulus that normally provokes pain” (Merskey & Bogduk 1994). In rodent 
models, allodynia is commonly reported as an increase in the number of painful 
responses (i.e. paw withdrawals) that are evoked by a normally innocuous stimulus. 
Hyperalgesia, on the other hand, is often reported as a lowered threshold for eliciting a 
response to a noxious stimulus. Mechanical and thermal hypersensitivity are the two most 
commonly utilized behavioral tests in animal models of chronic pain (Mogil 2009). 
Although thermal hyperalgesia can describe a lowered threshold to a cold or hot stimulus, 
the studies in this thesis refer to thermal hyperalgesia as a lowered threshold to heat. It is 
important to distinguish that noxious stimuli are those that can cause tissue damage and 
“nociception” is the neural process and associated cellular mechanisms of encoding 
noxious stimuli by nociceptive neurons (Merskey & Bogduk 1994, Sandkuhler 2009). 
Pain that is caused by a lesion or a disease of the central or peripheral nervous system is 
broadly defined as neuropathic pain (Merskey & Bogduk 1994, Sandkuhler 2009). 
Radicular pain describes a specific subtype of neuropathic pain that is associated with 
nerve root lesions (Merskey & Bogduk 1994, Wainner & Gill 2000).  
The clinical syndrome of cervical radiculopathy encompasses a pathology of the 
cervical nerve roots with symptoms of pain and numbness that radiate from the spine to 
  3 
the shoulders, arms, and hands (Abbed & Coumans 2007, Wall & Melzack 1994). Disc 
herniation and cervical spondylosis are common sources of sustained loading to the nerve 
root (Abbed & Coumans 2007). Yet, nerve roots are also susceptible to transient loading 
via trauma from sports and automotive injuries (Krivickas & Wilbourn 2000, Panjabi et 
al. 2006, Stuber 2005, Tominaga et al. 2006). Although each of these loading scenarios 
can result in pain (Bergfield & Aulicio 1988, Swanik et al. 1996), only a subset of them 
actually develops into chronic pain (Mogil 2009). Identifying critical loading conditions, 
such as the duration of the applied insult, that induce chronic pain after transient nerve 
root compression will help understand and design for the prevention and diagnosis of 
painful radiculopathy. Studies to investigate nociceptive-related responses within the 
nerve root and spinal cord, including neuron activity and chemical signaling, will provide 
insight into treating painful radiculopathy by identifying the critical neurochemical 
pathways that contribute to chronic radicular pain. 
 The studies detailed in this thesis use a rat model of cervical radiculopathy to 
define the mechanical and neuronal mechanisms of nerve root-mediated pain. The 
relationship between the duration of a nerve root compression and afferent signaling 
through the nerve root is first established by identifying the critical duration of 
compression that reduces the frequency of peripherally-evoked action potentials through 
the nerve root during its compression. For compression durations that are above or below 
that critical duration, additional studies evaluate the firing rate of action potentials 
through the root immediately after compression was removed and the subsequent 
development of axonal pathology in the root, spinal neuronal hyperexcitability and 
behavioral sensitivity. Together, those studies describe the relationship between 
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compression duration, behavioral sensitivity and associated neuronal pathologies in both 
the nerve root and the spinal cord. To characterize the contribution of the glutamatergic 
system to nerve root-mediated pain, the temporal expression of spinal glutamate 
transporters is quantified after both painful and nonpainful nerve root compressions; 
different drugs are used to (1) modulate the spinal expression of the glutamate 
transporter, GLT-1 and (2) inhibit pre-synaptic glutamate release, separately. Ceftriaxone 
was administered by daily lumbar punctures in order to increase the expression of GLT-1 
and, therefore, reduce extracellular glutamate concentrations in the central nervous 
system (Rasmussen et al. 2011). In a separate study, the sodium channel blocker, 
Riluzole, was administered by a single intraperitoneal injection in order to inhibit 
glutamate release by pre-synaptic neurons (Wu et al. 2013). Behavioral sensitivity and 
neuronal hyperexcitability were quantified following both treatments to determine 
relative pain symptoms when glutamate uptake is increased or when glutamate release is 
inhibited. Despite the multi-dimensional aspects of pain, mechanical allodynia is the only 
behavioral assessment that has been characterized for transient cervical nerve root 
compressions to date. Therefore, the studies in this thesis also assess the development and 
maintenance of both mechanical allodynia and thermal hyperalgesia following 
compression durations above and below the critical duration described earlier, and for 
each of the pharmacological interventions. 
 The three aims and associated hypotheses of this thesis are summarized in the 
next chapter (Chapter 2), which also outlines the organization of the remaining chapters. 
Specific background is presented separately in each chapter, as appropriate to those 
topics, hypotheses and specific experiments. The general background material presented 
  5 
in this chapter is intended to provide relevant information on the topics of nerve root 
anatomy, cervical radiculopathy and nerve root biomechanics. That foundation in the 
anatomy and biomechanics of the nerve roots provides the context for the discussions of 
animal models of radiculopathy and the sensory circuits involved in pain that follow. A 
brief overview is included describing neuronal circuits in the nerve root and dorsal horn 
of the spinal cord (Fig. 1.1) and also a general description of synaptic glutamatergic 
signaling in the central nervous system. Axonal conduction and morphology are the focus 
here, as related to the primary afferents in the nerve root; the role of spinal glutamate and 
spinal neuronal signaling in mediating neuropathic pain is also described (Fig. 1.1).  
 
1.2 Background 
1.2.1 Cervical Spine & Nerve Root Anatomy  
The vertebral column of the spine consists of 33 vertebrae, divided into five 
separate anatomic regions: cervical, thoracic, lumbar, thoracic, sacral, and coccygeal. 
local responses in the nerve root 
axonal conduction & morphology 
forepaw sensitivity (i.e. pain) 
mechanical allodynia & thermal hyperalgesia 
spinal cord responses 
neuronal excitability & glutamatergic signaling 
 
dorsal nerve root dorsal horn 
to forepaw 
Fig. 1.1 The sensory pathways in the nerve root and the dorsal horn mediate pain are shown, with 
particular relevance to this thesis. Signaling and morphologic properties of axons in the primary 
afferents of the nerve root are the inciting pathways for injury and pain. In the spinal cord, where these 
primary afferents synapse, glutamatergic and neuronal signaling mediate the initiation and maintenance 
of radicular pain that develops in the forepaw after a transient cervical nerve root injury.  
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There are seven vertebrae in the cervical region (Martini et al. 2003). The spinal canal is 
formed by the vertebral foramen of each bony vertebra that encloses and surrounds the 
spinal cord (Fig. 1.2A). The bilateral pedicles lie along the posterolateral border of each 
vertebral foramen and the opposing pedicles from the adjacent vertebrae collectively 
form the intervertebral foramen that encloses the afferent (dorsal) and efferent (ventral) 
nerve roots as they extend from the spinal cord to the periphery at each spinal level (Fig. 
1.2A) (Haller et al. 1971, Martini et al. 2003, Olmarker 1991, de Peretti et al. 1989). A 
pair of afferent and efferent nerve roots fuses together at each spinal level to form a nerve 
as the dorsal and ventral roots pass through the foramen (Haller et al. 1971, Martini et al. 
2003).  
 
Fig. 1.2 Relevant spinal and nerve root anatomy. (A) Dorsal view of the ventral and dorsal roots exiting 
the spinal cord and forming a nerve as they pass through the intervertebral foramen formed by the 
adjacent vertebrae. The dorsal root ganglioin (DRG) is at the distal end of the dorsal nerve root and 
contains the cell bodies of afferent axons. (B) Schematic showing a generic nerve root, it structures and 
the organization of its axons. The nerve root is enclosed by three layers of meninges (pia matter, 
arachnoid matter, dura matter); cerebrospinal fluid (CSF) lies between the arachnoid and pia matter. For 
clarity, the outlined region in the oblique view is enlarged. 
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Once the nerve enters the periphery, it branches out as the individual axons within 
it continue towards their specific sites of innervation. By convention, in the cervical 
region, each nerve root is named for the spinal level of the vertebra inferior to (i.e. below) 
it; although, in the remaining regions of the spine the nerve roots are named for their 
superior vertebra. Despite there being only seven cervical vertebrae, the nerve root 
between the lowest cervical vertebra (C7) and the next first thoracic vertebra (T1) is 
named as the C8 nerve root (Martini et al. 2003). 
At each spinal level, the ventral and dorsal nerve roots exit the spinal cord 
anteriorly and posteriorly, respectively (Figs. 1.2 & 1.3) (Martini et al. 2003). The 
efferent neurons that relay information from the spinal cord to the periphery compose the 
ventral nerve root. The afferents, which relay information from the periphery to the 
central nervous system, are contained in the dorsal nerve root. As the ventral and dorsal 
nerve roots pass through the intervertebral foramen, they join together to form a spinal 
nerve. At the distal, more-peripheral, end of the dorsal nerve root there is a visible 
enlargement called the dorsal root ganglion (DRG) that contains the cell bodies of the 
afferent neurons (Figs. 1.2 & 1.3). The cell bodies of the efferent neurons in the ventral 
nerve root lie within the spinal cord (Figs. 1.2 & 1.3). Due to the separation of afferents 
and efferents, an injury to a single dorsal or ventral nerve root has either sensory or motor 
consequences.  
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The nerve root is a collection of axons enclosed together by three layers of 
meninges (Fig. 1.2) that form synapses with second order neurons in the dorsal horn of 
the spinal cord (Fig. 1.3) (Haller et al. 1971, Martini et al. 2003). The meninges are 
organized, from deep to superficial: the pia mater, the arachnoid mater, and the dura 
mater. Cerebrospinal fluid (CSF) flows within the subarachnoid space, between the 
arachnoid mater and pia mater, and transports nutrients and chemical messengers to the 
neural tissues (Martini et al. 2003). The dura mater of the nerve roots is continuous with 
the epineurium of the nerve, as well as with the dura mater of the spinal cord.   
Anatomically, the nerve roots are protected by the meninges, the CSF and the 
bony elements that surround them. The dura is thought to provide much of the tensile 
support for the nerve roots (Beel et al. 1986, Maikos et al. 2008). Tensile testing of the 
dura mater of rat cranial and spinal dura mater has shown it to be 2-1,000 times stiffer 
than the neural tissue it surrounds, suggesting a similar role for the dura of the nerve roots 
(Maikos et al. 2008). Just as the meninges protect the afferent axons in tension, the CSF 
Fig 1.3 Axial section of the spinal cord and the nerve roots that exit towards the periphery. The primary 
afferent axons transmit sensory information from the periphery to the primary synapse at the axon 
terminal in the dorsal horn of the spinal cord. (adapted from Germann & Stanfield 2002) 
to periphery
from periphery
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and vertebrae protect the nerve root from compressive forces. The CSF protects the 
neural tissue it encloses, including the brain and spinal cord, by damping any blunt forces 
to these structures (Ommaya 1968). However, it has also been hypothesized that the 
pressure gradients that can be established within the CSF surrounding the spinal cord and 
nerve roots during rapid motions of the spine, such as can occur during trauma, can be 
sufficiently high to cause injury to the axons within the nerve root (Boström et al. 1996, 
Svensson et al. 1993). The intervertebral foramen, through which the nerve roots pass, 
normally protects them from direct blunt trauma. However, rapid and/or nonphysiological 
motions of the neck that is associated with trauma can narrow the intervertebral space, 
and compress the nerve root (Nuckley et al. 2002, Panjabi et al. 2006, Tanaka et al. 
2000). Osteoarthritis of the intervertebral foramen, known as spondylosis, can also 
narrow the foramen and impinge on the nerve roots that pass through it (Wainner & Gill 
2000). Therefore, although the CSF and the adjacent vertebrae provide mechanical 
protection to the nerve roots under normal conditions, these fluid and bony structures 
may themselves compress the nerve roots when trauma and/or degenerative disease is 
present. 
 
 
1.2.2 Cervical Radiculopathy 
Nerve roots are susceptible to injuries from a variety of trauma-related causes in 
the neck, as well as additional local changes in the surrounding environment that result 
from progression of other diseases and/or disorders (Abbed & Coumans 2007). For 
example, nerve roots can be injured from a slow-onset foraminal narrowing due to aging 
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or from a disc herniation that can impart both mechanical and inflammatory influences on 
the nerve root (Abbed & Coumans 2007, Jenis & An 2000). In addition, traumatic 
loading events of the cervical spine can compress the nerve root by altering the geometry 
of the intervertebral foramen or by putting the nerve root in traction when stretching of 
the spinal cord generates tension along the nerve roots (Sairyo et al. 2010, Sunderland 
1974). Brachial plexopathies, commonly referred to as burners or stingers, is a collection 
of trauma-related nerve root injuries that are hypothesized to be caused by traction or 
compression to the nerve roots in the cervical region of the spine (Clancy et al. 1977, 
Stuber 2005).  Compression-related burners can occur when there is compression of the 
nerve root by the intervertebral foramen as a result of cervical spine extension that is 
combined with rotation, lateral flexion, and/or compression of the spine (Stuber 2005). 
Traumatic nerve root injuries occur over rapid time frames with high-magnitude loads 
applied to the tissue. In contrast, nerve root injuries associated with local pathologies 
often have a slower-onset of loading than those associated with trauma and can be more 
chronic in nature. 
Both trauma- and pathology-induced nerve root injuries can produce symptoms of 
varying severity and persistence. Clinically, nerve root injuries can manifest as radicular 
pain and numbness, and/or deficits in motor and reflex functions (Abbed & Coumans 
2007, Wainner & Gill 2000). The severity of the symptoms can be classified as acute, 
subacute, or chronic (Abbed & Coumans 2007). Acute radiculopathy typically results 
from a traumatic event and presents with the most severe pain, often described as “sharp” 
or “burning” pain that can be persistent. The symptoms of subacute radiculopathy, on the 
other hand, are typically short-lived, but may be reoccurring. Subacute radiculopathy is 
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most-often associated with a pre-existing condition of the spine such as spondylosis. Both 
acute and subacute radiculopathy can develop into chronic radiculopathy when the 
symptoms do not respond to treatment (Abbed & Coumans 2007, Thoomes et al. 2013). 
The specific location of the presenting symptoms after a nerve root injury depends on 
which nerve root is injured. In general, areas of skin are innervated by a single nerve root; 
the term dermatome is used to describe such an area of skin. Injuries to the C7 nerve root, 
for example, result in sensitivity and numbness in the associated dermatome, which 
includes the arm, forearm, and middle finger (Abbed & Coumans 2007). Injuries to the 
C4 nerve root affect the neurons that innervate the back of the neck and shoulder regions 
(Abbed & Coumans 2007). Clinical studies cite the C7 nerve root as the most commonly 
affected cervical root in patients diagnosed with cervical radiculopathy, with a reported 
incidence rate of 46-69% (Carette & Fehlings 2005, Kuijper et al. 2009, Wainner & Gill 
2000).  
 Treatment for radiculopathy can be broadly categorized into operative and non-
operative interventions (Carette & Fehlings 2005, Thoomes et al. 2013, Wainner & Gill 
2000). When surgery is appropriate, the most common procedure is an anterior cervical 
decompression and fusion (ACDF) to relieve the nerve root of impingement by the local 
vertebrae and/or the intervertebral disc (Wainner & Gill 2000). A posterior surgical 
approach involving a laminectomy or laminoplasty is often used when multiple levels of 
decompression are required (Carette & Fehlings 2005). Surgical complications are not 
common (<5% incident rate), but can be severe, including spinal cord injury, nerve palsy, 
perforation of the esophagus and/or mechanical failure of implanted instruments (Carette 
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& Fehlings 2005). For these reasons, non-operative treatments are preferred as the first 
course of therapy for radicular pain.  
 In most cases, cervical radiculopathy is initially treated conservatively with 
analgesics, physiotherapy or immobilization (Thoomes et al. 2013). The current analgesic 
agents for radiculopathy fall into two categories: opioids and nonsteroidal anti-
inflammatory drugs (NSAIDs) (Carette & Fehlings 2005, Thoomes et al. 2013). 
However, there is limited clinical data regarding the effectiveness of each type of drug 
and there are significant risks associated with each, including addiction (opioids) and 
renal failure (NSAIDs) (Carette & Fehlings, Kuijper et al. 2009, Thoomes et al. 2013). 
Epidural nerve root injections, also known as nerve root blocks, are another common 
treatment for cervical radiculopathy and can provide long-term relief for up to 60% of 
patients (Carette & Fehlings 2005). Like surgery, complications to nerve root blocks are 
rare, but can be severe, and include spinal cord or brainstem infarctions that can cause 
severe neurological damage (Carette & Fehlings 2005). When taken as prescribed, 
analgesics carry the least risk. However, due to a lack of clinical evidence that opioids 
and NSAIDs are effective in resolving radicular pain (Carette & Fehlings 2005, Kiujper 
et al. 2009), a 2011 report commissioned by the National Institute of Health (NIH), cites 
a critical need for new pharmacological approaches to treat chronic pain (Institute of 
Medicine 2011).  
 
1.2.3 Nerve Root Biomechanics 
As with other soft tissues in the body, the response of neural tissue to mechanical 
loading depends on the size, shape, organization, and composition of that tissue (Beel et 
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al., 1986, Maikos et al. 2008, Ommaya 1968, de Peretti et al. 1989). Additionally, the 
mechanical properties depend on the specific conditions related to loading, such as the 
rate and duration of an applied load or deformation (Bedford & Liechti 2000, Fung 1967, 
Gefen & Margulies 2004). The simplest description of a material’s response to 
mechanical loading relates the amount of stress in the material to the amount of strain.  
Stress and strain are scaled measures of the force and deformation within a material that 
are normalized with respect to the geometry of the specimen. As such, they inherently 
account for shape effects as they contribute to mechanical responses.  Stress (σ) is 
defined as the amount of force over a given cross-sectional area. Accordingly, it can vary 
with direction and at different points in a structure.  Strain (ε) represents the amount of 
deformation a material undergoes with respect to its original shape.  For a linear elastic 
material, the amount of stress is linearly related to the amount of strain it experiences, 
and the slope of the line relating the two is the modulus of elasticity (E) of the material. 
Similarly, the relationship between the applied force and the resulting deformation of a 
structure is described by the stiffness of that structure.  
Many tissues, including neural tissue, exhibit complicated biomechanical 
responses that are not easily described by simple linear relationships (Fung 1967, Gefen 
& Margulies 2004, Hubbard et al. 2008b).  Elastic materials deform instantaneously with 
an applied force and, likewise, instantaneously return to their original shape after the 
applied force is removed. For this type of material, the amount of stress is only a function 
of strain. Viscous fluids demonstrate a time-dependent deformation to an applied load, 
and the stress that develops in response to that deformation depends on the rate of strain. 
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In general, neural tissue responds to loading partly as if it were an elastic material, but 
also by undergoing viscous fluid flow. This type of mechanical behavior is viscoelastic 
and describes many biologic tissues (Fig. 1.4) (Bedford & Liechti 2000, Fung 1967, 
Navajas et al. 1995, Provenzano et al. 2001).   
 
Nerve roots exhibit viscoelastic responses when loaded (Fig. 1.4). This is due to 
the mechanical behavior of the materials they contain as well as the interaction between 
those materials (Haller et al. 1971, Stodieck et al. 1986). Viscoelastic materials exhibit 
Fig 1.4 Representative response of the rat nerve root under a compressive displacement of 0.73mm. 
Images of the nerve root prior to compression (uncompressed) and under compression are shown. After 
reaching a peak load (127mN), the root undergoes a rapid relaxation in load until the tissue approaches 
a steady-state equilibrium response. This load-relaxation response is typical of viscoelastic materials. 
  15 
several time-dependent responses to load; most basically, the stress-strain relationship 
varies with the rate of loading and with the length of time that a tissue is held under 
deformation (Fig. 1.4) (Hubbard et al. 2008b). For such tissues, the modulus of elasticity 
varies with the rate at which the tissue is strained. Additionally, when the tissue is held 
under constant deformation, the amount of applied stress experienced in the tissue 
actually decreases with time (Fig. 1.4). Conversely, the tissue will also continue to 
deform over time when it is held under a constant stress. These two behaviors of the 
material are referred to as stress-relaxation and creep, respectively. The specific loading 
conditions applied to nerves and nerve roots are, therefore, important to consider when 
describing the mechanical response of these tissues.  
The mechanical behavior of neural tissues in compression or tension is typically 
characterized by reporting the load-deformation or stress-strain behavior as described 
above, but for specific rates of loading. The typical stress-strain curve describing the 
elastic response has three distinct regions; a toe region, a linear region, and a yield or 
failure region (Beel et al. 1986, Haftek 1970, Kwan et al. 1992, Singh et al. 2006). In the 
toe region, the tissue can undergo substantial deformation with the generation of only 
minimal force. For example, the isolated tibial nerve of the rabbit can sustain tensile 
strains as large as 15% before any appreciable stress develops in that tissue (Kwan et al. 
1992). As neural tissue undergoes further tensile deformation beyond the initial toe 
region, more force is required to produce the deformation, and the slope of the load-
deformation curves becomes approximately linear. Finally, as deformation continues and 
the nerve or nerve root is stretched beyond its linear elastic region, the tissue will begin to 
yield, marked by a reduction in slope of the stress-strain slope.  As with other materials, 
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yield indicates the initiation of sub-structural failures and is followed by a complete 
rupture of the tissue that occurs when deformation continues beyond its ability to support 
any additional force (Martin et al. 1998). Both the stiffness and the yield of the nerve root 
are important in characterizing thresholds for its injury. A quasi-linear viscoelastic model 
for in vivo compression has been developed for the lumbar nerve roots in the rat 
(Hubbard et al. 2008b). Using that model, it was determined that deformation thresholds 
for axonal injury in the nerve root depend on the rate of loading. Specifically, the 
displacement required to reach the magnitude threshold for inducing axonal injury is 23% 
less when the root is dynamic loaded (2mm/sec) compared to quasistatic loading 
(0.004mm/sec) (Hubbard et al. 2008b). Magnitude and duration thresholds for nerve root 
injuries are likely similarly modulated by the loading rate. To date, that study by Hubbard 
et al. (2008) is the only reported experimental work defining the compressive stress-strain 
properties of the nerve root, owing largely to experimental challenges that exist with 
making such measurements to these small and very soft materials. Although the 
mechanical properties of nerve roots in compression is limited, many studies have 
reported that the physiologic consequences of compression do depend on the magnitude, 
duration, and rate of loading; these are discussed in more detail in the next section 
(Section 1.2.4). 
 
1.2.4 In Vivo Models of Mechanical Injury to the Nerve Root 
 Although complete rupture or separation of the nerve root is certainly an injury, 
less severe damage to nerve root tissue also produces serious physiological consequences, 
including tears to the meninges and/or the axon membrane, cytoskeletal fragmentation 
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within the axons, and impaired blood flow in the nerve root tissues (Clark et al. 1992, 
Dyck et al. 1990, Garfin et al. 1990, Singh et al. 2009). For that reason, injuries to the 
nerve root must also be understood in the context of the physiological responses that are 
induced, as well as the associated mechanical response of the axons, meninges and CSF 
that make up the nerve root. Specific clinical symptoms of nerve root injury include 
weakness, paralysis, pain and sensitivity (Abbed & Coumans 2007, Jensen & Baron 
2003, Woolf & Mannion 1999). However, the severity of these symptoms is not always 
easily quantifiable, making it difficult for clinicians to diagnose and treat the condition. 
Pain, in particular, is difficult to evaluate objectively because the sensation and verbal 
description of pain can vary from one individual to another (Backonja & Stacey 2004). 
Although pain is subjective and is not typically quantified, increased sensitivity to stimuli 
can be evaluated in humans and in animal models. Allodynia is one measure of 
behavioral sensitivity that provides a quantitative assessment of increased sensitivity to a 
nonpainful stimulus and can be measured by counting the frequency of responses that is 
evoked for a given stimulus. Other methods for measuring pain in animal models include 
observing changes in gait, posture or the frequency of directed behaviors such as 
guarding or licking (Mogil 2010).  
Nerve roots are subject to many loading conditions that modulate their 
physiology. It has been demonstrated in animal models that compression to the nerve root 
can produce a host of biologic responses, including behavioral hypersensitivity, 
decreased axonal conduction velocity and blood flow, as well as edema and swelling 
(Garfin et al. 1990, Hubbard & Winkelstein 2005, Igarashi et al. 2005, Olmarker et al. 
1989a,b). Moreover, many of these physiologic responses depend on the magnitude, 
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duration and rate of applied tissue compression (Kobayashi et al. 1993, 2005a,b, 
Olmarker et al. 1989a,b, Pedowitz et al. 1992). In a study of compression to the cauda 
equina in pigs, blood flow in the capillaries of the nerve roots was stopped for 
compression pressures above 40mmHg (Olmarker et al. 1989b). In a similar model, 
compression of 100mmHg resulted in a decrease in the amplitude of axonal conduction 
after 30 minutes of applied compression, while 200mmHg produced an immediate 
decrease in axonal conduction amplitude with complete blockage of axonal conduction if 
applied for 100 minutes (Garfin et al. 1990). Similarly, the rate of compression has also 
been shown to affect neuronal function. Olmarker et al. (1990) demonstrated a more-
pronounced decrease in conduction velocities if the porcine nerve root is compressed 
rapidly when compared to slower compression rates. These findings indicate a 
multidimensional response of the nerve root physiology to compressive loading that is 
sensitive to magnitude, duration, and rate. 
Studies of nerve root injury in the rat show that functional and sensory behavioral 
changes are modulated by the degree of tissue deformation, the magnitude of 
compression load, and the duration of the applied compression (Hubbard et al. 2008a, 
Rothman et al. 2010, Winkelstein et al. 2002). For example, a compression load of only 
26mN to the rat C7 nerve root for 15 minutes elicits behavioral sensitivity in the forepaw 
within 24 hours, but a compression load of 38mN is required to induce behavioral 
mechcanical sensitivity that is sustained for 1 week (Hubbard et al. 2008a). Using that 
same rat model, for similar magnitudes of load, allodynia is significantly elevated after 
15 minutes of compression compared to that produced for a compression applied for only 
30 seconds (Rothman et al. 2010).  In that study, the loads applied to the nerve root were 
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above the threshold previously identified for inducing sustained allodynia (Hubbard et al. 
2008a). The magnitude threshold for producing changes in behavioral sensitivity at this 
shorter duration of compression (30 seconds) was hypothesized to be higher than that 
needed for a longer duration of compression (Rothman et al. 2010). The amount of strain 
applied to the nerve root in compression also modulates allodynia. Both 19% and 42% of 
strain to the L5 nerve root of rats elicits increased sensitivity in the hind paw, with more 
sensitivity for higher tissue strains (Winkelstein et al. 2002). Identifying the mechanical 
basis by which transient and chronic nerve root injuries are produced is an important step 
in understanding the mechanisms by which clinical symptoms vary with respect to the 
magnitude and duration of a nerve root compression. 
In order to study pain responses and relationships to tissue loading, a rat model of 
transient C7 nerve root compression was developed (Hubbard & Winkelstein 2005, 
Hubbard et al. 2008a) (Fig. 1.4). The dermatome associated with the C7 nerve root in the 
rat includes the forepaw and studies establish that transient compressions to this root 
elicit persistent forepaw sensitivity (Hubbard & Winkelstein 2005, Takahashi & 
Nakajima 1996).  Increased sensitivity in that model of cervical radiculopathy develops 
within one day of the injury and can persist for nearly four weeks (Rothman et al. 2007). 
Due to the different rates of development and aging between rats and humans, that study 
suggests that a transient nerve root compression could produce pain for at least 14 months 
in humans (Andreollo et al. 2012, Rothman et al. 2007). That same model of a transient 
cervical nerve root compression also shows that the development of behavioral sensitivity 
is modulated by both the magnitude and duration of compression (Hubbard et al. 2008a, 
Rothman et al. 2010).  
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Painful transient nerve root compression produces an early inflammatory response 
in the nerve root tissues, spinal inflammation, and axonal damage in the compressed root 
(Hubbard & Winkelstein 2005, Hubbard & Winkelstein 2008, Hubbard et al. 2008a,b, 
Rothman et al. 2009a,b, Rothman et al. 2010). In the context of that model, a transient 
injury to the nerve root is one that is not sustained, but can last for up to 15 minutes. 
Although this duration can be longer than those associated with most traumatic events, it 
is considerably shorter than a sustained compression that can last for one day to several 
weeks (Colburn et al. 1999, Hashizume et al. 2000, Kobayashi et al. 2004).  Within one 
hour of a compression of the C7 nerve root that is sufficient to produce persistent 
behavioral sensitivity, mRNA levels of the inflammatory cytokines, IL-6 and TNF-α, are 
elevated in the ipsilateral DRG spinal cord (Rothman et al. 2009b). This almost 
immediate increase in pro-inflammatory cytokine mRNA levels provides evidence that 
the early response of afferents to a transient compression may play a role in establishing 
the persistent pain that develops following nerve root trauma.  
As early as one day after that same painful nerve root injury, hallmarks of spinal 
inflammation, including activation and proliferation of microglia, also develop (Rothman 
et al. 2009a). Further, by seven days after a transient painful injury, the axons of the 
injured nerve root show signs of degeneration and the spinal inflammation becomes even 
more pronounced, with both activated astrocytes and microglia (Hubbard & Winkelstein 
2005, Hubbard & Winkelstein 2008). Together with a decrease in neuropeptide 
expression in the spinal cord at this same time point (Hubbard et al. 2008a), the 
pathology of the nerve root axons suggests that neuronal signaling through the nerve root 
to the spinal cord may be altered following a painful injury. Although these prior studies 
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collectively demonstrate that transient cervical nerve root compression produces a host of 
nociceptive responses, they do not address how the neural tissue responds during the 
applied compression or whether the neuropathologies that develop in the root are 
associated with dysfunctional signaling in the central nervous system. 
 
  
1.2.5 Nociception in the Nerve Root & Spinal Cord 
 Axons in the nerve root are categorized with respect to their degree of myelination 
and physiologic properties (Basbaum et al. 2009, Wall & Melzack 1994). Myelinated, A 
fibers include the Aβ fibers that respond to nonnoxious mechanical stimulation, and the 
Aδ nociceptors that transmit acute, “fast” pain (Basbaum et al. 2009, Todd 2010). The 
smaller, unmyelinated, C fibers transmit diffuse, “slow” pain (Basbaum et al. 2009, Todd 
2010). The C fibers are further classified into two subpopulations according to their 
biochemical properties: (1) peptidergic and (2) non-peptidergic fibers. Peptidergic fibers 
release neuropeptides, such as substance P, while non-peptidergic fibers express the c-Ret 
neurotrophic receptor and bind isolectin-IB4 (Basbaum et al. 2009).  Dorsal nerve root 
crush can produce degeneration of both myelinated and unmyelinated axons in the nerve 
root (Di Maio et al. 2011, Ramer et al. 2000). Treatments that selectively restore only the 
population of myelinated nerve root fibers after the crush injury do not restore sensation 
by day 20 (Ramer et al. 2000). Only when treated with the neurotrophic factor, glial cell 
line-derived neurotrophic factor (GDNF), that promotes neuronal survival, do both fiber 
populations regenerate and does sensation return to the forepaw (Ramer et al. 2000), 
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suggesting that normal function and sensation requires preservation of both myelinated 
and unmyelinated fibers. 
Mechanical trauma to neural tissue, including the nerve root, damages the 
cytoskeleton of the neurons and impairs action potential conduction through them (Chen 
et al. 1992, Jancalek & Dubovy 2007, LaPlaca & Prado 2010, Serbest et al. 2007). 
Neurofilaments are one of the major components of the neuron cytoskeleton; they give 
axons their mechanical strength and stability and are involved in axonal transport 
(Serbest et al. 2007). Blunt force trauma to, or stretching of, neurons disrupts their 
neurofilament structure, resulting in a loss of axonal transport and an accumulation of 
neurofilament proteins within the axon (Chen et al. 1992, Serbest et al. 2007). 
Mechanical trauma to axons also damages the plasma membranes and myelin sheath, 
preventing the propagation of action potentials, which is required for neuronal signaling 
(Chen et al. 1992, Mosconi & Kruger 1996, Serbest et al. 2007, Staal & Vickers 2011). 
For the axons in the nerve root, the magnitude of an applied compression has been shown 
to determine whether Wallerian degeneration develops and axonal transport is reduced; 
each of these pathologies are only evident if the magnitude of compression is sufficiently 
large (Hubbard & Winkelstein 2008, Kobayashi et al. 2005). Furthermore, the magnitude 
threshold for reducing the expression of neurofilament proteins in the nerve root is 
similar to the magnitude threshold for eliciting persistent mechanical allodynia in the rat 
after a nerve root compression (Hubbard & Winkelstein 2008, Hubbard et al. 2008a). 
This close relationship between axonal pathology in the root and behavioral sensitivity 
strongly suggests that morphological changes in the nerve root may be an indicator, if not 
a contributor, to nerve root-mediated pain (Hubbard & Winkelstein 2008).  
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 In the dorsal horn of the spinal cord, sensory neurons are categorized by their 
response to different types of stimuli, which is dictated by the type(s) of primary afferents 
that synapse with them (Basbaum et al. 2009, Todd 2010, Urch & Dickenson 2003, 
Woolf & Fitzgerald 1983). In general, the nociceptive C fibers terminate in the 
superficial laminae (I-II) of the dorsal horn and the mechanoreceptors terminate in the 
deep laminae (III-V) (Fig. 1.5A) (Basbaum et al. 2009, Todd 2010). Second order 
neurons that selectively respond to innocuous stimuli are low-threshold 
mechanoreceptors (LTMs), while nociceptive specific (NS) neurons are only activated by 
noxious stimuli (Fig. 1.5B) (Hains et al. 2003, Saito et al. 2008). Wide dynamic range 
(WDR) neurons receive both nonnoxious and noxious stimuli and there is a positive 
correlation between the frequency of firing by these neurons and the strength of the input 
stimulus (Fig. 1.5B) (Hains et al. 2003, Urch & Dickenson 2003).   
 
Fig. 1.5 (A) The A and C fibers synapse in distinct regions of laminae I-V of the dorsal horn. (B) 
Characteristic responses of wide dynamic range (WDR) and nociceptive specific (NS) neurons, and low 
threshold mechanoreceptors (LTMs) in the spinal cord when mechanical stimuli of graded magnitudes 
(1-26g) are applied to the peripheral tissues. (parts of this figure are adapted from Todd 2010) 
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 Electrophysiological recordings in the spinal cord of rats demonstrate that 
mechanical deformation to neural tissues changes the frequency of evoked action 
potentials through the deformed region (Cata et al. 2006, Hains et al. 2003, Terashima et 
al. 2011, Urch & Dickenson 2003). Electrically-evoked compound action potentials, 
which sum the amplitude of action potentials from a group of neurons, decrease in 
amplitude in the nerve roots of the porcine cauda equina during an applied compression 
(Garfin et al. 1990, Pedowitz et al. 1992). Although those studies demonstrate that 
compression of the nerve root can reduce the number of action potentials transmitted by 
the axons within it, behavioral sensitivity was not evaluated in that context. Therefore, it 
is not clear whether there is a relationship between the radicular pain and neuronal 
dysfunction that develops while compression is applied to the nerve root (Garfin et al. 
1990, Pedowitz et al. 1992).  
 After pain is established in rodent models of injury to the peripheral nerve and 
spinal cord, dorsal horn neurons increase their frequency of firing in response to 
stimulation by peripheral stimuli (Hains et al. 2003, Hao et a. 1992, Liu et al. 2011, Shim 
et al. 2005). Although the firing rate of spontaneous neurons is known to increase after a 
painful sustained lumbar nerve root ligation (Terashima et al. 2011), it is not known 
whether the firing rate of spinal neurons also increases when evoked in the periphery by 
stimuli known to elicit withdrawal responses in rats after a painful nerve root 
compression (Hubbard & Winkelstein 2005, Rothman et al. 2010). An increase in the 
firing rate of spinal cord neurons is associated with an increase in the proportion of WDR 
neurons after a spinal cord hemisection or a constriction of the sciatic nerve (Hains et al. 
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2003, Keller et al. 2007). However, whether a nerve root compression similarly changes 
the phenotype distribution of spinal cord neurons is unknown. 
 
1.2.6 The Glutamatergic System in the Spinal Cord 
 Glutamate is the primary excitatory neurotransmitter in the CNS (Basbaum et al. 
2009, Danbolt 2001, Inquimbert et al. 2012). It is released by pre-synaptic neurons, 
which package the cytoplasmic glutamate of axon terminals in vesicular glutamate 
transporters (VGluts) (Featherstone 2009, Takamori et al. 2000). When the intracellular 
calcium concentration of the axon terminal increases in response to an action potential, 
the VGluts fuse with the plasma membrane allowing the contents (glutamate) to enter the 
synaptic cleft (Fig. 1.6). Action potentials are generated by voltage-gated sodium 
channels, which have an activation gate and an inactivation gate (Armstrong 2006). At 
rest, sodium channels are in their deactivated state, with the activation gate closed and the 
inactivation gate open. When the transmembrane potential depolarizes, the activated gate 
opens and there is a fast sodium current as sodium ions rapidly flow into the neuron, 
further depolarizing the transmembrane potential. The action potential ceases when the 
inactivation gate of the sodium channel closes. However, a small percentage of sodium 
channels fail to inactivate and remain activated (open), causing a persistent sodium 
current that outlasts the fast sodium current during the initial action potential event (Lee 
et al. 2000, Stafstrom 2007).  
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 Selective inhibition of the persistent sodium current reduces repetitive firing (action 
potentials) after a single stimulus, decreasing the amount of glutamate released at the pre-
synaptic terminal (Bellingham 2010, Lee et al. 2000, Wang et al. 2004). Although there 
are several sodium channel blockers that preferentially inhibit the persistent sodium 
current, including Phenytoin, Lamotrigine and Riluzole (Coderre et al. 2007, Stafstrom 
2007), Riluzole has been shown to be particularly effective for reducing glutamate 
concentrations in the CNS (Coderre et al. 2007, Lamanauskas 2008). In fact, spinal 
glutamate concentrations are reduced by more than 50% within 30 minutes of a systemic 
injection of Riluzole (Coderre et al. 2007). Although glutamate is required for normal 
afferent signaling, excess glutamate following traumatic brain and spinal cord injuries 
can induce excitotoxicity due to overstimulation of glutamate receptors (Basbaum et al. 
2009, Ren & Dubner 2008, Tao et al. 2005). Therefore, sodium channel blockers that 
Fig. 1.6 Synaptic glutamatergic signaling in the central nervous system. Glutamate is released by the 
terminal of the pre-synaptic axon and activates glutamate receptors (NMDA, mGluR) on the dendritic 
spine of the post-synaptic neuron. Glutamate transporters on neurons (EAAC1) and astrocytes  (GLT-1, 
GLAST) take up excess extracellular glutamate from the synaptic cleft. 
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have traditionally been used as anesthetics and anticonvulsants, are now being explored 
for their potential clinical use as a neuroprotective agent after neural tissue injuries. 
  Once released into the synaptic space, glutamate can either act on a glutamate 
receptor or be taken up by a glutamate transporter (Fig. 1.6). Under normal conditions the 
glutamate receptors are responsible for regulating neuronal excitability, but may also 
contribute to neuro-excitotoxicity when excessively stimulated by glutamate (Basbaum et 
al. 2009, Ren & Dubner 2008, Tao et al. 2005). The activation of glutamate receptors is 
regulated by glutamate transporters. However, findings from rodent models of 
neuropathy indicate that down-regulation of these transporters in the spinal cord may 
contribute to persistent behavioral sensitivity (Hu et al. 2010, Sung et al. 2003, Xin et al. 
2009). Three excitatory amino acid transporters (EAATs) have been identified in the 
human spinal cord (Queen et al. 2007): EAAT1 and EAAT2 are expressed on glial cells 
and their rodent homologues are GLT-1 and GLAST, respectively. EAAT3, with the 
rodent homologue EAAC1, is primarily found on neurons (Queen et al. 2007). After a 
painful nerve injury, each of these transporters is downregulated in the dorsal horn by day 
7 (Hu et al. 2010, Sung et al. 2003, Xin et al. 2009, Yang et al. 2009). It has been 
reported that both astrocytes and microglia are activated in the dorsal horn for painful 
nerve root compressions by day 7 (Hubbard & Winkelstein 2005, Rothman et al. 2010), 
suggesting that the glial-specific transporters (GLT-1, GLAST) may also be modulated 
by a painful nerve root compression as well. The spinal expression of these transporters, 
however, has not been evaluated in any model of radiculopathy to date. 
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CHAPTER 2 
 
Rationale, Context, Hypotheses & Aims 
 
 
2.1 Rationale & Context 
 Cervical radiculopathy is a common, painful condition involving injury to the 
cervical nerve root (Abbed & Coumans 2007, Hogg-Johnson et al. 2008). The 
development of behavioral sensitivity from a cervical nerve root compression has been 
shown to be determined by the compression mechanics, including both the magnitude 
and duration of the applied load (Hubbard et al. 2008a, Rothman et al. 2010). Clinically, 
cervical nerve roots are prone to both sustained and transient compressions associated 
with disc herniations and trauma induced rapid neck motions, respectively (Carette et al. 
2005, Thoomes et al. 2012, Wainner & Gill 2000). These different modes of loading can 
mediate the course of clinical symptoms that develops (Abbed & Coumans 2007). 
Symptoms associated with radiculopathy, including pain and weakness, may resolve 
within minutes, but most often persist for as long as five months (Krivickas & Wilbourn 
2000, Wainner & Gill 2000). Animal models of nerve root injury also demonstrate that 
the severity of symptoms and tissue injury are both mediated by the type of insult 
(Colburn et al. 1999, Hubbard et al. 2008a, Kobayashi et a. 2005a); yet, the relationship 
between the duration of a nerve root compression and the subsequent development of 
pain as well as the underlying pathophysiology still remains unclear. 
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Studies demonstrate that nerve root compressions that occur for longer durations 
lead to the development of more pronounced deficits in conduction of afferent signals 
across the nerve root of the cauda equina in the pig (Pedowitz et al. 1992, Rydevik et al. 
1991). It is unclear, however, whether impaired signaling during compression is an 
indicator for the development of subsequent behavioral sensitivity or of other neuronal 
pathophysiologies that develop after a nerve root injury, including axonal degeneration in 
the root and enlargement of axon terminals in the dorsal horn of the spinal cord (Hubbard 
& Winkelstein 2008, Kobayashi et al. 2008). Furthermore, the signaling properties of 
afferents are undefined at time-points when behavioral sensitivity persists after a painful 
nerve root compression, despite evidence of spinal inflammation and altered 
neurotransmitter levels that would suggest disruption of the normal neurotransmission in 
the spinal cord after a nerve root compression (Kobayashi et al. 2005, Rothman & 
Winkelstein 2007).  
Enhanced excitatory signaling by the neurotransmitter, glutamate, is a hallmark of 
pain after neural tissue trauma (Laird & Bennett 1993, Nguyen et al. 2009, Shim et al. 
2005). In addition to its role as an excitatory neurotransmitter, glutamate can also modify 
the excitability of neurons by modulating the strength of excitatory synapses (Diamond 
2001, Jordain et al. 2007). Thus, regulation of extracellular glutamate is vital for normal 
neuronal function. Glutamate transporters regulate synaptic glutamate by removing 
glutamate from the extracellular space (Danbolt 2001, Kim et al. 2011, Rothstein et al. 
1996, Tao et al. 2005, Zhang et al. 2012) and an imbalance in these transporters is 
associated with neuronal hyperexcitability in the spinal cord of rats (Cata et al. 2006, 
Somers & Clemente 2002, Sung et al. 2003). In many animal models of neural tissue 
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trauma, including spinal cord and peripheral nerve injury, the normal expression of spinal 
glutamate transporters is downregulated in the presence of behavioral sensitivity (Sung et 
al. 2003, Wang et al. 2008b, Xin et al. 2009), suggesting that an imbalance in glutamate 
uptake by these transporters contributes to neuropathic pain. It is unclear, however, 
whether spinal glutamate transporter expression is mediated by a painful nerve root 
compression or whether the spinal glutamatergic system contributes to the development 
of nerve root-mediated pain.   
 
2.2 Overall Hypothesis & Specific Aims 
 The objective of this work is to use a rodent model of cervical radiculopathy to 
determine the role of the duration of a transient nerve root compression for producing 
sustained behavioral sensitivity and associated changes in spinal neuronal activity and 
glutamate transporter expression. The overall hypothesis is that there is a duration 
threshold, longer than which, compression of the nerve root disrupts the normal activity 
of its afferents that also is associated with the subsequent development of persistent pain 
and axonal degeneration within the nerve root. Further, painful nerve root compression is 
associated with an imbalance in the spinal glutamatergic system which contributes to 
hyperexcitability of the spinal neurons. This hypothesis is tested through the following 
specific hypotheses and specific aims: 
 
Hypothesis 1. Neuronal conductance across the C7 nerve root held under an applied 
compression continuously decreases until a critical duration is reached. When a nerve 
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root compression is held for a period beyond that critical duration, signaling across the 
axons of the nerve root remains depressed even after the applied compression is removed 
from the root. Furthermore, the axons of the nerve root will have a morphology that 
exhibits characteristics of injury as late as 7 days after the root compression and 
behavioral sensitivity will develop in the forepaw of the rat. Conversely, when an applied 
compression to the nerve root is removed before the critical duration is reached, neuronal 
signaling in the root will return to pre-compression levels soon after the nerve root is 
relieved of compression and there will be no evidence of axonal damage or behavioral 
sensitivity 7 days after the applied compression. 
 
Aim 1: Measure evoked neuronal activity in the spinal cord during an applied 
compression to the nerve root and evaluate the extent of axonal degeneration induced in 
the nerve root and the temporal behavioral sensitivity response.  
1a. Record evoked neuronal responses in the superficial dorsal horn of the spinal cord 
using electrical stimulation of the forepaw during compression of the C7 dorsal 
nerve root. Quantify the number of evoked action potentials as a function of the 
compression duration to define a duration that significantly decreases evoked 
activity relative to baseline in the context of behavioral sensitivity. 
1b. Validate the nerve root compression duration identified in Aim 1a for producing 
painful and nonpainful responses, by measuring mechanical allodynia and thermal 
hyperalgesia in the affected forepaws for up to 7 days following injury.  
1c. Quantify and compare the degree of axonal degeneration in the nerve root that 
develops at day 7 following nerve root compressions for both the painful and 
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nonpainful groups, separately, using immunohistochemistry and fluorescence 
microscopy. Myelinated fibers will be identified using NF200, and peptidergic 
and non-peptidergic unmyelinated fibers will be identified using CGRP and IB4, 
respectively. 
 
Hypothesis 2. Neuronal hyperexcitability due to insufficient glutamate uptake underlies 
the persistent behavioral sensitivity that develops after a transient nerve root injury. 
 
Aim 2. Define and compare the response of spinal glutamate transporters and evoked 
neuronal activity in the spinal cord induced by a painful and a nonpainful nerve root 
compression, separately. 
2a. Quantify and compare the glial and neuronal expression of glutamate transporters 
(GLT1, GLAST, EAAC1) in the dorsal horn following painful and nonpainful 
root compressions, using immunofluorescence at days 1 and 7. 
2b. Record and compare the neuronal activity in the superficial spinal cord that is 
evoked by mechanical stimulation to the forepaw at day 7, following painful and 
nonpainful nerve root compressions, separately. 
 
Hypothesis 3. Regulating glutamate signaling after a painful nerve root compression will 
alleviate behavioral sensitivity as well as the spinal neuronal hyperexcitability that 
develops. In addition, inhibiting sodium channel-dependent glutamate release will 
prevent the development of injury in the nerve root axons. 
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Aim 3. Pharmacologically block spinal glutamate release and promote spinal glutamate 
clearance, separately, to evaluate the role of glutamatergic signaling in persistent 
behavioral sensitivity and neuronal hyperexcitability following a painful nerve root 
compression. 
3a. Deliver ceftriaxone via daily intrathecal injection following a painful nerve root 
compression; evaluate forepaw sensitivity for up to 7 days and quantify spinal 
GLT-1 expression at day 7 using immunofluorescence.  
3b. Deliver Riluzole via an intraperotoneal injection following a painful nerve root 
compression; evaluate forepaw sensitivity for up to 7 days and quantify axonal 
degeneration in the nerve root at day 7 using immunofluorescence. 
3c. Measure the mechanically-evoked neuronal activity in the superficial spinal cord 
at day 7 after painful nerve root compressions treated with ceftriaxone and 
Riluzole, in separate studies. 
  
 In completing these aims, spinal electrophysiological recordings were made in vivo 
using a model of a painful nerve root compression developed in our lab (Hubbard & 
Winkelstein 2005). By measuring the number of action potentials in the spinal cord that 
were evoked by a peripheral, electrical stimulus, a critical duration of applied 
compression (6.6±3.0 minutes) to inhibit neuronal signaling across the root was identified 
in Aim 1a. Using that duration threshold, studies in Aims 1a, 1c and 2b compared 
neuronal properties immediately after the applied compression and at day 7 between 
nerve root compression durations that were above (15 minutes) and below (3 minutes) 
that critical duration. Specifically, after removing the applied compression, afferent 
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conductance across the root was measured for 10 minutes and, in separate studies, the 
subsequent development of axon pathology in the root (Aim 1c) and hyperexcitability of 
dorsal horn neurons (Aim 2b) were evaluated at day 7. To contextualize that duration 
threshold in terms of the development of pain, behavioral sensitivity was evaluated for 7 
days in Aim 1b following compressions above and below (3, 10, 15 minutes) the 6.6 
minute threshold. Together, these studies establish the conditions used throughout the rest 
of the thesis that identify the role of spinal excitatory signaling in the initiation or 
persistence of pain resulting from mechanical nerve root trauma. 
 An imbalance in the glutamatergic system is associated with the development of 
behavioral sensitivity in rodent models of peripheral inflammation, sciatic nerve ligation 
and spinal cord contusion (Inquimbert et al. 2012, Kim et al. 2008, Liaw et al. 2008). 
Studies in Aim 2a investigated the temporal expression of glutamate transporters in the 
spinal cord, which regulate extracellular glutamate. The glial glutamate transporter, GLT-
1, is thought take up as much as 80% of the glutamate in the central nervous system 
(Danbolt 2001). Therefore, studies in Aims 3a and 3c evaluated neuronal excitability of 
dorsal horn neurons and behavioral sensitivity after pharmacologically upregulating 
GLT-1 with ceftriaxone following a painful nerve root compression. To also evaluate the 
role of pre-synaptic glutamate signaling in nerve root-mediated pain, studies in Aims 3b 
and 3c pharmacologically inhibited pre-synaptic glutamate with Riluzole; axonal 
degeneration in the root and neuronal excitability in the spinal cord were assessed using 
the methods established in Aims 1c and 2b. 
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CHAPTER 3 
 
Defining a Duration Threshold to Modulate 
Evoked Neuronal Firing Rates in the Spinal Cord 
& the Development of Axonal Pathology 
 
 
This chapter has been adapted from a published manuscript: 
 
Nicholson KJ, Quindlen JC, Winkelstein BA. “Development of a Duration Threshold for 
Modulating Evoked Neuronal Responses After Nerve Root Compression Injury.” Stapp 
Car Crash Journal, 55:1-24, 2011. 
 
 
3.1 Overview 
 Cervical radiculopathy is a painful neurologic condition that is often attributed to 
an impingement of the cervical nerve root (Carette et al. 2005, Wainner & Gill 2000). 
Pain that radiates down the shoulder and arm can persist even if there is no evidence of 
sustained compression to the root (Krivickas & Wilbourn 2000, Kuijper et al. 2011). In 
the rat, a transient compression to the cervical nerve root produces persistent behavioral 
sensitivity in the forepaw (Hubbard et al. 2008a, Rothman & Winkelstein 2007). The 
development of behavioral sensitivity has been shown to be mediated by the duration of 
the compression (Rothman et al. 2010). Specifically, when the magnitude of an applied 
load to the nerve root is held constant, pain only develops if the compression is applied 
for a sufficiently long duration (Rothman et al. 2010); however, the duration threshold for 
eliciting behavioral sensitivity has not been defined. Like behavioral sensitivity, the 
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compression duration also mediates the development of pathophysiological responses in 
the tissues of the nerve root that develop during the applied compression (Rydevik et al. 
1991, Pedowitz et al. 1992). For example, when the cauda equina is held under 
compression, afferent conduction, blood flow and nutrient flow all continuously decrease 
in the compressed roots with increasing time of compression (Garfin et al. 1990, 
Olmarker et al. 1989b, Rydevik et al. 1991, Pedowitz et al. 1992). Despite the critical role 
that afferents have in transmitting nociceptive signals, no study has established whether 
transmission through the afferents of the root is impaired by a painful nerve root 
compression or whether impaired signaling through the root during the compression 
period is associated with the subsequent pathology of the nerve root axons that only 
develops after a painful nerve root compression (Hubbard & Winkelstein 2008). 
 Work presented in this chapter focuses on the studies outlined in Aims 1a and 1c. 
These studies define the functional and morphological response of the afferents in the C7 
nerve root both during and after a transient nerve root compression. The frequency of 
electrically-evoked afferent firing through the C7 nerve root of the rat was quantified 
during a compression known to elicit persistent behavioral sensitivity (Section 3.3). In 
that study, a duration threshold of 6.6±3.0 minutes was defined as the critical duration for 
inhibiting axonal conduction through the root. Using that threshold, recovery of afferent 
signaling through the C7 nerve root was compared between separate groups of rats that 
underwent a C7 nerve root compression for longer (15 minutes) or shorter (3 minutes) 
times than the critical duration by measuring the frequency of afferent discharge rates for 
the first 10 minutes after compression was removed. In a second study (Section 3.4), the 
development of axonal pathology in the root at day 7 after compression was compared 
  37 
between groups of rats that underwent the same 3 or 15 minute root compressions as in 
the first study.  
The studies presented here establish the role of compression duration in mediating 
both electrophysiologic and morphological responses of the axons in the nerve root in a 
painful model of nerve root trauma. In order to contextualize these neuron-specific 
outcomes to the development of persistent behavioral sensitivity, the studies in Chapter 4 
quantify mechanical allodynia and thermal hyperalgesia in groups of rats that underwent a 
nerve root compression below or above the critical duration of 6.6±3.0 minutes identified 
in this study. Studies presented in Chapter 5 complement the current studies by measuring 
the frequency of evoked action potentials in the spinal cord at day 7 in order to 
characterize neuronal signaling at a time-point when behavioral sensitivity is maintained. 
 
3.2 Relevant Background 
Although neck pain can originate from a variety of spinal tissues, the cervical 
nerve roots are vulnerable to injury from foraminal impingement, disc herniation, direct 
spinal trauma, and/or foraminal stenosis (Cornefjord et al. 1997, Krivickas & Wilbourn 
2000, Nuckley et al. 2002, Olmarker et al. 1989a, Panjabi et al. 2006, Wainner & Gill 
2000). The effect of compression duration is of particular relevance to nerve root injury 
because the nerve root can be susceptible to both sustained and transient mechanical 
loading (Abbed & Coumans 2007, Panjabi et al. 2006, Svensson et al. 1993). Sustained 
nerve root loading occurs from a disc herniation and spondylosis (Abbed & Coumans 
2007, Wainner & Gill 2000), while transient loading to the root can result from sports 
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and automotive traumas (Krivickas & Wilbourn 2000, Panjabi et al. 2006, Stuber 2005, 
Tominaga et al. 2006).  
The clinical course of symptoms and rate of recovery have been reported to differ 
from different modes of loading to the nerve root (Abbed & Coumans 2007). Pain and 
weakness associated with a transient insult to the nerve root exhibit varied responses 
which can resolve within minutes or persist for as long as five months (Krivickas & 
Wilbourn 2000, Wainner & Gill 2000).  Although nerve root injuries may result from a 
variety of loading scenarios and the severity of the symptoms may differ considerably, 
the relationships between the duration of the nerve root compression, pathophysiology 
and symptoms are poorly defined.   
Compression to the nerve root produces immediate changes in the evoked signal 
conduction along the fibers of the compressed root, both clinically and in animal models 
(Fumihiko et al. 1996, Morishita et al. 2006, Pedowitz et al. 1992, Rydevik et al. 1991, 
Takahashi et al. 2003, Takamori et al. 2010). Intraoperative studies in patients with 
symptomatic lumbar radiculopathy from root impingement associated with disc 
herniation and spinal stenosis demonstrate decreases in the amplitude of compound 
muscle action potentials that are evoked by an electrical stimulation to the affected nerve 
root (Morishita et al. 2006, Takamori et al. 2010). Furthermore, the severity of the 
amplitude decrease is mediated by the magnitude of the pressure in the intervertebral 
foramen (Morishita et al. 2006). This finding suggests that neuronal signaling across the 
root may be mediated by the local mechanical loading profile of the root. In support of 
this hypothesis, Takamori et al. (2010) demonstrated that the duration of the root 
compression also mediates the response of electrically-evoked neuronal activity. In that 
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study, pre-operative patients were placed in a prone position with their leg slowly raised 
until the onset of pain and/or numbness. When that position was reproduced during 
surgery, the amplitude of the action potentials evoked at the S1 root and measured in the 
gastrocnemius muscle decreased by 41% as early as within one minute, and by 63% after 
three minutes of impingement (Takamori et al. 2010). This change in evoked action 
potentials that continued to develop throughout the period of nerve root impingement 
demonstrates that there is a time-dependent response of the nerve root’s 
electrophysiologic properties to deformation and suggests that changes in neuronal 
signaling through the root during compression may contribute to radiculopathy 
symptoms. Further, it is likely that specific loading parameters, such as magnitude and 
duration, may play a role in modulating these electrophysiologic responses. Finally, 
although clinical electrophysiologic studies, such as nerve conduction tests and needle 
electromyography, are sensitive and specific diagnostic tools for nerve root compression 
(Abbed & Coumans 2007, Wainner & Gill 2000), a clear understanding of the functional 
changes that neurons undergo during compressions and that result in pain is still limited, 
which also impairs injury prevention efforts. 
Many animal models of evoked neuronal signaling through the nerve roots in the 
cauda equina demonstrate that this signaling is modulated during and after compression 
(Fumihiko et al. 1996, Garfin et al. 1990, Rydevik et al. 1991, Pedowitz et al. 1992). In 
studies compressing the cauda equina of pigs, both 75mmHg and 100mmHg of pressure 
applied for 120 minutes each decreased the amplitude of electrically-evoked compound 
nerve action potentials by 41% and 74%, respectively (Rydevik et al. 1991). After 
compression was removed from the cauda equina, the amplitude of the action potentials 
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returned to pre-compression levels in the pigs that received 75mmHg of compression, but 
not in those receiving 100mmHg of compression (Rydevik et al. 1991). When 100mmHg 
of compression was applied to the cauda equina for 240 minutes, the decrease in action 
potential amplitude during compression was even greater and remained more-pronounced 
even after compression was removed relative to the shorter (120 minute) compression 
period (Pedowitz et al. 1992). Although these electrophysiological studies suggest that 
neuronal function is related to nerve root loading and that it is mediated by the 
compression duration, the outcomes in those studies reflect the collective response of all 
of the nerve roots in the cauda equina and do not recapitulate the mechanical scenario 
applied to an individual nerve root. Further, those studies only investigated the acute 
responses and did not define the relationship between the onset, or extent, of longer-
lasting damage in the nerve root. 
The immediate changes in the electrophysiological properties of compressed 
axons in the nerve root may likely be related to the longer-term pathophysiology that 
develops in the nerve root, such as edema, inflammation, and thickening of the 
intraradicular connective tissue (Beck et al. 2010, Jancalek & Dubovy 2007, Kobayashi 
et al. 2004, Mosconi & Kruger 1996). Neuronal dysfunction, in particular, may be more 
indicative of developing pain symptoms due to its central role in pain transmission. 
Injured axons following mechanical trauma and compression exhibit axonal swelling, 
loss of cytoskeleton proteins, separation and disorganization of the myelin sheath, loss of 
axonal transport, Wallerian degeneration, and a decrease in axon packing density 
(Guertin et al. 2005, Jancalek & Dubovy 2007, Kobayashi et al. 2004, Kobayashi et al. 
2005a, Mosconi & Kruger 1996, Myers et al. 2003, Serbest et al. 2007). Like the 
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functional changes in neurons during compression, the degenerative changes in axons 
that develop at later times after a transient compression are also mediated by compression 
magnitude (Hubbard & Winkelstein 2008, Kobayashi et al. 2005a), suggesting that there 
may be an association between the neuronal responses during nerve root compression and 
those neuronal responses that develop after compression. Yet, no study has established 
whether these acute neuronal outcomes are related to the persistent neuronal injury and/or 
dysfunction that develop. 
Mechanical loading to the nerve root initiates a cascade of neuronal, 
inflammatory, and degenerative responses by producing an acute insult to the axonal, 
connective, and vascular tissues of the nerve root (Kobayashi et al. 2004, Rydevik et al. 
1984, Winkelstein et al. 2002). For example, severe axonal injury can induce 
degeneration of the axonal process distal to the cell body via Wallerian degeneration 
(Park et al. 2004, Stoll & Müller 1999). For the central axons of primary afferents, which 
make up the dorsal nerve root, this degeneration can occur proximal to the site of injury, 
nearer to the spinal cord (Hubbard & Winkelstein 2008, Kobayashi et al. 2008). Axonal 
degeneration, marked by neurofilament degradation and loss of axonal integrity, is 
evident as early as 15 minutes after spinal cord injury, but may also be present as late as 
three weeks after injury to the peripheral nerves (Kobayashi et al. 2008, Park et al. 2004, 
Ramer et al. 2000, Schumacher et al. 1999). The degree of degeneration is modulated by 
the local tissue mechanics and is also associated with persistent pain after a transient 
compression to the cervical nerve root (Dyck et al. 1990, Kobayashi et al. 2005a, 
Hubbard & Winkelstein 2008). Disruption to the axonal structure at both early and late 
time points has been found to be more pronounced for greater loads and for longer 
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durations of applied loads (Dyck et al. 1990, Hubbard & Winkelstein 2008, Kobayashi et 
al. 2005a, Kobayashi et al. 2008). Previous studies also have demonstrated that the 
presence of axonal degeneration of the myelinated axons in the nerve root is associated 
with sustained behavioral sensitivity after compression, making axonal integrity an 
important tissue-injury marker for nerve-root mediated pain and suggesting that neuronal 
dysfunction and pathology may be related to pain (Hubbard & Winkelstein 2008, 
Hubbard et al. 2008a). Despite the fact that both myelinated and unmyelinated axons are 
important for normal sensation and also for detecting the location and intensity of a 
noxious stimulus (Ramer et al. 2000, Wall & Melzack 1994), no study has evaluated the 
response of unmyelinated nerve root fibers to a transient nerve root compression. 
Furthermore, although there is an association between degeneration of the axons and the 
magnitude of the load that is applied to the root (Hubbard & Winkelstein 2008), it is not 
known how compression duration affects axonal injury or whether axonal degeneration is 
associated with the duration-mediated neuronal responses initiated during compression. 
Defining the role of compression duration in altering the morphology of unmyelinated 
and myelinated axons in the nerve root at a time-point relevant to pain provides added 
insight into how neuronal dysfunction and/or injury following mechanical root loading 
relates to symptoms of radiculopathy. 
The studies in this chapter test the hypothesis that when nerve roots undergo 
compression, there is an associated change in the number of electrically-evoked action 
potentials through the compressed nerve root. It is further hypothesized that there is a 
period of compression longer than which that applied compression can produce 
prolonged changes in the function of the affected axons; those modifications can manifest 
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as sustained changes in the electrophysiologic properties and structural breakdown of the 
axons after the initial insult. As such, the goal of the studies in this chapter was to 
identify if there is a critical duration of applied compression to the nerve root that alters 
the electrically-evoked discharge rate of the neurons from that root during and after 
compression, and also to evaluate if that neuronal activity relates to the sustained changes 
in function and the extent of neuronal damage in the root that develop after such 
compression. 
 
3.3 Afferent Discharge Rates During & After Root Compression 
3.3.1 Methods 
All procedures were approved by the Institutional Animal Care and Use 
Committee at the University of Pennsylvania. Rats were housed under USDA- and 
AAALAC-compliant conditions with a 12-12 hour light-dark cycle and free access to 
food and water. Studies were performed using only male Holtzman rats (Harlan Sprague-
Dawley; Indianapolis, IN), weighing 300-480g at the start of the study. 
In order to evaluate the electrophysiologic response of the afferents in the 
compressed nerve root, extracellular recordings were made in the superficial laminae of 
the dorsal horn during and after compression was applied to the C7 nerve root for 15 
minutes, a period previously determined to produce immediate and sustained pain 
(Hubbard et al. 2008a). Spinal extracellular recordings were made while afferents were 
evoked using an electrical stimulus applied to the area of the forepaw that corresponds to 
the dermatome innervated by the C7 root (Fig. 3.1). Neuronal activity was quantified by 
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measuring the number of electrically-evoked action potentials (spikes) during the painful 
compression in order to define the time at which the conduction of peripherally-evoked 
spikes is significantly reduced (Fig. 3.2). Based on that critical compression duration, a 
separate electrophysiological study was also performed in which the nerve root 
compression was applied for a period of time that was shorter than that identified 
compression duration. The goal of that study was to define the neuronal activation 
patterns for a subcritical duration of compression and to compare the prolonged, post-
compression response in those patterns to the response for the longer duration, painful 
compression (Fig. 3.2). 
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Fig. 3.1 Schematic showing experimental test set-up for recording peripherally-evoked spikes in the 
superficial dorsal horn of the spinal cord. An electrical stimulus (16-train pulse) is applied to the 
forepaw at 1-minute intervals using a pair of stainless steel electrodes to stimulate neurons in the 
forepaw. Extracellular (EC) recordings of the evoked action potentials are made in the superficial dorsal 
horn by initially inserting the tungsten recording probe at a depth of 150µm below the pial surface and 
searching through the depth of 350µm. The number of action potentials evoked by each stimulus train is 
quantified during and after a transient compression to the C7 nerve root. 
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Anesthesia was induced via intraperitoneal injection of sodium pentobarbital 
(50mg/kg). To maintain proper levels of anesthesia, supplementary doses of sodium 
pentobarbital were given as needed throughout the procedures. With the rat placed in a 
prone position, a dorsal incision was made along the back of the neck at the midline from 
the base of the skull to the spinous process of T2. The C5-T1 vertebrae were exposed by 
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removing the paraspinal muscle and soft tissue. The cervical spinal cord from C6-C8 and 
the C7 nerve root on the right side were exposed using a bilateral dorsal laminectomy and 
partial facetectomy. The overlying dura was also removed and warm mineral oil (Fisher 
Scientific; Pittsburgh, PA) was used to cover the exposed spinal cord to prevent the cord 
from dehydrating. Following the surgical exposure, the rat was immobilized on a 
stereotaxic frame (Kopf Instruments; Tujunga, CA) using bilateral ear bars and a 
vertebral clamp at the T2 vertebra (Fig. 3.3). The core temperature of the rat was 
maintained between 36–37° during all procedures using a heating plate with a 
temperature controller and isolated rectal probe (Physitemp Instruments, Inc.; Clifton, 
NJ). 
 
For each rat, extracellular voltage potentials were continuously recorded using a 
127µm diameter tungsten electrode (A-M Systems; Sequim, WA) that was inserted into 
the superficial dorsal horn medial to where the C7 right dorsal root enters the spinal cord 
(Figures 3.1 & 3.3). The recording probe was inserted to depths of between 150–350µm 
recording 
probe
T2 clamp 
ear bar 
stimulus probe 
inserted in 
forepaw 
Fig. 3.3 Surgical exposure and experimental test set-up for recording extracellular potentials in the 
dorsal horn while applying an electrical stimulus to the forepaw. 
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below the pial surface in order to measure extracellular potentials in the superficial dorsal 
horn, where the primary afferent neurons of the dorsal root synapse with the spinal 
neurons (Wall & Melzack 1994). The extracellular signal from the recording electrode 
was amplified with a gain of 1000 (World Precision Instruments; Sarasota, FL), 
processed with a 60Hz noise eliminator (Quest Scientific; North Vancouver, BC), and 
then digitized and stored at 25kHz (CED; Cambridge, UK), using methods previously 
reported (Pezet et al. 2008, Quinn et al. 2010). 
To identify the afferent neurons that are associated with the C7 dermatome, 
sensory fields in the right forepaw were located at the start of each study using a light 
brush stroke applied to the plantar surface of the forepaw with a cotton swab followed by 
a series of 10 stimuli using a noxious (10gf) von Frey filament (Hubbard & Winkelstein 
2005) (Fig. 3.4). A load cell (5N capacity; SMT S-Type Model; Interface, Inc., 
Scottsdale, AZ) was attached to the von Frey filament and used to synchronize the 
application of the mechanical stimulus with the extracellular recordings that were made 
in the spinal cord (Fig. 3.4). Each von Frey stimulus was applied for one second at a time. 
A stainless steel electrode (A-M Systems; Sequim, WA) was then inserted into the 
forepaw in the location of the sensory field and a train of 16, 2msec-wide pulses was 
delivered at 0.5Hz with an amplitude of 1V at 1-minute intervals (Lapirot et al. 2009, 
Pezet et al. 2008, Yu et al. 2009) (Figs. 3.1 & 3.2). A ground electrode (A-M Systems; 
Sequim, WA) similar to the stimulus probe was also inserted into the forepaw, near the 
stimulus electrode (Figs. 3.1 & 3.3). The electrical stimulation protocol was repeated 
throughout the duration of each experiment (Fig. 3.2). The stimulus strength of 1V was 
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selected such that the stimulus itself did not produce any muscle contractions or twitches, 
but was sufficiently strong to evoke afferent action potentials. 
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Fig. 3.4 Flow chart illustrating the experimental procedures for identifying (shaded ovals) and selecting 
neurons (white boxes) for inclusion in the electrophysiologic studies. The number of neurons that was 
selected at each procedure in the 15 minute compression and sham groups is also shown. 
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Electrically-evoked action potentials were recorded in the spinal cord before, 
during, and after the applied compression for all rats. The baseline response of each rat to 
the electrical stimulation of the right forepaw was first established by delivering the 
stimulation train once every minute for a period of 10 minutes, prior to any additional 
stimulation or manipulation (Fig. 3.2) (Fumihiko et al. 1996, DeLaTorre et al. 2009, 
Martindale et al. 2001, Rydevik et al. 1991). After the baseline period, compression was 
applied to the nerve root using a calibrated 10gf microvascular clip (World Precision 
Instruments; Sarasota, FL) to apply a compressive strain of 81.7±4.7% over an area of 
4.0mm2 (Hubbard et al. 2004), and the 16-pulse stimulation train was applied at 1-minute 
intervals during the compression period (Fig. 3.2). In the first series of rats (n=3 rats; 10 
neurons), nerve root compression was applied for 15 minutes. Each rat received only one, 
single compression to the right C7 nerve root. After that time, the clip was removed from 
the nerve root and the electrical stimulation to the right forepaw continued at 1-minute 
intervals for a post-compression period of 10 minutes (Fig. 3.2). To account for the 
effects of the surgical exposure and the repeated stimulations, a separate rat (4 neurons) 
underwent sham procedures that included the same experimental and stimulation 
protocols without application of nerve root compression. Regardless of the surgical 
procedure, at the end of the 10 minute post-compression recording period, the C7 nerve 
root was fully transected and an additional electrical stimulus train was delivered in order 
to determine whether the spikes that were evoked by the electrical stimulus and recorded 
previously during the protocol were associated with an axon in the C7 root (Fig. 3.2). 
Any neurons that were detected to continue to respond to forepaw stimulation after the 
root had been transected were removed from subsequent analysis and not included in this 
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study (Fig. 3.4). In this way, neurons not associated with the C7 root that was being 
compressed were not erroneously included in the action potential counts. 
All extracellular voltage recordings measured during the stimulation protocol 
were spike-sorted using Spike2 software (CED; Cambridge, UK) to separate the action 
potentials associated with individual neurons. In order to focus on the inputs of the 
sensory neurons in the forepaw, only those neurons that were identified to respond to the 
von Frey filament stimulus were analyzed in Spike2 (Figs. 3.4 & 3.5). On average, for 
every three mechanoreceptors that were identified during the von Frey filament stimuli, 
only one neuron would also be evoked by the electrical stimulus (Fig. 3.4). Thus, only 
that one neuron that was evoked by both the mechanical and electrical stimuli would be 
included in the analysis for that rat. For each sensory neuron included in the study, the 
baseline firing rate was determined by counting the number of spikes that occurred 
during one second prior to the first application of the von Frey filament (Quinn et al. 
2010) (Fig. 3.5). A sensory neuron was defined as any neuron whose firing rate increased 
over its baseline firing rate during at least one of the 10 1-second von Frey stimulations. 
Neurons that did not respond to any of the applied von Frey stimuli before the start of the 
electrical stimulation were removed from subsequent data analysis. Activity that was 
evoked by electrical stimulation of the forepaw was quantified at each 1-minute interval 
throughout the protocol. Specifically, this was done by summing the number of spikes for 
each neuron that were elicited within the 10-40msec window immediately after each of 
the 16 stimulation pulses in order to exclude stimulus artifact and spontaneous activity 
(DeLaTorre et al. 2009; Ramer et al. 2000; Yu et al. 2009) (Fig. 3.6). Specific details of 
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the protocol to determine the latency of action potentials after the electrical stimulus are 
described in Appendix A.  
 
In order to account for each neuron’s individual discharge rate, the number of 
spikes measured at each 1-minute interval of the compression and post-compression 
periods was each normalized against the average number of spikes that occurred during 
the last five stimulations of the baseline period (Fig. 3.2). The normalized number of 
spikes was then averaged across neurons in the compression group and also across 
neurons recorded in the sham group. The number of action potentials recorded at each 
time period was represented as the percentage change from baseline±SEM for that group.  
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Fig. 3.5 A representative extracellular (EC) recording during the application of a von Frey (vF) 
filament. The extracellular data are spike-sorted to identify neurons evoked by the mechanical stimulus 
to the forepaw. Neurons are determined to be evoked by the stimulus if the number of spike events 
during any application with the vF filament is greater than the number of spike events recorded during 
baseline (BL), corresponding to 1-second prior to the first stimulus. 
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For each of the neurons from which recordings were made in the 15 minute 
compression group, post hoc analysis was performed to determine the time during the 
compression at which the evoked neuronal activity was substantially modulated. This 
critical duration was defined as the average time during compression when changes in the 
evoked activity relative to baseline reached a maximum, using all of the neurons (10 
neurons total from 3 rats) that were recorded from during the 15 minute compressions. 
Differences in the number of evoked spikes between the compression and sham 
groups during the applied root compression were detected using a two-way, repeated 
measures analysis of variance (ANOVA) for injury group (sham, compression) and time 
(baseline through C15). All statistical analyses were performed using the raw data (i.e. 
the number of spikes). Action potentials counts for each neuron in the sham and 
compressions groups are provided in Appendix B. The percent change from baseline is 
reported in order to show trends in discharge rates that would otherwise be unclear due to 
the variation in baseline discharge rates between individual neurons. 
Based on the duration threshold identified for modulating evoked neuronal 
activity during the 15 minute compression, a second group of rats underwent a nerve root 
compression that was applied for a subthreshold period of three minutes (n=6 rats; 9 
neurons) (Fig. 3.2). The duration period of three minutes was selected because it is more 
than one standard deviation shorter than the threshold duration that was identified to 
modify peripherally-evoked action potentials in the spinal cord (see Section 3.3.2 for 
specific details). All other surgical and electrophysiological procedures were the same as 
described for the 15 minute compressions. Similarly, for the subthreshold compression 
studies, the evoked spikes were recorded during an initial 10 minute baseline period and 
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during the entire period of applied compression to the nerve root (i.e. three minutes) (Fig. 
3.2). Recordings were also made for 10 minutes after the compression was removed from 
the root, analogous to the protocol for the 15 minute compression studies (Fig. 3.2). In 
order to account for changes in the extracellular recordings due to the surgical exposure 
and repeated electrical stimulus, one additional rat (3 neurons) also underwent sham 
procedures with the electrical stimulus protocol matching that used for the 3 minute 
compression group. 
Comparisons during the first three minutes of compression between the 15 minute 
compression group and the 3 minute compression group were made using a two-way, 
repeated measures ANOVA for group (3 minutes, 15 minutes) and time (baseline through 
C3). The post-compression data for each of the two duration groups were separately 
compared using a two-way, repeated measures ANOVA for group (compression, sham) 
and time (baseline, P1-P10). In addition, to specifically evaluate the effect of 
compression duration on discharge rates at the end of the 10 minute recovery period 
(Pedowitz et al. 1992), a separate two-way, repeated measures ANOVA for group 
(compression, sham) and time (baseline, P10) was performed for each compression 
duration study. To make a more direct comparison between the pre-compression 
discharge rate (baseline), and the post-compression discharge rates, comparisons were 
also made between baseline and the average number of spikes measured over the last five 
minutes post-compression (P6-P10), using a two-way ANOVA for group (compression, 
sham) and time (baseline, average of P6-P10) for each duration group, separately. Post-
hoc, pairwise comparisons with Bonferroni correction tested for differences in the main 
effects, where applicable. Significance for all comparisons was defined at α=0.05. 
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3.3.2 Results 
A total of 10 neurons that responded to the von Frey and electrical stimuli were 
recorded at a mean depth of 221±63µm in the dorsal horn of the spinal cord in the studies 
with 15 minutes of applied compression. In the corresponding sham group, recordings 
were made from a total of 4 neurons at a depth of 150µm. Compression of the C7 nerve 
root significantly decreased the discharge rate over the entire compression and post-
compression period (C1-P10) compared to sham procedures (p=0.035, two-way 
interaction group X time). Similarly, during the compression period alone (C1-C15), 
there was also a significant decrease in the discharge rate during the C7 nerve root 
compression compared to sham (p=0.012, two-way interaction group X time; Fig. 3.7). 
As early as two minutes after the start of the applied compression, evoked spikes were 
reduced by 37±24% relative to baseline. The number of action potentials that was evoked 
by the electrical stimulus continued to decrease over time during the compression and 
was 76±13% lower than baseline at 7 minutes into the compression (Fig. 3.7A), while the 
discharge rate during sham procedures was only 9±9% less than baseline (Fig. 3.7A). 
After seven minutes of compression, neuronal discharge rates remained 50-80% lower 
than the comparable baseline activity for the remaining period of the compression and the 
entire post-compression period (Fig. 3.7A). On average, the maximum decrease in 
neuronal activity occurred at 6.6±3.0 minutes into the compression period. As such, this 
time was taken as the duration-threshold for modulating evoked neuronal activity during 
a 98mN compression to the nerve root. Moreover, for the subsequent electrophysiologic 
and immunohistochemistry studies, a subthreshold duration of 3 minutes of compression 
was applied because it was a time less than the average minus one standard deviation (i.e. 
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3.6 minutes); experimentally, it was not feasible to both apply a compression for 3.6 
minutes and to synchronize the electrical stimulation and measurement protocols across 
studies (Fig. 3.2). Appendix B summarizes the action potential count for each of the 
neurons that was recorded in the 15 minute compression study and the subsequent 3 
minute compression study, as well as each of the corresponding sham groups. 
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In the subthreshold compression study, recordings were made from nine neurons 
at a depth of 251±79µm in rats that received compression for 3 minutes (Fig. 3.7B). 
There was no significant difference in the depth of the neurons from which recordings 
were made in the 15 minute and 3 minute compression groups (p=0.370), as evaluated by 
a t-test. For the corresponding sham group for the 3 minute study, recordings were made 
from three neurons at a depth of 160µm. No significant differences were detected during 
the first three minutes of compression between the group that received 15 minutes of 
compression and the group that received 3 minutes of compression (p=0.373, group; 
p=0.543, group X time). Significance was only detected over time (p=0.032) for the two 
injury groups; there was a significant difference in the discharge rates measured during 
compression from baseline at C2 (p=0.005) and C3 (p=0.035). At two minutes into the 
compression, the discharge rate was reduced by 42±21% relative to baseline in the three 
minute group (Fig. 3.7B). This decrease in evoked action potentials at two minutes of 
compression in the subthreshold duration group was similar to that observed in the 15 
minute compression group (37±24%; Fig. 3.7A).  
The electrically-evoked discharge rate that was measured after the compression 
was removed from the nerve root exhibited differences based on the duration of the 
applied compression (Figures 3.6-3.8). Although there was a significant difference 
(p=0.001) between the post-compression discharge rates (average of baseline, P1-P10) 
after 15 minutes of compression compared to its sham, no significant differences were 
detected in post-compression discharge rates after 3 minutes of compression compared to 
its corresponding sham group. At the end of the post-compression period (P10), the 
number of evoked spikes in the 15 minute compression group remained lower than 
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baseline by 58±25% and was significantly different than sham and baseline (p=0.018, 
two-way interaction group X time) (Fig. 3.7A). Yet, in the 3 minute compression group 
evoked activity had returned to within 3±33% of baseline and was not significantly 
different from baseline or sham (p=0.088, two-way interaction group x time) (Fig. 3.7B). 
Similarly, 15 minutes of compression significantly reduced the average discharge rate 
measured during the last five minutes of the post-compression period (P6-P10) compared 
to baseline and sham (p=0.020, two-way interaction group X time), but not a 3 minute 
compression (p=0.125, two-way interaction group X time) (Fig. 3.8). On average, the 
number of spikes measured at P6-P10 after a 15 minute compression was 56±14% lower 
than baseline, while the number of spikes after a 3 minute compression was 22±12% 
lower than baseline during this 5-minute period (P6-P10) (Fig. 3.8). 
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Fig. 3.8 Average change from baseline during the last 5 minutes of the post-compression period (P6-
P10) after compression applied for 3 or 15 minutes, or the corresponding sham procedures. The number 
of spikes after 15 minutes of compression is significantly (p=0.020) less than sham and baseline.  
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3.4 Axonal Morphology in the Root After 3 or 15 Minute Compressions 
3.4.1 Methods 
Rats used in this study were included to evaluate if the duration threshold of 
6.6±3.0 minutes for inducing immediate changes in neuronal discharge patterns (Section 
3.3) relates to the development of axonal pathology in the root 7 days after a nerve root 
compression that is applied to the root for either 3 or 15 minutes. In order to evaluate the 
extent of axonal injury in the C7 nerve root 7 days after a nerve root compression, a 
morphological examination of the root was performed using immunohistochemistry to 
fluorescently label the axons of the nerve root. On post-injury day 7 the nerve roots were 
harvested from rats that received a compression applied for 3 minutes (subthreshold) 
(n=6 rats) or 15 minutes (n=4 rats). A sham group (n=5 rats) that underwent the same 
nerve root exposure without compression was also included to account for the effects of 
anesthesia, surgical exposure and any tissue manipulation.  
Surgical procedures were performed under anesthesia induced with inhalation 
isoflurane (4% for induction, 2% for maintenance). Previously described procedures for 
transiently compressing the nerve root with a calibrated microvascular clip were used to 
vary the duration of an applied compression, as described in Section 3.3 (Hubbard & 
Winkelstein 2005, Rothman et al. 2010).  With the rat in a prone position, a dorsal 
incision was made from the base of the skull to the spinous process of T2. The overlying 
muscle and soft tissue were removed to expose the C6 and C7 vertebrae. The right C7 
dorsal nerve root was exposed via a C6-C7 hemilaminectomy and facetectomy on the 
right side. A small incision was made in the dura over the C7 nerve root and the 10gf clip 
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was used to apply compression to the dorsal nerve root (Fig. 3.9). After surgery, the 
wound was closed using 3-0 polyester suture surgical staples. The rats were allowed to 
recover in room air with free access to food and water. 
 
At day 7 after the surgical procedure, rats were given an overdose of sodium 
pentobarbital (65mg/kg) via intraperitoneal injection and then transcardially perfused 
with 200ml of Dulbecco’s Phosphate-Buffered Saline (PBS; Mediatech, Inc.; Manassas, 
VA) followed by 300ml of 4% paraformaldehyde (Sigma; St. Louis, MO). The C7 
ipsilateral nerve root was exposed via a bilateral C6-C7 laminectomy and facetectomy 
and harvested en bloc with the adjacent spinal cord and dorsal root ganglion attached at 
the proximal and distal ends of the root, respectively (Fig. 3.1). Tissues were post-fixed 
in 4% paraformaldehyde overnight and then transferred to 30% sucrose at 4°C for five 
days and embedded in OCT medium (Sakura Finetek USA, Inc.; Torrance, CA) for 
cryosectioning. The nerve roots were sectioned (14µm) along the long-axis, near the 
Fig. 3.9 Image showing the surgical procedure to apply a 10gf clip to the C7 nerve root.  
spinal cord 
10g clip on C7 nerve 
rostralcaudal 
C5 lamina 
T1 lamina
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centerline of the root and then thaw-mounted directly onto slides. Matched nerve roots 
were also harvested from normal naïve rats (n=2) and were also included in tissue 
processing for comparison. 
Slides were immunofluorescently labeled for neurofilament-200 (NF200) and 
isolectin-B4 (IB4) to identify myelinated and unmyelinated fibers, respectively. Slides 
were blocked in 10% normal donkey serum (Millipore; Billerica, MA) with 0.3% Triton 
X-100 (Bio-Rad Laboratories; Hercules, CA) for two hours and incubated overnight at 
4°C in mouse anti-NF200 (1:500; Sigma; St. Louis, MO) and biotinylated IB4 (5µg/ml; 
Sigma; St. Louis, MO). Slides were then incubated for two hours at room temperature in 
donkey anti-mouse Alexa Fluor 546 (1:1000; Invitrogen; Carlsbad, CA) and streptavidin 
conjugated with dichlorotriazinyl amino fluorescein (DTAF) (1:500; Jackson 
ImmunoResearch Laboratories, Inc.; West Grove, PA). Three tissue sections from each 
rat were analyzed for axonal damage. Digital images were taken of the nerve root 
proximal to the site of compression at 200X magnification. Each axonal marker was 
evaluated, separately, for signs of axonal swelling and loss of immunoreactivity as 
indicators of axonal damage (Hubbard et al. 2008b, Serbest et al. 2007, Singh et al. 
2006). Tissue sections that displayed any signs of these abnormalities were assigned a 
positive score (+) and those sections that were not different from the normal 
uncompressed roots were assigned a score indicating the absence (–) of any changes. 
Evaluations were performed blinded to the group. 
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3.4.2 Results 
Generally, axonal staining for NF200 and IB4 in the C7 right nerve root did not 
differ from normal tissue for either the sham or 3 minute compression groups (Table 3.1). 
Yet, when the nerve root was compressed for 15 minutes, both axonal markers (NF200 & 
IB4) demonstrated robust changes, including a loss of immunoreactivity and axonal 
swelling (Fig. 3.10 & Table 3.1). In all but one of the nerve roots compressed for 3 
minutes (Rat #118), NF200 labeling exhibited long, myelinated axons with an even 
distribution in their staining (Fig. 3.10). IB4 labeled long, thin axons that also exhibited 
an even distribution along the nerve root for all samples except Rat #118 (Table 3.1). 
Neither the myelinated nor the unmyelinated populations of axons exhibited substantial 
signs of axonal discontinuity or axonal swellings in either the sham or the 3 minute 
compression groups. Of the six rats that underwent a nerve root compression for 3 
minutes, only one (Rat #118) exhibited signs of decreased NF200-immunoreactivity and 
axonal swelling in both the unmyelinated (IB4) and myelinated (NF200) axon 
populations (Table 3.1). However, the remaining five rats that received compression for 3 
minutes showed normal morphology. Likewise, no pathology was observed in any of the 
five roots that that received sham procedures (Fig. 3.10 & Table 3.1). In contrast, three of 
the four nerve roots that were compressed for a period of 15 minutes exhibited altered 
immunoreactivity for both NF200 and IB4, including both a decrease in NF200-
immunoractivity and also the presence of axonal swelling (Fig. 3.10 & Table 3.1). 
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Group Rat ID NF200 IB4 
Sham 97 – – 
 104 – – 
 105 – – 
 117 – – 
 121 – – 
3min 98 – – 
 99 – – 
 103 – – 
 115 – – 
 118 + + 
 120 – – 
15min 82 – – 
 83 + + 
 84 + + 
 85 + + 
Table 3.1 Summary of NF200 and IB4 ratings. 
Fig. 3.10 Representative images of C7 nerve roots labeled for myelinated axons (NF200) and 
unmyelinated axons (IB4) at day 7 following sham procedures or a C7 root compression. Sham 
operated roots show even distribution of immunolabeling for both NF200 and IB4. Both the myelinated 
and unmyelinated axons appear intact along the length of the root. Most of the nerve roots in the 3 
minute (3min) compression group also exhibit this even distribution of NF200 and IB4. However, most 
of the nerve roots in the 15 minute (15min) compression group have evidence of root damage, including 
a loss of NF200-immunoreactivity (*) and axonal swelling (arrow). Scale bar (50µm) applies to all. 
*
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3.5 Discussion 
This study provides the first quantitative evaluation of the role of compression 
duration in altering the frequency of neuronal signaling across the nerve root during an 
applied compression to the C7 nerve root. The electrophysiological data demonstrate that 
15 minutes of compression of the cervical nerve root induces immediate neuronal 
dysfunction that is sustained even after the compression is removed and also produces 
robust axonal injury in the nerve root 7 days after the injury (Figs. 3.6-3.8, 3.10 & Table 
3.1). Yet, neither neuronal function nor axonal morphology are significantly affected 
after a nerve root compression that is applied for only 3 minutes (Figs. 3.6-3.8, 3.10 & 
Table 3.1). Compression to the nerve root is accompanied by an immediate and 
continuous decrease in the number of peripherally-evoked action potentials in the spinal 
cord that reaches its peak at 6.6±3.0 minutes (Fig. 3.7A). Compression that is held longer 
than that time also maintains a decrease in evoked action potentials by between 50-80%, 
but does not decrease further in the evoked activity during compression (Figs. 3.6-3.8). In 
addition, for a nerve root compression held longer than that duration threshold, evoked 
action potentials remain lower than baseline responses by 56±14% during the last 5-
minute period after compression is removed (Figures 3.7A & 3.8). Although 3 minutes of 
nerve root compression reduces the number of action potentials evoked from peripheral 
stimulation by as much as 68±17%, neuronal activity returns to pre-compression levels 
within 10 minutes after the compression is removed from the nerve root (Figs. 3.6-3.8). 
In addition, for that same subthreshold duration of compression (3 minutes), there is no 
evidence of axonal injury in either of the NF200- or IB4-labeled axons at day 7 after 
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compression (Fig. 3.10 & Table 3.1). The lack of widespread axonal injury in that group 
is in contrast to the substantial decrease in NF200-immunoreactivity, axonal swelling, 
and myelin degeneration that is observed at that time point after a compression of the C7 
nerve root for 15 minutes (Fig. 3.10 & Table 3.1) (Hubbard & Winkelstein 2008). 
Accordingly, the prolonged decrease in evoked action potentials after a 15 minute 
compression observed here is likely associated with the hallmarks of axonal injury that 
are observed 7 days later (Hubbard & Winkelstein 2008). Taking these data together with 
the literature, it can be inferred that compression of the nerve root that is sustained for a 
period longer than 6.6 minutes not only produces sustained neuronal dysfunction, but 
may be associated with the neurodegenerative cascades in the axons that are associated 
with nerve root pathophysiology.  
The established relationship between altered afferent signaling to the spinal cord 
and the development of behavioral sensitivity in neuropathy (Hao et al. 1992, Khan et al. 
2002, Shim et al. 2005) suggests that 15 minutes of nerve root compression not only 
produces a sustained decrease in peripherally-evoked action potentials (Figures 3.6-3.8), 
but also induces behavioral sensitivity to mechanical stimuli. In fact, several rat models 
of inflammatory pain have demonstrated that there is an association between pain-related 
behaviors and the number of action potentials evoked by a transcutaneous electrical 
stimulus, and that both the behavioral and electrophysiologic responses are produced as 
early as 10 minutes after the injection of the inflammatory agent, formalin, into the 
hindpaw (Asante et al. 2009, DeLaTorre et al. 2009, Martindale et al. 2001, Pezet et al. 
2008, Stanfa et al. 1992). Those studies suggest that the significant reduction in the 
number of action potentials that is observed to persist for at least 10 minutes after a 15 
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minute compression (Figs. 3.6-3.8) may be a sensitive indicator of enhanced nociception 
following nerve root compressions of this duration. Moreover, the duration-threshold of 
6.6±3.0 minutes identified here that maximally reduces electrically-evoked neuronal 
signaling also falls within the range of root compression durations (3-15 minutes) that 
produces mechanical allodynia in this model of cervical radiculopathy that was 
previously reported (Rothman et al. 2010). Persistent mechanical allodynia of the 
forepaw developed immediately (within one day) after a 15 minute compression to the 
C7 nerve root; yet, when the same compression is applied for a shorter, 3 minute, period 
it does not induce allodynia (Rothman et al. 2010). Although the current study did not 
investigate afferent discharge rates beyond 10 minutes after the compression was 
removed, studies of compression to the cauda equina in the pig report that impaired 
signaling across the root can continue for at least 90 minutes after the compression is 
removed (Pedowitz et al. 1992, Rydevik et al. 1991). Taking all of these 
electrophysiologic and behavioral findings together suggests that compression of the 
nerve root lasting longer than 6.6±3.0 minutes is sufficient to produce sustained neuronal 
dysfunction and that this change in the electrophysiologic properties of the compressed 
neurons may be associated with the development of mechanical allodynia and pain. 
Seven days after a 15 minute compression to the nerve root, robust morphological 
changes were evident in the myelinated and unmyelinated axons of the injured axon, 
compared to uninjured axons (Fig. 3.10 & Table 3.1). In contrast, seven days after a 3 
minute compression, both populations appear intact throughout the length of the nerve 
root, with morphology consistent with uninjured axons (Fig. 3.10 & Table 3.1). Previous 
studies in several animal models of radiculopathy demonstrate that chronic nerve root 
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compression applied over a period of 1-8 weeks produces substantial pathology in the 
neurons of the nerve root including axonal swelling, axonal condensation, myelin 
fragmentation, and loss of axonal transport (Cornefjord et al. 1997, Jancalek & Dubovy 
2007, Kobayashi et al. 2004). None of those studies measured nociceptive responses, but 
the indicators of axonal injury that were investigated are also associated with changes in 
pain and functional behavioral outcomes (Chen et al. 1992, Hubbard & Winkelstein 
2008).  
Both the rate and magnitude of compression have been shown to contribute to the 
development of axonal injury (Hubbard et al. 2008b, Kobayashi et al. 2005a, Olmarker et 
al. 1990). The 10gf compressive load applied in this study is more than twice the 
magnitude-threshold of 3.5gf (34.1mN) that has been identified as requisite to produce 
decreased NF200-immunoreactivity at day 7 after a 15 minute compression (Hubbard et 
al. 2008b). Although that same 98mN compressive load was used for the 3 minute 
compression conducted in this study, no such decrease in NF200-immunoreactivity was 
evident in five of the six nerve roots that were compressed for 3 minutes (Fig. 3.10 & 
Table 3.1). Likewise, IB4-immunoreactivity was only altered in the nerve roots that 
sustained a 15 minute compression and not after a 3 minute compression (Fig. 3.10 & 
Table 3.1). The difference in the response of NF200-labeled and IB4-labeled axons after 
3 and 15 minutes of this compression magnitude suggests that compression duration may 
play a role in mediating the development of axonal pathology in the nerve root.  
Changes in the nerve root structure as a whole that develop over time during its 
compression, such as compaction of the axons and a decrease in the overall nerve root 
width, may be among the underlying factors that contribute to the ability of the 
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compressed axons to tolerate 3 minutes of compression (Dyck et al. 1990, Rothman et al. 
2010), despite the suprathreshold pain-provoking load of 98mN. Although pathology is 
not apparent after a 3 minute compression to the C7 nerve root (Fig. 3.10 & Table. 3.1), 
our evaluation approach did not incorporate more sensitive techniques, such as higher 
magnification scanning electron microscopy and/or axial views of the nerve root, that can 
detect subtle pathology in the axons, such as changes in axonal diameter size, axonal 
splitting, or disorganization in the myelin sheath (Guertin et al. 2005, Jancalek & Dubovy 
2007, Myers et al. 1993). However, the presence of those morphologic changes in the 
axons parallels the presence of decreased NF200-immunoreactivity (Hubbard & 
Winkelstein 2008). So, the normal expression of NF200 that is observed in the nerve root 
after a 3 minute compression (Fig. 3.10 & Table 3.1) is likely a true indication of normal 
axonal morphology. Also, the absence of axonal injury after a 3 minute compression is 
consistent with previous reports suggesting that the development of axonal pathology 
after a nerve root compression is associated with behavioral sensitivity, which is also not 
elicited after a 3 minute compression to the nerve root (Hubbard & Winkelstein 2008, 
Rothman et al. 2010). Although the findings from our study demonstrate that 
compression duration mediates the electrophysiologic and morphologic responses of the 
nerve root (Figs. 3.6-3.8 & 3.10) and provides clinically-relevant insight into its response 
to compression, these relationships and the specific outcomes for the durations used here 
are specific to the rat. Additional studies are needed to determine if there are scaling 
issues in these metrics and outcomes as they relate to the human. Indeed, the nerve root’s 
apparent ability to tolerate a short period of compression (Figs. 3.6-3.8, 3.10 & Table 3.1) 
suggests that early intervention alleviating any root compression may be sufficient for 
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improved functional recovery following trauma. In fact, clinical studies have shown that 
early treatment of nerve root and spinal cord injuries does reduce the severity and number 
of complications associated with injuries to these tissues (Carlstedt et al. 2000, Fehlings 
& Perrin 2006). In addition, intraoperative monitoring of nerve root function using 
electromyography and/or electrophysiology reduces the rate of neurological 
complications associated with spine fusion surgeries by allowing surgeons to quickly 
detect and resolve unintentional compression to the root that may occur during surgical 
manipulation (Bose et al. 2002, Kelleher et al. 2008). Although the nerve root may be 
able to recover from certain mechanical injuries, the fact remains that nerve root tissues 
are still susceptible to sustained neuronal damage even for transient compressions (Figs. 
3.6-3.8, 3.10 & Table 3.1). Additional studies investigating the tolerance of nerve root 
tissue to traumatic injuries will provide an improved understanding of the need to prevent 
these injuries, provide rapid treatment, and the expected degree of recovery following 
these types of injuries.  
Compression in this study was applied to the nerve root transiently. Yet, even a 
brief, 15 minute, compression is sufficient to produce sustained neuronal dysfunction and 
abnormal axonal morphology (Figs. 3.6-3.8, 3.10 & Table 1). Despite being transient, 
this duration is substantially longer than those associated with tissue loading in the neck 
during real-world traumatic exposures (Panjabi et al. 2006, Svensson et al. 1993). The 
physiologic response of the root to compression likely depends on a combination of 
inputs and signaling as a result of both the duration and magnitude of the insult (Fig. 
5.11) (Garfin et al. 1990, Kobayashi et al. 2005b, Olmarker et al. 1989b, Olmarker et al. 
1990, Pedowitz et al. 1992). Although the compression magnitude (10gf) was held 
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constant here, the axonal damage observed in the 15 minute group (Fig. 3.10 & Table 
3.1) is also evident even when the magnitude of compression is at, or near, the magnitude 
threshold of 3.9gf (38.2mN) for developing persistent behavioral sensitivity (i.e. pain) in 
this rat model (Hubbard & Winkelstein 2008, Hubbard et al. 2008a). Furthermore, tissue 
damage following a transient nerve root compression has been shown to accompany 
sustained neuronal dysfunction (Rydevik et al. 1992). Thus, it is likely that any 15 minute 
compression applied using a load above the threshold load (38.2mN) for producing pain 
would similarly induce sustained neuronal dysfunction and axonal damage. Conversely, 
because axonal damage has been reported not to develop in the root after compressions 
below that load threshold, even for those held as long as 15 minutes (Hubbard & 
Winkelstein 2008), neuronal function is likely to recover following application of less 
severe compressions, as was observed for the 3 minute group (Figs. 3.6-3.8). Further, it is 
likely that for loads below 3.9gf (38.2mN) there is a similar duration of compression that 
would also produce pain and/or neuronal dysfunction. Such a duration would presumably 
be required to be much longer, and possibly even permanent, as in the case of stenosis. 
Indeed, currently the relationship defining the “response-space” between load, duration, 
neuronal dysfunction and symptomatic outcomes is not defined (Fig. 3.11). However, the 
present study, together with studies in the literature, begins to establish such a multi-
dimensional response.  
Certainly, the magnitude and durations applied to the nerve root in the present 
study represent only two points along the duration-magnitude response curve of the nerve 
root (Fig. 3.11). At the two extremes of this spectrum are (1) transient compressive 
injuries that deliver a brief compression with a high magnitude of force and (2) chronic  
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compressions applied at a low magnitude. In vivo studies of nerve roots crushed with a 
high, but undetermined, force for a very brief period (2-15 seconds), report that axonal 
injury and neuronal dysfunction develop in the injured nerve root, as well as pain that 
persists for at least seven days (Ramer et al. 2000, Sekiguchi et al. 2003). Likewise, 
chronic compressions also produce substantial axonal damage, the onset of which occurs 
earlier for higher magnitudes of compression (Kobayashi et al. 2005a). Chronic 
compression to the canine lumbar nerve root reduces axonal transport within one week 
for compressions applied with 7.5gf load and as early as one day for compressions 
applied with 15gf a load (Kobayashi et al. 2005a); it is not known whether pain 
developed for either of those compression magnitudes. Nevertheless, that study does 
support the notion that for chronic compressions, the rate at which pathology develops is 
mediated by the magnitude of the force applied to the tissue, with a greater force leading 
to earlier onset pathology. Based on those findings, the time-dependent decrease in 
discharge rates observed during compression in the present study (Figs. 3.6-3.7), also 
Fig. 3.11 Schematic representation exemplifying the complex “response-space” between biomechanical 
injury parameters (magnitude, duration) of an applied compression and the development of behavioral 
sensitivity (O) or degree of associated root injury (X) after a transient C7 nerve root compression. 
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likely varies with the magnitude of the load applied (Fig. 3.11). By extension, for any 
force greater or less than the 10gf applied in the current study, the duration-threshold for 
mediating changes in neuronal activity would be expected to develop earlier or later, 
respectively, than the 6.6 minutes determined during the compression period.  
The current study demonstrated that nerve root compression reduces the number 
of peripherally-evoked action potentials in the spinal cord (Figs. 3.6-3.8). This outcome 
of spinal neurons was evaluated as an indicator of the electrophysiologic response of the 
neurons of the compressed nerve root. Inserting the recording probe in the spinal cord 
rather than the nerve root itself was selected because it limited the injurious exposure to 
the nerve root to only the compression-induced injury by the microvascular clip. Previous 
similar studies of nerve root crush also demonstrate that neuronal activity in the spinal 
cord that is evoked by a peripheral stimulus correlates with the presence of pathology in 
the nerve root (Ramer et al. 2000, Rydevik et al. 1991, Wang et al. 2008a). Furthermore, 
all extracellular recordings in the present study were made in the superficial dorsal horn, 
where the afferents from the nerve root synapse with second order neurons (Basbaum et 
al. 2009, Wall & Melzack 1994). In contrast to our findings of a sustained decrease in the 
discharge rate after a nerve root compression (Fig. 3.8), chronic compression of the root 
has been previously reported to increase the period of repetitive firing that is evoked by a 
mechanical stimulus applied directly to the nerve root (Howe et al. 1977). This 
discrepancy suggests that the changes in the electrophysiologic properties of the neurons 
after nerve root injury depend on the type and location of the stimulus. While no attempt 
was made to differentiate between primary or second order neurons in our study, 
transection of the nerve root at the conclusion of each recording session ensured that the 
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evoked responses are associated with the C7 root. It should also be noted that the 
electrophysiologic properties of neurons that are evoked by a peripheral electrical 
stimulus do not vary within the 150-350µm range of depths measured in the present study 
(Wall et al. 1981, Woolf & Fitzgerald 1983). Therefore, despite the fact that the neurons 
measured in the 3 minute and 15 minute sham groups were 71µm and 91µm shallower 
than their corresponding compression groups, respectively, it is unlikely that this 
experimental condition contributed to the differences in the neuronal responses measured 
in those groups.  
Of note, the identification of the duration threshold of 6.6 minutes in this study 
only considered the response of action potentials that were evoked early (10-40msec) 
after the electrical stimulus (Fig. 3.6). The neurons associated with such action potentials 
are the myelinated A fibers (DeLaTorre et al. 2009, Pezet et al. 2008, Yu et al. 2009), 
which have a lower electrical threshold for excitation than the unmyelinated C fibers 
(Ramer et al. 2000). However, both fiber types have been shown to exhibit a uniform 
decrease in the amplitude of electrically-evoked compound action potentials in response 
to axonal stretch (Shi & Whitebone 2006), suggesting that the electrophysiologic results 
of the present study may extend to the unmyelinated C fiber population. Conversely, 
morphologic studies of peripheral nerve compression suggest that the myelinated fibers 
are more susceptible to mechanical injury (Jancalek & Dubovy 2007, Mosconi & Kruger 
1997, Strain & Olson 1975). Thus, the response of myelinated fibers, rather than 
unmyelinated fibers, may be the more conservative estimate for nerve root compression 
injuries. Furthermore, several studies suggest that mechanical and thermal sensitivity are 
transmitted along distinct neuronal subpopulations, with A fibers transmitting mechanical 
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sensitivity (Cavanaugh et al. 2009, Scherrer et al. 2009). Sensitivity to a mechanical 
stimulus after a transient C7 nerve root compression has been well-documented (Hubbard 
et al. 2008a, Rothman et al. 2010). The results of the current study provide the 
electrophysiologic response of the compressed neurons that are associated with 
transmitting pain in this model of radiculopathy. As such, in addition to demonstrating a 
sustained decrease in normal afferent discharge rates and the development of axonal 
injury in the primary afferents, the present study identifies immediate neuronal 
dysfunction as a potential initiator of the mechanisms leading to persistent pain, even 
when the nerve root injury is only transient with no observable macroscopic signs of 
structural injury. 
 
3.6 Integration & Conclusions 
 The studies presented in this chapter are the first to demonstrate that a painful 
nerve root compression critically inhibits the frequency of evoked discharge rates through 
the nerve root during the compression (Fig. 3.7). Furthermore, these studies also 
demonstrate that when the compression duration is shorter than the duration required to 
critically inhibit neurotransmission through the root, the frequency of evoked discharge 
rates returns to pre-compression levels within 10 minutes of the removal of the 
compressive insult (Figs. 3.7 & 3.8) and that the morphology of the axons at day 7 in the 
injured root show no indications of axonal swelling or irregularities in the axonal 
distribution, which are normally evident after a painful nerve root compression (Fig. 3.10 
& Table 3.1; Hubbard et al. 2008b). The electrophysiological impairment that develops 
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during the root compression (Figs. 3.7 & 3.8) and cytoskeletal damage that is evident at 
day 7 (Fig. 3.10 & Table 3.1) are both associated with abnormal afferent signaling 
(LaPlaca & Prado 2010, Serbest et al. 2007, Takamori et al. 2000). Therefore, in this 
model of painful nerve root trauma, radicular pain may be initiated and maintained by 
irregular neurotransmission through the root. 
The duration of a nerve root compression mediates both the immediate functional 
response and the subsequent development of afferent pathology. Blocked axonal 
conduction due to a mechanical insult (Figs. 3.7 & 3.8) can be indicative of neuronal 
membrane mechanoporation, in which the permeability properties of the plasma 
membrane are changed without causing cell death (Geddes et al. 2003, LaPlaca & Prado 
2010). Mechanoporation of the neuronal membrane is associated with an influx of 
calcium (Featherstone 2009, Takamori et al. 2000). The sustained decrease in the 
frequency of evoked action potentials after the 15 minute compression was removed (Fig. 
3.8) further supports the hypothesis that the plasma membrane was likely unable to 
immediately recover after the mechanical insult and that cytosolic calcium concentrations 
remained elevated for a period beyond the initial compressive insult (LaPlaca & Prado 
2010, LaPlaca & Thibault 1998). Persistently, high, intracellular calcium can damage 
mitochondria and destabilize the axon’s cytoskeleton, leading to the morphological 
changes that are observed at day 7 (Fig. 3.10) (Serbest et al. 2007). An influx in calcium 
also signals the neuron to release synaptic glutamate (Featherstone 2009, Takamori et al. 
2000). Therefore, even though compression to the root decreases the action potential 
propagation through the root, the associated damage to the plasma membrane of the 
primary afferents likely increases the glutamate signaling at the axon terminals in the 
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spinal cord (Featherstone 2009, Takamori et al. 2000). Therefore, the critical 
compression duration of 6.6±3.0 minutes that impairs axonal signaling through the root 
(Fig. 3.7) implies that compressions to the root that last longer than 6.6 minutes likely 
also produce sustained damage to the neuronal membrane, leading to elevated synaptic 
glutamate release in the dorsal horn (Featherstone 2009, Geddes et al. 2003, LaPlaca & 
Prado 2010, Takamori et al. 2000). Elevated spinal glutamate also is associated with 
behavioral sensitivity (Cata et al. 2007, Coderre et al. 2007); therefore, that 6.6 minute 
critical duration may also approximate a duration threshold for the development of nerve 
root-mediated pain. 
Studies presented in Chapter 4 test the hypothesis that the critical duration for 
mediating afferent discharge rates in the spinal cord during a C7 nerve root compression 
in the rat approximates the duration threshold for eliciting behavioral sensitivity. 
Mechanical allodynia is quantified following compressions applied to the nerve root that 
are more than one standard deviation shorter than (3 minutes) or longer than (10 minutes) 
the duration threshold (6.6±3.0 minute) identified in Section 3.3 (Fig. 3.7). To date, 
neurotrophic, neuropeptidergic and neurodegenerative responses that are relevant to 
persistent pain have only been characterized for compression durations of 15 minutes 
(Hubbard & Winkelstein 2005, Hubbard et al. 2008a, Rothman et al. 2010). Therefore, 
the studies in Chapter 4 also evaluate mechanical allodynia following a 15 minute 
compression in order to provide context for the mechanical allodynia response after the 3 
and 10 minute compressions. Additionally, in order to characterize another clinically-
relevant modality of radicular pain, thermal hyperalgesia is also measured following the 
same 3 and 15 minute nerve root compression durations (see Section 4.4). 
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As described above, elevated spinal glutamate due to damage sustained by the 
neuronal membrane during compression, may contribute to the behavioral sensitivity that 
develops after nerve root compressions (Featherstone 2009, Geddes et al. 2003, LaPlaca 
& Prado 2010, Takamori et al. 2000). Furthermore, increased concentrations of spinal 
glutamate and behavioral sensitivity are both associated with neuronal hyperexcitability 
in the spinal cord (Cata et al. 2006, Inquimbert et al. 2012, Sung et al. 2003). Under 
normal conditions, however, an over-accumulation of spinal glutamate is prevented by 
glutamate transporters that take up extracellular glutamate (Rothstein et al. 1996, Sung et 
al. 2003, Tao et al. 2005). Studies in Chapters 5-7 evaluate what role glutamate and its 
transporters have in mediating nerve root-mediated pain and neuronal excitability in the 
spinal cord. Specifically, the temporal expression of spinal glutamate transporters and the 
development of neuronal hyperexcitability are characterized for painful (15 minutes) and 
nonpainful (3 minutes) nerve root compressions in Chapter 5. Studies in Chapters 6 and 7 
use two different pharmacological approaches to modulate separate aspects of the 
glutamatergic system.  The effects of each pharmacological agent on persistent 
behavioral sensitivity and neuronal excitability in the spinal cord are evaluated following 
painful nerve root compression. In Chapter 6, the spinal expression of the glutamate 
transporter, GLT-1 is increased by daily injections of ceftriaxone, while studies in 
Chapter 7 inhibit pre-synaptic glutamate release using a single intraperitoneal injection of 
Riluzole at day 1 after root injury. By identifying the contribution of glutamate to nerve 
root-mediated pain in Chapters 5-7, additional insight can be garnered about how the 
duration-mediated neuronal dysfunction and pathology observed in the current studies 
(Figs. 3.7 & 3.10) drive persistent radicular pain. 
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CHAPTER 4 
 
Behavioral Sensitivity is Mediated by the 
Duration of a Transient Dorsal Root Compression  
 
Parts of this chapter have been adapted from: 
Nicholson KJ, Guarino BB, Winkelstein BA. “Transient Nerve Root Compression Load 
and Duration Differentially Mediate Behavioral Sensitivity and Associated Spinal 
Astrocyte Activation and mGluR5 Expression.” Neuroscience, 209:187-95, 2012. 
 
 
 
4.1 Overview 
Cervical radiculopathy is characterized by pain that radiates from the neck to the 
shoulder and arms (Abbed & Coumans 2007). Radiculopathy can be diagnosed by 
physical examination, imaging studies and/or electrophysiologic tests (Kuijper et al. 
2009, Wainner & Gill 2000). In the majority of cases, however, only the patient’s history 
and a physical examination of the sensory symptoms are used to differentiate 
radiculopathy from other neurological disorders (Jensen & Baron 2003, Thoomes et al. 
2012, Wainner & Gill 2000). In order to improve clinical diagnosis, recent efforts have 
focused on characterizing the differences in presentation of hypersensitivity to thermal, 
vibration and pressure stimuli between patients with non-specific arm pain and those with 
cervical radiculopathy (Moloney et al. 2013). Because symptoms are the primary 
methods for diagnosing nerve root injuries, the development and utilization of animal and 
associated cellular models that accurately reflect the clinical sensory profile of cervical 
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radiculopathy can elucidate the injury mechanisms of nerve root injury, leading to 
improved diagnosis and treatment of these types of injuries. 
The studies in this chapter focus on the experiments outlined under Aim 1b. The 
primary goal of work in this chapter is to evaluate the development of different types of 
behavioral sensitivity following nerve root compressions that are applied for varying 
lengths of time. In order to evaluate two of the most commonly reported types of evoked 
pain in clinical neuropathy (Backonja & Stacey 2004, Mogil 2009), assays focused on 
mechanical allodynia and thermal hyperalgesia; these are presented in Section 4.3 and 
Section 4.4, respectively. Based on the critical duration to mediate afferent discharge 
rates during compression that was identified in Chapter 3 (Nicholson et al. 2011), 
compression to the nerve root was applied in these studies for durations above (10, 15 
minutes) and below (3 minutes) that duration in order to investigate if, and to what 
extent, changes in behavioral sensitivity are produced.  
The findings from studies in this chapter establish the compression durations that 
are used in subsequent chapters to characterize the spinal glutamatergic system and 
excitatory signaling after painful nerve root compressions (Chapter 5) and to evaluate the 
effectiveness of pharmacological treatments in alleviating these types of behavioral 
sensitivities after a painful nerve root compression (Chapters 6 & 7). In Chapter 5, the 
nerve root compressions that are identified here that do and do not elicit behavioral 
sensitivity will be used to characterize the relationship between nerve root-mediated pain 
and the spinal expression of glutamate transporters and dorsal horn neuronal excitability. 
Chapters 6 and 7 will then use pharmacological interventions, such as ceftriaxone to 
reduce spinal glutamate levels by increasing glutamate uptake, and Riluzole to inhibit 
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glutamate release, respectively. Those studies help to more specifically characterize the 
role of glutamate signaling in the persistence of mechanical allodynia and thermal 
hyperalgesia after painful nerve root compression. 
 
4.2 Relevant Background 
 In a rodent model of cervical nerve root injury, the development of mechanical 
allodynia depends on both the magnitude and duration of compression that is applied to 
the nerve root (Hubbard et al. 2008a, Rothman et al. 2010). In that same model, the 
critical duration for mediating neuronal signaling during a 10gf compression to the C7 
nerve root is 6.6±3.0 minutes (Nicholson et al. 2011). Although that duration-threshold 
was defined as the critical duration to inhibit neuronal discharge rates during the applied 
compression, axonal damage and behavioral sensitivity were also found to develop only 
after a longer duration nerve root compression and to be absent in compressions applied 
for durations shorter than that threshold (Nicholson et al. 2011, Rothman et al. 2010).  
Dysfunction in afferent signaling is associated with the subsequent development of 
axonal injury and pain (Ramer et al. 2000, Gabay & Tal 2004), indicating that the 
reduced firing rate of afferents in the nerve root during compression may be an indicative 
marker for the behavioral sensitivity that develops within one day (Hubbard & 
Winkelstein 2005, Nicholson et al. 2011). Specifically, the association between 
dysfunction of the afferents and pain (Gabay & Tal 2004) would suggest that behavioral 
sensitivity only develops following compressions above the 6.6±3.0 minute critical 
duration (greater than 9.6 minutes), but not for shorter durations (less than 3.6 minutes). 
However, this relationship between the critical duration for modulation afferents during 
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compression and the subsequent development of behavioral sensitivity after a nerve root 
compression has not been defined. 
 Several modalities of pain are present, both clinically and in animal models, such 
as sensitivity to pressure, heat, cold, vibration and/or punctuate stimuli (Carette et al. 
2005, Thoomes et al. 2012). Clinically, different types of neuropathic pain are 
characterized by the type of pain present (Moloney et al. 2013). Therefore, it is required 
that animal models of neuropathy, including radiculopathy, reflect the clinically relevant 
type(s) of pain (Mogil et al. 2010). In patients with chronic neuropathic pain, the two 
most reported modes of hypersensitivity are to mechanical and thermal stimuli, which are 
experienced by 64% and 38% of patients, respectively (Backonja et al. 2004). It should 
be noted that spontaneous, ongoing pain is, by far, the most common symptom and is 
reported in up to 96% of neuropathic pain patients (Backonja et al. 2004, Mogil et al. 
2010). Evoked hypersensitivity, however, is currently considered a more reliable measure 
than spontaneous pain in animal models (Backonja et al. 2004, Gagliese & Melzack 
2000, Mauderli et al. 2000). Nonetheless, because spontaneous pain is the best match to 
the human experience, researchers continue to seek to improve pain assessment in animal 
models. Some examples include evaluating aggression, food intake, rearing, guarding or 
licking (Mogil 2009). However, none of these have been shown to be reliable or sensitive 
measures and changes in these behaviors could be due to factors other than pain, such as 
stress or dehydration (Mogil 2009). 
Behavioral sensitivity to different types of stimuli is mediated by specific 
subpopulations of afferent fibers (Braz et al. 2005, Jensen & Baron 2003). Specifically, 
mechanical allodynia that is evoked by a punctate stimulus, such a von Frey filament, is 
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mediated by sensitization of the myelinated Aδ fibers (Jensen et al. 2001). Thermal 
hyperalgesia, on the other hand, is mediated by sensitization of unmyelinated C 
nociceptors (Jensen et al. 2001). Both the A and C fibers in the nerve root are susceptible 
to injury from root compression and axonal injury to these fibers, such as swelling and 
loss of myelination, has been reported to be evident as late as two weeks after a painful 
transient compression (Chang & Winkelstein 2011, Hubbard et al. 2008b, Kobayashi et 
al. 2008, Nicholson et al. 2011). Furthermore, myelin degeneration in the nerve root after 
a transient injury is present only after compressions that also produce mechanical 
allodynia (Hubbard & Winkelstein 2008), suggesting that injury to the myelinated A 
fibers may be an indicator and/or a requirement for the development of mechanical 
sensitivity in this model. Furthermore, the development of morphological damage to the 
A and C fibers is also mediated by the compression duration (Nicholson et al. 2011); 
however, to date only mechanical allodynia had been evaluated for nerve root 
compressions of varying durations (Nicholson et al. 2012, Rothman et al. 2010). Despite 
evidence that both transient and sustained compressions to the nerve root elicit thermal 
hyperalgesia (Hashizume et al. 2000, Huang et al. 2012), it is not known whether the 
development of thermal hyperalgesia after a transient nerve root compression is, like 
mechanical allodynia, sensitive to the compression duration.  
Thermal hyperalgesia in the hind paw or forepaw of a rat can be evaluated by 
measuring the length of time that a rat tolerates application of a heat stimulus before 
removing its paw (Hargreaves et al. 1988). An automated measurement device detects a 
painful response (indicated by a paw withdrawal) by applying a radiant heat source that is 
synchronized to a timer that stops when a photoelectric cell detects a withdrawal response 
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(Dirig et al. 1997, Hargreaves et al. 1988). This method is sensitive enough to distinguish 
the severity of inflammatory-induced hyperalgesia and can track recovery over time 
(Jackson et al. 1995, Loyd et al. 2012, Hargreaves et al. 1988). Furthermore, this method 
of quantifying thermal hyperalgesia has been used to differentiate the severity of 
hypersensitivity following different types of nerve root injury and also to discern the 
development of hypersensivity and hyposensitivity following cervical nerve root injuries 
(Hashizume et al. 2000, Huang et al. 2012). Its effectiveness to differentiate the severity 
and type of thermal sensitivity after nerve root injuries demonstrates its utility in 
characterizing the development of thermal hyperalgesia following nerve root 
compressions of varying durations. 
Studies presented in this chapter test the hypothesis that the critical duration 
(6.6±3.0 minutes) (Nicholson et al. 2011) for inhibiting afferent action potentials during 
an applied compression to the C7 nerve root in the rat also approximates the duration 
threshold for eliciting mechanical allodynia and thermal hyperalgesia in the affected 
forepaw. A 10gf load was applied to the C7 nerve root for compressions below (3 
minutes) and above (10 & 15 minutes) that critical duration. Mechanical allodynia in the 
forepaw was measured for 7 days after each type of loading condition, and thermal 
hyperalgesia was evaluated for 7 days following the 3 and 15 minute compressions. 
These studies define the role of the compression duration for mediating both mechanical 
allodynia and thermal hyperalgesia and will also establish the loading conditions for 
painful and nonpainful nerve root compressions that will be used in Chapter 5. 
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4.3 Mechanical Allodynia Depends on the Duration of Compression 
The goal of this study is to evaluate the development and maintenance of 
mechanical allodynia following a nerve root compression applied to the root for a period 
that is outside one standard deviation below (3 minutes) or above (10 minutes) the 
6.6±3.0 minute critical compression duration, above which electrically evoked action 
potentials transmitted through the root are critically inhibited (Nicholson et al. 2011). 
Previous studies established that a 15 minute compression to the nerve root elicits 
mechanical allodynia (Rothman et al. 2010, Hubbard & Winkelstein 2005). To provide 
context for the behavioral outcomes measured after the 3 minute and 10 minute 
compressions, mechanical allodynia was also measured in a separate group of rats 
following a 15 minute compression. 
 
4.3.1 Methods 
Experiments were performed using male Holtzman rats (300-400g), housed under 
USDA- and AAALAC-compliant conditions and given free access to food and water. All 
procedures were approved by the Institution Animal Care and Use Committee and 
adhered to the guidelines of the Committee for Research and Ethical Issues of the 
International Association for the Study of Pain (Zimmermann 1983). Using the same 
surgical methods detailed in Chapter 3, compression was applied to the C7 nerve root for 
either 3 minutes or 10 minutes (n=6 rats/group) using a 10gf clip (WPI, Inc., Sarasota, 
FL). Sham procedures (n=6 rats) with dorsal nerve root exposure but no compression 
were also included as controls. In a separate study to provide context, rats underwent 
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either a C7 nerve root compression applied for 15 minutes (n=5 rats) or the sham 
exposure (n=4 rats). 
Behavioral hypersensitivity was evaluated by measuring bilateral forepaw 
mechanical allodynia prior to (baseline) and on days 1, 3, 5, and 7 following surgery 
(Hubbard and Winkelstein 2005, Rothman et al. 2005). For each behavioral testing 
session, following 20 minutes of acclimation, rats were stimulated on the plantar surface 
of each  of the ipsilateral and contralateral forepaws using a 4.0gf von Frey filament 
(Stoelting Co.; Wood Dale, IL). Each testing session consisted of three rounds of 10 
stimulations each, separated by 10 minutes. The total number of paw withdrawals was 
recorded for each forepaw of each rat and averaged across each group on each day. 
Significant differences in the number of paw withdrawals were determined 
between groups over time using a two-way, repeated measures ANOVA. A one-way 
ANOVA with post-hoc Bonferroni correction tested for differences in the number of paw 
withdrawals between each group on each day.  
 
4.3.2 Results 
Ipsilateral mechanical allodynia was only elicited by a compression applied for 10 
or 15 minutes (Figs. 4.1 & 4.2). On each day that behavioral testing was performed, the 
number of paw withdrawals following a compression applied for 10 minutes was 
significantly (p<0.019) elevated over the number of responses for both sham and the 
compression applied for only 3 minutes (Fig. 4.1). Furthermore, the number of paw 
withdrawals significantly increased over baseline (p<0.004) only for the 10 minute 
compression group. There were no differences in the number of paw withdrawals 
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between the 3 minute compression and sham groups. Similar to the response in the 10 
minute compression group, the number of paw withdrawals elicited after a 15 minute 
compression was significantly greater (p<0.011) than those of sham and baseline 
(p<0.012) at each post-operative time-point (Fig. 4.2). 
 
Fig. 4.1 Average mechanical allodynia assessed in the ipsilateral and contralateral forepaws 
following sham, a 3 minute compression or a 10 minute compression. The number of ipsilateral paw 
withdrawals significantly (*p<0.019) increased at each post-operative time-point following a 10 
minute compression compared with sham and the 3 minute compression.  
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There were no significant differences in the contralateral forepaw between any 
group (Figs. 4.1 & 4.2). Specifically, contralateral paw withdrawals were slightly greater 
following a 10 minute than a 3 minute compression or sham procedures, but this was not 
significant (Fig. 4.1). The number of contralateral paw withdrawals following the 15 
minute compression also was not significantly different from sham. There were no 
differences in the number of contralateral paw withdrawals from baseline for any injury 
group. Please see Appendix C for the individual behavioral data for all rats in this study. 
 
Fig. 4.2 Average mechanical allodynia assessed in the ipsilateral and contralateral forepaws following 
sham procedures or a 15 minute compression. On each testing day after compression, the number of 
withdrawals in the ipsilateral paw significantly increased (*p<0.011) compared to sham. 
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4.4 Thermal Hyperalgesia After Transient Nerve Root Compressions 
The temporal response of mechanical allodynia after a 15 minute compression 
(Fig. 4.2) is similar to that produced by a 10 minute compression (Fig. 4.1). Furthermore, 
the number of paw withdrawals elicited after the 10 and 15 minute compressions were 
similar. Therefore, in this study, thermal hyperalgesia was evaluated following nerve root 
compression durations known to either elicit mechanical allodynia (15 minutes) or to 
produce no changes to the mechanical sensitivity of the rat’s forepaw (3 minutes). 
Thermal hyperalgesia was evaluated at post-operative days 1 and 7, when mechanical 
allodynia is initiated and maintained, respectively (Figs. 4.1 & 4.2). 
 
4.4.1 Methods 
Surgical procedures were as described in Chapter 3 with rats receiving a 
compression injury to the right C7 nerve root or sham (Hubbard & Winkelstein 2005, 
Nicholson et al. 2011). Each rat either received a 10gf transient nerve root compression 
applied for 3 or 15 minutes, or a surgical sham exposure (n=7/group).  Bilateral thermal 
hyperalgesia was evaluated prior to (baseline) and on day 1 and day 7 after injury. 
Bilateral mechanical allodynia was also measured at baseline and at both post-operative 
time-points to ensure that the 3 and 15 minute compression conditions were comparable 
to those reported in Section 4.3. For each testing session, mechanical allodynia was 
evaluated using the methods described in Section 4.3 and was completed before testing 
for thermal hyperalgesia.  
Thermal hyperalgesia was evaluated by placing rats in a wire mesh cage on a 
glass surface (Fig. 4.3) and allowed to acclimate to the environment for 20 minutes prior 
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to testing. Thermal hyperalgesia was measured using a commercially available device 
(Fig. 4.3; UC San Diego) by applying a radiant heat source (projection bulb) focused on 
the plantar surface of each forepaw using established methods to quantify withdrawal 
latency (Dirig et al. 1997, Hargreaves et al. 1988). The projection bulb was positioned 
under the plantar surface of the forepaw with the assistance of an angled mirror attached 
to the stimulus. The latency time between when the heat source was first applied and 
when the paw withdrawal occurred (withdrawal latency) was measured by an automatic 
timer that was synchronized with the stimulus (Fig. 4.3).  On each day of testing, the 
withdrawal latency was measured three times for each paw, with a 10 minute rest 
between each measurement, and the average for each of the ipsilateral and contralateral 
paws across the three rounds was recorded for each rat on each day.  
 
Fig. 4.3 Device for measuring thermal hyperalgesia in the rat. A rat is placed in the wire mesh cage 
enclosure on a glass surface and the thermal stimulus is positioned under the forepaw. The timer 
measures the time between the application of the stimulus and when the paw is withdrawn. 
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Differences in the withdrawal latency and mechanical allodynia between groups 
over time was determined by a two-way repeated measures ANOVA for the ipsilateral 
and contralateral forepaws, separately. At each day, separate one-way ANOVAs with a 
post-hoc Bonferroni correction tested for differences in the ipsilateral and contralateral 
forepaws between groups. T-tests compared the number of paw withdrawals elicited in 
the 3 and 15 minute compression groups to their respective groups in the studies 
presented in Section 4.3. 
 
4.4.2 Results 
Thermal hyperalgesia varied significantly between groups (p<0.013) only for the 
ipsilateral forepaw, and only developed following a 15 minute compression (Fig. 4.4). At 
day 1, the withdrawal latency for the thermal stimulus after a 15 minute compression 
significant decreased (p<0.020) compared to the latencies after both sham and a 3 minute 
root compression and remained significantly lower (p<0.010) than both groups at day 7 
(Fig. 4.4). Thermal hyperalgesia after a 3 minute compression did not significantly differ 
from sham procedures at either time-point. Furthermore, the withdrawal latency for both 
the 3 minute compression and sham groups was not different baseline at either post 
operative time-point. In the contralateral forepaw, no differences were observed between 
any group, nor did the withdrawal latency vary from the associated baseline values (Fig. 
4.4). The withdrawal latency measured for each rat is summarized in Appendix C. 
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Like thermal hyperalgesia, mechanical allodynia was only elicited in the 
ipsilateral forepaw following a 15 minute compression (Fig. 4.5). Within 1 day, the 
number of paw withdrawals to the 4.0gf filament significantly increased (p<0.001) after a 
15 minute compression compared to sham and the 3 minute compression and remained 
significantly greater (p<0.005) than both groups at day 7 (Fig. 4.5). The 3 minute 
compression and sham groups did not vary from baseline at either time-point. There were 
no significant differences in the number of ipsilateral paw withdrawals elicited after a 3 
minute compression or a 15 minute compression in the present study compared to the 
Fig. 4.4 Thermal hyperalgesia in the forepaw. The thermal latency after a 15 minute compression is 
significantly (*p<0.020) decreased at both day 1 and day 7 compared to a 3 minute compression and 
sham. No significant differences in the withdrawal latency were observed in the contralateral forepaw 
between any group at any time-point. 
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same compression duration groups presented in Section 4.3 (Figs. 4.1-4.2 & 4.5). 
Appendix C summarizes the paw withdrawal response for each day for each rat. 
 
 
4.5 Discussion 
Thermal hyperalgesia only developed following compressions that also elicited 
mechanical allodynia (Figs. 4.1-4.2 & 4.4-4.5). Furthermore, there were no robust 
differences in the number of paw withdrawals evoked by the von Frey filament stimulus 
after the 10 or 15 minute compression durations (Figs. 4.1 & 4.2) indicating that 
allodynia is not differentiated by compression durations longer than 10 minutes. Previous 
Fig. 4.5 Mechanical allodynia in the ipsilateral forepaw is significantly elevated (*p<0.005) following a 
15 minute compression compared to a 3 minute compression and sham procedures at days 1 and 7. 
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studies that applied graded compression magnitudes in the range of 5.30-108.99mN 
demonstrated that above an applied load of 76.2mN, allodynia is insensitive to the 
compression duration (Hubbard et al. 2008a). The present study suggests that there is 
likely a similar duration threshold for eliciting maximum allodynia that lies between 3 
and 10 minutes; above 10 minutes, there is no further increase in the mechanical 
allodynia response (Figs. 4.1 & 4.2). The compression mechanics required to elicit 
thermal hyperalgesia appear to be similar to, if not the same as, those required to elicit 
mechanical allodynia (Figs. 4.4 & 4.5). Therefore, like mechanical allodynia, the 
withdrawal latency is likely not further reduced by compressions applied for durations 
longer than 15 minutes (Fig. 4.4). 
Damage sustained to both the myelinated Aδ fibers and unmyelinated C fibers by 
a mechanical compression to the nerve root likely underlies the development of 
mechanical and thermal hyperalgesia in this model (Figs. 4.1-4.2 & 4.3-4.5; Braz et al. 
2005, Jensen & Baron 2003). Both types of fibers exhibit axonal swelling and irregular 
morphology by day 7 after the painful 15 minute compression (Nicholson et al. 2011) and 
in other animal models of mechanical trauma to the nerve root (Kobayashi et al. 2005a, 
Kobayashi et al. 2008). To date, nerve root conduction studies have only demonstrated 
neuronal dysfunction in the fast transmitting, myelinated A fibers during an applied 
compression (Nicholson et al. 2011, Pedowitz et al. 1992). The development of thermal 
hyperalgesia (Fig. 4.4), which is mediated by sensitized C fibers (Jensen et al. 2001) 
suggests that these nociceptive fibers of the nerve root are also susceptible to altered 
neurotransmission during the applied compression. 
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The relationship between compression duration and the development of 
behavioral sensitivity observed here (Figs. 4.1-4.2 & 4.4-4.5) expands our understanding 
of how the mechanical loading profile of a nerve root compression mediates pain (Huang 
et al. 2012, Hubbard et al. 2008a, Rothman et al. 2010, Winkelstein et al. 2002). Just as 
there is a magnitude threshold (Hubbard et al. 2008a), there is also a compression 
duration threshold between 3 and 10 minutes for eliciting behavioral sensitivity (Figs. 4.1 
& 4.2). A recent study reports that compression magnitudes to the nerve root that are 15 
times greater than the threshold for inducing hypersensitivity will actually induce 
hyposensitivity to mechanical stimuli (Huang et al. 2012, Hubbard et al. 2008a), 
suggesting that if the mechanical thresholds for eliciting hypersensitivity, including the 
compression duration threshold, are greatly exceeded, sensation may actually decrease 
and this may be one contributing factors to the paresthesia and numbness that develop in 
some cases of radiculopathy (Abbed & Coumans 2007). It has previously been reported 
that the extent of demyelination and degeneration that develops in the root is more 
extensive after a root compression that elicits hyposensitivity than a compression that 
elicits hypersensitivity (Huang et al. 2012). The more severe pathology that accompanies 
loss of sensation after a root compression suggests that pain may require intact axons 
whose response to stimuli is exaggerated due to surrounding inflammatory responses in 
the root itself or the spinal cord, including glial activation, cytokine upregulation and 
macrophage infiltration (Chang et al. 2011, Colburn et al. 1999, Rothman et al. 2009). 
Because the magnitude threshold for reducing mechanical sensitivity in the 
forepaw is higher than the threshold for developing persistent pain, there may also be a 
duration threshold greater than the 15 minutes applied here (Fig. 4.4), above which 
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thermal hypoalgesia develops. Given that both the duration and magnitude of 
compression determine the development of hypersensitivity or hyposensitivity, the 
behavioral responses to the mechanical and thermal stimuli observed here (Figs. 4.1-4.2 
& 4.4-4.5) expands, but does not complete, our understanding of the complex relationship 
between the compression mechanics and behavioral outcomes (Figs. 4.1-4.2 & 4.3 & 4.4; 
Huang et al. 2012, Hubbard et al. 2008a, Rothman et al. 2010). Although additional 
studies could further define the relationship between nerve root compression mechanics 
and radicular pain, defining this relationship in the rat has limited applications when 
extrapolating to human nerve root mechanics. The value of defining compression 
durations that do and do not elicit pain is that the nonpainful compression provides a 
study control group for differentiating pathologies that are specific to nerve root-
mediated pain from those that may solely be attributed to the effects of mechanical 
compression of the root. 
One limitation of most animal pain models of trauma or injury is that the painful 
condition is only compared to a surgical control without consideration for the severity of 
the injury (Mogil et al. 2010). Such study designs may errantly identify chemical and/or 
anatomical responses that are not necessarily specific to pain (Grace et al. 2010). For 
example, in the same model of a nerve root compression used in the present study, spinal 
mGluR5 can be upregulated or unchanged after both painful and nonpainful nerve root 
compressions, depending on the magnitude of the applied compression (Nicholson et al. 
2012). Because of such disparities between pain and physiology or tissue pathology, 
models that replicate graded pain responses after spinal cord and peripheral nerve injury 
have been developed to specifically correlate neurochemical, anatomical and 
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inflammatory responses to the development and maintenance of behavioral sensitivity 
(Carlson et al. 2003, Grace et al. 2010, Lotz & Chin 2010).  In a similar manner, specific 
radicular pain-associated tissue responses can be determined by utilizing the painful and 
nonpainful transient cervical nerve root compressions that are defined by the compression 
duration (Figs. 4.1-4.2 & 4.5).  
In addition to defining graded pain responses, characterizing mechanical allodynia 
and thermal hyperalgesia increases the utility of animal models of pain for 
pharmacological studies (Mogil et al. 2010, Moloney et al. 2013).  Some treatments may 
only target one modality of sensitivity; thus, analgesic agents must be assessed across 
many different pain modalities (Hama et al. 2003, Hudson et al. 2002, Wang et al. 2005). 
The NMDA antagonist, MK-801, for example, alleviates mechanical, but not thermal, 
hyperalgesia in a rat model of peripheral inflammation (Hama et al. 2003). Characterizing 
the type(s) of pain present after injury is, therefore, critical for analgesic drug 
development. Prior to this study, there were limited data regarding the development of 
thermal hyperalgesia after a transient cervical nerve root injury (Huang et al. 2012). By 
characterizing the onset and persistence of both mechanical allodynia and thermal 
hyperalgesia (Figs. 4.3 & 4.4), pharmacological studies in this model can use both of 
these behavioral assessments to strengthen our understanding of mechanisms driving the 
different aspects of nerve root-mediated pain.  
The present study characterized sensory changes after a transient cervical nerve 
root compression; yet, motor weakness is also a symptom of radiculopathy (Abbed & 
Coumans 2007). Although muscle function and strength have been measured in this 
model of cervical radiculopathy, no motor impairment was observed (Dunk et al. 2011). 
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The dorsal nerve root only contains afferent neurons. However, it is possible that injury 
to the ventral root and/or proximal spinal cord may be required to induce the motor 
impairment that is observed in some models of nerve root injury (Shamji et al. 2009). 
While there is certainly room to further characterize the sensory and motor deficits 
associated with a nerve root compression, the present study identified and characterized 
the development of the two most common types of clinically reported evoked neuropathic 
pain: mechanical and thermal sensitivity (Figs. 4.1-4.2 & 4.3; Backonja & Stacey 2004). 
Furthermore, this study demonstrates that the development of mechanical allodynia and 
thermal hyperalgesia are both mediated by the compression duration, suggesting that 
duration-mediated neuronal responses in the nerve root during the applied compression 
may initiate these painful outcomes (Nicholson et al. 2011) 
 
4.6 Integration & Conclusions 
The studies in this chapter demonstrate that duration mediates the development of 
both mechanical allodynia (Figs. 4.1 & 4.2) and thermal hyperalgesia (Fig. 4.4). 
Specifically, behavioral sensitivity only develops when the compression that is applied to 
the nerve root is longer than the 6.6±3.0 minute critical duration for reducing electrically-
evoked action potentials through the root during the applied compression (Nicholson et 
al. 2011). When compression is applied for times shorter than one standard deviation 
below (3 minutes) or longer than one standard deviation above (10 minutes) this critical 
duration, only the 10 minute compression elicited mechanical allodynia (Fig. 4.1). This 
suggests that the changes that are produced in the electrophysiological properties of the 
nerve root afferents while the root is compressed may be indicative of the subsequent 
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development of pain, or may even be the initiator of the nerve root-mediated pain that 
develops (Nicholson et al. 2011). 
Studies presented in Chapter 5 will use the painful (15 minute) and nonpainful (3 
minute) compression conditions established in this chapter to characterize the relationship 
between a painful compression to the nerve root and development of hyperexcitability in 
spinal neurons. Although Chapter 3 measured afferent function during an applied 
compression, neuronal signaling after a painful nerve root compression has not been 
defined at a time-point when behavioral sensitivity persists. Therefore, studies in Chapter 
5 will record afferent activity from dorsal horn neurons at day 7 after injury. The studies 
in Chapter 5 will also characterize the temporal expression of spinal glutamate 
transporters, which regulate glutamate, the neurotransmitter that underlies excitatory 
neuronal activity (Tao et al. 2005). In order to further define the role of spinal excitatory 
signaling in the persistence of nerve root-mediated pain, studies in Chapters 6 and 7 
measure behavioral sensitivity and spinal neuronal hyperexcitability after 
pharmacologically modulating the uptake and release of the excitatory neurotransmitter, 
glutamate, respectively. Specifically, ceftriaxone is administered to increase glial uptake 
of extracellular glutamate by upregulating the spinal expression of the glutamate 
transporter, GLT-1 (Chapter 6). The studies presented in Chapter 7 deliver Riluzole after 
a painful nerve root injury in order to inhibit glutamate release by pre-synaptic neurons. 
Because many pharmacological treatments may only alleviate either mechanical or 
thermal sensitivity, both mechanical allodynia and thermal hyperalgesia are evaluated in 
those studies of painful nerve root compression treated with ceftriaxone or Riluzole in 
order to characterize the effect of each treatment on each of these pain modalities. 
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CHAPTER 5 
 
Glutamate Transporters & Excitatory  
Signaling in the Spinal Cord following Painful 
Nerve Root Compression 
 
Parts of this chapter were adapted from: 
Nicholson KJ, Gilliland TM, Winkelstein BA. “Up-regulation of GLT-1 by Treatment 
with Ceftriaxone Alleviates Radicular Pain by Reducing Spinal Astrocyte Activation and 
Neuronal Hyperexcitability” submitted. 
 
Zhang S, Nicholson KJ, Smith JR, Syré PP, Gilliland TM, Winkelstein BA. “The Roles 
of Mechanical Compression and Chemical Irritation in Regulating Spinal Neuronal 
Signaling in Painful Cervical Nerve Root Injury” Stapp Car Crash Journal, submitted. 
 
 
5.1 Overview 
 The interaction between astrocytes and neurons in the central nervous system is 
bi-directional and because of this “tripartite synapse,” neuronal function in the central 
nervous is modulated by the neuron-astrocyte network. Astrocytes not only regulate 
signaling at neuronal synapses, but also respond to neuronal synaptic activity and, in so 
doing, they provide neuroprotective support under normal conditions (Markowitz et al. 
2007, Perea et al. 2009, Ren & Dubner 2008). Activation of astrocytes, which can be 
initiated by neurodegeneration, however, can switch the role of astrocytes from that of 
maintaining normal synaptic transmission to enhancing neuronal excitability (Markowitz 
et al. 2007, Perea et al. 2009, Ren & Dubner 2008). In particular, glutamate transporters 
on the cellular membrane of astrocytes regulate excitatory synaptic transmission by 
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taking up excess extracellular glutamate, the primary excitatory neurotransmitter in the 
central nervous system (Basbaum et al. 2009, Tao et al. 2005, Rothstein et al. 2005). In 
many animal models of neural tissue injury or disease, however, the glutamate 
transporters on both astrocytes and neurons are downregulated, resulting in elevated 
glutamate concentrations at the synapse which can enhance neuronal excitability (Cata et 
al. 2006, Rothstein et al. 2005).  Although many rodent and canine models of nerve root 
injury demonstrate that activation of spinal astrocytes and neurodegeneration of primary 
afferents are associated with persistent behavioral sensitivity (Colburn et al. 1999, 
Hubbard & Winkelstein 2008, Kobayashi et al. 2008, Rothman & Winkelstein 2007), no 
study has characterized neuronal excitability in the spinal cord or glutamate transporter 
expression following painful nerve root compression.  
 Work presented in this chapter focuses on the experiments outlined in Aims 2a 
and 2b. Studies implicate dysregulation of spinal neuronal and glial glutamate 
transporters in the persistence of behavioral sensitivity following trauma both in the 
peripheral and central nervous systems (Kim et al. 2011, Sung et al. 2003, Xin et al. 
2009). Therefore, studies in this chapter investigate the hypothesis that downregulation of 
spinal glutamate transporters and the development of neuronal hyperexcitability in the 
dorsal horn are associated with behavioral sensitivity following a painful transient C7 
cervical nerve root compression in the rat. As such, the studies presented in Section 5.3 
characterize the temporal expression of these transporters following the painful (15 
minute) and nonpainful (3 minute) nerve root compressions that were defined in Section 
4.4. Specifically, the spinal expression of the glial glutamate transporters, GLT-1 and 
GLAST, and the neuronal glutamate transporter, EAAC1, are quantified at days 1 and 7 
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to evaluate their association with the initiation and maintenance of behavioral sensitivity 
in this radiculopathy model. In a second set of studies (Section 5.4), the frequency of 
evoked afferent firing in the spinal cord is evaluated at day 7 to define whether a painful 
nerve root compression leads to excitability of dorsal horn neurons. In that work, separate 
studies characterize the response of neurons in the superficial and deep laminae to 
evaluate whether such neuronal hyperexcitability is localized to the region associated 
with primary synapses of nociceptors (superficial laminae) or to the synapses of neurons 
that transmit non-noxious mechanical stimuli (deep laminae). Based on the results of this 
chapter, Chapters 6 and 7 further test the contribution of the glutamatergic system to 
nerve root-mediated pain and neuronal hyperexcitability in the dorsal horn by 
administering ceftriaxone to promote GLT-1 expression (Chapter 6) and Riluzole to 
block pre-synaptic glutamate release (Chapter 7), respectively.  
 
5.2 Relevant Background 
The annual incidence for neck pain is reported to be 14-50% and as many as one-
half of these cases can persist for more than one year (Côté et al. 2004, Hill et al. 2004, 
Hogg-Johnson et al. 2008). Injury to the cervical nerve roots is a common source of neck 
pain due to their mechanical susceptibility from foraminal impingement, disc herniation, 
direct spinal trauma, and/or foraminal stenosis (Eichberger et al. 2000, Nuckley et al. 
2002, Wainner & Gill 2000). Rodent models of nerve root injury have established that 
behavioral sensitivity develops after mechanical insults to the root (Colburn et al. 1999, 
Hashizume et al. 2000, Huang et al. 2012, Hubbard & Winkelstein 2005) and that the 
development of mechanical allodynia and thermal hyperalgesia is sensitive to the 
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duration of the transient nerve root compression (Chapter 4; Rothman et al. 2010). 
Furthermore, spinal glial activation is only evident following a painful nerve root 
compression (Nicholson et al. 2012, Rothman et al. 2010). Due to the role spinal glia play 
in maintaining normal neuronal synaptic transmission, their activation following a painful 
root compression suggests that altered neurotransmission in the spinal cord may 
contribute to nerve root-mediated pain (Paixão & Klein 2010, Ren & Dubner 2008). 
However, afferent signaling in the spinal cord has not been characterized for painful 
nerve root compressions nor have the cellular mechanisms by which spinal glia 
contribute to enhanced nociception after such injuries been defined. 
Animal models of pain demonstrate that the neurotransmitters, substance P (SP), 
calcitonin gene related peptide (CGRP) and glutamate, play an important role in 
nociception (Basbaum et al. 2009). Elevated concentrations of each of these transmitters 
in the spinal cord is associated with behavioral sensitivity (Bausbaum et al. 2009, Kuner 
2010, Sun et al. 2003) Yet, a mechanical injury to the nerve root decreases SP and CGRP 
in the superficial dorsal horn, where the primary afferents synapse (Koyashi et al. 2005a, 
Hubbard et al. 2008a). Because both SP and CGRP are trafficked to the spinal cord from 
the dorsal root ganglion (DRG), nerve root injuries are thought to disrupt the normal 
axonal flow of SP and CGRP (Kobayashi et al. 2005a, Hubbard et al. 2008a). Glutamate 
on the other hand, does not rely on normal transport across the dorsal root because it is 
synthesized in the pre-synaptic terminal from glutamine, which is released by 
perisynaptic glial cells (Basbaum et al. 2009, Tao et al. 2005). Despite the central role of 
glutamate in potentiating synaptic transmission in the central nervous system, its role in 
nerve root-mediated pain has not been investigated. 
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 Extracellular glutamate concentration is tightly regulated in the spinal cord by 
neurons and glial cells, which take up synaptic glutamate via glutamate transporters 
(Rothstein et al. 1996, Tao et al. 2005). In the rat spinal cord there are three glutamate 
transporters: excitatory amino-acid carrier 1 (EAAC1), glutamate-aspartate transporter 
(GLAST) and glial glutamate transporter 1 (GLT-1) (Rothstein et al. 2005, Queen et al. 
2007, Tao et al. 2005). EAAC1 is predominantly expressed by neurons; GLAST and 
GLT-1 are expressed by glial cells. After spinal cord and peripheral nerve injuries there is 
a transient increase in expression of all three transporters within the first day (Kim et al. 
2011, Sung et al. 2003, Vera-Portoccarrero et al. 2002). However, several models of 
peripheral nerve injury demonstrate that glutamate transporters decrease within a week, 
when behavioral sensitivity is established, indicating that a decrease in glutamate 
transporter expression may contribute to neuropathic pain (Hu et al. 2010, Sung et al. 
2003, Tao et al. 2005, Xin et al. 2009). In fact, behavioral sensitivity is alleviated and 
normal glutamate signaling is restored when glutamate transporters are 
pharmacologically upregulated (Hu et al. 2010, Ramos et al. 2010, Nie et al. 2010). 
Although those studies implicate glutamate transporters in pain, it is not known whether a 
painful nerve root injury also mediates glutamate transporter expression in the spinal 
cord. 
 Downregulation of spinal glutamate transporters reduces synaptic glutamate 
clearance which increases the excitability of spinal neurons in the rat (Cata et al. 2006, 
Inquimbert et al. 2012, Tao et al. 2005). Increased spontaneous and evoked discharge 
rates of spinal dorsal horn neurons is associated with pain in rodent models of peripheral 
inflammation, nerve trauma and spinal cord injury (Asante et al. 2009, Hao et al. 1992, 
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Hains et al. 2003, Pitcher et al. 2004, Shim et al. 2005). Spinal excitability also mediates 
behavioral responses in nerve root injury (Ramer et al. 2000, Terashima et al. 2011). 
Specifically, rodent models of nerve root trauma demonstrate that loss of sensation in the 
rat forepaw after crush injury of multiple cervical nerve roots is associated with reduced 
afferent activity in the spinal cord, while enhanced behavioral sensitivity is associated 
with an increase in the amplitude of excitatory post-synaptic currents (EPSCs) after a 
lumbar root constriction (Ramer et al. 2000, Terashima et al. 2011). EPSCs were only 
evaluated in lamina II of the superficial dorsal horn (Terashima et al. 2011); but, the 
amplitude increase does suggest that post-synaptic neurons in the spinal cord are more 
likely to propagate an action potential in response to excitatory input, thereby increasing 
the firing rate of second order neurons in the spinal cord (Cata et al. 2009, Inquimbert et 
al. 2012, Kuner 2009, Nguyen et al. 2009). However, it has not been determined whether 
mechanical trauma to the nerve root increases the frequency of evoked action potentials 
of dorsal horn neurons nor has it been established whether such responses occur in the 
superficial laminae, where the primary nociceptors synapse, and/or the deep laminae, 
where many low-threshold mechanoreceptors synapse to polysynaptic neurons that also 
respond to noxious stimuli (Basbaum et al. 2009, Todd 2010). 
These studies test the hypothesis that spinal glutamate transporters and neuronal 
hyperexcitability contribute to behavioral sensitivity following a transient C7 nerve root 
compression. As such, the spinal expression of GLT-1, GLAST and EAAC1 were 
evaluated following compression durations that do (15 minutes) and do not (3 minutes) 
elicit mechanical allodynia (Rothman et al. 2010). Glutamate transporter expression was 
assessed at days 1 and 7 (Section 5.3), to evaluate the expression of these transporters at 
 105 
time-points relevant to the establishment and persistence of both mechanical allodynia 
and thermal hyperalgesia in this model (Chapter 4). In the second study (Section 5.4), 
neuronal excitability was evaluated in the spinal cord at day 7 following the same 15 
minute and 3 minute compression durations, in separate groups. Extracellular recordings 
were made in the dorsal horn while a range of mechanical stimuli strengths were applied 
to the forepaw. Collectively, these studies characterize and identify glutamate transporter 
and neuronal excitability responses in the spinal cord that are specific to painful nerve 
root compressions. 
 
5.3 Temporal Response of Spinal Glutamate Transporters 
5.3.1 Methods 
Male Holzman rats (275-375g) were housed in USDA- and AAALAC-compliant 
conditions with a 12–12 hour light–dark cycle and free access to food and water. All 
studies were IACUC-approved and carried out under the guidelines of the Committee for 
Research and Ethical Issues of the International Association for the Study of Pain 
(Zimmermann, 1983). 
Rats underwent a C7 nerve root compression applied for 15 minutes or 3 minutes, 
or sham procedures (n=14/group) (Nicholson et al. 2012, Rothman et al. 2010). 
Mechanical allodynia and thermal hyperalgesia were evaluated prior to surgery (baseline) 
and on days 1 and 7 after injury. The rats used for the current study were the same as 
those presented in Section 4.4; detailed methods for the surgical procedures and 
behavioral assessments are also described in Chapter 4. 
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In order to assess the temporal profile of spinal glutamate transporters, C7 spinal 
cord tissue was harvested at day 1 (n=7/group) and day 7 (n=7/group). Matched spinal 
cord sections were harvested from normal, naïve rats (n=2) and were included in all 
assays as controls. Rats were anesthetized with an intraperitoneal injection of 65mg/kg 
pentobarbital then transcardially perfused with 200ml Dulbecco’s Phosphate-Buffered 
Saline (PBS; Mediatech, Inc.; Manassas, VA) followed by 300ml of 4% 
paraformaldehyde (Sigma; St. Louis, MO). The C7 spinal cord was removed and post-
fixed over night. The samples were then transferred to 30% sucrose for cryoprotection 
and embedded in OCT media (Sakura Finetek USA, Inc.; Torrance, CA) then stored at  
-80˚C. Each spinal cord tissue was axially sectioned (14µm) and thaw-mounted onto 
slides.  
Sections were labeled for the glial glutamate transporters GLT-1 and GLAST, or 
the neuronal glutamate transporter, EAAC1, by blocking in 5% normal goat serum 
(Vector Laboratories; Burlingame, CA) with 0.3% Triton-X100 (Bio-Rad Laboratories; 
Hercules, CA) and then incubated overnight at 4°C in either rabbit anti-GLT-1 (1:1000; 
Abcam, Inc.; Cambridge, MA), rabbit anti-GLAST (1:1000; Abcam, Inc.; Cambridge, 
MA) or rabbit anti-EAAC1 (1:1000; Alpha Diagnostics). The slides were then 
fluorescently labeled with goat anti-rabbit Alexa Fluor 546 (1:1000; Invitrogen; Carlsbad, 
CA) and the ipsilateral and contralateral dorsal horns were digitally imaged at 200x from 
3-6 sections per slide.  
To quantify the expression of each glutamate transporter in the superficial dorsal 
horn, images were cropped to include laminae I-II and quantitative densitometry was 
used to measure the percent positive pixels as a measure of positive labeling (Abbadie et 
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a. 1996, Nicholson et al. 2012, Romer-Sandoval et al. 2008, Rothman et al. 2007). 
Results are reported relative to the expression of each marker as measured in normal 
tissue. Ipsilateral and contralateral transporter expression was evaluated separately. A 
two-way ANOVA tested for differences in the expression of each glutamate transporter 
over time for each injury group. At each day, a one-way ANOVA tested for differences 
between each injury group and normal. 
 
5.3.2 Results 
 As detailed in Chapter 4 and summarized in Appendix C, mechanical allodynia 
and thermal hyperalgesia were only elicited in the ipsilateral forepaw following the 15 
minute compression (Figs. 4.4 & 4.5). At both time-points assessed (days 1 & 7), the 
number of paw withdrawals following the 15 minute compression was significantly 
elevated (p<0.005) over both the 3 minute compression and sham groups (Fig. 4.5). 
Likewise, the withdrawal latency in the 15 minute compression group was significantly 
shorter (p<0.020) than the groups receiving a 3 minute compression or the sham 
procedures (Fig. 4.4). 
The spinal expression of GLT-1 in the ipsilateral dorsal horn decreased only at 
day 7 following the 15 minute compression (Fig. 5.1). All groups exhibited GLT-1 
expression that was comparable to normal levels at day 1. But, by day 7, the expression 
of GLT-1 in the ipsilateral superficial dorsal horn after the 15 minute compression 
(0.79±0.28 relative to normal) significantly decreased (p=0.002) compared to the 
expression levels in normal, naïve tissue (Fig. 5.1). Furthermore, this decrease in GLT-1 
expression was also significant when compared to sham and the 3 minute compression 
 108 
(p<0.035) at day 7, and also to the GLT-1 expression levels after a 15 minute  
compression at day 1 (p=0.046). The GLT-1 expression on the side contralateral to the 
applied nerve root injury was not different between any group or from normal levels at 
either time point (Fig. 5.1). A detailed summary of the quantification of spinal GLT-1 
expression for each rat is provided in Appendix D. 
 
The expression of GLAST in the ipsilateral dorsal horn increased in all injury 
groups at day 1 but this increase remained at day 7 only after a 15 minute compression 
(Fig. 5.2). GLAST expression increased significantly (p<0.033) over normal levels (by 
1.2-1.3 fold) on day 1 after all of the surgical procedures, including sham (Fig. 5.2). At 
day 7, GLAST expression in the ipsilateral dorsal horn after a 15 minute compression 
remained significantly (p=0.049) elevated over normal, and it significantly decreased  
Fig. 5.1 GLT-1 expression in the superficial laminae of the dorsal horn. GLT-1 expression decreased only at 
day 7 after a 15 minute compression compared to expression levels in normal tissue (Φp=0.002) and 
expression in the sham and 3 minute compression groups at day 7 (†p<0.035). GLT-1 expression was 
significantly decreased (δp=0.046) from day 1 to day 7. The expression of GLT-1 in the contralateral dorsal 
horn did not change over time or between injury groups. 
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(p=0.017) after sham between days 1 and 7 (Fig. 5.2). No differences in the expression of 
GLAST were observed in the contralateral dorsal horn between any injury group at day 1 
or day 7 (Fig. 5.2). Appendix D summarizes the detailed spinal expression levels of 
GLAST for each rat. 
 
No significant differences in the spinal expression of EAAC1 were observed 
between any group in both the ipsilateral and contralateral dorsal horns (Fig. 5.3). For 
each injury group, the expression of EAAC1 was also unchanged over time, from day 1 
to day 7. See Appendix D for the spinal expression of EAAC1 for each rat. 
Fig. 5.2 Spinal GLAST expression after nerve root compressions. At day 1, GLAST significantly 
increased (Φp<0.033) over normal levels in the ipsilateral dorsal horn following sham, 3 minute 
compression and 15 minute compression. GLAST expression remained significantly elevated over 
normal (Φp=0.049) at day 7 only after a 15 minute compression. GLAST expression significantly 
decreased (δp=0.017) after sham from day 1 to day 7. No differences in the contralateral GLAST 
expression were observed between any group or over time. 
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5.4 Evoked Afferent Signaling in the Spinal Cord 
5.4.1 Methods 
All studies used male Holtzman rats (300-400g; Harlan Sprague–Dawley; 
Indianapolis, IN). Rats were housed in a 12-12 hour light-dark cycle and given free 
access to food and water. Studies were approved by our Institutional Animal Care and 
Use Committee and carried out under the guidelines of the Committee for Research and 
Ethical Issues of the International Association for the Study of Pain (Zimmermann 1983). 
Rats underwent procedures for a C7 nerve root compression applied for 3 minutes 
(n=2) or 15 minutes (n=13), using the methods described in Chapters 3 and 4 (Hubbard & 
Winkelstein 2005, Nicholson et al. 2011, Nicholson et al. 2012, Rothman & Winkelstein 
Fig. 5.3 The spinal expression of EAAC1 after a transient nerve root compression. At days 1 and 7, the 
bilateral spinal expression of EAAC1 in the superficial laminae was not different from sham or normal 
levels following a 3 minute or a 15 minute nerve root compression.  
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2007). A control group that underwent sham procedures was also included (n=13). 
Bilateral mechanical allodynia was evaluated at day 7 by counting the total number of 
paw withdrawals elicited by 30 stimulations of a 4.0gf filament applied to the forepaw. 
Detailed methods for assessing mechanical allodynia are described in Section 4.3 
(Hubbard & Winkelstein 2005, Nicholson et al. 2012). Differences in the number of paw 
withdrawals between each group were determined by a one-way ANOVA with post-hoc 
Bonferroni correction. At day 7, electrophysiologic recordings were made in the 
superficial laminae (50-450µm below the pial surface) and the deep laminae (450-
1000µm), in separate groups. Recordings were made in the superficial laminae following 
a 15 minute compression or sham procedures (n=8 rats/group). Recordings were made in 
the deep laminae following a 15 minute compression (n=5 rats), a 3 minute compression 
(n=2 rats) and sham procedures (n=5 rats). 
In order to record extracellular potentials in the dorsal horn of the spinal cord, rats 
were anesthetized with 45mg/kg pentobarbital via an intraperitoneal injection. Adequate 
anesthesia was confirmed by a hind paw pinch and was maintained with an additional 
dose of pentobarbital (1-5mg/kg i.p.) given approximately every 40-50 minutes, or as 
needed. The cervical spine was re-exposed at day 7 via a dorsal, midline incision and any 
scar tissue that had formed over the right C6/C7 spinal cord from the initial surgery was 
carefully removed. A laminectomy removed any remaining bone at C6 and C7 on the left 
side to fully expose the spinal cord at those levels; then the dura was removed. The rat 
was placed on a stereotaxis frame using bilateral ear bars and a clamp to the spinous 
process of T2. Mineral oil was applied to the spinal cord to maintain its hydration. A 
thoracotomy was performed to minimize spinal cord motion associated with normal 
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breathing and respiration was maintained by mechanical ventilation via a mid-cervical 
tracheotomy (40-50 cycles/min; Harvard Small Animal Ventilator Model 683; Harvard 
Apparatus; Holliston, MA) (Crosby et al. 2013). Expired CO2 concentration was 
continuously monitored (Capnogard; Novametrix Medical Systems; Wallingford, CT) 
and the core body temperature was maintained between 35-37°C using a heat plate and a 
rectal probe (TCAT-2DF; Physitemp Instruments Inc.; Clifton, NJ).  
Extracellular spinal cord recordings were acquired using a glass-insulated 
tungsten probe (<1µm tip; FHC; Bowdoin, ME) inserted vertically into the dorsal spinal 
cord proximal to the site where the C7 nerve root exits the spinal cord. Recordings were 
made in both the ipsilateral and contralateral superficial laminae; in the deep laminae, 
recordings were only made in the ipsilateral dorsal horn. The signal was amplified with a 
gain of 3000 (ExAmp-20KB; Kation Scientific, Inc.; Minneapolis, MN), processed with a 
60Hz noise eliminator (Hum Bug; Quest Scientific; North Vancouver, BC) and digitally 
stored at 25kHz (MK1401; CED; Cambridge, UK). Mechanoreceptive neurons 
innervating the forepaw were searched for by lightly brushing the plantar surface of the 
forepaw and slowly advancing the probe through the dorsal horn (50-450µm or 450-
1000µm below the pial surface for the superficial and deep laminae, respectively) until a 
neuron responsive to the light brushing was found (Crosby et al. 2013, Hains et al. 2003, 
Quinn et al. 2010). Once a neuron was identified, a sequence of six mechanical stimuli 
was applied to the forepaw: (1) 10 light brush strokes with a brush applied over 10 
seconds; (2-5) a series of four von Frey filaments (1.4, 4.0, 10.0, 26.0gf), each applied 
five times for 1 second with a 1-second rest between application; and (6) a 10-second, 
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60gf pinch by a microvascular clip (Roboz, Inc.; Gaithersburg, MD) (Crosby et al. 2013, 
Quinn et al. 2010).  
Voltage recordings were spike-sorted in Spike2 (CED; Cambridge, UK) to count 
the number of action potentials evoked by each stimulus for individual neurons. For the 
brush stimulus, the number of action potentials was summed over the period of light 
brushing. For each von Frey filament application, the number of action potentials was 
summed over both the stimulation period and the rest period that immediately followed. 
For both the brush and the von Frey filament stimuli, the baseline number of spikes 
occurring in the 10-second period prior to the first stimulation was subtracted from the 
spike counts to identify only the spikes evoked by those stimuli (Hains et al. 2003). For 
the 60gf pinch, the number of spikes was summed over the 5-second period between 3-8 
seconds after the clip was applied, in order to only consider those spikes evoked by the 
pinch and to exclude the spikes evoked by the application and removal of the clip (Quinn 
et al. 2010). The number of spikes evoked by the clip stimulus was determined by 
subtracting the baseline number of spikes that occurred in the 5-second window prior to 
the first stimulation from the spike count. For statistical analysis, the spike count was log-
transformed because of a positive-skew in the distribution of data (Quinn et al. 2010). 
Separate two-way repeated measures ANOVAs tested for differences in the number of 
evoked spikes between groups and filament strength for each of the superficial and deep 
laminae and for the ipsilateral and contralateral dorsal horns, separately. Tukey HSD 
post-hoc tests compared the number of evoked spikes between groups that were evoked 
by each filament. 
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Neurons were classified as either wide dynamic range (WDR), low-threshold 
mechanoreceptive (LTM) or nociceptive specific (NS) by comparing the spike rate 
(spikes/sec) evoked by the light brushing and the 60gf clip stimuli (Hains et al. 2003, 
Laird & Bennett 1993, Saito et al. 2008). Neurons that responded maximally to the light 
brush were identified as LTM and those that responded in a graded manner were 
identified as WDR (Hains et al. 2003, Woolf & Fitzgerald 1983). Neurons that responded 
only to the noxious clip stimulus were classified as NS (Hains et al. 2003). The 
distribution of WDR, LTM and NS neurons between groups was compared using 
Pearson’s chi-squared tests for the ipsilateral and contralateral neurons and for each of 
the superficial and deep laminae, separately. All electrophysiology data are expressed as 
the mean±SEM. 
  
5.4.2 Results 
Behavioral sensitivity only developed in the ipsilateral forepaw by day 7 
following a 15 minute compression (Fig. 5.4). There was a significant increase in the 
number of paw withdrawals in the group that received a 15 minute compression 
compared to both the 3 minute compression (p=0.043) and the sham (p<0.001) groups. In 
the contralateral forepaw, there were no differences in the number of paw withdrawals 
between any of the groups (Fig. 5.4). The number of paw withdrawals that were elicited 
by each rat are detailed in Appendix C. 
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A total of 146 neurons were recorded in the superficial laminae (266±86µm) and 
78 neurons were recorded in the deep laminae (635±120µm). For the neurons recorded in 
the superficial (Fig. 5.5) and deep (Fig. 5.6) laminae, there were no differences between 
the depth of recording for each surgical group. The depth of recording and the number of 
spikes evoked by each filament are summarized for each neuron in Appendix E.  
There were no significant differences detected in the number of evoked spikes 
that were recorded for each group in either the superficial or deep laminae. In both the 
ipsilateral and contralateral dorsal horns, the frequency of neuronal firing in the 
superficial laminae after the painful 15 minute compression was comparable to that 
measured in the sham group (Fig. 5.5). The frequency of neuronal firing in the deep 
laminae of the ipsilateral dorsal horn was, in general, about 50% higher after the painful 
nerve root compression (15 minutes) compared to sham (Fig. 5.6), but this was not 
significant. Yet, neuronal firing in the deep laminae after a 3 minute compression 
remained near sham levels (Fig. 5.6). For example, the 10gf filament evoked 33.6±8.1 
Fig. 5.4 Mechanical allodynia at day 7 after a 15 minute compression, a 3 minute compression or sham. 
There was a significant (*p<0.044) increase in the number of paw withdrawals on the ipsilateral side 
elicited by a 4.0gf filament in the 15 minute compression group compared to the other groups. 
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spikes in the 15 minute compression group, 21.8±6.7 spikes in the 3 minute compression 
group and 21.0±4.4 spikes in the sham group (Fig. 5.6). 
 
 
The proportion of WDR neurons increased only in the ipsilateral superficial 
dorsal horn after a 15 minute compression (Fig. 5.7). In the ipsilateral spinal cord, 74% of 
the recorded neurons were classified as WDR in the 15 minute compression group; this 
Fig. 5.6 Total number of spikes in the deep dorsal horn evoked by a range of von Frey filaments applied 
to the ipsilateral forepaw at day 7. 
Fig. 5.5 Frequency of neuronal firing in the ipsilateral and contralateral superficial dorsal horns at day 7.
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was significantly (p=0.002) more than the proportion of WDR neurons identified after 
sham procedures (43%) (Fig. 5.7). Although the proportion of NS neurons did not change 
after the 15 minute compression, the proportion of LTM neurons decreased from 38% 
after sham to 10% after the painful nerve root compression (Fig. 5.7). In the contralateral 
superficial dorsal horn (Fig. 5.7) and in the ipsilateral deep laminae (Fig. 5.8), the 
phenotype distribution was unchanged between groups. No NS neurons were identified in 
the deep laminae of the dorsal horn for any of the groups. 
 
 
Fig. 5.8 Neuronal phenotype distribution in the deep laminae is not different between injury groups. No 
NS neurons were identified in the deep laminae for any group. 
Fig. 5.7 Neuronal phenotype distribution in the superficial dorsal horn at day 7. The distribution of 
LTM and WDR neurons in the ipsilateral dorsal horn is significantly different (p=0.002) after a painful 
15 minute compression than sham. There is also an increase in the proportion of WDR neurons and a 
decrease in the proportion of LTM neurons. The phenotype distribution in the contralateral dorsal horn 
does not change. 
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5.5 Discussion 
Downregulation of GLT-1, upregulation of GLAST, neuronal hyperexcitability 
and an increase in WDR neurons were only observed at day 7 following a painful (15 
minute) nerve root compression (Figs. 5.1-5.2 & 5.4-5.7). Like the transient nerve root 
compression used in the present study, spinal cord and peripheral nerve injuries also 
mediate spinal cord glutamate transporter expression in the rat (Kim et al. 2011, Sung et 
al. 2003). However, whether GLT-1, GLAST or EAAC1 is downregulated or upregulated 
depends on the type of injury sustained (Kim et al. 2011, Sung et al. 2003, Vera-
Portocarrero et al. 2002, Xin et al. 2009). Specifically, mechanical trauma to spinal cord, 
peripheral nerve or nerve root each differentially modulates spinal glutamate transporter 
expression (Kim et al. 2011, Sung et al. 2003, Vera-Portocarrero et al. 2002, Xin et al. 
2009). For example, both GLT-1 and EAAC1 are downregulated and GLAST is 
unchanged at day 7 after a sciatic nerve ligation (Sung et al. 2003). After a spinal cord 
contusion, GLT-1 and GLAST are downregulated, and EAAC1 is upregulated (Kim et al. 
2011). Therefore, while spinal cord trauma, peripheral nerve injury and nerve root 
compression are each characterized by neuronal hyperexcitability in the spinal cord (Figs. 
5.5 & 5.6; Hains et al. 2003, Hao et al. 1992, Liu et al. 2011, Pitcher et al. 2004) that is 
associated with dysregulation of spinal glutamate transporter expression (Figs. 5.1-5.3; 
Kim et al. 2011, Sung et al. 2003, Vera-Portocarrero et al. 2002, Xin et al. 2009), there 
are likely unique cellular mechanisms that contribute to these spinal responses that 
depend on the site and/or type of mechanical trauma. It is well-known that 
neurodegeneration can trigger oxidative stress, but non-injured neurons are protected 
from this oxidative stress, in part by removal of excess extracellular glutamate 
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(Markowitz et al. 2007, Tao et al. 2005). Neurodegeneration is localized to distinct 
regions of the nervous system following painful spinal cord, nerve root and peripheral 
nerve injuries. Specifically, neurodegeneration is evident in the spinal cord following a 
spinal cord compression, the central branch of the primary afferents after a nerve root 
compression, and the distal branch of the primary afferents following a sciatic nerve 
ligation (Carlton et al. 2009, Chen et al. 1992, Hubbard & Winkelstein 2008, Jancalek & 
Dubovy et al. 2007, Kobayashi et al. 2008).  Therefore, dysregulation of glutamate 
transporters in the spinal cord that is triggered by neurodegeneration is likely determined 
by whether neurodegeneration is present in the cord itself, the afferents that synapse in 
the cord or in peripheral regions of the nervous system (Carlton et al. 2009, Chen et al. 
1992, Hubbard & Winkelstein 2008, Jancalek & Dubovy 2007, Kobayashi et al. 2008). 
The damage to the primary afferents that develops after a painful nerve root injury 
likely contributes directly to the downregulation of GLT-1 that is observed in our study 
(Fig. 5.1; Hubbard & Winkelstein 2008, Kobayashi et al. 2008, Nicholson et al. 2011). 
Such damage, including axonal swelling and loss of axonal transport (Section 3.4), is 
only evident after the same painful 15 minute compression that was associated with a 
decrease in spinal GLT-1 here (Fig. 5.1; Hubbard & Winkelstein 2008, Nicholson et al. 
2011). Astrocytes require pre-synaptic neuronal signaling in order to express GLT-1 
(Ghosh et al. 2011, Yang et al. 2009). This damage extends to the primary synapse in the 
dorsal horn after a nerve root compression (Kobayashi et al. 2008), which provides a 
putative mechanism for impairment of the normal afferent signaling to spinal astrocytes 
and to the downregulation of spinal GLT-1 (Fig. 5.1). At one day after injury, when 
GLT-1 was unchanged (Fig. 5.1), the primary afferents also retain their normal 
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morphology in this injury model (Hubbard & Wikelstein 2008); the fact that the temporal 
profiles of GLT-1 downregulation and afferent degeneration are similar is further 
evidence that the primary afferents contribute, or are closely related, to the reduction in 
spinal GLT-1 after painful nerve root injury.  
Unlike GLT-1, GLAST expression does not require neuronal signaling, but is 
regulated by extracellular glutamate via positive feedback by which elevated glutamate 
concentrations increases GLAST expression (Aronica et al. 2001, Perego et al. 2000). 
The downregulation of GLT-1 after a painful nerve root compression (Fig. 5.1) likely 
increases the extracellular glutamate in the dorsal horn, thereby increasing GLAST (Figs. 
5.2). Interestingly, GLAST increased at day 1 in all groups (Fig. 5.2), suggesting that the 
surgical procedures alone are sufficient to increase spinal glutamate, but normal 
glutamate clearance after the non-painful procedures (sham; 3 minute compression) 
prevented the development of any further imbalances in the glutamatergic system. Even 
when extracellular glutamate concentrations are elevated in the central nervous system of 
rats or in neuron cultures, neuronal degeneration and excitotoxicity are prevented if an 
increase in glutamate uptake activity is able to prevent the sustained over-accumulation 
of glutamate (Gilad et al. 1990, Sher & Hu 1990, Springer et al. 1997). Even though 
GLAST remained elevated after the painful root compression, it was not able to 
compensate for the loss of GLT-1, which dominates glutamate uptake activity in the 
central nervous system (Danbolt 2001, Holmseth et al. 2012). EAAC1 was unchanged 
from sham and normal levels following both the nonpainful and painful nerve root 
compressions in the present study (Fig. 5.3). After a spinal cord contusion, EAAC1 is 
rapidly upregulated within one hour at the site of injury, but returns to normal levels 
 121 
within one day (Vera-Portocarrero et al. 2002, Xin et al. 2009). A similar, transient 
increase in spinal EAAC1 could have also occurred within hours after a nerve root 
compression, contributing to the initiation of nerve root-mediated pain (Vera-
Portocarrero et al. 2002, Xin et al. 2009). By day 7, however, the unchanged expression 
of spinal EAAC1 after a painful nerve root compression (Fig. 5.3) suggests that this 
transporter does play a significant role in the maintenance of nerve root-mediated pain. 
Understanding the pathways that regulate EAAC1 expression in this model, such as 
protein kinase signaling (Gonzalez et al. 2002, Holmseth et al. 2012), would provide 
additional insight into whether painful root compression modulates the function of 
EAAC1. 
 The frequency of neuronal firing after a painful nerve root compression increased 
in the deep laminae of the dorsal horn, but was not different from sham responses in the 
superficial laminae (Figs. 5.5 & 5.6). Few studies have evaluated neuronal firing rates in 
different laminae regions of the spinal cord in models of pain (Ramer et al. 2000, 
Seagrove et al. 2004, Urch et al. 2003, Wall et al. 1981). Unlike the present findings 
(Figs. 5.5 & 5.6), hyperexcitability in the superficial dorsal horn in a rat model of bone 
cancer pain was more robust than in the deeper laminae (Urch et al. 2003) indicating that 
different types of chronic pain may be mediated by hyperexcitability of distinct 
populations of dorsal horn neurons (Fig. 5.6; Urch et al. 2003). After a painful nerve root 
compression (15 minute), the frequency of neuronal firing in the deep dorsal horn 
increased by 40-60% compared to sham responses (Fig. 5.6). Specifically, the same 4.0gf 
filament that elicited mechanical allodynia at day 7 after the 15 minute compression (Fig. 
5.4) also evoked 40% more action potentials in the deep laminae compared to sham when 
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that filament was applied to the forepaw at this same time-point (Fig. 5.6), suggesting 
that mechanical sensitivity is likely mediated by hyperexcitability of deep dorsal horn 
neurons. Contrary to this, the frequency of neuronal firing in the superficial dorsal horn 
evoked by the 4.0gf filament slightly decreased after a painful nerve root compression 
compared to sham responses (Fig. 5.7). Cervical radicular pain is not likely encoded by 
the frequency of evoked neuronal firing in the superficial laminae due to the fact that the 
frequency of neuronal signaling evoked by a 4.0gf is unchanged in this region of the 
spinal cord even though that same filament evokes significantly more paw withdrawals 
after a painful compression (Figs. 5.4 & 5.5). Future studies should identify the 
neurochemical properties of deep dorsal horn neurons contributing to hyperexcitability in 
these neurons; it is possible that such studies may also identify a role for superficial 
dorsal horn neurons in mediating cervical radicular pain due to the interconnections 
between spinal neurons across laminae regions. 
Treatments to restore normal sensation following a cervical nerve root crush are 
able to do so by restoring electrically-evoked afferent signaling only in the deep dorsal 
horn (Ramer et al. 2000). The contribution of deep dorsal horn neurons to normal 
sensation (Ramer et al. 2000) and behavioral sensitivity (Figs. 5.4 & 5.6) following 
mechanical injury to the cervical nerve root implicate these neurons in driving nerve root-
mediated pain. Spinal circuits between the superficial and deep laminae do, however, 
suggest that changes to the intrinsic properties of superficial dorsal horn neurons may 
contribute to the hyperexcitability of the deep dorsal horn neurons (Suzuki et al. 2002, 
Urch et al. 2003). The increased hyperexcitability of the deep dorsal horn neurons 
observed in the present study may (Fig. 5.6), therefore, be attributed to an increase in the 
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amplitude of excitatory post-synaptic currents in laminae II that was reported in a rat 
model of lumbar root constriction (Terashima et al. 2011). Deep dorsal horn excitability 
could also be attributed to the increase in the proportion of WDR neurons that was 
observed in the superficial laminae (Fig. 5.7) given that WDR neurons are thought to 
mediate neuropathic and inflammatory pain (Hao et al. 1991, Liu et al. 2011, Urch et al. 
2003). Even though the present study did not detect any robust changes in the firing rate 
of superficial dorsal horn neurons (Fig. 5.5), nerve root mediated pain may be driven by 
changes in the intrinsic properties of neurons in the superficial dorsal horn, including the 
phenotype shift that was observed here (Fig. 5.7).   
 An increase in the synaptic strength between neurons in the superficial dorsal 
horn may contribute to the increase in WDR neurons in this region (Fig. 5.7; Keller et al. 
2010, Kohno et al. 2003, Okamoto et al. 2001). Astrocytes modulate synaptic strength, in 
part, by regulating extracellular glutamate (Paixão & Klein 2010, Tao et al. 2005). After a 
painful nerve root compression, there was a shift in the spinal expression of both 
glutamate transporters that are associated with astrocytes (GLT-1, GLAST) (Figs. 5.1 & 
5.2) indicating that there was also likely a shift in the neuronal synapse properties that are 
regulated by astrocytes in the spinal cord (Nguyen et al. 2009, Paixão & Klein 2010, Tao 
et al. 2005). The shift from LTM to WDR (Fig. 5.8) suggests that normally 
monosynaptic, LTM, neurons become polysynaptic, forming synapses with nociceptors 
(Keller et al. 2010). Such plasticity of the spinal neurons could be attributed to enhanced 
excitability or disinhibition of interneurons, which are predominantly localized to 
laminae I-III (Basbaum et al. 2009, Todd 2010). Downregulation of GLT-1 at day 7 (Fig. 
5.1) indicates that an increase in excitatory signaling in the superficial laminae likely 
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contributed to the spinal plasticity in this model of radiculopathy (Fig. 5.1; Cata et al. 
2006, Inquimbert et al. 2011), but does not rule out the contribution of reduced inhibitory 
signaling. It should be noted that reduced afferent synaptic connections, an hypothesized 
mechanism for GLT-1 downregulation (Ghosh et al. 2011, Yang et al. 2009), also may 
reduce the synaptic strength of inhibitory neurons (Todd 2010). Therefore, a decrease in 
inhibition along with the increase in excitatory signaling that is associated with GLT-1 
downregulation may have both contributed to the neuronal plasticity observed in this 
model of nerve root-mediated pain (Basbaum et al. 2009, Cata et al. 2006, Inquimbert et 
al. 2011, Todd 2010). Additional studies of the inhibitory and excitatory circuits after a 
nerve root compression are necessary to determine the role that each of these neuronal 
circuits have in nerve root-mediated pain.  
In the spinal cord, neuronal excitability and the glial expression of GLT-1 and 
GLAST at day 7 are each sensitive to the duration of an applied nerve root compression 
(Figs. 5.1, 5.2 & 5.6). Even though the same 10gf compression was applied to the nerve 
root for all studies, a compression period of 3 minutes was found to be insufficient to 
modulate glutamate transporter expression and neuronal excitability in the spinal cord 
(Figs. 5.1, 5.2 & 5.6). That same 3 minute compression also does not elicit behavioral 
sensitivity (Fig. 5.4), neuronal pathology in the nerve root or spinal glial activation, all of 
which are evident by day 7 after a painful 15 minute compression (Nicholson et al. 2011, 
Rothman et al. 2010). These behavioral, neuronal and glial responses are likely each 
initiated by the physiological responses of the nerve root tissues that develop during the 
applied compression, such as impaired intraradicular blood flow, nutrient transport and 
afferent signaling (Kobayashi et al. 2008, Nicholson et al. 2011, Olmarker et al. 1989b, 
 125 
Pedowitz et al. 1992). Indeed, studies show that the duration of an applied compression 
mediates the degree of impaired neurotransmission through the root (Nicholson et al. 
2011, Pedowitz et al. 1992) and that, in the same model of cervical radiculopathy used 
here, afferent discharge rates through the root continuously decrease for the first 6.6 
minutes of applied compression (Nicholson et al. 2011). Removing compression to the 
root before that critical duration (i.e. 3 minutes), precludes the development of behavioral 
sensitivity and associated neuronal and glial responses that normally occur after 
mechanical trauma to the nerve root (Hubbard & Winkelstein 2005, Hubbard et al. 2008a, 
Rothman et al. 2010). By characterizing spinal glutamate transporters and neuronal 
excitability for both painful and nonpainful nerve root compressions, the current study 
suggests that downregulation of GLT-1 and neuronal hyperexcitability are specifically 
associated with radicular pain (Figs. 5.1 & 5.6). Certainly, additional studies are required 
to test the contribution of spinal GLT-1 and neuronal excitability to nerve root-mediated 
pain; however, this is the first study to demonstrate that shifts in glutamate uptake by glia 
in the superficial laminae are associated with neuronal phenotype switches, which likely 
mediates neuronal hyperexcitability in the deep dorsal horn (Figs 5.1-5.2 & 5.5-5.7). 
Together, these studies suggest a role for glia in enhancing spinal excitatory signaling, 
which mediates radicular pain. 
 
5.6 Integration & Conclusions 
Studies reported in this chapter demonstrate that spinal GLT-1 decreases and 
neuronal excitability is enhanced (Figs. 5.1 & 5.5) only after a 15 minute compression 
that also elicits behavioral sensitivity (Chapter 4) and inhibits neurotransmission through 
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the root during compression (Chapter 3). Although a decrease in the frequency of 
afferent signaling through the root may initiate the development of behavioral sensitivity 
(Chapter 3 & 4), radicular pain is likely maintained by an increase in neuronal firing in 
the spinal cord (Fig. 5.6; Chapter 4). In the superficial laminae, neuronal 
hyperexcitability was unchanged at day 7 following a painful nerve root compression 
when a 4.0gf filament was applied to the forepaw of the rat despite the fact that the 4.0gf 
filament elicits more paw withdrawals at day 7 (Fig. 5.5). Yet an increase in the 
proportion of WDR neurons in the superficial dorsal horn may contribute to neuronal 
hyperexcitability that develops in the deeper laminae (Figs. 5.6 & 5.7; Suzuki et al. 2002, 
Urch et al. 2003). The glial glutamate transporter, GLAST, was upregulated at day 7 after 
a painful nerve root injury (Fig. 5.2). Although most studies would suggest that this 
upregulation is indicative of elevated glutamate clearance by this transporter, there are 
data suggesting that an increase in GLAST may also contribute to neuronal 
hyperexcitability (Niederberger et al. 2006). The downregulation of GLT-1 and the 
upregulation of GLAST (Figs. 5.1 & 5.2), may therefore, both contribute to neuronal 
hyperexcitability in nerve root-mediated pain. 
The electrophysiological studies in this chapter were performed in parallel with 
the electrophysiological studies presented in Chapter 7. In the studies presented here 
(Section 5.4), the frequency of neuronal firing increased by as much as 60% in the deep 
dorsal horn after a painful nerve root compression (Fig. 5.6). However, this increase was 
not statistically significant using the current group sizes (n=2-5 rats/group). Despite the 
small sample size, the robust differences in the deep dorsal horn were sufficient to inform 
the group sizes required for the Riluzole treatment experiments (Chapter 7) that were 
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performed concurrently. Therefore, in order to minimize the use of animals, in 
accordance with guidelines of the Committee for Research and Ethical Issues of the 
International Association for the Study of Pain (Zimmermann 1983), no additional 
electrophysiologic studies were conducted using these injury groups alone to characterize 
neuronal excitability in the spinal cord following 3 minute or 15 minute compression 
durations (Section 5.4). Instead, two control groups in the Riluzole study received an 
intraperitoneal injection of β-cyclodextrin as the vehicle on day 1; one group of rats 
underwent a painful 15 minute compression while the other group received the sham 
exposure. The electrophysiological recordings made in the deep dorsal horn from those 
two vehicle-control groups were consistent with those reported here; after a painful nerve 
root compression there is an increase in frequency of neuronal firing compared to sham 
responses in the deep laminae of the dorsal horn (Fig. 5.6). 
The downregulation of GLT-1 that is only observed following a painful (15 
minute) nerve root compression suggests that radicular pain is, in part, mediated by 
elevated spinal glutamate concentrations (Cata et al. 2006, Inquimbert et al. 2012, Tao et 
al. 2005). To test this hypothesis, studies in Chapter 6 will lower spinal glutamate 
concentrations by pharmacologically upregulating GLT-1 with daily intrathecal injections 
of ceftriaxone after a painful nerve root compression (Rothstein et al. 2005). To reduce 
spinal glutamate without altering its uptake by GLT-1, studies in Chapter 7 will block 
pre-synaptic glutamate release by administering Riluzole on day 1 after painful injury. 
Behavioral sensitivity and neuronal hyperexcitability are assessed in each 
pharmacological study. Together, Chapters 5-7 define the role of extracellular glutamate 
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in mediating both neuronal hyperexcitability and behavioral sensitivity following a 
painful nerve root compression. 
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CHAPTER 6 
 
Upregulation of GLT-1 by Ceftriaxone Treatment 
Alleviates Nerve Root-Mediated Pain 
 
Parts of this chapter have been adapted from: 
Nicholson KJ, Gilliland TM, Winkelstein BA. “Upregulation of GLT-1 by Treatment 
with Ceftriaxone Alleviates Radicular Pain by Reducing Spinal Astrocyte Activation and 
Neuronal Hyperexcitability” submitted. 
 
 
 
6.1 Overview 
A recent report by the Committee on Advancing Pain Research, Care, and 
Education of the Institute of Medicine identifies chronic pain as a leading public health 
issue in the United States (Institute of Medicine 2011). That report cites the fact that most 
new drugs for chronic pain are variations of existing treatments (i.e. opioids, non-
steroidal anti-inflammatory drugs) and suggests that basic science research should focus 
instead on novel approaches (Institute of Medicine 2011). Although the glutamatergic 
system has long been targeted for its role in mediating pain and therapies to alleviate 
neuropathic pain by antagonizing glutamate receptors show promise in animal studies, 
these drugs have psychosocial and cardiovascular side effects that prohibit their 
widespread clinical use (Muir & Lees 1995). Therefore, recent efforts to modulate the 
glutamatergic system have focused on the glutamate transporters, which regulate 
extracellular glutamate (Amin et al. 2012, Hajhashemi et al. 2012, Verma et al. 2010, 
Yamada & Jinno 2011). Maintaining normal extracellular glutamate by modulating 
glutamate transporters has the potential to maintain the normal function of glutamate 
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signaling in the central nervous system without producing significant deleterious side 
effects that are associated with many glutamate receptor antagonists (Muir & Lees 1995, 
Tao et al. 2005). The glutamate transporter, GLT-1, dominates glutamate uptake in the 
central nervous system of rats, and studies have shown that some antibiotics upregulate 
the spinal expression of this transporter (Amin et al. 2012, Nie et al. 2010, Rothstein et al. 
2005). One such antibiotic, ceftriaxone, relieves neuropathic pain after peripheral nerve 
injury in many animal models (Amin et al. 2012, Eljaja et al. 2011, Hajhashemi et al. 
2012, Hu et al 2010, Ramos et al. 2010). The studies presented in Chapter 5 demonstrate 
that painful nerve root compression is associated with a significant decrease in the spinal 
expression of GLT-1 by day 7 after injury, suggesting that this transporter may mediate 
the persistence of nerve root-mediated pain. To further define the relationship between 
spinal GLT-1 and cervical radicular pain, ceftriaxone was given intrathecally daily after 
painful nerve root injury to upregulate spinal GLT-1. In addition to behavioral sensitivity, 
spinal GLAST, GFAP and neuronal excitability were measured to characterize the 
contribution of GLT-1 on the astrocytic activation and increased neuronal activity that are 
normally observed after a painful nerve root compression (Chapter 5; Hubbard & 
Winkelstein 2005, Rothman et al. 2010). 
The work presented in this chapter focuses on the experiments outlined in Aims 
3a and 3c. Due to a large number of recent reports implicating GLT-1 downregulation in 
maintaining neuropathic pain after peripheral nerve injuries, including chronic 
constriction to the sciatic nerve and a spinal nerve ligation (Amin et al. 2012, Eljaja et al. 
2011, Hajhashemi et al. 2012, Hu et al 2010, Ramos et al. 2010), the studies in this 
chapter test the hypothesis that the downregulation of GLT-1 that is evident by day 7 
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after a painful nerve root compression (Chapter 5) contributes to the maintenance of 
mechanical allodynia and thermal hyperalgesia. Ceftriaxone was administered daily, 
starting on day 1, when the spinal expression of GLT-1 expression remains unchanged 
(Chapter 5). Spinal GLT-1 was measured at day 7 to assess whether the expression of this 
transporter is increased by such treatment. Mechanical allodynia and thermal 
hyperalgesia were measured for 7 days and comparisons were made to evaluate if 
treatment was effective in attenuating behavioral sensitivity.  
There is limited information about the relationship between ceftriaxone and other 
astrocytic and neuronal responses that normally develop in the spinal cord after a painful 
nerve root compression, including upregulation of GFAP and GLAST and enhanced 
neuronal excitability (Sections 5.3 & 5.4; Ramos et al. 2010, Rothman et al. 2010, 
Trantham-Davidson et al. 2012). Furthermore, few in vivo studies have characterized the 
dose-response of ceftriaxone on behavioral sensitivity (Amin et al. 2012, Hajhashemi et 
al. 2012, Hu et al. 2010) and, to-date, the dose-response of ceftriaxone on spinal cellular 
responses has only been reported for GLT-1 expression and pro-inflammatory cytokines 
levels (Amin et al. 2012). Even though ceftriaxone does reduce pro-inflammatory 
cytokines after a sciatic nerve constriction injury in the rat, the dose-response of 
ceftriaxone was only evaluated when given in combination with minocycline, an inhibitor 
of microglia (Amin et al. 2012, Raghavendra et al., 2003). Astrocytes, rather than 
microglia, however have a crucial role in the maintenance of neuropathic pain (Colburn 
et al. 1999, Hashizume et al. 2000, Milligan & Watkins 2009, Raghavendra et al. 2003, 
Wieseler-Frank et al. 2004) and astrocyte activation, along with neuronal activity, is 
associated with persistent cervical radicular pain (Chapter 5; Nicholson et al. 2012, 
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Rothman et al. 2010). Therefore, in order to characterize the dose-response of ceftriaxone 
to spinal astrocytic and neuronal responses that are relevant to chronic pain, two doses of 
ceftriaxone were administered using concentrations (10µg and 150µg) previously 
determined to alleviate neuropathic pain in the rat (Hu et al. 2010, Ramos et al. 2010). 
For each dose, spinal GLT-1, GLAST and GFAP were quantified at day 7 using 
immunohistochemistry. In separate groups of rats, spinal neuronal hyperexcitability was 
also measured at day 7 after treatment using electrophysiological techniques. 
 
6.2 Relevant Background 
The cervical nerve root is a common source of neck pain due to its susceptibility 
to injury from foraminal impingement, disc herniation and/or foraminal stenosis (Abbed 
& Coumans 2007, Carette & Fehlings 2005, Wainner & Gill 2000). In the rat, trauma to 
the nerve root induces persistent behavioral sensitivity (Colburn et al. 1999, Hashizume 
et al. 2000, Huang et al. 2012, Hubbard & Winkelstein 2005, Rothman et al. 2010). 
Glutamate is the primary neurotransmitter in pain signaling and its synaptic concentration 
is tightly regulated by glutamate transporters (Anderson & Swanson 2000, Basbaum et al. 
2009, Gegelashivilia et al. 2000, Tao et al. 2005). Because the glial glutamate transporter, 
GLT-1, removes as much as 90% of extracellular glutamate in the central nervous system 
(Danbolt 2001, Holmseth et al. 2012, Rothstein et al. 1996) normal glutamate uptake by 
this transporter is essential for maintaining the proper extracellular glutamate 
concentration (Inquimbert et al. 2012, Sung et al. 2003 ). In the spinal cord, GLT-1 has 
been shown to decrease within a week of a painful transient cervical nerve root 
compression (Chapter 5) and also peripheral nerve injury in association with behavioral 
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sensitivity, supporting a decrease in spinal GLT-1 expression as possibly contributing to 
neuropathic pain (Hu et al. 2010, Sung et al. 2003, Tao et al. 2005, Xin et al. 2009). 
Furthermore, upregulation of GLT-1 via administration of ceftriaxone has been shown to 
alleviate behavioral sensitivity and restore the normal spinal concentration of glutamate 
after painful nerve injury, without directly regulating either of the other two spinal 
glutamate transporters, EAAC1 and GLAST (Inquimbert et al. 2012, Rothstein et al. 
2005). Although those studies implicate GLT-1 in pain, it is not known whether restoring 
spinal GLT-1 expression would be sufficient to alleviate nerve root-mediated pain. 
Astrocytic activation and neuronal hyperexcitability are both mediated in the 
spinal cord by glutamate signaling and are associated with neuropathic pain (Cata et al. 
2006, Gao & Ji 2000, Liaw et al. 2005, Weng et al. 2006). Because astrocytic activation 
is only induced by transient nerve root compressions that are painful (Nicholson et al. 
2012, Rothman et al. 2010), spinal astrocyte activation via elevated glutamate signaling is 
hypothesized as contributing to nerve root-mediated pain. Increased spinal glutamate also 
enhances neuronal excitability (Cata et al. 2006, Jourdain et al. 2007, Nguyen et al. 2009, 
Sung et al. 2003). The amplitude of evoked excitatory post-synaptic currents increases in 
laminae II of the dorsal horn following a sustained constriction of the lumbar nerve root 
in the rat (Terashima et al. 2011) suggesting that excitatory neurotransmitters, such as 
glutamate, increase in the superficial dorsal horn (Jourdain et al. 2007, Nguyen et al. 
2009). Elevated glutamate concentrations in the dorsal horn may increase the excitability 
of the second order neurons that project into the deeper laminae from this region (Suzuki 
et al. 2000, Todd 2010, Urch et al. 2003), contributing to the neuronal hyperexcitability 
that develops in this region after a painful nerve root compression (Chapter 5). It is 
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unknown whether pharmacologic modulation of spinal glutamate by upregulation of 
GLT-1 would mediate the spinal neuronal signaling and/or astrocytic activation that is 
evident after a painful nerve root compression (Chapter 5; Hubbard & Winkelstein 2005, 
Nicholson et al. 2012, Rothman et al. 2010, Terashima et al. 2011). 
This study tests the hypothesis that spinal GLT-1 contributes to maintaining 
behavioral sensitivity following a transient cervical nerve root compression. Using 
ceftriaxone treatment paradigms previously determined to alleviate behavioral sensitivity 
following chronic constriction of the sciatic nerve, two doses of ceftriaxone (10µg and 
150µg) were administered daily into the intrathecal space (Amin et al. 2012, Eljaja et al. 
2011, Hu et al. 2010, Inquimbert et al. 2012, Ramos et al. 2010) after a painful root 
compression to determine their relative effectiveness in modulating spinal GLT-1 
upregulation and/or alleviating nerve root-mediated pain. Because pain is multi-modal 
(Jensen et al. 2001, Mogil 2009), both mechanical allodynia and thermal hyperalgesia 
were evaluated in order to define the contribution of GLT-1 on each of these pain 
modalities. Spinal GFAP and GLAST were evaluated at day 7 after ceftriaxone treatment 
to evaluate whether restoring GLT-1 also suppresses astrocyte activation and/or restores 
the normal spinal expression of this glutamate transporter. The effect of ceftriaxone on 
dorsal horn neuronal excitability also was evaluated by measuring evoked action 
potentials at day 7 after treatment. Although ceftriaxone has been reported to reduce 
spinal GFAP expression at a dose that also abolishes neuropathic pain and restores spinal 
GLT-1 in the rat (Ramos et al. 2010), in vitro studies suggest that astrocytic expression of 
GLT-1 and GFAP is independently modulated across varying concentrations of 
ceftriaxone (Bachetti et al. 2010, Beller et al. 2011, Lee et al. 2008). Therefore, in order 
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to define and compare the effectiveness of ceftriaxone in vivo on spinal GLT-1 and 
GFAP, along with its modulation of GLAST expression and neuronal excitability in the 
spinal cord, each were evaluated following both doses (10µg and 150µg). Collectively, 
these studies characterize the contribution of spinal GLT-1 to behavioral sensitivity after 
a painful nerve root compression. 
 
6.3 Methods 
6.3.1 Surgical Procedures & Ceftriaxone Administration 
Male Holzman rats (Harlan Sprague-Dawley; Indianapolis, IN; 275-375g) were 
housed in USDA- and AAALAC-compliant conditions with a 12–12 hour light–dark 
cycle and free access to food and water. All studies were IACUC-approved and carried 
out under the guidelines of the Committee for Research and Ethical Issues of the 
International Association for the Study of Pain (Zimmermann 1983). 
Rats underwent a 15 minute compression applied to the nerve root or sham 
exposure using methods described in Chapter 3 (Hubbard & Winkelstein 2005, Nicholson 
et al. 2011). Briefly, under isoflurane anesthesia, the right C7 nerve root was compressed 
by removing the right C6/C7 lamina and applying a 10gf microvascular clip for 15 
minutes. Starting on the first day after injury (day 1), rats were randomly assigned to 
receive either ceftriaxone treatment or the saline vehicle. Within the treatment group, one 
group of rats received a 40µL intrathecal injection of 10µg ceftriaxone (Wockhardt; 
Parsippany, NJ) dissolved in saline (injury+10µg; n=16); a second group of rats received 
a 40µL intrathecal injection of 150µg of ceftriaxone dissolved in saline (injury+150µg; 
n=16). In the vehicle treatment group (injury+saline; n=15), rats received a 40µL 
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intrathecal injection of saline alone. The same vehicle treatment was administered to rats 
that underwent sham procedures (sham+saline; n=15). Both the treatment and the vehicle 
were administered in the intrathecal space between L4 and L5 via a lumbar puncture on 
days 1-6, immediately following behavioral assessments (Hu et al. 2010, Rothman & 
Winkelstein 2010).  
 
6.3.2 Behavioral Assessments & Immunohistochemistry 
A subgroup of rats from each treatment group was evaluated for behavioral 
sensitivity (injury+10µg, n=8; injury+150µg, n=8, injury+saline, n=7; sham+saline, 
n=7). Detailed methods are described in Chapter 4 (Dirig et al. 1997, Hubbard & 
Winkelstein 2005). Bilateral mechanical allodynia was evaluated daily at baseline and on 
post-operative days 1 through 7 by counting the total number of paw withdrawals elicited 
(out of 30, for each filament) by a 1.4, a 2.0 and a 4.0gf von Frey filament. Bilateral 
thermal hyperalgesia also was evaluated by measuring the withdrawal latency to a 
thermal stimulus at baseline and on post-operative days 1 and 7, when thermal sensitivity 
is normally initiated and maintained in this model of cervical radiculopathy (Chapter 4). 
Two-way, repeated measures ANOVAs tested for differences in each behavioral 
assessment over time for the ipsilateral and contralateral forepaws, separately. At each 
time-point, a separate one-way ANOVA with post-hoc Bonferroni correction tested for 
differences between groups in mechanical allodynia and thermal hyperalgesia. The 
ipsilateral and contralateral forepaws were evaluated separately for all comparisons. 
The C7 spinal cord was harvested at day 7 and labeled for the glial glutamate 
transporters, GLT-1 and GLAST, using the methods described in Chapter 5. In addition, 
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spinal GFAP expression was also assessed as a marker of activated astrocytes (Colburn et 
al. 1999, Nicholson et al. 2012). Briefly, spinal sections were labeled for GLT-1, 
GLAST, or GFAP. Sections were blocked in 5% normal goat serum (Vector 
Laboratories; Burlingame, CA) with 0.3% Triton-X100 (Bio-Rad Laboratories; Hercules, 
CA) then incubated overnight at 4°C in rabbit anti-GLT-1 (1:1000; Abcam, Inc.; 
Cambridge, MA), rabbit anti-GLAST (1:1000; Abcam, Inc.; Cambridge, MA), or mouse 
anti-GFAP (1:500; Millipore; Bellerica, MA). The slides were then fluorescently labeled 
with goat anti-rabbit Alexa Fluor 546 (1:1000; Invitrogen; Carlsbad, CA) or goat anti-
mouse Alexa Fluor 546 (1:1000; Invitrogen; Carlsbad, CA) and the ipsilateral and 
contralateral dorsal horns from 3-6 sections per slide were digitally imaged at 200x and 
then cropped over the superficial dorsal horn (laminae I-II). Positive labeling was 
quantified using quantitative densitometry (Abbadie et al. 1996, Rothman et al. 2010). 
Results are reported relative to the expression of each marker measured in tissue samples 
from normal, naïve rates (n=2). For each labeled protein (GLT-1, GLAST, GFAP), a one-
way ANOVA tested for differences between each injury group for the ipsilateral and 
contralateral dorsal horns, separately. 
 
6.3.3 Electrophysiological Recordings 
In separate groups of rats, electrophysiological recordings were made in the spinal 
cord at day 7 (n=8/group). Bilateral mechanical allodynia was also assessed at baseline 
and on days 1 and 7 using the methods described in Section 5.4 such that mechanical 
sensitivity was measured in response to stimulation by the 1.4, 4.0 and 10.0gf filaments 
in order to match the mechanical stimuli that were applied to the forepaw during the 
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extracellular recordings. A t-test compared the number of paw withdrawals elicited by the 
4.0gf filament at day 7 between each group used for the electrophysiological study and 
their matched group in the immunohistochemistry study to test that the two studies used 
comparable conditions at the time of the electrophysiological recordings and tissue 
harvest, respectively. For statistical analysis, a one-way ANOVA tested for differences in 
the number of paw withdrawals between groups at each day that were elicited by each 
filament (1.4, 4.0, 10.0gf), for the ipsilateral and contralateral forepaws, separately. 
Extracellular recordings were made in the deep laminae of the spinal cord (400-
1000µm). Detailed methods are described in Section 5.4. A glass-insulated tungsten 
probe (<1µm tip; FHC; Bowdoin, ME) was inserted into the spinal cord proximal to the 
C7 nerve root in rats anesthetized with an intraperitoneal (i.p.) injection of pentobarbital 
(45mg/kg, supplemented by 1-5mg/kg doses, as needed). Mechanoreceptive neurons 
innervating the forepaw were searched for by lightly brushing the plantar surface of the 
forepaw (Crosby et al. 2013, Hains et al. 2003, Quinn et al. 2010). Once a neuron was 
identified, a sequence of six mechanical stimuli was applied to the forepaw: (1) 10 light 
brush strokes with a brush applied over 10 seconds; (2-5) a series of four von Frey 
filaments (1.4, 4.0, 10.0, 26.0gf), each applied five times for 1 second with a 1-second 
rest between application; and (6) a 10-second, 60gf pinch by a microvascular clip 
(Roboz, Inc.; Gaithersburg, MD) (Quinn et al. 2010). There was 60 seconds of rest 
between the applications of each of the different stimuli.  
Voltage recordings were spike-sorted in Spike2 (CED; Cambridge, UK) to count 
the number of action potentials that was evoked by each stimulus for individual neurons. 
For the brush stimulus, the number of action potentials was summed over the period of 
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the light brushing. For each von Frey filament application, the number of action 
potentials was summed over both the stimulation period and the 1-second rest period that 
immediately followed. For both the brush and the von Frey filament stimuli, the baseline 
number of spikes occurring in the 10-second period prior to the first stimulation was 
subtracted from the spike counts during stimulation in order to identify only the spikes 
evoked by those stimuli (Hains et al. 2003). For the 60gf pinch, the number of spikes was 
summed over the 5-second period between 3-8 seconds after the clip was applied, in 
order to only consider those spikes evoked by the pinch and to exclude the spikes evoked 
by the application and removal of the clip (Quinn et al. 2010). The number of spikes 
evoked by the clip stimulus was determined by subtracting the baseline number of spikes 
that occurred in the 5-second window prior to the first stimulation from the spike count.  
Neurons were classified as either wide dynamic range (WDR) or low-threshold 
mechanoreceptive (LTM) neurons by comparing the spike rate (spikes/sec) evoked by the 
light brushing and the 60gf clip stimuli (Hains et al. 2003, Laird & Bennett 1993, Saito et 
al. 2008). Neurons that responded maximally to the light brush were identified as LTM 
and those that responded in a graded manner were identified as WDR (Hains et al. 2003, 
Woolf & Fitzgerald 1983).  
For statistical analysis, the number of spikes counted in the electrophysiological 
study was log-transformed because of a positive-skew in the distribution of data (Quinn 
et al. 2010). Separate mixed-effect one-way ANOVAs with Tukey HSD post-hoc tests 
compared differences in the number of action potentials that were evoked by each 
filament between groups; neurons were nested within rats and rats were nested in groups. 
A mixed-effect one-way ANOVA with the same levels of nesting tested for differences 
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between groups for the depth at which the neurons were recorded from. The distribution 
of neurons identified as WDR and LTM was compared between groups using Pearson’s 
chi-squared tests. All electrophysiology data are expressed as the mean±standard error of 
the mean (SEM). 
 
6.4 Results 
6.4.1 Spinal GLT-1 Upregulation by Ceftriaxone 
The expression of GLT-1 in the ipsilateral dorsal horn at day 7 after a painful 
nerve root compression is increased by both of the 10µg and the 150µg doses of 
ceftriaxone treatment after a painful nerve root compression (Fig. 6.1). Spinal GLT-1 
expression in the ipsilateral dorsal horn decreased significantly (p=0.021) from sham 
(sham+saline) following a painful nerve root treated with saline (injury+saline); it was 
also significantly decreased (p=0.010) compared to the 150µg ceftriaxone treatment 
(injury+150µg). In fact, the expression of GLT-1 was not different between the 
sham+saline and either of the two ceftriaxone treatment groups (Fig. 6.1). In the 
contralateral dorsal horn, the expression of GLT-1 was unchanged between all of the 
groups. Quantification of spinal GLT-1 expression for each rat can be found in Appendix 
D. 
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6.4.2 Behavioral Sensitivity After Ceftriaxone Treatment 
 Both doses of ceftriaxone abolished mechanical allodynia and thermal 
hyperalgesia that developed in the ipsilateral forepaw after a painful nerve root 
compression (Figs. 6.2 & 6.4). Appendix C summarizes the behavioral data for each rat 
used in this study. At day 1, the number of paw withdrawals elicited by the 4.0gf von 
Frey filament significantly increased (p<0.001) in all of the groups that received a nerve 
root compression (injury+saline, injury+10µg, injury+150µg) compared to sham+saline 
(Fig. 6.2). However, by day 3 (2 days after the start of treatment), the number of paw 
withdrawals elicited by the 4.0gf filament in the treatment groups (injury+10µg, 
injury+150µg) returned to sham levels and remained significantly less (p<0.003) than the 
Fig. 6.1 Spinal GLT-1 at day 7 following root compression treated with 10µg or 150µg of ceftriaxone 
(injury+10µg, injury+150µg) or the saline vehicle (injury+saline), or following sham procedures 
(sham+saline). In the ipsilateral dorsal horn, the 150µg dose of ceftriaxone (injury+150µg) 
significantly (Φp=0.010) increased the expression of GLT-1 compared to the vehicle treatment 
(injury+saline). The expression of GLT-1 in the injury+saline group was also significantly reduced 
(*p=0.021) compared to sham+saline in the ipsilateral dorsal horn.  
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number of paw withdrawals elicited in the vehicle-treated group (injury+saline) for the 
remainder of the study (Fig. 6.2). The number of paw withdrawals in the sham+saline 
group did not significantly differ from baseline at any time-point.  
 
Fig. 6.2 Mechanical allodynia in the ipsilateral forepaw for daily ceftriaxone treatments starting on day 
1, quantified as the number of paw withdrawals for stimulation with a 1.4, 2.0 and 4.0gf filament. Prior 
to treatment on day 1, the number of paw withdrawals elicited by the 4.0gf filament in the ipsilateral 
forepaw of each group undergoing root compression (#injury+10µg, +injury+150µg, *injury+saline) 
was significantly greater (p<0.001) than sham+saline. The number of paw withdrawals in the 
injury+saline group was significantly elevated over sham (*p<0.001) for all post-operative time-points. 
Yet, starting on day 3, the number of withdrawals after ceftriaxone treatment significantly decreased 
(δp<0.001, injury+10µg; Φp<0.002, injury+150µg) compared to injury+saline. The 2.0gf filament 
responses were similar to those evoked by the 4.0gf filament, but not as robust; the number of paw 
withdrawals in the injury+10µg (δp=0.012) and injury+150µg (Φp=0.006) groups were significantly 
less than injury+saline starting at day 4. 
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 Testing with the 2.0gf filament elicited similar responses in the ipsilateral forepaw 
to those elicited by the 4.0gf in all groups (Fig. 6.2). At day 1, the number of paw 
withdrawals after ceftriaxone treatment (injury+10µg, injury+150µg) were significantly 
(p<0.005) increased over sham+saline; sham+saline did not vary from baseline at any 
time-point. The number of paw withdrawals elicited in the vehicle treatment group 
(injury+saline) was significantly elevated (p<0.019) over sham+saline on days 2 through 
7 (Fig. 6.2). On day 4, the number of paw withdrawals in the injury+vehicle group was 
also significantly elevated over both treatment groups (injury+10µg, p=0.012; 
injury+150µg, p=0.006) and remained significantly elevated over injury+10µg (p<0.019) 
through day 7 and injury+150µg (p<0.005) through day 6 (Fig. 6.2). 
 The number of withdrawals elicited by the 1.4gf filament applied to the ipsilateral 
forepaw did not significantly differ from baseline for any group and there were no 
differences in the number of paw withdrawals between any group (Fig. 6.2). Similarly, 
for testing with each of the three filaments in the contralateral forepaw, the number of 
paw withdrawals did not vary over time or between groups (Fig. 6.3). 
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 Like mechanical allodynia, thermal hyperalgesia in the ipsilateral forepaw after 
the nerve root compression treated with ceftriaxone decreased by day 7, regardless of the 
dose (Fig. 6.4). At day 1, the withdrawal latency was significantly shorter (p<0.038) after 
a nerve root compression (injury+saline, injury+10µg, injury+150µg) compared to sham 
(sham+saline) (Fig. 6.4); sham+saline did not differ from baseline at either time-point. 
But, by day 7, the withdrawal latencies in the groups receiving the 10µg ceftriaxone 
Fig. 6.3 Mechanical allodynia in the contralateral forepaw for testing with a 1.4, 2.0 and 4.0gf filament 
did not vary over time or from sham (sham+saline) after a nerve root compression treated with 
ceftriaxone (injury+10µg, injury+150µg) or the saline vehicle (injury+saline). 
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treatment (injury+10µg, 10.1±3.2 seconds) and the 150µg ceftriaxone treatment 
(injury+150µg, 10.4±2.1 seconds) were significantly greater (p<0.003) than the latency 
for the vehicle-treated group (injury+saline, 5.8±0.7 seconds) and was not different from 
sham+saline (9.4±1.1 seconds) (Fig. 6.4). Thermal hyperalgesia in the contralateral paw 
was unchanged from baseline for all groups (Fig. 6.4). 
 
Fig. 6.4 Thermal hyperalgesia prior to (baseline, day 1) and after (day 7) daily treatments of 
ceftriaxone, starting on day 1. On day 1, there was a significant decrease in the withdrawal latency in 
the ipsilateral forepaw in each of the three groups undergoing root compression (#p=0.007, 
injury+10µg; +p=0.027, injury+150µg; *p=0.038, injury+saline) compared to sham+saline. By day 7, 
the withdrawal latency significantly increased in each of the groups receiving the ceftriaxone treatment 
(δp=0.002, injury+10µg; Φp=0.001, injury+150µg) compared to injury+saline. The withdrawal latency 
in injury+saline group remained significantly lower (*p=0.014) than sham+saline at day 7. 
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6.4.3 Effect of Ceftriaxone on Spinal GLAST & GFAP Expression 
Only the 10µg dose of ceftriaxone treatment (injury+10µg) decreased the 
expression of GFAP that was upregulated after the vehicle treatment (injury+saline) (Fig. 
6.5).  The expression of GFAP in the ipsilateral dorsal horn was significantly elevated 
(p<0.004) after a nerve root compression with vehicle treatment (injury+saline) and 
150µg of ceftriaxone (injury+150µg) compared to sham+saline. In the injury+10µg 
group, the ipsilateral expression of GFAP was not different from any group (Fig. 6.5).  
 
Fig. 6.5 Ceftriaxone dose-dependently modulated bilateral spinal expression of GFAP at day 7. In the 
ipsilateral dorsal horn, the expression of GFAP was significantly elevated in the injury+saline 
(*p=0.001) and the injury+150µg (+p=0.003) groups compared to sham+saline. The expression of 
GFAP in the injury+10µg group was not different from any other group in the ipsilateral dorsal horn. In 
the contralateral dorsal horn, the expression of GFAP was also elevated after injury+saline compared to 
both sham+saline (*p=0.001) and injury+10µg (δp<0.001). After treatment with ceftriaxone, the 
expression of GFAP in the contralateral dorsal horn significantly increased (θp=0.012) in injury+150µg 
compared to injury+10µg. 
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In the contralateral dorsal horn, GFAP expression was significantly elevated 
(p<0.002) in the vehicle treatment group (injury+saline) compared to both the 
sham+saline and injury+10µg groups (Fig. 6.5). Following treatment with 150µg of 
ceftriaxone (injury+150µg), the expression of GFAP was significantly elevated (p=0.012) 
over the 10µg treatment group (injury+10µg) (Fig. 6.5).  
Both doses of ceftriaxone returned the ipsilateral expression of GLAST to sham 
levels at day 7 after a nerve root injury (Fig. 6.6). After a nerve root compression treated 
with the saline vehicle (injury+saline), the expression of GLAST in the ipsilateral dorsal  
horn was significantly increased (p=0.047) over sham+saline. For each ceftriaxone  
 
Fig. 6.6 Spinal GLAST expression at day 7 after a root compression treated with ceftriaxone 
(injury+10µg, injury+150µg) and the saline vehicle (injury+saline), and sham exposure (sham+saline). 
The expression of GLAST only increased in the ipsilateral dorsal horn after injury+saline compared to 
injury+10µg (δp=0.033), injury+150µg (Φp=0.042) and sham+saline (*p=0.047). 
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treatment dose, GLAST expression in the ipsilateral dorsal horn was significantly 
reduced (injury+10µg, p=0.033; injury+10µg, p=0.042) compared to injury+saline, and 
not different from sham levels (Fig. 6.6). The expression of GLAST in the contralateral 
dorsal horn was unchanged between all groups. Appendix D summarizes the 
quantification of spinal GFAP and GLAST for the individual rats in this study. 
 
6.4.4 Evoked Action Potentials in the Spinal Cord After Ceftriaxone Treatment  
 As with the behavioral sensitivity and spinal GLAST responses (Figs. 6.2, 6.4 & 
6.6), ceftriaxone reduced the neuronal hyperexcitability that develops in the ipsilateral 
spinal dorsal horn after a nerve root compression. As was observed in the rats used in the 
immunohistochemical study (Fig. 6.2), the number of paw withdrawals elicited by the 4.0 
filament at day 7 was significantly elevated in the vehicle treated group (injury+saline; 
p<0.001) over both of the ceftriaxone treatment groups (injury+10µg, injury+150µg) and 
the sham exposure (sham+saline) (Fig. 6.7). Likewise, for testing with the 10.0gf 
filament at day 7, a significant increase (p<0.001) in the number of ipsilateral paw 
withdrawals was observed in the injury+saline group compared to the injury+10µg, 
injury+150µg and sham+saline groups (Fig. 6.7). There were no differences in the 
number of paw withdrawals elicited by the 1.4gf filament between any group; no 
differences were observed in the contralateral forepaw between groups for testing with 
any filament (Fig. 6.7). Please see Appendix C for a summary of the behavioral data for 
each rat.  
 149 
 
A total of 273 neurons were recorded for all four groups, at an average depth of 
646±138µm. The average depth of neurons that was recorded for each group was not 
significantly different from each other. The recording depth and spike counts for each 
neuron are summarized in Appendix E. 
Similar to the behavioral responses, the number of action potentials evoked by the 
4.0, 10.0 and 26.0gf filaments increased significantly (p<0.024) in the injury+saline 
group compared to sham (sham+saline) and the 10µg treatment group (injury+10µg) 
(Fig. 6.8). The number of evoked spikes in the 150µg treatment group (injury+150µg) 
was only significantly elevated over sham+saline (p<0.042) for testing with the 10.0 and 
26.0gf filaments (Fig. 6.8). On average, the number of spikes evoked in the injury+saline 
group was 2-3 times greater than the number of spikes evoked in any other group. For 
Fig. 6.7 Bilateral mechanical allodynia at day 7 after a painful root compression treated with 
ceftriaxone (injury+10µg, injury+150µg) or vehicle (injury+saline), or sham procedures 
(sham+saline). The number of withdrawals elicited in the ipsilateral forepaw by the 4.0 and 10.0gf 
filaments in the injury+saline group was significantly elevated (†p<0.001) over all other groups. 
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example, for stimulation by the 10.0gf filament, the number of evoked spikes in the 
injury+saline group was 51.3±8.6, which was significantly greater than the number of 
spikes evoked by that filament for the sham+saline (17.5±3.3; p=0.002), the injury+10µg 
(24.2±2.8; p=0.023) and the injury+150µg (28.8±5.0; p=0.041) groups. Although the  
Fig. 6.8 Ceftriaxone reduces neuronal hyperexcitability in the spinal cord at day 7 after injury 
(injury+10µg, injury+150µg) compared to vehicle (injury+saline). (A) Representative extracellular 
potentials recorded in the ipsilateral spinal cord for each group during application of the 4.0gf filament 
stimulus (stim) are shown. (B) The number of spikes evoked in the ipsilateral spinal cord by the 4.0, 
10.0 and 26.0gf filaments applied to the paw was significantly elevated in injury+saline compared to 
sham+saline (*p<0.008), injury+10µg (δp<0.024) and injury+150µg (the 10.0 and 26.0gf filaments 
only, Φp<0.042). (C) Contralateral neuronal excitability was not different between any group.  
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number of spikes elicited by the 1.4gf was elevated in the injury+saline group, this 
increase was not significant. Similarly, the small increase in the number of spikes in the 
contralateral dorsal horn that was evoked in the injury+saline group by stimulation using  
the 10.0 and 26.0gf filaments was not statistically different from sham+saline, 
injury+10µg or injury+150µg (Fig. 6.8). In addition, the proportion of WDR neurons 
identified in the ipsilateral spinal cord that were recorded from in the injury+saline group 
(91%) was significantly greater (p<0.015) than the proportion of WDR neurons recorded 
in ipsilateral dorsal horn of any of the other groups (Fig. 6.9): sham+saline (60%), 
injury+10µg (64%), injury+150µg (67%). The proportion of WDR neurons in the 
contralateral dorsal horn (63-72%) did not differ between any of the groups (Fig. 6.9). 
 
 
 
Fig. 6.9 Both 10µg and 150µg of ceftriaxone reduced the proportion of WDR neurons detected in the 
spinal cord at day 7 after injury (injury+10µg, injury+150µg) compared to vehicle (injury+saline) and 
sham (sham+saline). The percent of WDR neurons after injury+saline increased only in the ipsilateral 
spinal cord compared to sham+saline (*p=0.004), injury+10µg (δp=0.008) and injury+150µg 
(Φp=0.014).  
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6.5 Discussion 
Ceftriaxone treatment restored GLT-1 expression in the spinal cord while also 
abolishing behavioral sensitivity and the associated GLAST upregulation and neuronal 
hyperexcitability that normally develop at day 7 (Figs. 6.1-6.4 & 6.6-6.9; Chapter 5). The 
spinal astrocytic activation that develops after a painful nerve root compression 
(Nicholson et al. 2012, Rothman et al. 2010) was abolished by the 10µg dose of 
ceftriaxone, but not by the 150µg dose (Fig. 6.5). Although this is the first study to 
demonstrate that daily intrathecal injection of ceftriaxone in the lumbar region of the rat 
upregulates GLT-1 in the cervical region, it is not the first to show that pharmacological 
agents delivered to the lumbar region can mediate cellular outcomes in the cervical spinal 
cord. In this same painful injury model, cervical spinal inflammation was attenuated by 
cytokine antagonists delivered via lumbar puncture (Rothman & Winkelstein 2010). 
Daily lumbar punctures of ceftriaxone, as was done in the current study, increases GLT-1 
expression in the lumbar cord, but has no effect on behavioral sensitivity in the hindpaw 
of normal rats (Hu et al. 2010). It is, therefore, unlikely that the delivery method chosen 
for the current study changed behavioral sensitivity in the hindpaw, which was not 
measured.  
 This is the first study to demonstrate that upregulation of GLT-1 by daily 
intrathecal injection of ceftriaxone abolishes radicular pain and, for the 10µg dose, 
associated spinal astrocyte activation (Figs. 6.1-6.5). In response to varying magnitudes 
and durations of nerve root compression, spinal astrocyte activation is evident only when 
behavioral sensitivity also develops, supporting the role of reactive astrocytes in 
providing substantial contributions to the persistence of behavioral sensitivity (Nicholson 
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et al. 2012, Rothman et al. 2010). Although it has been reported that glial activation is 
necessary for the maintenance of pain (Weiseler-Frank et al. 2004), the results of this 
study indicate that astrocyte activation alone is not sufficient to induce behavioral 
sensitivity due to the fact that the 150µg dose of ceftriaxone did reduce behavioral 
sensitivity in the absence of a reduction in spinal GFAP expression (Figs. 6.2 & 6.5). In 
addition to their role in taking up extracellular glutamate, the activated spinal glia also 
contribute to pain by modulation of neuronal synapse strength and neuronal excitability 
through the release of neurotransmitters, neuropeptides and cytokines (Milligan & 
Watkins 2009, Wieseler-Frank et al. 2004). Glia likely mediate radicular pain by a 
combination of their functions; however, the results of this study indicate that 
maintenance of normal GLT-1 uptake of glutamate by glial cells is, in itself, sufficient to 
abolish nerve root-mediated pain, with or without, a reduction in spinal astrocyte 
activation (Figs. 6.1-6.5). Many studies demonstrate that cervical radicular pain is 
associated with activated astrocytes in the spinal cord (Hubbard & Winkelstein 2005, 
Nicholson et al. 2012, Rothman et al. 2010) and that astrocytes contribute to chronic 
neuropathic pain by releasing pro-inflammatory cytokines, ATP, nitric oxide and 
prostaglandin E2 (Markowitz et al. 2007, Milligan & Watkins 2009, Perea et al. 2009, 
Ren & Dubner 2008). Although previous reports suggest that astrocytes contribute to the 
initiation of nerve root-mediated pain by releasing pro-inflammatory cytokines (Rothman 
et al. 2009b, Rothman & Winkelstein 2010), this is the first study to identify a potential 
cellular mechanism (GLT-1) by which these astrocytes contribute to the maintenance of 
cervical radicular pain (Figs. 6.1-6.5). 
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Ceftriaxone modulates the astrocytic expression of GFAP and GLT-1 in vitro 
through the NF-κβ signaling pathway (Bachetti et al. 2010, Lee et al. 2008, Yamada & 
Jinno 2011). In cultured astrocytes, ceftriaxone decreases GFAP promoter activity and 
suppresses GFAP upregulation by reducing NF-κβ activity, but increases the expression 
of GLT-1 by promoting NF-κβ signaling (Bachetti et al. 2010, Lee et al. 2008, Yamada & 
Jinno 2011). There is a dose-dependent relationship between ceftriaxone and NF-κβ 
activity, which may explain the divergent effects of ceftriaxone on astrocytes (Bachetti et 
al. 2010, Lee et al. 2008, Yamada & Jinno 2011). In separate studies, low concentrations 
of ceftriaxone activate NF-κβ and increases GLT-1 promoter activity in vitro (Ghosh et 
al. 2011, Lee et al. 2008) while higher concentrations are required to suppress the activity 
NF-κβ and reduce GFAP promoter activity in cultured astrocytes (Bachetti et al. 2010, 
Yamada & Jinno 2011). Although GLT-1 expression has not been evaluated under 
conditions required for ceftriaxone to reduce NF-κβ signaling and GFAP promoter 
activity, it is likely that GLT-1 is reduced or unchanged at these higher concentrations 
due to its dependence on NF-κβ activation (Bachetti et al. 2010, Lee et al. 2008, Yamada 
& Jinno 2011).  Taken together, these in vitro studies suggest that both the 10µg and 
150µg doses used in the present study were sufficiently low to up-regulate GLT-1 (Fig. 
6.1) by promoting the NF-κβ signaling pathway (Ghosh et al. 2011, Lee et a. 2008). It is, 
therefore, likely that ceftriaxone did not directly modulate GFAP expression (Fig. 6.5). It 
could be hypothesized then, that the decrease in GFAP expression that is evident after the 
10µg treatment (Fig. 6.5) was a consequence of reduced extracellular glutamate. This 
would not explain why GFAP remained elevated after treatment with the 150µg dose 
(Fig. 6.5), however. Although previous studies demonstrate that ceftriaxone alleviates 
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behavioral sensitivity and reduces astrocyte activation while promoting GLT-1 
expression in peripheral nerve injury and multiple sclerosis (Ramos et al. 2010), the 
current study demonstrates that there is no clear relationship between ceftriaxone and its 
effects on GLT-1 and GFAP. Additional in vitro and in vivo studies are needed to clarify 
the mechanism(s) by which ceftriaxone modulates the expression of GLT-1 and GFAP in 
order to fully understand how astrocytes contribute to the maintenance of nerve root-
mediated pain.  
 Spinal GLAST expression and neuronal hyperexcitability are both mediated, in 
part, by extracellular glutamate activation of metabotropic glutamate (mGluRs) and N-
methyl-D-aspartate (NMDA) receptors (Aronica et al. 2003, Jourdain et al. 2007, Ren & 
Dubner 2008, Tilleux & Hermans 2007). The reduction in both spinal GLAST expression 
and neuronal hyperexcitability that was observed after painful root compression treated 
with ceftriaxone (Figs. 6.6 & 6.8) serve as proxies suggesting reduced spinal glutamate 
signaling (Aronica et al. 2003, Jourdain et al. 2007, Ren & Dubner 2008, Tilleux & 
Hermans 2007). Very few studies have evaluated the effects of ceftriaxone on GLAST 
expression or neuronal hyperexcitability (Mimura et al. 2011, Rothstein et al. 2005, 
Trantham-Davidson et al. 2012). Ceftriaxone has no effect on GLAST in both normal rats 
and brain-injured neonate pups (Mimura et al. 2011, Rothstein et al. 2005), indicating 
that the downregulation of spinal GLAST at day 7 after the ceftriaxone treatment (Fig. 
6.6) was not likely a direct consequence of ceftriaxone. Excitatory signaling in the 
nucleus accumbens of the rat after cocaine administration is also reduced by upregulating 
GLT-1 with ceftriaxone (Knackstdedt et al. 2010, Trantham-Davidson et al. 2012). 
Although that study, along with our results (Fig. 6.8), indicates that ceftriaxone can 
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modulate neuronal excitability, it is not clear whether neuronal signaling is directly 
modulated by ceftriaxone or by GLT-1 regulation of extracellular glutamate in the spinal 
cord. Interestingly, inhibition of spinal GLAST in the rat reduces extracellular glutamate 
and excitatory neuronal signaling, which is contrary to the notion that glutamate 
transporter inhibition would increase excitatory signaling (Niederberger et al. 2006). 
Although it is not clear how GLAST regulates excitatory signaling, the downregulation 
of GLAST after ceftriaxone treatment may also contribute to reducing the spinal neuronal 
hyperexcitability (Figs. 6.6 & 6.8) (Niederberger et al. 2006). 
 Ceftriaxone also reduced the distribution of WDR neurons in the spinal cord after 
injury (Fig. 6.9). There is an increase in neurons exhibiting a WDR phenotype after a 
painful root compression (Fig. 6.9); this is consistent with rodent models of spinal cord 
hemisection, facet joint distraction and sciatic nerve compression (Hains et al. 2003, 
Keller et al. 2007, Quinn et al. 2010) and may be a functional reorganization of afferents 
in the dorsal horn such that normally monosynaptic neurons become polysynaptic (Baba 
et al. 2003, Keller et al. 2007, Kohno et al. 2003, Okamoto et al. 2001). Specifically, the 
shift from LTM to WDR neurons (Fig. 6.9), suggests that after injury, high threshold Aδ 
and C fibers form synapses with neurons that normally only synapse with low-threshold 
Aβ fibers (Basbaum et al. 2009, Keller et al. 2007, Okamoto et al. 2001). Alternatively, 
the phenotypic shift could indicate enlarged WDR neuron receptive fields after injury 
(Hanai et al. 1996, Konodo et al. 2003, Suzuki et al. 2000), increasing the likelihood of 
finding this type of neuron using the search protocol employed in this study. However, 
increased receptive field size is also attributed to central reorganization of afferents in the 
spinal cord after nerve injury (Konodo et al. 2003, Suzuki et al. 2000). Regardless, 
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whether the phenotypic shift observed here reflects an increase in the number of WDR 
neurons or an increase in WDR receptive field sizes, it does indicate plasticity in the 
spinal cord after a painful nerve root injury (Baba et al. 2003, Keller et al. 2007, Kohno et 
al. 2003, Konodo et al. 2003, Okamoto et al. 2001, Suzuki et al. 2000). Enhanced 
excitability of excitatory neurons is believed to be responsible for such reorganization 
(Keller et al. 2007, Kohno et al. 2003). The intrathecal injection of ceftriaxone, which has 
been shown to reduce excitatory glutamate signaling in the spinal cord (Hu et al. 2010, 
Inquimbert et al. 2012), restored the distribution of WDR neurons after injury to the 
cervical nerve root (Fig. 6.9). These two effects of ceftriaxone indicate that enhanced 
excitatory signaling, rather than reduced inhibitory signaling, contributes, at least in part, 
to spinal reorganization after a painful nerve root injury (Baba et al. 2003, Keller et al. 
2007, Kohno et al. 2003, Okamoto et al. 2001). 
Both doses of ceftriaxone (10µg, 150µg) abolished mechanical allodynia and 
thermal hyperalgesia in the forepaw after a painful nerve root compression (Figs. 6.2 & 
6.4). Contrary to these findings, mechanical allodynia has been reported to exhibit a 
graded decrease for doses from 50µg to 100µg after a sciatic nerve injury in the rat; at 
least 100µg is required to abolish behavioral sensitivity when treatment begins at day 9 
(Hu et al. 2010). Even though that study, like the one presented here, administered 
ceftriaxone daily by lumbar puncture, there was a 10-fold increase in the amount of 
ceftriaxone required to abolish mechanical allodynia produced by a peripheral nerve 
injury (100µg vs. 10µg; Fig. 6.2) (Hu et al. 2010). The different dose-response of 
ceftriaxone on behavioral sensitivity between that neuropathic pain model and the 
radicular pain model used here could be attributed to differences between nerve- and 
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nerve root-mediated pain, but is more likely due to the earlier time of intervention (day 1) 
that was used in the current study. In that same painful nerve injury model, 50µg of 
ceftriaxone (the lowest dose tested), administered at the time of injury, completely 
prevented the development of mechanical allodynia (Hu et al. 2010). Twice as much 
ceftriaxone (100µg) was required to abolish behavioral sensitivity when treatment did not 
begin until day 9 (Hu et al. 2010), demonstrating that higher doses of ceftriaxone are 
needed to effectively alleviate pain when treatment is delayed until after the injury or 
pain has already been established. Because people often delay medical treatment for neck 
pain until it is severe enough to interfere with everyday activities (Côté et al. 2001), 
clinically-relevant doses of ceftriaxone for alleviating nerve root-mediated pain may be 
higher than the 10 and 150µg that were administered at day 1 in the current study. 
However, it is worth noting that daily, intrathecal injections of 150µg of ceftriaxone can 
alleviate behavioral sensitivity even if administration is not started until 12 days after a 
chronic constriction injury of the sciatic nerve in the rat (Ramos et al. 2010). Although 
additional studies are required to determine whether ceftriaxone can similarly attenuate 
radicular pain when treatment is administered at later time-points, the study by Ramos et 
al. (2010) does suggest that ceftriaxone can alleviate cervical radicular pain in the rat 
even if treatment begins at a late time after persistent behavioral sensitivity is established 
(Ramos et al. 2010). 
The current study did not determine whether the analgesic effects of ceftriaxone 
persist even after treatment is discontinued. The half-life of a single dose of ceftriaxone 
in the cerebrospinal fluid (CSF) of rodents is estimated to be 7-8 hours (Lutsar et al. 
1998); so within 3 days, less than 1% of the ceftriaxone would remain in the CSF after 
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the last treatment is given. Yet, after a chronic constriction to the sciatic nerve of the rat, 
ceftriaxone alleviates mechanical allodynia for at least 7 days after the final dose (Amin 
et al. 2012, Hajhashemi et al. 2012, Hu et al. 2010). These studies suggest that if 
ceftriaxone is administered until behavioral sensitivity resolves, pain symptoms will 
remain attenuated even after treatment is discontinued (Amin et al. 2012, Hajhashemi et 
al. 2012, Hu et al. 2010). It is likely, therefore, that ceftriaxone would have long lasting 
effects of abolishing mechanical allodynia and thermal hyperalgesia out to at least day 13 
in the current study, had behavioral testing been continued. Unlike its effects on 
behavioral sensitivity and GLT-1 expression (Hu et al. 2010, Ramos et al. 2010, 
Rothstein et al. 2005), few studies have characterized the effects of ceftriaxone on spinal 
inflammation, neuronal signaling or the expression of other glutamate transporters 
involved in pain. These results help to define the effects of ceftriaxone by evaluating 
spinal astrocytic activation, GLAST expression and neuronal hyperexcitability after 
treatment in a model of painful nerve root compression (Figs. 6.5, 6.6 & 6.8). Although 
the present study did not directly measure glutamate clearance in the spinal cord, 
ceftriaxone specifically increases the expression of the membrane-bound, dimer form of 
GLT-1, which is the only functionally active form of GLT-1 and also increases the 
activity of GLT-1 even when the transporter’s expression is unchanged in the rat 
(Haugeto et al. 1996, Lipski et al. 2007, Ramos et al. 2010). Therefore, the upregulation 
of GLT-1 by ceftriaxone (Fig. 6.1) strongly suggests that glutamate uptake also increases. 
By restoring the normal balance of glutamate uptake via GLT-1, ceftriaxone alleviates 
nerve root-mediated pain by reducing spinal hyperexcitability and also normalizing the 
spinal expression of GLAST and distribution of WDR neurons.  
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6.6 Integration & Conclusions 
Downregulation of spinal GLT-1 after a nerve root compression is only evident 
when behavioral sensitivity is also present (Chapters 4 & 5). Pharmacologic upregulation 
of this transporter with ceftriaxone alleviates both the mechanical allodynia and thermal 
hyperalgesia that develop after a painful nerve root compression (Figs. 6.2 & 6.4), 
suggesting that spinal GLT-1 contributes to radicular pain in this model and is not simply 
an indicator of a painful nerve root compression (Section 5.3). Interestingly, ceftriaxone 
also reduces spinal GLAST expression (Fig. 6.6), despite the fact that ceftriaxone does 
not alter the expression of GLAST in the central nervous system of normal, naïve rats 
(Rothstein et al. 2005). It is likely that ceftriaxone reduces spinal GLAST in this study by 
reducing glutamate concentration in the spinal cord, due to the increase in glutamate 
uptake by spinal GLT-1 (Figs. 6.1 & 6.6; Aronica et al. 2003, Jourdain et al. 2007, Ren & 
Dubner 2007, Tilleux & Jinn 2007). Therefore, even though studies in Chapter 5 show 
that a painful nerve root compression is associated with an increase in the expression of 
GLAST in the spinal dorsal horn (Figure 5.2), this upregulation is likely an indicator of, 
but is not a contributor to, nerve root-mediated pain (Aronica et al. 2003, Jourdain et al. 
2007, Ren & Dubner 2007, Rothstein et al. 2005, Tilleux & Jinn 2007). In fact, in vitro 
studies demonstrate that GLAST is neuroprotective when rapidly upregulated by 
extracellular glutamate and that upregulation of GLAST by glial cell-line-derived 
neurotrophic factor (GDNF) prevents axotomy-induced apoptosis in vivo (Duan et al. 
1999, Koeberle & Bähr 2008). Although its effects on spinal GLAST were not 
determined, GDNF also attenuates nerve root-mediated pain when it is applied directly to 
the affected root in this model (Hubbard et al. 2009). In addition to those studies 
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demonstrating the neuroprotective effects of GLAST, it should also be noted that spinal 
GLAST is upregulated at day 1 in the model of cervical radiculopathy used here even 
after the non-painful nerve root exposure (sham) and non-painful 3 minute root 
compression (Figure 5.2), indicating that GLAST upregulation in the spinal cord is not, 
by itself, sufficient for the development of behavioral sensitivity in the forepaw of the rat.  
Both doses (10µg and 150µg) of ceftriaxone abolished behavioral sensitivity after 
a painful nerve root compression (Figs. 6.2 & 6.4). Previous studies suggest that higher 
doses of ceftriaxone are required to alleviate behavioral sensitivity if treatment does not 
begin until after spinal GLT-1 is downregulated after the painful nerve injury (Hu et al. 
2010). Because the current study administered ceftriaxone at day 1, when spinal GLT-1 is 
unchanged after a painful nerve root compression (Figure 5.1), the 10µg dose may not be 
sufficient to reduce pain if it is administered at later time-points (Hu et al. 2010); even a 
larger dose (50µg) has been shown not to be sufficient to abolish behavioral sensitivity 
after a sciatic nerve constriction when it is administered at day 9 (Hu et al. 2010). 
However, 150µg of ceftriaxone does alleviate behavioral sensitivity after a painful sciatic 
nerve injury in the rat, even when treatment begins as late as day 12 (Ramos et al. 2010). 
If ceftriaxone is administered later than day 1 after a painful nerve root compression, it is 
possible that only the 150µg dose would be sufficient to alleviate behavioral sensitivity. 
Therefore, even though the 10µg dose does alleviate nerve root-mediated pain, it may not 
be a clinically-relevant dose for treating cervical radiculopathy, which is often not 
diagnosed until symptoms have already persisted for many months (Côté et al. 2001). 
Unlike its effects on behavioral sensitivity, the two doses of ceftriaxone (10µg and 
150µg) did differentially modulate spinal GFAP expression (Fig. 6.5). Specifically, 
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astrocyte activation decreased after the 10µg treatment, but remained significantly 
elevated over sham levels after treatment with 150µg of ceftriaxone. Although 
ceftriaxone may have directly modulated spinal GFAP (Fig. 6.5), separate studies of 
ceftriaxone’s mechanisms of action in cultured astrocytes suggest that the concentrations 
of ceftriaxone required to upregulate GLT-1 have no effect on GFAP promoter activity 
(Bachetti et al. 2010, Beller et al. 2011, Lee et al. 2008). Those in vitro studies suggest 
that the spinal expression of GFAP observed in the current study was likely a 
consequence of reduced extracellular glutamate resulting from the upregulation of GLT-1 
(Bachetti et al. 2010, Beller et al. 2011, Lee et al. 2008). Contradicting this hypothesis, 
however, is the 150µg dose of ceftriaxone, had no effect on spinal GFAP expression, but 
did restore the expression of GLT-1 in the dorsal horn (Figs. 6.1 & 6.6). To date, no study 
has directly compared the dose-response of ceftriaxone on the promoter activities of 
GLT-1 and GFAP promoter activity. Future in vitro studies that further define 
ceftriaxone-mediated NFκβ modulation of GLT-1 and GFAP may provide additional 
insight into the differential effects of ceftriaxone on spinal GFAP that were observed in 
the current study (Fig. 6.6). 
The concentration of extracellular glutamate in the central nervous system is a 
function of its release by neurons and its uptake by glutamate transporters (Tao et al. 
2005). The present study demonstrated that an increase in spinal GLT-1 alleviates nerve 
root-mediated pain (Figs. 6.2 & 6.4), presumably by decreasing extracellular glutamate in 
the spinal cord (Haugeto et al. 1996, Inquimbert et al. 2012, Lipski et al. 2007, Ramos et 
al. 2010). Spinal glutamate levels are also reduced by blocking its release from pre-
synaptic neurons using sodium-channel inhibitors (Blackburn-Munro et al. 2002, 
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Lamanauskas & Nistri 2008, MacIver et al. 1996). Because the present study abolished 
mechanical allodynia and thermal hyperalgesia by increasing spinal GLT-1, blocking pre-
synaptic glutamate release may also alleviate behavioral sensitivity after a painful nerve 
root compression. To test this hypothesis, the studies in Chapter 7 administer the sodium 
channel blocker, Riluzole (Kuo et al. 2006, Lamanauskas & Nistri 2008, Staftstrom et al. 
2007, Wang et al. 2004), to test whether reducing spinal glutamate by blocking its release 
also attenuates behavioral sensitivity in this model of cervical radiculopathy. 
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CHAPTER 7 
 
Riluzole Treatment of Nerve Root-Mediated Pain 
 
Parts of this chapter have been adapted from: 
Nicholson KJ, Zhang S, Gilliland TM, Winkelstein BA. “Riluzole abolishes behavioral 
sensitivity & prevents the development of axonal damage and spinal modifications that 
are evident after painful nerve root compression,” submitted. 
 
7.1 Overview  
 Neck pain is often attributed to an injury of the cervical roots (Abbed & Couman 
2002, Carette & Fehlings 2005, Krivickas & Wilbourn 2000, Wainner & Gill 2000). 
Mechanical compression to the nerve root reduces axonal flow and induces degeneration 
of the primary afferents in both rodent and canine models (Hubbard & Winkelstein 2008, 
Kobayashi et al. 2005a). Riluzole, an FDA-approved drug for the treatment of the 
neurodegenerative disease, amyotrophic lateral sclerosis (ALS), inhibits the loss of motor 
function and the development of spinal motor neuron degeneration that are associated 
with that disease (Bellingham 2011, Doble 1996). Riluzole has also been shown to  
inhibit neurodegeneration, promote normal motor function and mitigate behavioral 
sensitivity in animal models after spinal cord trauma, ventral nerve root avulsion and 
chronic construction of the sciatic nerve (Coderre et al. 2007, Hama & Sagen 2011, 
Pintér et al. 2010, Schwartz & Fehlings 2001, Sung et al. 2003, Wu et al. 2013). Like the 
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dorsal nerve root, peripheral nerves enclose primary afferents (Basbaum et al. 2009). 
However, the regenerative properties of the distal axons in peripheral nerve differ from 
those of the central axons in the nerve root (Di Maio et al. 2011, Jancalek & Dubovy 
2007). No study has determined whether Riluzole’s effects on pain from neural tissue 
pathologies in the perihery (Coderre et al. 2007, Sung et al. 2003) are also effective in 
mitigating pain mediated by a compression injury to the axons of the nerve root. 
Riluzole alleviates behavioral sensitivity even when it is administered after pain 
develops in rodent models of spinal cord trauma and sciatic nerve compression  (Hama & 
Sagen 2011, Sung et al. 2003). However, Riluzole’s ability to attenuate behavioral 
sensitivity after it is already established has only been evaluated for up to 48 hours after 
treatment (Sung et al. 2003). Because Riluzole has a half-life of up to 31 hours in the rat 
(Wu et al. 2013) it is not known whether Riluzole can continue to alleviate pain long after 
it is cleared from the spinal cord. A single dose of Riluzole immediately after spinal cord 
compression improves motor function, reduces spinal cord tissue loss and preserves 
axonal transport in the descending pathways of the spinal cord for at least six weeks 
(Schwartz & Fehlings 2011). Therefore, a single dose of Riluzole within minutes of 
injury appears to be sufficient to provide lasting neuroprotection for at least six weeks 
(Schwartz & Fehlings 2011). However, that study did not determine whether a single 
dose of Riluzole can simultaneously alleviate persistent behavioral sensitivity and limit 
the development of neuropathology if behavioral sensitivity is already established before 
Riluzole is administered. 
The work in this chapter correspond to Aims 3a and 3c of the overall thesis and 
evaluate the analgesic and neuroprotective properties of a single dose of Riluzole that is 
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administered after the initiation of nerve root-mediated pain. The studies detailed here 
test the hypothesis that Riluzole can alleviate nerve root-mediated pain by reducing the 
neuropathology that normally develops in the nerve root after a root compression 
(Kobayashi et al. 2005a, Hubbard & Winkelstein 2008, Nicholson et al. 2011). 
Behavioral sensitivity was measured for seven days to evaluate the time-course of 
mechanical allodynia and thermal hyperalgesia for six days after treatment. The studies in 
Chapters 3 and 5 demonstrate that extensive axonal damage develops in the nerve root 
and that the excitability of dorsal horn neurons in the spinal cord is enhanced at day 7 
after a painful nerve root compression (Nicholson et al. 2011). Therefore, in order to 
evaluate the neuroprotective properties of Riluzole after a painful C7 nerve root 
compression in the rat, neuropathology in the root and neuronal excitability in the spinal 
cord were both evaluated at day 7. Neuropathology was assessed by evaluating the 
morphology of the myelinated and unmyelinated axons in the root and also by assessing 
axonal transport through the root. Myelinated axons were labeled for NF200, while the 
unmyelinated axons were labeled for calcitonin-gene related peptide (CGRP) and 
isolectin-B4, labeling the peptidergic and nonpeptidergic populations, respectively. The 
spinal expression of CGRP was also quantified in order to evaluate axonal transport of 
this neuropeptide through the root, which is normally impaired after a painful nerve root 
compression (Hubbard et al. 2008a). 
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7.2 Relevant Background 
Neck pain affects nearly one-half of the adult population annually (Côté et al. 
2004, Hogg-Johnson et al. 2008). Injury to the cervical nerve root is a common source of 
pain and can result from disc herniation, spinal stenosis or neck trauma (Abbed & 
Coumans 2007, Carette and Fehlings 2005, Krivickas et al. 2008, Wainner & Gill 2000). 
In animal models of root compression, axonal degeneration develops in the root and 
extends towards the synapses in the dorsal horn, where axon terminals become enlarged 
and neurotransmitter levels are altered (Hubbard et al. 2008a, Hubbard & Winkelstein 
2008, Kobayashi et al. 2008). Although these spinal modifications that are documented 
after painful root compression suggest that injury may mediate afferent signaling, the 
signaling properties of spinal neurons have not been evaluated after a painful nerve root 
compression. 
Neuronal hyperexcitability is associated with neural tissue damage, including 
axonal injury – a hallmark of nerve root compression injuries – and altered phenotypic 
behavior in the spinal cord (Hubbard & Winkelstein 2008, Inquimbert et al. 2012, 
Kobayashi et al. 2008, Neugebauer et al. 1996). Sensitization of wide dynamic range 
(WDR) neurons, in particular, is thought to drive neuronal hyperexcitability and 
behavioral sensitivity after spinal cord ischemia and spinal nerve ligation (Hao et al. 
1992, Liu et al. 2011). Although increased calcitonin gene-related peptide (CGRP) and 
associated signaling contribute to neuronal hyperexcitability after painful neural trauma 
(Bennett et al. 2000, Neugebauer et al. 1996), painful root compression decreases CGRP 
in the superficial dorsal horn (Hubbard et al. 2008a, Kobayashi et al. 2005a). No study 
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has evaluated CGRP expression in the deep laminae, despite the known involvement of 
neurons in that region of the dorsal horn in pain from peripheral nerve injuries (Chao et 
al. 2008, Kerr & David 2007). 
Riluzole is an anticonvulsant that has neuroprotective properties in animal models 
of neurodegenerative disease and neural tissue injury, which are attributed to its 
inhibition of presynaptic glutamate release by blocking voltage-gated sodium channels 
(Bellingham 2011, Coderre et al. 2007, Doble 1996, Jehle et al. 2000, Siniscalchi et al. 
1997). Riluzole decreases the size of spinal cord lesions, promotes motor function 
recovery, and restores the electrophysiological properties of spinal neurons after spinal 
cord compression (Schwartz & Fehlings 2001, Stutzmann et al. 1996, Wu et al. 2013). It 
also mitigates axonal degeneration and promotes axonal regeneration after nerve injury 
(Costa et al. 2007, Pintér et al. 2010, Vorwerk et al. 2004). Those studies suggest that 
Riluzole may inhibit the axonal degeneration that is induced after a painful root 
compression (Hubbard & Winkelstein 2008, Nicholson et al. 2011). Although 
regeneration of dorsal roots after their crush injury restores normal sensation (Ramer et 
al. 2000) and Riluzole is anti-allodynic for neuropathic pain (Coderre et al. 2007, Sung et 
al. 2003), it is not known if, and to what extent, Riluzole may preserve the normal axonal 
structure and afferent signaling and alleviate the pain that develops after compression of 
the nerve root. It is also unclear whether a single dose of Riluzole is sufficient to provide 
sustained pain relief when administered early after pain has developed (Hama & Sagen 
2011).  
This study investigates whether a single dose of Riluzole can eliminate behavioral 
sensitivity and axonal damage in the injured root, as well as prevent the spinal changes 
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that develop after a painful root compression. We hypothesized that Riluzole would 
abolish behavioral sensitivity by preserving axonal morphology and would abate the 
spinal modifications of CGRP and neuronal excitability that are observed after painful 
root compression. Mechanical allodynia and thermal hyperalgesia were assessed after 
injury, with and without Riluzole treatment, or a sham surgical procedure. The 
morphology of myelinated, peptidergic and nonpeptidergic axons in the root and spinal 
CGRP were evaluated at day 7 using immunohistochemistry. At that same time-point, 
electrophysiological recordings were made in the spinal cord to evaluate the effect of 
Riluzole on neuronal firing evoked by peripheral stimuli to the paw after a painful root 
compression.  
 
7.3 Methods 
All studies used male Holtzman rats (300-400g; Harlan Sprague–Dawley; 
Indianapolis, IN). Rats were housed in a 12-12 hour light-dark cycle and given free 
access to food and water. Studies were approved by our Institutional Animal Care and 
Use Committee and carried out under the guidelines of the Committee for Research and 
Ethical Issues of the International Association for the Study of Pain (Zimmermann 1983). 
 
7.3.1 Surgical Procedures & Riluzole Administration 
The C7 dorsal nerve root was compressed under isoflurane inhalation anesthesia 
(4% for induction, 2% for maintenance). The rat was placed in a prone position and an 
incision was made along the midline over the cervical spine from the base of the skull to 
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the spinous process of the second thoracic vertebra (Hubbard & Winkelstein 2005, 
Nicholson et al. 2011, Rothman et al. 2005, Rothman et al. 2010). The C6 and C7 
vertebrae were exposed by carefully separating the overlying musculature and a 
hemilaminectomy and partial facetectomy on the right side were performed at C6/C7 to 
expose the right C7 nerve root. A small incision was made in the dura over the C7 nerve 
root and a 10gf microvascular clip (World Precision Instruments; Sarasota, FL) was 
placed on the dorsal root for 15 minutes and then removed. A surgical control group 
received sham procedures, which included all of the same procedures as the surgical 
manipulation and nerve root exposures, but without any compression applied. Wounds 
were closed using 3-0 polyester sutures and surgical staples and rats were monitored 
while they recovered in room air. 
On day 1 after compression, rats were randomly assigned to receive either 
Riluzole or its vehicle carrier. The Riluzole treatment group (inj+Ril; n=7) received a 
1ml intraperitoneal (i.p.) injection of 3mg/kg Riluzole (Sigma; St. Louis, MO) dissolved 
in the vehicle 10% β-cyclodextrin (Sigma; St. Louis, MO). In the group receiving vehicle 
treatment (inj+veh; n=7), a 1ml injection of 10% β-cyclodextrin dissolved in saline was 
given. The same vehicle treatment was also given on day 1 to the rats that had received a 
sham surgery (sham+veh; n=7). All injections were administered after behavioral 
assessments were performed on day 1. 
 
7.3.2 Behavioral Assessments 
Bilateral mechanical allodynia and thermal hyperalgesia were assessed in the 
forepaw as measures of behavioral sensitivity. Mechanical allodynia was measured prior 
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to (baseline) and on post-injury days 1, 2, 3, 5, and 7 (Hubbard & Winkelstein 2005, 
Rothman et al. 2005). After a 20 minute period of acclimation, the 1.4, 2.0 and 4.0gf von 
Frey filaments (Stoelting Co.; Wood Dale, IL) were each applied to the plantar surface of 
each forepaw 10 times, in three rounds, separated by 10 minutes of rest between rounds. 
For each filament, the total number of paw withdrawals for each forepaw and for each rat 
was summed for the three rounds on each day and averaged across groups.  
Thermal hyperalgesia was measured at baseline and on days 1 and 7 using 
established methods (Dirig et al. 1997, Hargreaves et al. 1988). After a 20 minute 
acclimation period, the thermal stimulus was focused on the plantar surface of each 
forepaw using a radiant heat source until a withdrawal response was provoked. A positive 
response was taken if the withdrawal was a sudden and quick movement and/or the rat 
licked, shook, curled or looked at the paw. The time period during which the thermal 
stimulus was applied to the forepaw until a positive response was observed was recorded 
as the withdrawal latency. On each testing day, the withdrawal latency time was 
measured for each forepaw three times, separated by 10 minutes of rest. For each 
forepaw, the average latency across the rounds for each day was recorded for each rat and 
averaged for each group. For each behavioral assessment (mechanical allodynia, thermal 
hyperalgesia), a two-way repeated measures ANOVA tested for differences between 
groups over time for the ipsilateral and contralateral forepaws, separately. To determine 
differences between groups at each day, separate one-way ANOVAs with post-hoc 
Bonferroni correction were performed, with significance for all tests at p<0.05. 
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7.3.3 Immunohistochemistry 
The dorsal nerve root and spinal cord at C7 were harvested on day 7 after 
behavioral testing to assess axonal morphology in the ipsilateral nerve root and bilateral 
expression of CGRP in the superficial and deep laminae of the dorsal horn. Rats were 
anesthetized via an intraperitoneal injection of 65mg/kg pentobarbital and transcardially 
perfused with 200ml Dulbecco’s PBS followed by 300ml of 4% paraformaldehyde. The 
C7 cervical spinal cord and adjacent nerve roots were harvested, post-fixed overnight, 
transferred to 30% sucrose for cryoprotection and then embedded in OCT media (Sakura 
Finetek USA, Inc.; Torrance, CA). Samples were cryosectioned at 14µm, such that the 
spinal cord tissue was sectioned axially and the adjacent nerve roots were sectioned along 
their longitudinal axis, and thaw-mounted onto slides. Each slide contained six non-
adjacent sections spanning a region at the centerline of the nerve root. For comparison, 
matched tissue samples also were harvested from normal, naïve rats (n=2) and included 
in tissue processing. 
Sections were colabeled for neurofilament-200 (NF200), CGRP and isolectin-B4 
(IB4) to label myelinated, peptidergic and non-peptidergic neurons, respectively. Sections 
were blocked in 10% normal goat serum (Vector Laboratories; Burlingame, CA) with 
0.3% Triton-X100 (Bio-Rad Laboratories; Hercules, CA) then incubated overnight at 4°C 
in mouse anti-NF200 (1:500; Sigma; St. Louis, MO), rabbit anti-CGRP (1:1000; 
Peninsula Laboratories; Sancarlos, CA) and biotinylated IB4 (5µg/ml; Sigma; St. Louis, 
MO). Sections were then fluorescently labeled with secondary antibodies for goat anti-
mouse Marina Blue (1:200; Invitrogen; Carlsbad, CA), goat anti-rabbit Alexa Fluor 546 
 173 
(1:1000; Invitrogen; Carlsbad, CA) and fluorescein (DTAF) conjugated streptavidin 
(1:500; Jackson ImmunoResearch, Inc.; West Grove, PA), respectively.  
Axonal morphology in the affected nerve root was evaluated by digitally imaging 
NF200, CGRP, and IB4 in the root at 200x (3-6 sections per sample). Two independent 
reviewers who were blinded to the sample groups assessed the extent of axonal 
abnormalities for each of the types of labeled axons, separately, using customary methods 
(Hubbard & Winkelstein 2008, Nicholson et al. 2011, Serbest et al. 2007, Singh et al. 
2006). Nerve roots that did not differ from normal uncompressed roots were assigned (-), 
indicating the absence of axonal pathology. Nerve roots that contained any evidence of 
axonal swelling or discontinuous labeling were assigned a positive (+) score. If the 
abnormalities extended across the entire length of the root, that section was assigned a 
positive score of (++), indicating extensive damage. For each rat, the ratings were 
averaged across the tissue sections, and between both reviewers, such that each nerve 
root was assigned a single score on a five-point scale: (-), (-/+), (+), (+/++) or (++).  
Axonal transport to the spinal cord was evaluated by quantifying the CGRP 
labeling in uniform sized regions of interest (ROI) in the superficial and deep laminae of 
the dorsal horn. The dorsal horn was imaged at 200x (ROI of 1360x1024 pixels) and 
images were separately cropped over the superficial laminae (I-II; ROI of 750x150 
pixels) and deeper laminae (IV-V; ROI of 696x380 pixels) in the ipsilateral and 
contralateral dorsal horns, separately. CGRP expression was measured in at least three 
sections from each rat using quantitative densitometry and reported as a percent of the 
expression in normal tissue (Abbadie et al. 1996, Kerr & David 2007, Romero-Sandoval 
et al. 2008, Rothman et al. 2010). Differences in the expression of CGRP between groups 
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in the superficial and deep laminae were tested by separate mixed-effect ANOVAs with 
sections nested by rat and rats nested within groups for the ipsilateral and contralateral 
dorsal horns, separately. Differences between the groups were determined by post-hoc 
Tukey HSD tests. 
 
7.3.4 Electrophysiology 
In a separate group of rats, neuronal hyperexcitability was measured in the deep 
laminae of the spinal cord at day 7. Rats underwent a C7 nerve root compression or sham 
procedure and were assigned to the same treatment paradigms as described above (n=7 
per group): inj+Ril, inj+veh or sham+veh. Bilateral mechanical allodynia was measured 
in the forepaws before injury (baseline) and on day 7, using stimulation by 1.4, 4.0 and 
10.0gf von Frey filaments, as described above. For each filament, a one-way ANOVA 
with post-hoc Bonferroni correction tested for differences in response between groups for 
the ipsilateral and contralateral forepaws, separately. A t-test compared the number of 
paw withdrawals elicited by the 4.0gf filament between each group used for this 
electrophysiological study and the matched group in the immunohistochemistry study 
(Section 7.3.1) to test that the studies used comparable injury and behavioral conditions.  
Following behavioral testing on day 7, rats were anesthetized with 45mg/kg 
pentobarbital via i.p. injection. Adequate anesthesia was confirmed by a hind paw pinch 
and was maintained with an additional dose of pentobarbital (1-5mg/kg i.p.) given 
approximately every 40-50 minutes, or as needed. The cervical spine was re-exposed via 
a dorsal, midline incision and any scar tissue that formed over the right C6/C7 spinal cord 
from the initial surgery was carefully removed. A laminectomy removed any remaining 
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bone at C6 and C7 on the left side to fully expose the spinal cord at those levels and the 
dura was then removed. The rat was placed on a stereotaxis frame using bilateral ear bars 
and a clamp on the spinous process of T2. Mineral oil was applied to the spinal cord to 
maintain hydration. A thoracotomy was performed to minimize spinal cord motion 
associated with normal breathing and respiration was maintained by mechanical 
ventilation via a mid-cervical tracheotomy (40-50 cycles/min; Harvard Small Animal 
Ventilator Model 683; Harvard Apparatus; Holliston, MA) (Crosby et al. 2013). Expired 
CO2 concentration was continuously monitored (Capnogard; Novametrix Medical 
Systems; Wallingford, CT) and the core body temperature was maintained between 35-
37°C using a heat plate and a rectal probe (TCAT-2DF; Physitemp Instruments Inc.; 
Clifton, NJ).  
Extracellular spinal cord recordings were acquired using a glass-insulated 
tungsten probe (<1µm tip; FHC; Bowdoin, ME) inserted vertically into the dorsal spinal 
cord proximal to the site where the C7 nerve root exits the spinal cord. In order to 
measure action potentials evoked by mechanical stimuli to the ipsilateral forepaw, the 
probe was placed proximal to the ipsilateral (right) C7 nerve root. Likewise, the probe 
was placed proximal to the contralateral (left) C7 nerve root to record action potentials 
evoked by mechanical stimulation to the contralateral forepaw. The signal was amplified 
with a gain of 3000 (ExAmp-20KB; Kation Scientific, Inc.; Minneapolis, MN), processed 
with a 60Hz noise eliminator (Hum Bug; Quest Scientific; North Vancouver, BC) and 
digitally stored at 25kHz (MK1401; CED; Cambridge, UK). Mechanoreceptive neurons 
innervating the forepaw were searched for by lightly brushing the plantar surface of the 
forepaw and slowly advancing the probe through the deep laminae (400-1000µm below 
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the pial surface) until a neuron responsive to the light brushing was found (Crosby et al. 
2013, Hains et al. 2003, Quinn et al. 2010). Once a neuron was identified, a sequence of 
six mechanical stimuli was applied to the forepaw: (1) 10 light brush strokes with a brush 
applied over 10 seconds, (2-5) a series of four von Frey filaments (1.4, 4.0, 10.0, 26.0gf), 
each applied five times for 1 second with a 1-second rest between application, and (6) a 
10-second, 60gf pinch by a microvascular clip (Roboz, Inc.; Gaithersburg, MD) (Quinn et 
al. 2010). There was 60 seconds of rest between applications of each of the different 
stimuli.  
Voltage recordings were spike-sorted in Spike2 (CED; Cambridge, UK) to count 
the number of action potentials evoked by each stimulus for individual neurons. For the 
brush stimulus, the number of action potentials was summed over the period of light 
brushing. For each von Frey filament application, the number of action potentials was 
summed over both the stimulation period and the rest period that immediately followed. 
For both the brush and the von Frey filament stimuli, the baseline number of spikes 
occurring in the 10-second period prior to the first stimulation was subtracted from the 
spike counts to identify only the spikes evoked by those stimuli (Hains et al. 2003). For 
the 60gf pinch, the number of spikes was summed over the 5-second period between 3-8 
seconds after the clip was applied, in order to only consider those spikes evoked by the 
pinch and to exclude the spikes evoked by the application and removal of the clip. The 
number of spikes evoked by the clip stimulus was determined by subtracting the baseline 
number of spikes that occurred in the 5-second window prior to the first stimulation from 
the spike count. For statistical analysis, the spike count was log-transformed because of a 
positive-skew in the distribution of data that is common with these experiments (Quinn et 
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al. 2010). Separate mixed-effect one-way ANOVAs with Tukey HSD post-hoc tests 
compared differences in the number of action potentials that were evoked by each 
filament between groups for the ipsilateral and contralateral neurons, separately; neurons 
were nested within rats and rats were nested in groups. A mixed-effect one-way ANOVA 
with the same levels of nesting tested for differences between groups for the depth at 
which the neurons were recorded from. 
Neurons were classified as either wide dynamic range (WDR) or low-threshold 
mechanoreceptive (LTM) neurons by comparing the spike rate (spikes/sec) evoked by the 
light brushing and the 60gf clip stimuli (Hains et al. 2003, Laird & Bennett 1993, Saito et 
al. 2008). Neurons that responded maximally to the light brush were identified as LTM 
and those that responded in a graded manner were identified as WDR (Hains et al. 2003, 
Woolf & Fitzgerald 1983). The distribution of WDR and LTM neurons between groups 
was compared using Pearson’s chi-squared tests for the ipsilateral and contralateral 
neurons, separately. All electrophysiology data are expressed as the mean±SEM. 
 
7.4 Results 
Sustained behavioral sensitivity is attenuated within one day after a single i.p. 
injection of Riluzole (Fig. 7.1 & 7.2). There is a significant difference (p<0.001) in the 
number of ipsilateral paw withdrawals in response to the 2.0 and 4.0gf mechanical 
stimuli between the groups over time (Fig. 7.1). At day 1, the number of paw withdrawals 
elicited by the 2.0 and 4.0gf in the ipsilateral forepaw is significantly (p<0.004) elevated 
over sham responses for both groups undergoing a nerve root compression (inj+veh, 
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inj+Ril). However, at day 2 after compression, the number of paw withdrawals elicited 
by the 4.0gf is reduced to sham levels with Riluzole treatment (Fig. 7.1), which is a 
significant decrease compared to injury with vehicle treatment (p=0.014). The number of 
paw withdrawals in the inj+veh group remains significantly greater than both the inj+Ril 
and sham+veh groups at all time points after day 1 (p<0.003), for testing with the 4.0gf 
filament. For testing with the 2.0gf filament, the number of paw withdrawals elicited in 
the inj+Ril is significantly less (p=0.034) than the inj+veh group only on day 5.  There 
are no differences between the sham+veh and inj+Ril groups at any time point after 
treatment on day 1, for testing with both the 2.0 and 4.0gf filaments (Fig. 7.1). No 
differences were detected between any group for testing with the 1.4gf filament. In the 
contralateral forepaw, there were no differences in the number of paw withdrawals 
between any group for any filament strength. Appendix C details the number of paw 
withdrawals elicited by each filament for each rat in this study. 
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Similarly, Riluzole also attenuates the thermal hyperalgesia that is evident after a 
nerve root compression (Fig. 7.2). At day 1, the withdrawal latency in the ipsilateral 
forepaw for both of the nerve root compression (inj+Ril & inj+veh) groups is 
significantly (p<0.025) shorter than that of sham (Fig. 7.2). After Riluzole is given, 
however, the withdrawal latency at day 7 in the injury group (6.6±0.9 seconds; inj+veh) 
is significantly shorter than the withdrawal latency for either the Riluzole treatment group 
Fig. 7.1 Mechanical allodynia tested with the 1.4, 2.0 and 4.0gf filaments after nerve root compression 
with and without Riluzole treatment in the ipsilateral and contralateral forepaws. Prior to treatment (day 
1), mechanical allodynia is significantly greater than sham (sham+veh) in both the vehicle-treated 
(inj+veh; *) and Riluzole-treated (inj+Ril; +) root compression groups, for testing with the 2.0 and 4.0gf 
filaments. For those same filaments, mechanical allodynia remains significantly greater in the inj+veh 
group than the sham+veh (*) group but is also increased over the treatment group (inj+Ril; #) for all 
subsequent days for testing with the 4.0gf filament. No differences are detected between any group for 
testing with the 1.4gf filament or in the contralateral forepaw for any filament strength. 
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(8.3±1.2 seconds; inj+Ril; p=0.044) or the sham group (9.6±1.3 seconds; sham+veh; 
p=0.001) groups (Fig. 7.2). There is no difference in latency between the inj+Ril and 
sham+veh groups at day 7 (Fig. 7.2). There are no differences latency time in the 
contralateral forepaw between any group (Fig. 7.2). The withdrawal latency recorded for 
each rat is summarized in Appendix C.  
 
Riluzole treatment after a painful nerve root compression partially prevents the 
axonal swelling, thinning of the myelinated axons and axon disorganization in the nerve 
root that is typically evident at day 7 after a painful root compression (Fig. 7.3 & Table 
7.1). The nerve root for one sample in the inj+veh group (#157) was damaged at the time 
of harvest so it was not evaluated (Table 7.1). After a painful nerve root compression, 
there are regions of discontinuous NF200 immunoreactivity along the length of the nerve 
root (Fig. 7.3). Axonal swelling is also evident for all three types of labeled axons (Fig. 
7.3), such that the diameter of the axons labeled for NF200, CGRP, and IB4 varies along 
the length of the root (Fig. 7.3).  In the nerve roots harvested from three rats in the 
vehicle-treated injury group (#156, #163, #198), axonal injury extends across the 
Fig. 7.2 Thermal hyperalgesia after nerve root compression with and without Riluzole treatment in the 
ipsilateral and contralateral forepaws. At day 1, the withdrawal latency from a thermal stimulus 
significantly decreases in both compression groups (inj+veh; *; inj+Ril; +) compared to sham+veh. 
After treatment, the withdrawal latency at day 7 is significantly less for inj+veh than both inj+Ril (#) 
and sham+veh (*). No differences are detected in the contralateral forepaw for any group. 
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majority of the root in at least two of the three types of labeled axons (Table 7.1). In 
contrast, the NF200-labeld axons remain uniform in diameter along the length of the root 
and are evenly distributed along the width of the root in the sham+veh group (Fig. 7.3). 
The unmyelinated axons (CGRP & IB4) are also uniform in their distribution within the 
root and are noticeably smaller in diameter than the myelinated axons (NF200). Although 
there is some evidence of axonal swelling in some of the axons of some of the rats in the 
inj+Ril group, the diameter of the axons remains relatively consistent across the length of 
the root (Fig. 7.3). Furthermore, only one root (#161) exhibits substantial axonal damage 
across the entire length of the root, and only in the NF200-labeled axons (Table 7.1). In 
two of the nerve roots in the inj+Ril group (#149, #160) there is no indication of injury in 
any of the NF200-, CGRP- or IB4-labeled neurons (Table 7.1).  
 
Fig. 7.3 Representative images of C7 nerve roots labeled for myelinated (NF200), peptidergic (CGRP) 
and nonpeptidergic (IB4) axons at day 7 for sham+veh, inj+veh, or inj+Ril. The region within the box 
is enlarged to show each of the three labels separately for clarity. After sham, axons are evenly labeled 
for NF200, CGRP and IB4 and are uniformly distributed throughout the root. After a painful root 
compression (inj+veh), axons exhibit regions of swelling (+) and the NF200-labeled axons, in 
particular, appear to thin (*). These hallmarks are not evident in the inj+Ril group, which exhibits 
characteristics similar to sham.  
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Similar to the neuroprotective effects of Riluzole on nerve root morphology that 
are observed at day 7 (Fig. 7.3 & Table 7.1), the expression of CGRP in the ipsilateral 
superficial laminae of the spinal cord is increased and the expression of this 
neurotransmitter in the deep laminae of the ipsilateral dorsal horn is reduced with 
Riluzole treatment (Fig. 7.4). CGRP expression in the dorsal horn of the inj+veh group is 
significantly decreased (p=0.009) in the superficial laminae compared to the sham group 
(Fig. 7.4B). In the deep laminae, CGRP significantly increased (p=0.003) after 
compression (inj+veh) compared to the sham+veh group (Fig. 7.4C). With Riluzole 
Table 7.1 Summary of the NF200, CGRP, and IB4 ratings. 
Group ID NF200 CGRP IB4 
sham+vehicle 162 - - - 
 193 - - - 
 195 - - -/+ 
 196 - - - 
 200 - - - 
 211 - - - 
 212 - - - 
inj+vehicle 156 +/++ + +/++ 
 157 * * * 
 163 +/++ + ++ 
 194 + + + 
 198 ++ +/++ +/++ 
 199 -/+ + -/+ 
 210 -/+ -/+ - 
inj+Riluzole 147 -/+ + -/+ 
 148 + + + 
 149 - - - 
 158 -/+ -/+ - 
 159 + -/+ + 
 160 - - - 
 161 +/++ + + 
 - No abnormalities 
 + Regions of axons exhibit abnormalities 
 ++ Abnormalities across most of the root 
 * No data due to damaged specimen 
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treatment, however, there are no differences in the expression of CGRP in either the 
superficial or deep laminae compared to either the sham+veh or the inj+veh groups (Fig. 
7.4). CGRP expression in the contralateral dorsal horn is unchanged from sham+veh for 
both the inj+veh and inj+Ril groups in both the superficial and deep laminae (Fig. 7.4). 
In Appendix D, the quantification of CGRP in the superficial and dorsal laminae for each 
rat is provided. 
 
Riluzole also abates the hyperexcitability of the deep dorsal horn neurons that is 
observed in the ipsilateral spinal cord following a painful nerve root compression. Similar 
to the lack of mechanical allodynia observed in the ipsilateral forepaw at day 7 after 
Riluzole treatment (Fig. 7.1), the number of paw withdrawals elicited by the 4.0 and 
Fig. 7.4 CGRP expression in the dorsal horn at day 7. (A) Representative images of CGRP-labeled 
dorsal horns in the ipsilateral superficial (s) and deep (d) laminae after sham (sham+veh), nerve root 
compression with vehicle (inj+veh) and with Riluzole (inj+Ril). (B-C) Quantification of CGRP 
labeling demonstrates that nerve root compression significantly (*) decreases only in the ipsilateral 
superficial dorsal horn (B) and increases only in the ipsilateral deep dorsal horn (C) after a painful 
nerve root compression compared to sham, but is not changed from sham with Riluzole treatment.  
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10.0gf filaments is also decreased compared to vehicle treatment (Fig. 7.5A). No 
significant differences are observed between any groups for testing with the 1.4gf 
filament in the ipsilateral forepaw (Fig. 7.5A) or for testing with any filament strength in 
the contralateral forepaw (Fig. 7.5B).  
 
Extracellular recordings were made from 215 neurons at an average depth of 
640±140µm and no significant differences are detected in the recording depth between 
groups. The depth of recording, the number of evoked spikes and the phenotype of each 
neuron is summarized in Appendix E. The number of spikes evoked by each of the 4.0, 
10.0 and 26.0gf filaments in the inj+veh group significantly increases (p<0.045) by 
nearly two-fold over the number of spikes evoked for sham+veh (Fig. 7.6B). After 
Fig. 7.5 Bilateral mechanical allodynia at day 7 for testing with the 1.4, 4.0 and 10.0gf filaments. 
(A) The number of paw withdrawals in the ipsilateral forepaw is significantly increased (p<0.002) in 
the inj+veh group compared to sham+veh (*; for 4.0 and 10.0gf filaments) and inj+Ril (#; 4.0gf). 
(B) Contralateral allodynia is unchanged from sham+veh for both the inj+veh and inj+Ril groups. 
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Riluzole treatment, the spike counts decrease to sham levels for each filament (Fig. 
7.6B). Specifically, for stimulation with the 4.0gf filament, the number of spikes in the 
inj+veh group (19±4 spikes) is significantly greater than the number evoked in the 
sham+veh group (11±2; p=0.0337) and the inj+Ril group (12±2; p=0.0421) (Fig. 7.6). No 
differences are detected in the number of spikes evoked by the 1.4gf filament between 
any of the groups. Regardless of the filament strength, no differences are detected in the 
number of evoked spikes in the contralateral spinal cord between any of the groups (Fig. 
7.6C). 
 
Fig. 7.6 Neuronal excitability at day 7 in the spinal cord. (A) Representative extracellular recordings for 
each group during the 1.4, 4.0, 10.0 and 26.0gf filament stimuli applied to the ipsilateral forepaw. (B) 
Neuronal excitability in the ipsilateral dorsal horn is significantly elevated in the inj+veh group 
compared to both sham+veh (*) and inj+Ril (#) in response to paw stimulation by the 4.0, 10.0 and 
26.0gf filaments. (C) In the contralateral dorsal horn, the number of evoked spikes is unchanged 
between all groups.  
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Riluzole treatment reduces the number of WDR neurons in the ipsilateral deep 
dorsal horn (Table 7.2). A total of 147 WDR neurons and 68 LTM neurons were 
identified in all groups. In the ipsilateral dorsal horn, there is a significantly greater 
proportion of WDR neurons (83%) in the inj+veh group than the sham+veh (61%; 
p=0.030) and inj+Ril groups (61%; p=0.042) (Table 7.2). The distribution of the neuron 
phenotypes in the contralateral dorsal horn is unchanged across all groups (Table 7.2). In 
general, the WDR neurons respond to the light brush and noxious pinch in a graded 
manner. The frequency of evoked firing to the light brush in the WDR and LTM neurons 
is 2.7±0.8 spikes/sec and 2.0±0.7 spikes/sec, respectively, and not different between the 
two neuron populations. During the noxious pinch, however, there is a significant 
increase (p<0.042) in the frequency of evoked firing by the WDR neurons compared to 
the LTM neurons (Fig. 7.7). Specifically, the frequency of evoked firing in the WDR 
neurons (5.7±3.5 spikes/sec) is more than three times the frequency of evoked firing in 
LTM neurons (1.7±1.5 spikes/sec) (Fig. 7.7). 
 
Table 7.2 Distribution of WDR and LTM neuron 
  neuron phoenotype distribution (%) 
location group WDR LTM 
ipsilateral sham+vehicle * 61 39 
 injury+vehicle *# 83 17 
 injury+Riluzole # 61 39 
contralateral sham+vehicle 67 33 
 injury+vehicle 74 26 
 injury+Riluzole 65 35 
*significant difference between injury+vehicle & sham+vehicle 
#significant difference between injury+vehicle & injury+Riluzole 
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7.5 Discussion 
This is the first study to demonstrate that a single dose of Riluzole delivered early 
after the onset of nerve root-mediated pain is sufficient to immediately abolish the 
mechanical and thermal sensitivity that develop otherwise, along with a prevention of the 
development of neuronal pathology and spinal hyperexcitability at a later time-point 
(Figs. 7.1-7.6). Riluzole mitigated the axonal damage of primary afferents that is 
normally observed after painful root compression (Fig. 7.3) and restored the normal 
CGRP expression in the dorsal horn, where many of those afferents synapse (Fig. 7.4). 
Further, the frequency of neuronal firing in the deeper laminae (640±140µm) and the 
proportion of WDR neurons also returned to sham levels after Riluzole treatment (Fig. 
7.6 & Table 7.2). Given that Riluzole abolished both behavioral and spinal neuronal 
sensitivity to the 4.0 and 10.0gf stimuli of the forepaw (Figs. 7.5 & 7.6), this study 
provides the first evidence that dorsal horn neuron sensitization contributes to forepaw 
sensitivity in this model of cervical radicular pain. The neuronal hyperexcitability that is 
observed in response to both non-noxious (4.0gf) and noxious (10.0 & 26.0gf) stimuli 
Fig. 7.7 The firing rate of WDR and LTM neurons in the spinal cord in response to light brushing and a 
noxious clip applied to the forepaw on day 7. WDR neurons exhibit a graded response, while the LTM 
neurons primarily respond to light brushing. During the noxious clip, the frequency of neuronal firing 
in WDR neurons is significantly greater (δ) than that of LTM neurons. 
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(Fig. 7.6) (Hubbard & Winkelstein 2005, Quinn et al. 2010) suggests that sensitization of 
WDR neurons, in particular, may drive nerve root-mediated pain since these neurons 
encode stimuli intensities across both input ranges, unlike the LTM neurons (Hains et al. 
2003, Urch & Dickenson 2003). The increase in the number of WDR neurons after injury 
(Table 7.2) further supports this notion that pain after root injury is mediated by WDR 
neurons. Interestingly, neuronal hyperexcitability and behavioral sensitivity were both 
completely abolished by Riluzole (Figs. 7.1, 7.2, 7.5 & 7.6), even though axonal swelling 
was still evident in some samples (Table. 7.1 & Fig. 7.3) and spinal CGRP expression did 
not completely return to sham levels (Table 7.1 & Fig. 7.4).  
Inhibiting neuronal signaling in the brain may be essential to Riluzole’s 
antinociceptive properties (Hama & Sagen 2011) and may augment its effects to produce 
the pronounced reduction in behavioral sensitivity and neuronal signaling despite the 
presence of axonal swelling and discontinuities in neurofilament labeling (Figs. 7.1-7.3 & 
7.6). Riluzole has been shown previously to cross the blood-brain barrier rapidly and to 
reduce spinal glutamate and mechanical hyperalgesia within one hour after an i.p. 
injection (Coderre et al. 2007, Hama & Sagen 2011, Wu et al. 2013). After spinal cord 
contusion, Riluzole alleviates pain when it is systemically administered via an i.p. 
injection or when it is administered directly into the brain by an intracerebroventricular 
(i.c.v.) injection; yet, it is ineffective in alleviating behavioral sensitivity when it is 
directly administered into the intrathecal (i.t.) space of the spinal cord (Hama & Sagen 
2011). Therefore, the effects of Riluzole on supraspinal glutamate appear to play a 
critical role in reducing pain associated with spinal cord injury. Since the supraspinal 
signaling after a painful root injury has not been well-defined, it is unclear whether such 
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supraspinal effects also contribute to the reduced behavioral sensitivity that is observed 
here (Figs. 7.1 & 7.2). 
Systemic delivery of Riluzole mitigated mechanical sensitivity within one day of 
its administration and maintained its analgesic effect on both mechanical and thermal 
sensitivity for at least six days after that single injection (Figs. 7.1 & 7.2). To date, 
Riluzole’s effects on behavior have been evaluated only for 2 hours after a single 
treatment and for four days after the final dose of daily repeated injections (Hama & 
Sagen 2011, Sung et al. 2003). Accordingly, this is the first study to demonstrate that a 
single dose, given after the development of pain has long-lasting effectiveness on 
behavioral sensitivity and nociceptive responses. Modulation of the glutamatergic system 
has long been considered a primary target for pain treatment (Bleakman & Nisenbaum 
2006, Kwon et al. 2010, Tao et al. 2005). Although spinal glutamate was not measured 
here, in vivo and in vitro studies demonstrate that Riluzole inhibits pre-synaptic glutamate 
release by blocking sodium channels (Bellingham 2011, Blackburn-Munro et al. 2002, 
Sung et al. 2003). Regulation of spinal glutamate may, therefore, provide more 
comprehensive relief than antagonists to specific glutamate receptors, like the 
metabotropic glutamate receptor 5 (Bellingham 2011, D’Antoni et al. 2008, Mao et al. 
2002), which only alleviate mechanical allodynia, but not thermal sensitivity, in 
neuropathy models (Dogrul et al. 2000, Hudson et al. 2002). Additional studies that 
identify activity of glutamate and its receptor following Riluzole treatment could better 
identify those mechanisms by which Riluzole alleviates radicular pain (Figs. 7.1 & 7.2).   
Although Riluzole promotes cell survival and neurite outgrowth in vitro 
(Shortland et al. 2006), this is the first in vivo study demonstrating that Riluzole reduces 
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damage to primary afferents after a compression injury (Fig. 7.3). Riluzole not only 
mitigated axonal damage in the compressed nerve root, but also restored CGRP transport 
to the superficial dorsal horn (Figs. 7.3 & 7.4A). In models of neuropathic pain, there is a 
positive correlation between spinal CGRP expression and behavioral sensitivity (Bennett 
et al. 2000, Kerr & David 2007, Neugebauer et al. 1996). Despite that, Riluzole reduced 
behavioral sensitivity while also increasing superficial dorsal horn expression of CGRP 
(Figs. 7.1, 7.2 & 7.4A); yet, CGRP transport is only one indicator of neuronal function. In 
addition to reduced CGRP transport in those models, myelin degeneration and reduced 
axonal conduction were also reported (Chang & Winkelstein 2011, Hubbard & 
Winkelstein 2008, Kobayashi et al. 2008, Pedowitz et al. 1992). Riluzole inhibits the 
development of both of these injury markers after nerve and spinal cord injury (Costa et 
al. 2007, Stutzmann et al. 1996). Therefore, in addition to preserving axonal morphology 
and CGRP expression in the superficial dorsal horn in this study (Figs. 7.3 & 7.4A), 
Riluzole likely also inhibited the development of myelin degeneration and changes to the 
conduction properties of the axons that normally develop after painful nerve root 
compressions (Chang & Winkelstein 2008, Hubbard & Winkelstein 2008, Kobayashi et 
al. 2008, Pedowitz et al. 1992). 
The reduced expression of CGRP that was observed in the deep laminae after 
Riluzole treatment (Fig. 7.4C) may be secondary to the improved neuronal health that is 
maintained after Riluzole treatment (Figs. 7.3). In vitro studies demonstrate that Riluzole 
has the opposite effect of increasing CGRP expression in neurons, together with 
promoting neurite growth (Leinster et al. 2010, Shortland et al. 2006). Therefore, it is 
likely that the reduced CGRP expression in the deep dorsal horn is an indirect 
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consequence of Riluzole. Aberrant sprouting of fibers from the superficial dorsal horn is 
thought to increase the expression of CGRP in the deeper laminae (Kerr & David 2007, 
Krenz & Weaver 1997). Extending those findings to the current study, the increased 
expression of CGRP after a painful nerve root compression (Fig. 7.4C) may indicate an 
increase in the number of CGRP-labeled fibers that do not normally extend into the 
deeper laminae. In fact, aberrant sprouting in the dorsal horn occurs when the nerve root 
is transected and primary afferents degenerate (McMahon & Kett-White 1991), 
suggesting that compression to the root may also induce similar sprouting. By preserving 
axonal morphology in the root, concurrent axonal degeneration is mitigated and aberrant 
sprouting of neurons into the deep dorsal horn is also prevented after Riluzole treatment. 
In the spinal cord, neurotransmission of CGRP is essential for enhancing neuron 
excitability in models of painful knee joint inflammation and spinal cord injury (Bennett 
et al. 2000, Neugebauer et al. 1996). Therefore, the elevated expression of CGRP in the 
deep dorsal horn after a painful nerve root compression likely contributed to the neuronal 
hyperexcitability observed in this same region (Figs. 7.4C & 7.6). In the rat spinal cord, 
anti-NGF reduces neuronal hyperexcitability by preventing CGRP-labeled afferents from 
aberrant sprouting after a spinal cord injury (Christensen & Hulsebosch 1997, Gwak & 
Hulsebosch 2011). Accordingly, Riluzole may have reduced neuronal hyperexcitability in 
the current study by similarly reducing the expression of CGRP in the deep laminae 
(Figs. 7.4C & 7.6).  
Our findings show, for the first time, that neuronal hyperexcitability and a shift in 
the phenotypic properties of dorsal horn neurons is evident following a painful transient 
root compression (Fig. 7.6 & Table 7.2). In contrast, a painful nerve root ligation does not 
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alter the frequency of evoked post-synaptic neuronal firing in the superficial dorsal horn 
(Terashima et al. 2011). That same study also reported that the amplitude of post-synaptic 
excitatory currents increases, which the authors suggested to be amplification of input 
from primary afferents by spinal neurons (Terashima et al. 2011). This amplification may 
be attributed to the increase in the number of WDR neurons observed in our study (Table 
7.2), which reflects an increase in the number of neurons that respond to noxious stimuli 
(Hains et al. 2003, Jensen et al. 2001, Quinn et al. 2010). The observed increase in the 
frequency of neuronal firing to both noxious and non-noxious stimuli after a transient 
nerve root compression (Fig. 7.6) is consistent with other studies of neuropathic pain 
(Pitcher et al. 2010, Shim et al. 2005, Sung et al. 2003). Hyperexcitability of WDR 
neurons, in particular, underlies pain after neural injury (Hains et al. 1993, Hao et al. 
1992).  Furthermore, WDR neurons, but not LTM neurons, enhance their firing rate in 
response to increased CGRP signaling (Bennett et al. 2000, Hao et al. 1992, Liu et al. 
2011). It is possible that the increased number of WDR neurons together with the 
elevated CGRP in the deep laminae may act together to enhance the neuronal excitability 
that develops after a painful root compression (Figs. 7.4C, 7.6 & Table 7.2).  
Riluzole has been reported to bind to voltage-gated sodium channels and inhibit 
the persistent sodium current, reducing the frequency of repetitive firing of neurons 
(Bellingham 2011, Jehle et al. 2000, Siniscalchi et al. 1997). This is consistent with the 
lower frequency of firing that was observed after its administration in this study (Fig. 
7.6). However, the effects of a single dose of Riluzole on the temporal response of 
neuronal signaling was not investigated here, nor were the specific relationships 
determined between axonal morphology, CGRP expression, and the frequency of 
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neuronal firing. Considering that an i.p. injection of Riluzole in the rat has a half-life up 
to 25-31 hours and, at high doses has sedative effects that last for only four hours (Liboux 
et al. 1999, Manz et al. 1992, Wu et al. 2013), it is likely that Riluzole has peak effects on 
glutamate signaling in the present study within the first day after its injection. By 
administering Riluzole at day 1, it may have prevented the development of tissue 
pathology in the root and spinal cord, thereby also preventing the development of 
heightened spinal neuronal firing even after the effects of Riluzole had worn off (Figs. 
7.1, 7.2 & 7.6) (Manz et al. 1992, Wu et al. 2013). At day 1 after the same painful 
compression, CGRP in the superficial dorsal horn is not modified from sham controls and 
axonal injury in the root is absent (Hubbard & Winkelstein 2008, Kobayashi et al. 2005a, 
Rothman et al. 2005). By administering Riluzole at this time-point, it likely inhibited, but 
did not reverse, the development of axonal pathology in the root and loss of CGRP 
transport to the spinal cord. Additional studies measuring the temporal responses in the 
glutamatergic system for nerve root-mediated pain are needed to fully understand the 
mechanism(s) by which Riluzole may be acting. Nonetheless, this study establishes that 
even a single dose of Riluzole administered after the onset of behavioral sensitivity can 
inhibit the evoked neuronal signaling in the spinal cord that develops in association with 
attenuation of thermal and mechanical behavioral sensitivity.  
 
7.6 Integration & Conclusions 
 This study supports the hypothesis that a systemic injection of Riluzole at day 1 
can alleviate behavioral sensitivity and reduce neuronal pathology that develops in the 
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nerve root and spinal cord. The known action of Riluzole decreasing the extracellular 
glutamate in the central nervous system suggests that an early increase in extracellular 
glutamate after a nerve root compression contributes to neuronal dysfunction and 
degeneration, consistent with cascades associated with traumatic brain and spinal cord 
injuries (Lau & Tymianski 2010). Therefore, even though spinal glutamate transporter 
expression is unchanged at day 1 following a painful nerve root compression (Chapter 5), 
elevated glutamate signaling at that time-point likely does contribute to the development 
of nerve root-mediated pain. The results of the current study suggest that nerve root-
mediated pain may initially be maintained by an increase in glutamate release, which is 
inhibited by Riluzole (Doble 1996, Kuo et al. 2006). By day 7, however, behavioral 
sensitivity is maintained by impaired glutamate uptake that is attributed to a decrease in 
the spinal expression of the glutamate transporter, GLT-1 (Chapters 5 & 6). Certainly, 
additional studies are needed to test this hypothesis. However, taken together, the studies 
in Chapters 5 and 6 and this current chapter, are the first to indicate that glutamate may 
contribute to both the initiation and the maintenance of nerve root-mediated pain.  
Unlike the wealth of animal studies demonstrating Riluzole’s ability to prevent 
motor impairment and to promote improvements in motor function after injury 
(Bellingham 2011, Cifra et al. 2012, Doble 1996, Janahmadi et al. 2009, Kwon et al. 
2010, Pintér et al. 2010, Schwartz & Fehlings 2001, Simard et al. 2012, Wu et al. 2013), 
the current study is one of only a handful of studies demonstrating that Riluzole also 
improves sensory function (Coderre et al. 2007, Hama & Sagen 2011, Sung et al. 2003). 
Contrary to the present findings, however, Riluzole does not alleviate hyperalgesia 
associated with a burn injury applied to the lower leg of human subjects (Hammer et al. 
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1999), suggesting that it may only be effective in treating pain associated with direct 
trauma to neural tissues (Coderre et al. 2007, Hama & Sagen 2011, Sung et al. 2003). The 
current study provides new insight into how Riluzole may alleviate nerve root-mediated 
pain by protecting the morphology of injured afferents, limiting redistribution of spinal 
neurotransmitters, and abolishing afferent hyperexcitability in the spinal cord. 
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CHAPTER 8 
 
Summary, Synthesis & Future Work 
 
 
8.1 Introduction  
Compression to the nerve root is a well-established mechanism for producing 
radiculopathy, and animal models have identified inflammatory and neuronal responses 
in both the nerve root and affected axons, as well as the spinal cord, that are associated 
with different painful nerve root compressions (Colburn et al. 1999, Garfin et al. 1990, 
Hubbard & Winkelstein 2005, Kobayashi et al. 2008, Olmarker et al. 1989a, Rothman et 
al. 2009a,b). Furthermore, compression magnitude and duration thresholds for eliciting 
behavioral sensitivity after a C7 transient root compression in the rat are associated with 
spinal inflammation and modifications to spinal neuropeptide expression by day 7 
(Hubbard & Winkelstein 2005, Hubbard et al. 2008a, Nicholson et al. 2012, Rothman et 
al. 2010). Those studies suggest a role for nerve root biomechanics in modulating spinal 
neuronal signaling, which is normally regulated, in part, by the glutamatergic system. 
However, prior to the studies in this thesis, it was not known whether the duration of a 
painful nerve root compression modulates the signaling patterns of neurons in the 
affected nerve root or the spinal cord or whether those neuronal responses have direct 
effects on modifying the glutamatergic system. Therefore, the purpose of this thesis was 
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to define the role of one injury parameter, compression duration, for inducing neuronal 
dysfunction in the nerve root during a painful root compression and to identify those 
neuronal and glutamatergic changes in the spinal cord that are relevant to persistent 
radicular pain. 
The key findings of this thesis are presented in this chapter, together with several 
considerations regarding the study design and the methodologies that were chosen 
(Section 8.2). The key findings from this collection of studies is then discussed in the 
context of the broader literature on nerve root and axonal compression, nociception and 
the biomechanics of nerve root tissues (Section 8.3). Finally, Section 8.4 outlines areas 
for future work that, based on the work in this thesis, would further define the role of 
neuronal and glutamatergic signaling in mediating pain after a cervical nerve root 
compression and also potential targets for alleviating the associated radicular pain. 
 
8.2 Summary 
Electrophysiological data demonstrate that mechanical compression to the C7 
nerve root induces immediate neuronal dysfunction in the axons of the nerve root in the 
rat (Fig. 8.1) (Nicholson et al. 2011). When a 10gf compression is applied to the nerve 
root, the number of action potentials that are electrically evoked in the periphery (at the 
forepaw) and recorded in the spinal cord decrease by 52-68% compared to pre-
compression levels within 3 minutes of the compression. On average, the number of 
action potentials recorded from each neuron continues to decrease until 6.6±3.0 minutes 
into the compression period, after which there are no further changes in 
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neurotransmission through the root (Fig. 8.1). Even though a 3 minute compression is 
sufficient to reduce the number of evoked action potentials that are transmitted through 
the root by more than 50%, axonal conduction returns to pre-compression levels within 
10 minutes if the compression is removed within 3 minutes (Nicholson et al. 2011).  
Conversely, when compression to the root is applied for 15 minutes, the number of  
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electrically-evoked action potentials recorded in the spinal cord remains at 58±25% lower 
than pre-compression levels for at least 10 minutes after the compression is removed. 
This sustained change in the conduction properties of the nerve root axons after the 15 
minute compression suggests that the 6.6±3.0 is a critical duration for inhibiting 
neurotransmission through the nerve root during an applied compression (Fig. 8.1). 
The conduction properties of an individual axon have been shown to vary with the 
amount of stress it undergoes in vivo in the spinal cord and peripheral nerve of rodents 
(Hosmane et al. 2011, Shi 2004, Shi & Whitebone 2006, Wall et al. 1992). However, 
when a peripheral nerve is held under compression, stress is not uniformly distributed 
across the individual axons (Strain & Olson 1975), and this is likely true for the nerve 
root as well. Therefore, the conduction properties of each axon within a compressed 
nerve root likely vary between axons, depending on the local stress gradients. The critical 
compression duration of 6.6 minutes was determined by averaging the critical duration 
determined for individual axons, defined as the duration required to block, or maximally 
reduce, the number of action potentials evoked in the spinal cord by a peripheral stimulus 
for each of the recorded neurons (Nicholson et al. 2011). That average critical duration of 
6.6 minutes may be biased by the search protocol used to identify afferents in the forepaw 
of the rat and may not reflect the conduction properties of the entire population of the 
nerve root axons. Specifically, mechanically sensitive, but not heat sensitive fibers were 
identified. Most afferent fibers are both thermally and mechanically sensitive, however 
(Basbaum et al. 2009). Because thermoreceptors are comprised of C and Aδ fibers, which 
are less vulnerable to mechanical injury than Aβ mechanoreceptors (Basbaum et al. 2009, 
Jancalek & Dubovy 2007, Mosconi & Kruger 1997, Strain & Olson 1975), the duration 
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threshold of 6.6 minutes is likely a conservative indicator of injury across all axons in the 
root. An alternative method for assessing axonal conduction through the root is to 
measure the collective response of all axons in the nerve root by measuring compound 
action potentials. Although studies have, in fact, measured compound action potentials 
through the nerve roots of the porcine cauda equina (Pedowitz et al. 1992, Rydevik et al. 
1992), those authors concede that it was not possible to exclude possible efferent 
conduction through the ventral nerve root from their recordings (Rydevik et al. 1992).  
Since the goal of this thesis was to evaluate afferent function during a dorsal 
nerve root compression known to elicit pain, spinal recordings were made in the 
superficial dorsal horn, where these afferent fibers synapse. Although it cannot be 
conclusively determined whether the neurons recorded in this thesis represent the average 
conduction properties of all axons in the compressed nerve root, the search protocol used 
here randomly selected mechanoreceptors of the forepaw (Nicholson et al. 2011), where 
mechanical allodynia is established after a painful nerve root compression. As such, the 
6.6±3.0 minute critical duration likely reflects the response of afferents that innervate the 
region where sensitivity develops in this rat model of cervical radiculopathy. 
That same critical duration (6.6±3.0 minute) for decreasing the rate of evoked 
action potentials through the root also approximates the compression duration threshold 
for eliciting sustained behavioral sensitivity in the forepaw of the rat (Chapter 4; 
Nicholson et al. 2012). Compression to the nerve root only induces mechanical allodynia 
when compression is applied longer than (10 minutes) that critical duration and not after 
a shorter (3 minute) compression. Although the development of mechanical allodynia 
was only determined for testing with a 4.0gf filament, a 2.0gf filament has elicited similar 
 201 
trends in the responses to those reported in this thesis after nerve root compression 
durations of 3 and 15 minutes (Rothman et al. 2010). Furthermore, previous studies 
establish that the stimulation magnitude threshold for eliciting a paw withdrawal response 
decreases from 13.0-15.0gf using Chaplan’s up-down threshold method (Chaplan et al. 
1994) to 2.0-4.0gf after a 15 minute nerve root compression (Hubbard & Winkelstein 
2005). It is possible that a 3 minute compression also induces mechanical hyperalgesia, 
but the threshold for eliciting a painful response lies between 4.0gf and 13.0gf. By only 
testing for mechanical allodynia with a 4.0gf filament, the studies presented here did not 
determine whether a 3 minute compression to the nerve root in the rat enhances the 
sensitivity of the forepaw to stimuli greater than a 4.0gf. However, a 3 minute 
compression does not lower the threshold for eliciting a painful response to a thermal 
stimulus (Chapter 4). The fact that a 3 minute compression does not lower that thermal 
response or increase the withdrawal frequency to mechanical stimuli (Nicholson et al. 
2013a), together support the hypothesis that there is a compression duration threshold, 
near 6.6±3.0 minutes, for eliciting behavioral sensitivity after a nerve root compression of 
10gf in the rat. 
The duration threshold for eliciting behavioral sensitivity after nerve root 
compression likely varies with the load magnitude. Although the studies presented in this 
thesis demonstrate that there is a duration threshold between 3 and 10 minutes for 
eliciting mechanical allodynia after a 10gf nerve root compression (Chapter 4; Nicholson 
et al. 2012), Sekiguchi et al. (2009) report that persistent mechanical hyperalgesia can 
develop after a nerve root compression applied for as short as 3 seconds in the rat. The 
magnitude of compression was not defined for that short, 3 second nerve root 
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compression, but was described as a crush injury by those authors (Sekiguchi et al. 2009) 
and was likely much higher than the 10gf applied in the studies presented throughout this 
thesis. In fact, even a compression load as high as 60gf applied for 3 minutes to the 
cervical nerve root in the rat is insufficient to elicit mechanical allodynia (Nicholson et al. 
2012), indicating that Sekiguchi et al. (2009) likely compressed the nerve root with load 
magnitudes much higher than 60gf. Although the magnitude of compression required to 
elicit behavioral sensitivity after a 3 second nerve root compression has not been defined, 
it is clear that the duration threshold for eliciting behavioral sensitivity that is near 
6.6±3.0 minutes after a 10gf compression far exceeds the duration threshold that lies 
between 0 and 3 seconds after a crush injury to the nerve root (Nicholson et al. 2011, 
2012, Sekiguchi et al. 2009). Therefore, the duration threshold for inhibiting 
neurotransmission through the root during compression and for the development of 
behavioral sensitivity is only applicable to a 10gf C7 nerve root compression in the rat 
(Chapters 3 & 5) (Nicholson et al. 2011, 2012).  
Blocking pre-synaptic glutamate release in the central nervous system (CNS) with 
a single injection of Riluzole or upregulating spinal GLT-1 with daily intrathecal 
injections after the development of behavioral sensitivity (day 1) both abolish behavioral 
sensitivity (Fig. 8.2; Chapters 6 & 7) (Nicholson et al. 2013a,b). It is well-established that 
Riluzole inhibits glutamate release by pre-synaptic neurons and decreases the overall 
extracellular concentration of glutamate in the spinal cord (Coderre et al. 2007, Hama et 
al. 2011, MacIver et al. 1996, Wang et al. 2004). Riluzole abolished mechanical allodynia 
for at least six days and preserved the normal morphology of the nerve root axons at day 
7 even though it was only administered on day 1 (Fig. 8.2) (Chapter 7; Nicholson et al. 
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2013b). These sustained behavioral and neuroprotective effects of Riluzole long after 
Riluzole would already have been metabolically cleared from the CNS (Wu et al. 2013), 
indicates that glutamatergic neurotransmission in the CNS at day 1 after a painful nerve 
root compression has an essential role for the subsequent development of sustained nerve 
root-mediated pain. Conversely, without modifying the release of glutamate, but 
increasing spinal glutamate uptake by upregulating GLT-1 with a daily ceftriaxone 
injection, nerve root-mediated pain is also abolished (Fig. 8.2) (Chapter 6; Nicholson et 
al. 2013a). By day 7, ceftriaxone restored spinal GLT-1 expression, which is normally 
downregulated at this time-point after a painful nerve root compression (Fig. 8.2; Chapter 
5). Therefore, findings from that ceftriaxone study suggest that glutamate signaling in the  
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spinal cord likely contributes to the maintenance of behavioral sensitivity at day 7 due to 
the impaired glutamate uptake by GLT-1 after a painful nerve root compression. Notably, 
neuronal hyperexcitability in the deep laminae of the spinal cord that normally develops 
by day 7 was reduced by both Riluzole and ceftriaxone (Nicholson et al. 2013a,b) 
implicating spinal neuronal hyperexcitability as one underlying mechanism meditating 
behavioral sensitivity. Together, the studies that administered Riluzole or ceftriaxone 
indicate that, by day 1, the glutamatergic system is essential to initiating the cellular 
mechanisms in the CNS associated with persistent behavioral sensitivity that is 
maintained, in part, by downregulation of GLT-1 in the spinal cord. 
In the superficial laminae of the dorsal horn, the expression of the neuronal 
glutamate transporter, EAAC1, was unchanged at days 1 and 7 after a painful nerve root 
compression, but may have mediated the phenotypic shift from low threshold 
mechanoreceptors (LTMs) to wide dynamic range (WDR) neurons that develops by day 7 
(Chapter 5; Jarzylo & Man 2012, Kondo et al. 2002, Lim et al. 2006, Nicholson et al. 
2013a, Zhang et al. 2013). Previous studies report that upregulation of AMPA receptors 
on post-synaptic LTM neurons in the spinal cord change the response characteristics of 
these neurons to that of WDR neurons after a painful sciatic nerve constriction injury in 
the rat (Kondo et al. 2002, Lim et al. 2006). The distribution of AMPA receptors on post-
synaptic neurons is determined, in part, by EAAC1 (Jarzylo & Man 2012), suggesting 
that EAAC1 may have increased the proportion of WDR neurons after a painful nerve 
root compression by trafficking AMPA receptors to the synapse of LTM neurons in the 
spinal cord. Unlike the glial glutamate transporters, as much as 70-80% of EAAC1 is 
intracellular, but can traffic to the plasma membrane in response to aberrant neuronal 
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firing (Holmseth et al. 2012, Ross et al. 2011). It has previously been reported that 
spontaneous firing increases in the superficial laminae after a chronic constriction root 
injury (Terashima et al. 2011), which provides one mechanism by which EAAC1 may be 
trafficked to the plasma membrane, thereby upregulating AMPA receptors (Jarzylo & 
Man 2012) and contributing to the phenotypic shift of neurons in this region of the spinal 
dorsal horn (Chapter 5).  
Downregulation of spinal GLT-1 after a painful nerve root compression is likely 
sufficient to increase spinal neuronal excitability even in the absence of any change in the 
expression of the neuronal glutamate transporter, EAAC1, in the dorsal horn (Chapter 5). 
The contribution of EAAC1 to overall glutamate uptake is thought to be minimal 
(Holmseth et al. 2012, Rothstein et al. 1996) and, in fact, it has been reported that a 78% 
reduction in EAAC1 expression in the rat brain does not change the concentration of 
extracellular glutamate (Rothstein et al. 1996). In contrast, downregulating GLT-1 by 
58% produces a 32-fold increase in extracellular glutamate in the rat brain (Rothstein et 
al. 1996). This large increase in extracellular glutamate due to impaired glutamate uptake 
by GLT-1 is sufficient to increase neuronal hyperexcitability (Cata et al. 2006, 
Inquimbert et al. 2012). Together, those studies suggest that downregulation of EAAC1 is 
not required to increase extracellular glutamate and the associated neuronal excitability 
that is observed after a painful nerve root compression (Chapter 5; Cata et al. 2006, 
Inquimbert et al. 2012, Rothstein et al. 1996). However, it should be noted that due to the 
low expression of EAAC1, immunohistochemistry may not be sensitive enough to detect 
subtle changes in the expression of this glutamate transporter after a painful nerve root 
compression (Chapter 5). Although immunoblotting may be more discriminating in 
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detecting EAAC1 concentrations (Holmseth et al. 2012, Sung et al. 2003), 
immunohistochemistry was chosen because this method provides spatial resolution. 
Furthermore, the same immunohistochemical methods used to quantify spinal EAAC1 
expression in this thesis are sensitive enough to detect changes in the spinal expression of 
EAAC1 following a painful facet joint distraction (Dong et al. 2012). In the studies 
presented here, no trends were observed in the spinal expression of EAAC1 after a 
painful nerve root compression (Chapter 5), indicating that more sensitive methods for 
quantifying EAAC1 protein concentrations would also likely not detect any robust 
modifications to the spinal expression of this transporter associated with radicular pain. 
This would suggest that AMPA receptor-mediated phenotypic shifts in the superficial 
dorsal horn after a painful nerve root compression may be due to increased activity of 
EAAC1 or increased glutamate activation of AMPA receptors due to impaired glutamate 
uptake by GLT-1 (Chapters 5 & 6; Nicholson et al. 2013a). 
There is a compression duration threshold between 3 and 15 minutes for inducing 
axonal damage in the nerve root, upregulating spinal GLT-1, downregulating spinal 
GLAST and enhancing neuronal hyperexcitability in the deep laminae, all of which 
develop by day 7 and are associated with persistent behavioral sensitivity after a transient 
C7 nerve root compression (Chapters 3-5). It is possible that the 6.6 minute critical 
duration for inhibiting electrically-evoked action potentials from the forepaw to the spinal 
cord also defines the duration threshold for eliciting these neuronal and glutamatergic 
responses at day 7. However, the studies in this thesis did not explicitly test that 
hypothesis. Instead, compression durations of 3 minutes and 15 minutes were used for all 
immunohistochemical and electrophysiologic studies. The 15 minute compression 
 207 
duration was specifically chosen in order to compare the outcomes of this thesis with the 
broader existing literature in nerve root compression since there is a wealth of literature 
already defining inflammatory, neurotrophic, neuropeptidergic, neurodegenerative and 
behavioral responses after a 10gf, 15 minute C7 nerve root compression in the rat 
(Hubbard & Winkelstein 2005, Hubbard & Winkelstein 2008, Hubbard et al. 2008a, 
Rothaman et al. 2007, Rothman et al. 2010). By only applying compressions for a 
duration of 15 minutes, the findings and implications from this thesis are limited. Further, 
the hypothesis that there is a relationship between the neuronal responses during a nerve 
root compression and the neuronal, glutamatergic and behavioral responses that develop 
was not explicitly tested. However, the compression duration threshold for eliciting 
mechanical allodynia and the development of astrocytic activation at day 7 is between 3 
and 10 minutes (Nicholson et al. 2012, Rothman et al. 2010). The 6.6±3.0 minute 
duration threshold for inhibiting neurotransmission through the root during compression 
does, therefore, approximate and, may even define, the duration threshold for eliciting 
behavioral sensitivity and spinal inflammation. Both of these are associated with 
downregulation of spinal GLT-1, increased firing rates of spinal neurons and the 
development of neuropathology in the nerve root after a transient cervical nerve root 
injury in the rat (Hubbard & Winkelstein 2008, Nicholson et al. 2011, 2012, 2013a,b). 
Therefore, the studies in this thesis do support the hypothesis that the 6.6 minute critical 
duration for inhibiting neurotransmission through the root during compression also 
defines the duration threshold for downregulating spinal GLT-1, eliciting neuronal 
hyperexcitability and inducing neuropathology in the nerve root. These studies are the 
first to establish a role for nerve root biomechanics in dysregulating spinal glutamate 
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transporter expression, enhancing spinal neuronal excitability and reducing cytoskeletal 
protein expression in the nerve root (Nicholson et al. 2011, 2013a,b). 
Mechanical compression to the nerve root by a herniated disc can also irritate the 
nerve root chemically due to contact with the nucleus pulposus of the disc (Abbed & 
Coumans 2007, Wainner & Gill 2000). Animal models that compare the cellular cascades 
in the peripheral and central nervous systems that are associated with a mechanical or 
chemical insult to the root demonstrate that each type of these root injuries (i.e. chemical, 
mechanical) may mediate radicular pain via different pathways (Chang et al. 2011, 
Maves et al. 1993, Rothman et al. 200b). Therefore, the conclusions in this study also 
may only be applicable to nerve root injuries that are solely attributed to its mechanical 
deformation. However, the incidence rate of a disc herniation in cervical radiculopathy is 
reported to be only 25-30% (Carrette & Fehlings 2005, Radhakrishnan et al. 1994, 
Thoomes et al. 2012). The model of cervical nerve root compression used in the studies 
here is, therefore, clinically relevant for the remaining 70-75% of reported cases of 
cervical radiculopathy. 
 The studies here did not look at time-points later than day 7. Rodent models of 
both chronic and transient nerve root compressions demonstrate that behavioral 
sensitivity can persist for up to 3-4 weeks (Rothman et al. 2007). Although pain 
symptoms are fully established by day 7 (Rothman et al. 2007), the cellular mechanisms 
that maintain behavioral sensitivity may differ over time. For example, after a painful 
nerve root compression, the neuropeptide, substance P (SP), is downregulated in the 
dorsal root ganglion (DRG) at day 7, but upregulated in the DRG at day 14, despite the 
fact that behavioral responses are similar to each other at both time-points (Chang et al. 
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2011, Hubbard et al. 2008a). SP is specifically associated with nociceptors in the DRG, 
suggesting that the mechanism underlying nociception continuously shift even after 
radicular pain is established at day 7. Therefore, even though day 7 is considered relevant 
to chronic pain in the rat (DeLeo & Winkelstein 2002), the behavioral, neuronal and 
glutamatergic responses demonstrated at day 7 in the studies presented here may not 
necessarily reflect the maintenance of pain at later time-points due to the temporal 
dynamics of neuronal cytoskeletal proteins, neuronal signaling and glutamate 
transporters, which undergo continuous modifications for weeks to months after neural 
tissue trauma (Chen et al. 1992, Kim et al. 2011, Serbest et al. 2007, Yoshizawa et al. 
1995). 
 
8.3 Synthesis 
Graded magnitudes of compression to axons produce graded decreases in axonal 
transport and axonal conduction in vivo and in vitro (Chen et al. 1992, Garfin et al. 1990, 
Gallant 1992, Pedowitz et al. 1992). As was observed during in vivo compression to the 
cervical nerve root in the rat (Nicholson et al. 2011) and in the nerve roots of the cauda 
equina in the pig (Garfin et al. 1990, Pedowitz et al. 1992), in vitro compression to an 
isolated squid axon inhibits electrically-evoked action potentials through the compressed 
region both during and immediately after a transient compression is applied (Gallant 
1992). Furthermore, those studies demonstrate that axonal conduction only recovers if the 
plasma membrane of the axon remains intact (Gallant 1992). After a 15 minute nerve root 
compression, spinal action potentials evoked by an electrical stimulus to the forepaw do 
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not recovery for at least 10 minutes (Nicholson et al. 2011), demonstrating that impaired 
axonal conduction is sustained well after the original insult (compression) is no longer 
present. Given the relationship between plasma membrane damage and impaired 
neurotransmission (Gallant 1992), the sustained decrease in axonal conduction that is 
evident after a 15 minute compression (Nicholson et al. 2011), suggests that a 10gf, 15 
minute compression compromises the plasma membrane of afferents in the nerve root. 
Even though the number of evoked action potentials from the periphery to the 
superficial dorsal horn decreases during a painful nerve root compression (Nicholson et 
al. 2011), the frequency of neuronal evoked firing rates in that same region of the dorsal 
horn is unchanged at day 7 (Chapter 5; Zhang et al. 2013). Unlike the electrophysiologic 
studies that measured neurotransmission during a nerve root compression, the studies that 
recorded evoked spinal neuronal activity from the forepaw at day 7 did not determine 
whether those action potentials were associated with the C7 or C8 nerve root, both of 
which innervate the rat forepaw (Takahashi & Nakajima 1996). Therefore, based on the 
studies presented in this thesis, it cannot be determined whether neurotransmission 
through the C7 nerve root to the superficial dorsal horn remains impaired or recovers by 
day 7 after a painful nerve root compression. The neuropathology in the C7 nerve root 
that develops by day 7 after a painful transient nerve root compression in the rat 
(Hubbard & Winkelstein 2008, Nicholson et al. 2011) and the loss of primary afferent 
synaptic contact in the superficial dorsal horn after canine or rat lumbar nerve root 
compression (Kobayashi et al. 2008, Terashima et al. 2011) suggest that 
neurotransmission from the periphery to the spinal cord does not recover in at least a 
subset of primary afferents in the affected root after its compression. In fact, Terashima et 
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al. (2011) report that there are “silent” spinal neurons in the superficial dorsal horn that 
have no identifiable receptive field after a painful lumbar nerve root ligation in the rat 
due to lost synaptic contact with the primary afferents that normally synapse onto these 
second-order neurons (Terashima et al. 2011). There may be similarly “silent” neurons in 
the superficial laminae after a painful transient cervical nerve root injury that were not 
recorded in the electrophysiologic studies of this thesis because all neurons were 
identified by applying a mechanical stimulus to the forepaw (Chapters 5-7) (Zhang et al. 
2013). Therefore, the frequency of evoked neuronal firing rates in the dorsal horn at day 
7 only reflects the response of those neurons that maintained at least one synaptic 
connection with a primary afferent innervating the forepaw (Chapter 5; Zhang et al. 
2013). Even though there may be an overall decrease in evoked neuronal firing in the 
superficial dorsal horn due to “silent” neurons (Terashima et al. 2011), for the spinal 
neurons that do maintain at least one primary synapse, the frequency of firing is 
unchanged in the superficial laminae at day 7 after a painful nerve root compression 
(Chapter 5; Terashima et al. 2011, Zhang et al. 2013). 
Downregulation of GLT-1 in the superficial laminae of the dorsal horn may 
contribute to the neuronal hyperexcitability that develops in the deep laminae by day 7 
after a painful nerve root compression (Chapter 5; Nicholson et al. 2013a, Zhang et al. 
2013). In vivo patch clamp studies in the rat confirm that the frequency of post-synaptic 
excitatory currents does not increase in the superficial dorsal horn after a painful lumbar 
ligation (Terashima et al. 2011). That same study does report, however, that the 
amplitude of post-synaptic excitatory currents does increase (Terashima et al. 2011), 
which could be attributed to increased glutamate receptor activation on these post-
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synaptic neurons due to impaired glutamate uptake by GLT-1 on perisynaptic glia 
(Chapter 5; Inquimbert et al. 2012, Nicholson et al. 2013a). Most primary afferents 
synapse onto an interneuron in the dorsal horn (Todd 2010) and patch clamp recordings 
on spinal cord slices reveal that primary nociceptors synapse onto excitatory interneurons 
in laminae I and II and that these interneurons increase the excitability of neurons in 
laminae III-V (Nakatsuka et al. 2002, Petitjean et al. 2012). An increase in the amplitude 
of excitatory currents on these post-synaptic interneurons in lamina II after a painful 
nerve root ligation (Terashima et al. 2011), potentially due to downregulation of GLT-1 
(Chapter 5; Nicholson et al. 2013a), may increase excitatory neurotransmission in the 
deep laminae (Nakatsuka et al. 2002, Petitjean et al. 2012), increasing the firing rate of 
deep dorsal horn neurons after a painful transient cervical nerve root compression 
(Chapter 5; Zhang et al. 2013). In this scenario, spinal GLT-1 has a pivotal role in 
amplifying interlaminar neuronal circuits by enhancing the excitability of dorsal horn 
neurons in the deep laminae. 
A violation of the plasma membrane of compressed axons due to an applied 
compression is associated with increased release of intracellular glutamate, raising the 
extracellular glutamate concentration (LaPlaca & Prado 2010). Riluzole may have 
restored normal extracellular glutamate concentrations at day 1 by inhibiting glutamate 
release in the central nervous system (Chapter 7). After a single injection of Riluzole, the 
neuronal hyperexcitability in the spinal cord and axonal pathology in the nerve root that 
are normally evident at day 7 after a painful nerve root compression were both abolished 
(Chapters 3, 5 & 7). This suggests that the elevated extracellular concentration of 
glutamate in the central nervous system at day 1 (Fig. 8.1) is essential for the neuronal 
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pathophysiology that develops in both the spinal cord and the nerve root by day 7 
(Nicholson et al. 2011, 2013b). In fact, an over-accumulation of synaptic glutamate can 
sensitize neurons and, if the concentration is high enough, cause glutamate-mediated 
neurotoxicity (Cargill & Thibault 1996, Geddes & Cargill 2001, LaPlaca & Prado 2010). 
Riluzole may have inhibited the development of neuronal hyperexcitability in the spinal 
cord and neuropathology in the nerve root at day 7 by reducing extracellular glutamate in 
the spinal cord at day 1. Even though Riluzole was administered after behavioral 
sensitivity developed in the forepaw (day 1), that time-point is likely early enough to 
mitigate the development of robust pathology in the nerve root because axonal 
degeneration develops sometime between days 1 and 7 (Hubbard & Winkelstein 2008). 
Therefore, the neuroprotective effects of Riluzole observed here may not be applicable if 
Riluzole is administered at later time-points, after the development of axonal 
degeneration in the nerve root. 
Early inflammatory responses after a painful C7 nerve root compression in the rat 
may also contribute to increased synaptic glutamate (Nie et al. 2010, Rothman et al. 
2009b, Rothman & Winkelstein 2010, Zou & Crews 2005). Within one hour of a painful 
C7 compression in the rat, pro-inflammatory cytokines, including TNFα, are upregulated 
in the spinal cord (Rothman & Winkelstein 2010). TNFα dose-dependently inhibits 
glutamate uptake in hippocampal slices by up to 25% (Zou & Crews 2005) and, in doing 
so, may have increased glutamate concentrations within one hour of a painful root 
compression (Rothman & Winkelstein 2010). Antagonizing TNFα with the soluble TNF 
receptor-1 attenuates, but does not abolish, radicular pain in this model (Rothman & 
Winkelstein 2010), suggesting that TNFα may work synergistically with the hypothesized 
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increase in pre-synaptic glutamate release to elevate synaptic glutamate. Minocycline 
also prevents the development of pain after a C7 nerve root compression in the rat by 
suppressing microglial activation and associated pro-inflammatory cytokine release by 
these cells (Amin et al. 2010, Rothman et al. 2009a, Yamada & Jinno 2011). It has also 
been shown that minocycline reduces NMDA receptor activation in the spinal cord by 
upregulating spinal glial glutamate transporters after a painful sciatic nerve ligation in the 
rat (Nie et al. 2010). Notably, spinal glutamate transporters are unchanged at day 1 after a 
painful nerve root compression (Chapter 5) and upregulating GLT-1 with ceftriaxone 
does not abolish behavioral sensitivity until day 3, two days after the initial treatment 
(Chapter 6). Therefore, even though minocycline also upregulates spinal glial glutamate 
transporters (Nie et al. 2010), it is more likely that minocycline prevents the development 
of radicular pain by suppressing microglial activation and associated TNFα release (Amin 
et al. 2010, Rothman et al. 2009a). Together, the studies that administered Riluzole, 
ceftriaxone, minocycline or the soluble TNF receptor-1 suggest that increased glutamate 
release along with microglial activation and associated glutamate uptake inhibition by 
TNFα likely mediate the initiation of nerve root-mediated pain while downregulation of 
GLT-1 contributes to the maintenance of radicular pain. 
The compression duration threshold for both the development of neuropathology 
in the nerve root and downregulation of spinal GLT-1 lies between 3 and 15 minutes after 
a C7 nerve root compression in the rat (Chapter 5; Nicholson et al. 2011). Astrocytic 
expression of GLT-1 is tightly regulated by pre-synaptic neurons (Ghosh et al. 2011, 
Yang et al. 2009). As such, the neuropathology in the nerve root that develops after 
painful compression (Hubbard & Winkelstein 2008, Nicholson et al. 2011) may mediate 
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the downregulation of this transporter in the spinal cord after a painful nerve root 
compression. As demonstrated in this thesis and previously reported, the axons of the 
nerve root are sensitive to both the magnitude and duration of compression (Hubbard & 
Winkelstein 2008, Garfin et al. 1990, Nicholson et al. 2011, Pedowitz et al. 1992). 
Furthermore, the load magnitude to induce neuropathology in the nerve root likely varies 
with the duration of compression. Above 3.2gf, the axonal cytoskeletal protein, NF200, is 
significantly reduced in the nerve root after a 15 minute compression (Hubbard & 
Winkelstein 2008). Yet, if a suprathreshold (10gf) compression is applied to the root for 
only 3 minutes, the axons retain their normal morphology (Nicholson et al. 2011). Axonal 
pathology only develops in the root after a painful nerve root compression (Hubbard & 
Winkelstein 2008, Nicholson et al. 2011) and even a 60gf compression is not sufficient to 
elicit behavioral sensitivity if applied for 3 minutes (Nicholson et al. 2012) suggesting 
that a 60gf, 3 minute compression also could not induce axonal degeneration in the nerve 
root (Hubbard & Winkelstein 2008, Nicholson et al. 2011). If, indeed, spinal expression 
of GLT-1 requires normal afferent input from the nerve root, the duration threshold for 
downregulating this transporter in the dorsal horn that is between 3 and 15 minutes after a 
10gf compression likely also varies with the compression magnitude. Furthermore, the 
magnitude and duration thresholds for producing injury in the nerve roots of the cauda 
equina in a porcine model decrease with increasing rates of compression (Olmarker et al. 
1989a). Given that the nerve root axons are sensitive to the combined contribution of the 
duration, magnitude and rate of compression and that damage to these axons likely 
precipitates the downregulation of spinal GLT-1 that results after a nerve root 
compression (Ghosh et al. 2011, Yang et al. 2009), this transporter may also be sensitive 
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to these mechanical parameters. The relationship between the primary afferents and 
spinal GLT-1, may have a central role in transducing the biomechanics of the nerve root 
tissues into the pain symptoms that develop. 
The neuropathology in the nerve root that is normally evident at day 7 after a 
painful nerve root compression does not develop when sodium channel-dependent 
glutamate release is blocked at day 1 by Riluzole (Chapter 7). The proposed relationship 
between the neuropathology in the afferents of the nerve roots and the downregulation of 
spinal GLT-1 suggests that when these afferents retain their normal morphology after 
Riluzole treatment, spinal GLT-1 also would not be downregulated. Unlike Riluzole, 
which rapidly reduces spinal glutamate concentration within 30 minutes of an 
intraperitoneal injection (Coderre et al. 2007), ceftriaxone did not abolish behavioral 
sensitivity until day 3 (Chapter 6; Nicholson et al. 2013a), suggesting ceftriaxone does 
not significantly modify synaptic glutamate concentration until this time-point. 
Therefore, it is possible that even though ceftriaxone presumably reduces extracellular 
glutamate, it only directly upregulates spinal GLT-1 without modifying the normal course 
of the associated neuropathologic responses in the nerve root after painful nerve root 
compression. Preliminary studies do support this hypothesis; when the nerve root axons 
retain their normal morphology after a nerve root compression treated with Riluzole, 
spinal GLT-1 expression is comparable to that in normal tissue (Fig. 8.3). Conversely, if  
spinal GLT-1 is upregulated by ceftriaxone, extensive axonal pathology is apparent in the  
nerve root (Fig. 8.3), indicating that maintaining spinal GLT-1 expression is not 
sufficient to mitigate damage to the primary afferents. These preliminary data support the 
studies in the rest of this thesis that suggest that neurodegeneration in the nerve root  
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cause spinal glia to downregulate the expression of GLT-1 (Ghosh et al. 2011, Nicholson 
et al. 2011, 2013a, Yang et al. 2009).  
The studies in this thesis, taken together with the literature, suggest that a 15 
minute, 10gf compression damages the plasma membrane of the axons during a 
Fig. 8.3 Proposed schema of the neuronal and glutamatergic responses in the nerve root and spinal cord 
after a painful 15 minute compression. Longitudinal sections of the nerve root labeled for IB4 and axial 
sections of the dorsal horn labeled for GLT-1 show that for a compression duration longer than 6.6±3.0 
minutes, there is a sustained decrease in neurotransmission through the root, which may be indicative of 
damage to the plasma membrane of the nerve root axons and may increase glutamate release in the 
spinal cord. By day 7, there is extensive axonal pathology in the nerve root associated with 
downregulation of GLT-1 in the dorsal horn, where those axons synapse. Downregulation of GLT-1 
increases synaptic glutamate and the firing rate of spinal neurons. Hyperexcitability of spinal neurons in 
the deep laminae of the dorsal horn mediates behavioral sensitivity. Ceftriaxone and Riluzole both 
abolish cervical radicular pain by maintaining normal spinal glutamate uptake by GLT-1. Ceftriaxone 
directly upregulates the expression of spinal GLT-1, while Riluzole prevents the development of 
neuropathology, thereby maintaining spinal GLT-1 expression. 
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sufficiently long applied compression, causing the axons contained within it to release 
excess synaptic glutamate in the spinal cord (Fig. 8.3). Elevated glutamate concentration 
in the spinal cord at day 1 after a painful nerve root compression contributes to changes 
in the neuronal circuits in the spinal cord at day 7 (Fig. 8.3). Specifically, the  
cytoskeleton of the injured axons in the nerve root is compromised and the firing rate of 
post-synaptic spinal neurons increases in the deep laminae of the dorsal horn (LaPlaca &  
Prado 2010, Nicholson et al. 2011). In response to the neurodegeneration that develops in 
the nerve root after a painful nerve root compression, spinal glial cells in the dorsal horn 
downregulate their expression of GLT-1 at day 7 (Fig. 8.3) (Nicholson et al. 2013a, Yang 
et al. 2009). Because GLT-1 is the dominant transporter responsible for glutamate uptake, 
impaired glutamate uptake by it may sensitize the spinal neurons, increasing the firing 
rate of these neurons (Fig. 8.3). Finally, evoked spinal neuronal hyperexcitability at day 7 
likely mediates the persistence of behavioral sensitivity at this same time-point. 
 
8.4 Future Work 
Although this thesis refers to nerve root compressions that elicit mechanical and 
thermal sensitivity as painful, it is not known whether a nerve root compression in this 
model elicits on-going, spontaneous pain and, if so, whether the presence of the evoked 
reflexes (mechanical and thermal sensitivity) that are used here, serve as an appropriate 
proxy for spontaneous pain. The pain field has, for decades, pursued the development of 
new pain assays that can reliability quantify on-going pain, which is the most-often 
reported clinical symptom of neuropathic pain (Backonja & Stacey 2004, Mogil et al. 
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2010). Future studies should investigate potential methods, such as place aversion 
(LaBuda & Fuchs 2000) that could assess ongoing pain better than evoked reflex tests.  
Measuring spontaneous activity of spinal afferents could also serve as a proxy for 
evaluating spontaneous pain after a cervical transient nerve root compression. The field 
potential recordings and the search protocol used in this thesis are not robust methods for 
quantifying spontaneous activity due to the fact that spontaneous neuronal firing can 
make it difficult to identify an evoked response. Because the goal of the studies in this 
thesis were to measure evoked firing of spinal neurons in response to the same 
mechanical stimuli that elicits mechanical allodynia, the electrophysiologic studies were 
optimized to evaluate evoked but not spontaneous neuronal firing rates. In vivo patch 
clamp techniques are a more robust method to measure spontaneous neuronal activity and 
can also identify the cellular mechanisms contributing to the neuronal firing patterns 
observed by extracellular recordings, such as excitatory and inhibitory post-synaptic 
currents (Covey et al. 1996, Takeda et al. 2010). Studies employing in vivo patch clamp 
techniques in the spinal cord to assess spontaneous neuronal activity would define the 
spinal neuronal firing at the synaptic level after a painful nerve root compression and 
further define the role of glutamate in nerve root-mediated pain by characterizing 
excitatory neuronal circuits in the dorsal horn. 
Neurotransmission through the root is sensitive to both the compression 
magnitude and the length of time that the compression is applied (Garfin et al. 1990, 
Nicholson et al. 2011, Pedowitz et al. 1992). The studies in this thesis suggest that 
impaired axonal conduction during an applied compression is an indicator, or even an 
initiator, of the subsequent behavioral sensitivity that develops (Nicholson et al. 2011, 
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2012). Impaired axonal conduction has been associated with structural damage to the 
axonal plasma membrane (Gallant 1992, LaPlaca et al. 2009). The structural integrity of 
the plasma membrane can be breached by mechanical overloading and/or an insufficient 
blood supply (Dyck et al. 1992, Gallant 1992, LaPlaca et al. 2009). Studies have 
established that intraradicular blood flow continuously decreases with increasing periods 
of compression to the nerve root (Olmarker et al. 1989b, Yoshizawa et al. 1989), and that 
ischemia alone is sufficient to reduce axonal conduction through the nerve root 
(Kobayashi et al. 2008). Therefore, with increasing durations of root compression, 
ischemic conditions may increasingly compromise the axons’ ability to maintain or repair 
their plasma membranes (LaPlaca et al. 2009). At the same time, the magnitude of an 
applied compression also modulates the degree of intraradicular ischemia and the extent 
of axonal plasma membrane damage within the nerve root (Garfin et al. 1990, Kobayashi 
et al. 2008, Olmarker et al. 1989a). Therefore, there are likely additive effects of 
compression magnitude and duration on the degree of intraradicular blood flow 
impairment and axonal membrane damage that develops during a nerve root 
compression.  
Superimposed upon these physiologic responses in the nerve root are the 
biomechanical properties of the nerve root tissue itself (Hubbard et al. 2008b). Because 
of its viscoelastic properties, the magnitude of an applied compression will continuously 
decrease when it is held under a constant deformation as can occur with foraminal 
stenosis or disc herniation. Conversely, when the compression magnitude is held 
constant, strain throughout the nerve root will continuously increase. Therefore, the 
loading conditions of a nerve root compression must be considered when determining the 
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relative effects of magnitude and duration on mediating circulatory and neuronal 
responses during compression. Future studies should further define the relative 
contributions of compression magnitude and duration on impaired axonal conduction by 
also evaluating intraradicular blood flow and the structural integrity of the axonal plasma 
membrane during a nerve root compression. Such studies would give further insight into 
role of nerve root biomechanics in mediating the pathophysiology that develops in root at 
the time of injury. 
Recent in vitro studies suggest that transcriptional regulation of both GLT-1 and 
GFAP by ceftriaxone is mediated by NF-κβ (Bachetti et al. 2010, Ghosh et al. 2011, Lee 
et al. 2008, Yang et al. 2009). Both the 10µg and the 150µg dose of ceftriaxone 
upregulated spinal GLT-1, but only the 10µg dose reduced the normal upregulation of 
spinal GFAP after a painful nerve root compression (Nicholson et al. 2013a). To date, no 
study has directly compared the dose-response of ceftriaxone on transcriptional 
regulation of GLT-1 and GFAP in cultured astrocytes. Studies that further elucidate the 
mechanism(s) by which ceftriaxone modulates astrocytic GLT-1 and GFAP expression 
would help to further define the role of astrocytes after a painful nerve root compression 
and could potentially aid clinicians and pharmacologists in developing more potent 
therapeutic agents for alleviating radicular pain.  
Because Riluzole is already FDA-approved for the treatment of amyotrophic 
lateral sclerosis (ALS) and is currently in clinical trials as a treatment for spinal cord 
injury (Fehlings et al. 2012), it has foreseeable potential to be translated from animal 
studies into clinical use for other types of neural tissue trauma, including nerve root 
compression. However, there are some important considerations regarding its use as a 
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treatment for cervical radicular pain. Although in vitro studies suggest that Riluzole may 
enhance neuronal survival and even promote neuronal growth, Riluzole’s effects in vivo 
suggest that this drug can only prevent and/or inhibit neuronal degeneration (Coderre et 
al. 2007, Fehlings et al. 2012, Sung et al. 2003, Wu et al. 2013). Based on these animals 
studies, Riluzole is unlikely capable of restoring normal axonal morphology or function 
once degeneration has fully developed after a painful nerve root compression at day 7 
(Coderre et al. 2007, Hubbard & Winkelstein 2008, Sung et al. 2003, Wu et al. 2013). In 
fact, because of this, the previously reported clinical trial design for Riluzole 
administered it within 12 hours after a traumatic spinal cord injury (Fehlings et al. 2012). 
For radiculopathy, particularly those cases with a slow onset associated with foraminal 
spondylosis or a bulging disc, it is not feasible to identify or implement treatment over 
such a short treatment window. Determining whether there is a therapeutic window for 
Riluzole treatment in nerve root-mediated pain after a C7 transient cervical nerve root 
compression would be beneficial. 
The studies presented in this thesis suggest that elevated synaptic glutamate due to 
impaired glutamate uptake contributes to the maintenance of cervical radicular pain 
(Nicholson et al. 2013a). However, synaptic glutamate concentrations were not measured 
nor was glutamate receptor activity evaluated. As such, alternative hypotheses could 
explain the findings in this thesis. Downregulation of spinal GLT- after a painful nerve 
root compression could reflect increased glutamate receptor activity at day 7 (Dong & 
Winkelstein 2010, Gwak & Hulsebosch 2005, Hudson et al. 2002, Lea & Faden 2001, 
Nicholson et al. 2012). Elevated glutamate receptor activity would decrease synaptic 
glutamate, which in turn, would downregulate GLT-1 (Aronica et al. 2003, Benediktsson 
 223 
et al. 2012, Perego et al. 2000). Under that paradigm, there is no impaired glutamate 
uptake and the upregulation of GLT-1 with ceftriaxone increases the competition for 
synaptic glutamate between GLT-1 and the glutamate receptors, reducing the available 
glutamate that can activate those receptors (Inquimbert et al. 2012, Sung et al. 2003). 
Even though the increased expression of spinal GLAST at day 7 after a painful nerve root 
compression (Chapter 6; Nicholson et al. 2013a) may indicate that spinal glutamate 
concentrations are, indeed, elevated after a painful nerve root compression (Perego et al. 
2000), identifying the relative contributions of glutamate transporters and glutamate 
receptors in mediating radicular pain are needed. Furthermore, the extracellular 
concentration of glutamate should be measured at days 1 and 7, which are the time-points 
identified here when elevated synaptic glutamate may perpetuate the development of 
axonal damage in the nerve root and when impaired glutamate uptake likely increases 
synaptic glutamate, respectively. 
 In summary, the studies presented in this thesis begin to define how the 
biomechanics of a nerve root compression can modify neuronal circuits in the primary 
afferents and in the dorsal horn that are relevant to persistent radicular pain. Although 
these studies lay the groundwork for defining the role of spinal excitatory signaling via 
glutamate in nerve root-mediated pain, the contribution of inhibitory signaling remains 
undefined for radicular pain. The primary afferents receive direct axo-axonic inhibitory 
input from GABAergic neurons (Todd 2010). Therefore, it is possible that the damage 
sustained to these afferents directly modulates inhibitory neuronal circuits in addition to 
modulating spinal glutamate transporter expression. Future studies that characterize both 
the excitatory and inhibitory circuits and the contribution of glial cells to each may be 
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useful to fully define the nociceptive pathways of nerve root-mediated pain. Overall, the 
studies in this thesis help guide future work understanding the excitatory system in the 
spinal cord and may also identify potential proteins for therapeutic targeting of radicular 
pain. 
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APPENDIX A 
 
Protocol to Count Electrically-Evoked Action 
Potentials 
 
  
This appendix details the spike counting methods used in the study described in 
Chapter 3. Spinal neurons in the superficial dorsal horn (150-350µm below the pial 
surface) of the C7 spinal cord were electrically evoked by a pair of stimulation probes 
inserted into the forepaw of the rat (Khan et al. 2002, LaPirot et al. 2009, Nicholson et al. 
2011, Urch et al. 2003. After data acquisition, single units were isolated from the 
extracellular recordings through spike sorting in Spike2 (CED; Cambridge, UK). A post-
stimulus histogram was generated in Spike2 to quantify the number of action potentials 
that were evoked within 10-40msec after application of the electrical stimulus (post-
stimulus latency) (Fig. A.1). The 10-40 millisecond post-stimulus latency period was 
selected in order to exclude any artifact due to the stimulus and also to exclude 
spontaneous action potentials. Detailed methods for the surgical exposure, 
instrumentation and recording protocols are described in Chapter 3. 
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 A detailed tutorial for spike-sorting and generating post-stimulus histograms is 
provided in the Spike2 Training Course Manual. This appendix provides additional 
details on data analysis, in particular, how to generate a post-stimulus histogram using the 
extracellular recordings collected in Chapter 3 (Appendix B). The first step is to spike-
sort the channel that contains the extracellular recording. Once spike-sorting is complete, 
create a new channel for each WaveMark code that Spike2 generates corresponding to 
each recorded neuron. Next, the channel that contains the recording from the stimulus 
needs to be spike-sorted in order to make an Event+ channel using the same methods to 
spike-sort action potentials from the extracellular recordings.  
 Each WaveMark code must be analyzed separately in order to quantify the 
number of evoked action potentials for each firing unit. To create the post-stimulus 
histogram, select “Stimulus histogram” under the “New results view” in the “Analysis” 
menu. A “Settings” dialogue will appear (Fig. A.2). 
1 –  Select the WaveMark channel containing the firing unit of interest from the 
“Channels” drop-down menu.  
Fig. A.1 Screen shot showing an example post-stimulus histogram generated by Spike2. The plot 
illustrates the number of spikes (vertical axis) that are counted in each 0.01 second bin for the first 1.0 
second after the stimulus. 
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2 –  Set the analysis width to 1.0 seconds and the bin size to 0.01 in order to 
count the number of spikes that occur within each 10 millisecond bin for the 
first 1.0 second period after the stimulus.  
3 –  Select the Event+ channel from the “Trigger” drop-down menu.  
4 –  Press “Change” to apply the above settings.  
 
With the settings in place, the next step is to quantify the number of spikes that 
were evoked by each stimulus. A post-stimulus histogram can be generated for the entire 
data or a subset of the data. To analyze a subset of the data, return to the window 
containing the data channels and place one vertical cursor on either end of data to be 
analyzed (Fig. A.3). 
Fig. A.2 Dialogue box specifying the settings for a post-stimulus histogram in Spike2. The WaveMark 
channel that contains the firing of a single unit is selected for “Channels” and the Event+ channel that 
contains the stimulus events is selected at the “Trigger.” The “width” of analysis identifies the period 
during which Spike2 analyzes the WaveMark after each stimulus and the “bin size” specifies the width 
of time into which spikes are binned.
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Return to the post-stimulus histogram window and open the “Process” dialogue 
box (Fig. A.4) 
5 – Select the vertical cursor from the “Start time” drop-down menu that was 
placed at the beginning of the stimulus period. 
6 – Select the vertical cursor from the “End time” drop-down menu that was 
placed at the end of the stimulus period. 
7 – Make sure that the options to “Process all data” and “Clear result data before 
process” are selected. 
8 – Select “Process” to generate the post-stimulus histogram (Fig. A.1). 
9 – Copy the data (either from the “edit” menu or by pressing ctrl+c) and paste the 
data into an excel spread sheet. The first column will contain the post-
Fig. A.3 Screen showing a 16-train stimulus (Stim) applied to the forepaw of the rat and extracellular 
potentials (EC data) recorded in the spinal cord. Also shown is the “Event+” and “WaveMark” channels 
generated by Spike2 to identify the onset time of each stimulus and the action potentials associated with 
a single neuron, respectively. Spike2 will generate a post-stimulus histogram for the data enclosed by 
two vertical cursors (1 & 2).  
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stimulus latency time (in 10 millisecond bins) and the second column will 
contain the number of spikes that occurred in that 10 millisecond period. 
10 – Move the two vertical cursors to the next 16-train stimulus period and repeat 
steps 5-9 until each stimulus period is analyzed. 
 
 
 
 
 
 
Fig. A.4 The Spike2 Process dialogue for generating a post-stimulus histogram for the data within the 
identified “Start time” and “End time.” 
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APPENDIX B 
 
Electrically-Evoked Action Potential Counts 
During a Nerve Root Compression 
 
 
 This appendix provides a summary of the number of action potentials for each 
neuron in the electrophysiologic studies presented in Chapter 3, for the sham and 
compression groups in the 15 minute (Table A.1) and 3 minute (Table A.2) studies. In 
each table, each neuron that is included is indicated by the rat number followed by a letter 
to distinguish neurons from the same rat. 
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Table B.1 Number of action potentials evoked at each time-point starting with baseline 
(BL) and running through the compression (C) times and post-compression (P) times for 
each neuron in the 15 minute study. 
 group sham n=4 neurons (1 rat) 
compression 
n=10 neurons (3 rats) 
 neuron 3A 3B 3C 3D 5A 5B 5C 6A 6B 7A 7B 7C 7D 7E 
BL-1 6 12 2 7 1 4 3 1 2 3 4 8 2 3 
BL-2 4 19 1 12 2 4 5 2 1 5 7 0 4 6 
BL-3 7 9 7 6 2 6 5 0 0 0 6 5 3 4 
BL-4 6 12 6 8 2 6 2 0 1 2 3 3 3 2 
BL-5 7 16 4 7 1 6 3 1 1 1 1 4 3 1 
C1 1 10 2 12 1 4 1 1 2 0 3 4 4 1 
C2 4 14 1 9 1 3 2 2 1 0 3 1 3 0 
C3 6 12 0 10 2 2 1 1 1 0 3 1 1 0 
C4 3 12 4 5 4 4 3 1 2 0 2 1 2 0 
C5 1 15 1 14 1 2 1 2 1 0 2 1 1 0 
C6 6 12 2 5 1 1 2 1 3 0 2 1 1 0 
C7 5 16 3 7 2 1 0 1 0 0 3 1 0 0 
C8 3 15 2 2 4 1 1 1 0 0 1 0 0 0 
C9 5 7 1 9 0 4 0 1 2 0 1 0 0 0 
C10 4 16 1 9 0 1 0 2 0 0 4 0 0 0 
C11 3 8 1 10 0 1 2 0 0 0 2 0 0 0 
C12 7 11 2 11 2 6 4 0 1 0 1 0 1 0 
C13 7 13 2 10 1 4 3 0 2 0 3 0 0 1 
C14 6 15 4 10 1 11 2 0 2 0 1 1 0 0 
C15 9 16 2 11 6 7 6 0 0 0 1 0 1 0 
P1 9 12 1 10 1 6 3 0 1 0 0 0 2 0 
P2 7 13 1 11 1 5 2 1 0 0 2 0 0 1 
P3 6 14 1 11 0 9 2 1 2 0 1 0 1 0 
P4 8 13 1 13 2 1 2 2 1 0 0 0 1 0 
P5 4 15 1 9 2 5 0 1 1 0 1 0 0 0 
P6 7 10 0 19 0 1 1 1 0 0 2 0 2 0 
P7 7 15 1 15 0 3 3 0 1 0 1 0 1 0 
P8 9 14 2 11 0 3 3 1 2 0 1 0 3 0 
P9 5 15 1 10 1 5 1 0 0 0 0 1 1 0 
tim
e-
po
in
t 
P10 6 18 2 12 4 2 1 0 1 0 0 0 0 0 
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Table B.2 Number of action potentials evoked at each time-point starting with baseline 
(BL) and running through the compression (C) times and post-compression (P) times for 
each neuron in the 3 minute study. 
 
group 
sham 
n=3 neurons 
(1 rat) 
compression 
n=9 neurons 
(6 rats) 
 neuron 16A 16B 16C 13A 14A 15F 17A 17B 18A 19A 19C 19D 
BL-1 70 4 1 4 3 5 20 2 2 1 1 3 
BL-2 52 6 2 7 2 1 23 0 1 0 1 1 
BL-3 50 3 1 16 4 2 20 1 0 1 1 2 
BL-4 56 10 1 11 0 2 28 0 0 1 0 0 
BL-5 47 10 1 10 3 2 23 0 2 1 1 0 
C1 37 3 1 11 3 2 14 0 0 1 0 0 
C2 43 6 1 8 3 1 23 1 0 0 0 0 
C3 52 8 1 13 2 0 16 0 0 0 0 0 
P1 39 6 1 7 0 0 14 0 0 0 3 1 
P2 53 8 2 10 3 0 16 0 0 1 0 0 
P3 63 8 3 9 0 1 11 0 0 0 1 2 
P4 74 4 1 9 1 1 8 0 2 0 0 1 
P5 64 6 1 6 2 2 15 1 1 0 1 1 
P6 73 5 1 12 1 0 37 0 0 0 0 0 
P7 75 3 0 9 3 0 23 0 1 0 1 0 
P8 85 5 0 11 0 2 17 0 2 1 2 1 
P9 70 3 1 8 1 0 22 1 2 1 1 0 
tim
e-
po
in
t 
P10 78 6 0 7 2 0 12 2 0 1 1 1 
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APPENDIX C 
 
Mechanical Allodynia & Thermal Hyperalgesia 
 
 
The tables within this appendix detail the individual behavioral responses for 
mechanical allodynia and thermal hyperalgesia for each rat included in the behavioral 
studies in Chapters 4-7. Mechanical allodynia is reported as the number of responses 
evoked by 30 stimulations with 1.4, 2.0, 4.0 or 10gf von Frey filaments, as noted in each 
table. Thermal hyperalgesia is reported as the amount of time (seconds) that a thermal 
stimulus was applied to the forepaw before the rat withdrew the paw from the stimulus 
(withdrawal latency). For each testing session, the withdrawal latency was measured 
three times and the average is reported here. Mechanical allodynia and thermal 
hyperalgesia are reported for the ipsilateral and contralateral forepaws, separately in each 
table. 
The behavioral data for each group is arranged by each chapter. Responses are 
reported for baseline (BL) and post-injury day 1 (D1) through day 7 (D7). Individual 
responses at each day are shown in Tables C.1-C.4 for all of the rats that are presented in 
the studies in Chapter 4. Tables C.1 and C.2 summarize mechanical allodynia following a 
3, 10 or 15 minute compression, or sham exposure (Section 4.3). Thermal hyperalgesia 
and mechanical allodynia following a 3 or a 15 minute compression or sham procedures 
(Section 4.4) are shown in Tables C.3 and C.4, respectively. The behavioral data in 
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Tables C.3 and C.4 also correspond to the rats used in the glutamate transporter 
characterization study presented in Chapter 5. Table C.5 details the individual mechanical 
allodynia responses for the rats used in the electrophysiology study presented in Chapter 
5 following a 3 or a 15 minute compression or the sham exposure.  
Tables C.6 and C.7 show individual mechanical allodynia and thermal 
hyperalgesia responses, respectively, following a painful compression treated with 10µg 
or 150µg of ceftriaxone (injury+10µg, injury+105µg) or the saline vehicle 
(injury+saline) or sham procedures treated with saline (sham+saline). Those studies are 
reported in Chapter 6. Table C.8 details the individual mechanical allodynia responses for 
the rats in those same ceftriaxone treatment groups (injury+10µg, injury+150µg, 
injury+saline, sham+saline) that were used in the electrophysiology study (Chapter 6). 
Tables C.9-C.11 detail the individual responses for the rats used in the Riluzole study 
(Chapter 7). Specifically, mechanical allodynia and thermal hyperalgesia are shown in 
Tables C.9 and C.10, respectively, for the rats used in the immunohistological study after 
a painful compression treated with Riluzole (injury+Riluzole) or the vehicle (β-
cyclodextrin; injury+vehicle), or sham procedures treated with β-cyclodextrin 
(sham+vehicle). For those same injury groups, (injury+Riluzole, injury+vehicle, 
sham+vehicle), mechanical allodynia responses are itemized for the rats that spinal 
electrophysiological recordings were made from (Table C.11).  
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Table C.1 Mechanical allodynia (number of paw withdrawals) for testing with a 4.0gf 
filament following a 3 minute or 10 minute nerve root compression, or sham procedures 
(corresponding to Section 4.3). 
  ipsilateral contralateral 
group rat ID BL D1 D3 D5 D7 BL D1 D3 D5 D7 
sham 11 0 1 1 1 0 2 0 0 1 0 
 29 0 2 0 2 2 1 2 0 0 0 
 79 0 1 1 2 2 0 0 0 0 1 
 80 0 0 1 1 2 0 0 1 1 1 
 104 0 0 1 0 0 0 0 1 0 0 
 105 2 2 3 2 2 1 0 2 1 2 
3 minute 44 2 4 4 3 3 0 0 0 1 2 
 49 0 1 0 0 1 0 0 0 1 1 
 52 0 4 4 1 1 0 1 2 1 0 
 98 0 1 0 1 2 0 0 0 0 0 
 99 0 1 2 1 1 0 0 1 1 2 
 103 0 1 0 1 1 1 1 0 0 0 
10 minute 22 0 5 4 4 3 1 1 0 1 1 
 26 1 7 4 5 5 1 2 1 1 0 
 28 0 3 9 3 7 1 1 1 0 1 
 90 1 6 8 9 9 0 0 0 0 0 
 93 0 7 6 4 7 0 1 0 0 2 
 94 1 14 8 6 7 1 7 7 5 5 
 
Table C.2 Mechanical allodynia (number of paw withdrawals) for testing with a 4.0gf 
filament following a 15 minute nerve root compression or sham procedures 
(corresponding to Section 4.3). 
  ipsilateral contralateral 
group rat ID BL D1 D3 D5 D7 BL D1 D3 D5 D7 
sham 14 0 0 0 0 0 0 1 0 0 0 
 15 0 1 1 1 0 2 0 0 1 0 
 19 0 0 0 0 0 0 0 0 0 0 
 21 0 2 0 2 2 1 2 0 0 0 
15 minute 12 1 11 15 7 10 0 6 8 3 3 
 13 0 6 8 6 9 0 0 3 2 2 
 16 0 8 4 7 6 0 2 1 0 0 
 17 1 8 7 5 8 0 0 2 0 0 
 18 1 7 8 9 9 1 2 3 4 4 
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Table C.3 Thermal hyperalgesia (average latency time in seconds) following a 3 minute 
or a 15 minute nerve root compression or sham procedures (corresponding to studies in 
Sections 4.4 & 5.3). 
  ipsilateral contralateral 
group rat ID BL D1 D7 BL D1 D7 
sham 216 9.79 10.69 9.36 9.39 11.35 11.12 
 220 10.46 10.60 10.12 9.11 9.13 9.30 
 226 10.80 10.29 10.15 10.40 9.69 8.75 
 228 10.77 10.02 8.80 9.49 10.42 9.63 
 229 10.10 9.16 10.46 9.92 8.86 10.26 
 234 9.85 7.92 8.36 10.98 8.77 9.41 
 238 10.31 9.19 8.87 10.27 7.87 8.58 
 109 10.45 9.25 -- 10.07 10.85 -- 
 113 11.10 11.96 -- 9.25 10.64 -- 
 254 10.05 9.09 -- 10.52 9.86 -- 
 258 8.29 9.28 -- 10.73 11.39 -- 
 280 9.12 9.08 -- 8.77 9.52 -- 
 281 10.83 10.74 -- 10.88 12.98 -- 
 282 9.57 8.35 -- 9.92 9.49 -- 
3 minute 218 9.94 6.55 6.54 10.71 9.09 6.82 
 223 9.82 8.76 9.03 11.39 10.01 9.42 
 225 11.34 9.92 9.84 11.05 10.46 11.01 
 227 9.30 9.65 9.14 10.04 8.70 11.06 
 231 10.97 10.27 9.34 9.93 10.23 10.77 
 235 9.58 8.49 6.54 9.57 7.97 8.18 
 236 10.62 9.10 8.82 9.85 7.35 9.41 
 251 11.48 9.54 -- 9.02 12.09 -- 
 253 10.29 9.11 -- 10.35 8.09 -- 
 255 8.10 11.23 -- 10.21 9.80 -- 
 275 12.07 12.36 -- 10.76 11.79 -- 
 276 11.77 8.99 -- 9.80 12.29 -- 
 277 10.53 8.34 -- 8.67 12.75 -- 
 278 8.23 10.01 -- 10.88 10.80 -- 
15 minute 213 9.95 5.95 8.16 8.80 9.72 10.11 
 214 10.24 5.22 5.76 10.14 10.01 9.93 
 217 10.22 7.01 5.53 9.56 6.91 10.22 
 224 10.73 8.27 6.98 10.38 10.48 9.34 
 230 9.38 9.51 7.32 10.04 9.25 8.74 
 233 9.56 7.75 6.98 10.24 8.13 8.28 
 237 8.95 7.29 7.52 9.74 10.73 10.42 
 106 8.18 6.15 -- 8.14 8.62 -- 
 107 8.08 5.36 -- 8.08 9.77 -- 
 108 9.96 7.91 -- 9.59 9.73 -- 
 111 12.03 7.39 -- 10.71 10.67 -- 
 112 8.04 7.83 -- 8.24 12.75 -- 
 252 10.04 4.89 -- 8.05 8.78 -- 
 256 8.09 5.76 -- 9.01 12.34 -- 
 237 
Table C.4 Mechanical allodynia (number of paw withdrawals) for a testing with a 4.0gf 
filament following a 3 minute or a 15 minute nerve root compression or sham procedures 
(corresponding to studies in Sections 4.4 & 5.3). 
  ipsilateral contralateral 
group rat ID BL D1 D7 BL D1 D7
sham 216 2 1 3 1 0 2
 220 0 1 0 0 0 1
 226 1 2 1 1 1 2
 228 0 2 2 1 1 0
 229 2 1 2 1 1 2
 234 0 2 0 2 2 0
 238 1 2 1 0 0 1
 109 0 1 -- 1 1 --
 113 0 1 -- 0 0 --
 254 1 2 -- 1 1 --
 258 1 3 -- 0 2 --
 280 2 1 -- 0 1 --
 281 1 0 -- 0 3 --
 282 1 0 -- 1 2 --
3 minute 218 1 3 1 0 0 0
 223 1 0 1 0 1 1
 225 0 1 1 1 0 0
 227 1 2 2 0 0 1
 231 0 1 1 0 1 0
 235 2 3 9 1 2 5
 236 1 4 3 1 0 0
 251 0 1 -- 1 0 --
 253 0 3 -- 1 1 --
 255 1 2 -- 0 1 --
 275 2 1 -- 1 2 --
 276 3 3 -- 2 1 --
 277 0 2 -- 0 3 --
 278 1 1 -- 2 1 --
15 minute 213 0 4 3 1 1 1
 214 0 7 7 0 1 0
 217 0 7 5 1 1 2
 224 3 7 9 3 3 5
 230 1 3 5 0 0 1
 233 2 8 8 1 1 2
 237 3 3 7 2 2 2
 106 1 8 -- 0 2 --
 107 0 6 -- 0 0 --
 108 1 6 -- 0 2 --
 111 1 5 -- 1 0 --
 112 0 6 -- 0 0 --
 252 1 8 -- 1 1 --
 256 2 4 -- 2 2 --
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Table. C.5 Mechanical allodynia (number of paw withdrawals) in the forepaw for testing 
with a 4.0gf filament following compression applied for 3 minutes or 15 minutes, or 
sham procedures (corresponding to studies in Section 5.4). 
  ipsilateral contralateral 
group id BL D1 D7 BL D1 D7 
sham 125 0 2 2 1 1 2 
 154 0 1 1 0 1 1 
 186 0 1 1 1 1 1 
 189 1 3 0 2 2 0 
 190 2 1 1 3 2 1 
 201 2 1 2 2 1 1 
 204 0 2 1 0 1 1 
 205 0 2 0 1 1 0 
 JRS 7 0 0 0 0 1 0 
 JRS 9 0 1 3 2 0 1 
 JRS 11 0 0 1 0 1 0 
 JRS 42 0 0 1 1 1 1 
 JRS 43 0 0 0 1 0 0 
3 minute 315 1 2 2 0 1 2 
 316 1 1 3 0 1 0 
15 minute 122 1 7 6 0 0 2 
 126 0 3 2 0 0 0 
 127 0 6 6 0 0 1 
 153 0 5 5 0 0 1 
 188 2 4 4 1 1 1 
 192 1 7 6 1 0 0 
 203 0 4 5 0 1 0 
 206 1 6 5 0 0 1 
 JRS 8 4 3 5 0 1 2 
 JRS 10 4 3 5 1 0 1 
 JRS 30 4 6 7 1 1 1 
 JRS 34 3 4 8 0 1 3 
 JRS 41 3 1 0 1 0 0 
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Table C.6 Mechanical allodynia (number of paw withdrawals) for daily treatments with 
10µg or 150µg ceftriaxone or saline after injury (injury+10µg, injury+150µg, 
injury+saline) or sham (sham+saline) (corresponding to studies in Chapter 6). 
   ipsilateral contralateral 
 group rat ID BL D1 D2 D3 D4 D5 D6 D7 BL D1 D2 D3 D4 D5 D6 D7
sham+saline 131 0 1 1 1 1 1 1 0 1 0 0 1 0 1 0 0 
 171 2 3 2 1 1 0 1 2 2 3 1 2 2 0 0 1 
 175 0 1 0 1 1 2 0 1 0 1 0 1 0 1 0 0 
 178 1 0 2 1 1 1 0 1 0 0 0 0 0 0 0 0 
 179 0 2 0 0 1 0 1 0 0 0 0 0 0 0 0 0 
 183 0 0 0 1 1 0 1 0 0 0 0 1 0 0 1 0 
 184 0 0 0 1 1 1 1 1 0 0 0 0 1 1 0 0 
injury+saline 128 0 2 0 2 3 4 5 3 0 0 0 0 1 0 2 1 
 129 0 2 2 3 4 3 4 5 1 0 1 1 1 1 0 1 
 130 0 1 0 1 0 1 1 1 0 0 0 0 0 0 1 0 
 164 0 0 1 0 0 1 1 1 1 0 2 2 0 0 1 0 
 165 1 1 3 2 3 3 2 2 1 1 1 1 1 0 1 1 
 174 0 2 0 0 1 1 2 2 0 0 0 0 0 0 0 1 
 182 0 0 1 2 1 2 2 2 0 0 0 0 0 2 0 0 
injury+10µg 138 2 2 1 0 0 0 1 1 0 0 0 1 1 1 1 0 
 139 0 2 0 1 1 1 1 1 2 1 0 0 0 0 0 1 
 140 0 1 0 0 0 0 1 1 1 0 0 0 0 0 1 1 
 141 2 3 1 2 1 0 1 3 2 1 1 0 1 1 2 2 
 168 1 4 2 2 3 1 3 2 0 1 1 0 2 0 0 1 
 169 0 2 2 0 2 1 0 0 1 0 0 1 1 0 0 1 
 176 1 1 1 1 1 1 0 0 1 0 0 1 0 0 0 0 
 177 0 3 2 1 1 2 1 2 1 0 1 0 0 0 1 1 
injury+150µg 136 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
 142 0 0 0 0 0 2 2 1 0 0 0 0 0 2 0 0 
 143 1 1 2 2 1 2 2 1 1 2 0 1 0 1 0 2 
 167 0 2 3 0 0 1 0 1 0 0 0 0 1 0 1 1 
 172 1 2 0 1 0 0 0 1 1 0 0 1 0 0 0 0 
 173 0 4 2 1 0 1 0 1 0 0 0 1 0 0 0 0 
 180 1 2 1 0 0 0 0 1 1 0 1 0 0 0 1 0 
1.
4g
f f
ila
m
en
t 
 181 0 4 2 2 3 1 1 1 0 3 0 1 1 1 0 0 
sham+saline 131 0 0 1 1 2 2 1 2 0 1 0 0 1 0 1 1 
 171 1 4 1 2 2 2 2 2 1 4 2 0 1 2 2 2 
 175 0 2 3 2 1 2 1 1 1 0 1 0 0 0 0 0 
 178 0 0 2 2 0 2 2 2 0 0 0 0 0 0 1 1 
 179 0 3 1 1 2 2 1 2 0 0 0 0 0 0 0 0 
 183 0 1 1 2 1 1 1 1 0 0 0 0 0 0 2 0 
 184 1 1 1 1 2 1 1 2 1 0 0 0 0 0 0 0 
injury+saline 128 0 2 3 5 6 5 6 5 0 1 0 1 1 3 2 1 
 129 0 5 6 5 7 5 5 5 1 2 1 1 2 1 1 2 
 130 0 2 3 2 3 3 5 4 0 1 0 0 1 0 2 0 
 164 0 4 2 1 2 3 3 2 0 0 1 0 1 1 0 0 
 165 0 3 5 4 4 6 3 3 1 0 0 1 0 2 1 1 
 174 0 4 4 5 5 5 4 5 0 0 0 0 0 1 0 1 
 182 0 6 6 5 4 4 5 8 1 0 0 1 1 0 1 1 
injury+10µg 138 2 4 2 2 1 1 2 2 1 0 0 0 0 1 0 1 
 139 1 5 0 1 1 0 1 0 1 1 0 0 1 0 1 0 
2.
0g
f f
ila
m
en
t 
 140 0 3 1 2 0 0 0 2 1 0 0 0 0 0 0 0 
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   ipsilateral contralateral 
 group rat ID BL D1 D2 D3 D4 D5 D6 D7 BL D1 D2 D3 D4 D5 D6 D7
injury+10µg 141 3 4 2 2 0 2 2 6 3 1 2 1 0 3 3 4 
(cont.) 168 2 5 4 1 3 1 2 3 1 2 2 2 1 1 0 0 
 169 0 7 3 1 1 1 0 1 0 1 1 0 1 0 0 1 
 176 0 4 6 5 4 4 3 1 0 1 1 1 2 1 0 0 
 177 1 7 4 5 5 4 4 2 1 1 0 0 1 1 1 1 
injury+150µg 136 0 6 2 1 0 1 0 3 0 1 0 0 0 2 0 2 
 142 0 2 4 2 1 2 3 2 0 0 1 2 1 2 2 0 
 143 2 4 3 3 0 4 3 5 1 0 0 0 0 3 3 3 
 167 0 4 3 3 2 2 3 2 0 1 0 0 0 1 0 1 
 172 1 6 2 1 3 0 1 1 1 0 0 0 0 0 1 0 
 173 1 5 4 4 2 3 2 3 0 1 1 0 0 0 0 0 
 180 0 5 2 2 2 1 1 3 0 0 0 0 0 0 0 0 
2.
0g
f f
ila
m
en
t (
co
nt
.) 
 181 0 9 5 3 3 3 3 4 1 2 2 1 1 1 0 1 
sham+saline 131 0 2 2 2 2 1 2 2 1 0 1 0 1 0 0 0 
 171 2 5 2 2 2 2 2 2 2 5 3 2 2 1 2 1 
 175 1 2 2 1 1 2 1 1 1 0 0 0 0 0 0 0 
 178 0 2 2 2 0 2 2 2 1 1 0 0 0 0 1 0 
 179 1 3 1 0 2 2 1 0 1 0 0 0 0 0 0 1 
 183 1 0 2 0 1 1 2 1 1 0 0 1 1 1 1 0 
 184 1 1 0 1 2 1 1 2 0 0 0 0 1 1 0 0 
injury+saline 128 0 6 6 6 8 8 9 8 0 0 1 2 2 2 3 3 
 129 1 8 7 8 7 7 7 10 2 3 2 3 2 2 2 3 
 130 1 4 3 3 4 4 6 4 0 2 1 1 0 1 2 1 
 164 0 5 6 5 4 6 6 5 1 0 2 0 0 2 3 0 
 165 1 6 6 6 6 7 6 7 1 1 2 2 0 1 2 1 
 174 0 7 4 6 5 5 4 5 0 0 1 0 0 1 0 1 
 182 1 8 7 6 6 7 6 8 0 0 0 0 1 1 0 1 
injury+10µg 138 2 8 2 1 1 2 0 1 2 0 0 0 0 1 0 2 
 139 0 6 1 1 2 1 1 0 0 1 1 0 2 0 1 0 
 140 0 6 2 1 0 1 1 2 1 2 1 0 0 0 1 0 
 141 2 7 2 2 2 5 3 7 2 2 1 1 1 5 3 7 
 168 1 8 6 3 5 2 3 3 0 1 2 3 1 1 1 1 
 169 1 8 2 1 2 1 1 2 0 3 1 0 1 2 0 0 
 176 0 7 6 3 4 4 3 3 0 1 1 1 2 1 0 0 
 177 1 9 5 3 5 4 4 3 1 2 0 1 1 1 1 1 
injury+150µg 136 0 8 1 2 1 2 0 0 0 4 0 0 0 1 0 0 
 142 0 6 5 1 0 3 2 4 0 1 0 0 0 2 1 3 
 143 1 7 7 3 2 3 4 6 1 0 0 2 1 3 1 5 
 167 0 6 6 4 2 3 1 3 0 2 0 2 1 1 0 1 
 172 0 7 4 1 3 0 1 1 0 0 0 0 0 0 1 0 
 173 1 8 4 4 2 3 2 3 0 0 0 0 0 0 0 0 
 180 1 7 4 3 1 2 2 3 0 0 0 0 0 0 1 0 
4.
0g
f f
ila
m
en
t 
 181 0 8 6 4 4 3 4 4 1 2 0 0 1 0 1 1 
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Table C.7 Thermal hyperalgesia (average latency time in seconds) for daily treatments 
with 10µg or 150µg ceftriaxone after injury (injury+10µg, injury+150µg) or the saline 
vehicle after injury (injury+saline) or sham procedures (sham+saline) (corresponding to 
studies in Chapter 6). 
  ipsilateral contralateral 
 rat ID BL D1 D7 BL D1 D7 
sham+saline 131 10.68 11.91 8.20 9.92 8.76 10.35 
 171 9.54 7.98 9.40 10.56 7.50 9.65 
 175 8.89 10.54 8.01 12.01 10.35 9.76 
 178 10.54 6.74 10.78 10.10 8.39 9.88 
 179 12.54 6.74 8.92 11.31 7.01 9.96 
 183 10.50 11.87 10.51 11.45 10.31 9.88 
 184 8.56 10.49 10.08 9.72 10.51 9.77 
injury+saline 128 7.87 10.55 5.52 7.74 10.28 8.56 
 129 10.37 8.09 5.83 10.22 11.23 7.73 
 130 8.48 6.52 5.52 9.94 7.39 8.18 
 164 8.51 8.34 5.97 7.44 10.80 8.16 
 165 8.56 6.57 4.63 7.78 10.52 7.41 
 174 9.79 6.95 5.91 8.07 9.71 9.22 
 182 11.04 5.07 7.10 11.18 11.62 12.03 
injury+10µg 138 10.71 8.00 12.71 11.09 9.47 13.20 
 139 11.65 8.91 13.08 8.43 15.13 10.93 
 140 10.37 4.66 14.39 10.43 13.58 17.90 
 141 11.72 7.94 9.47 8.97 12.54 10.06 
 168 10.29 5.99 10.51 9.94 8.66 10.14 
 169 10.53 7.63 7.50 12.64 8.12 7.75 
 176 10.08 6.42 8.33 10.83 10.80 9.30 
 177 11.08 5.00 4.68 9.56 7.73 9.17 
injury+150µg 136 7.91 8.08 12.77 8.77 12.07 13.30 
 142 9.63 8.37 13.80 6.79 10.43 8.91 
 143 9.44 8.14 10.24 11.40 11.03 8.46 
 167 11.22 5.05 7.53 10.10 9.15 8.65 
 172 10.46 8.43 8.85 11.23 11.32 9.35 
 173 9.40 7.80 10.01 7.35 10.13 9.25 
 180 9.56 5.61 8.73 8.56 10.33 10.51 
 181 10.60 7.48 11.43 9.68 12.31 10.85 
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Table C.8 Mechanical allodynia (number of paw withdrawals) for daily treatments with 
10µg or 150µg ceftriaxone or saline after injury (injury+10µg, injury+150µg, 
injury+saline) or sham (sham+saline) (corresponding to studies in Chapter 6). 
   ipsilateral contralateral 
 group rat ID BL D1 D7 BL D1 D7 
sham+saline 301 1 1 0 0 2 0 
 302 2 0 1 2 0 1 
 303 0 0 2 1 1 0 
 304 2 1 0 0 0 1 
 305 1 2 1 1 1 2 
 306 0 2 2 0 0 0 
 313 0 0 2 2 0 0 
 314 2 0 1 1 0 0 
injury+saline 287 1 2 0 1 2 0 
 288 0 1 0 1 0 1 
 297 1 2 5 2 1 1 
 298 1 8 6 1 1 2 
 299 1 4 2 1 2 0 
 300 0 3 1 0 1 2 
 307 2 1 1 1 0 0 
 308 1 1 1 1 1 1 
injury+10µg 285 0 2 2 1 1 1 
 286 0 1 2 1 0 0 
 290 0 0 1 2 0 0 
 293 0 1 2 2 0 1 
 294 1 0 0 0 0 1 
 296 0 0 0 1 1 0 
 311 0 3 1 1 0 0 
 312 0 1 0 0 0 1 
injury+150µg 283 1 3 0 0 0 2 
 284 1 1 0 1 1 1 
 289 0 1 0 0 1 1 
 291 1 0 0 0 0 0 
 292 1 4 1 1 1 1 
 295 0 4 0 0 0 0 
 309 1 1 2 1 0 1 
1.
4g
f f
ila
m
en
t 
 310 2 4 0 2 0 1 
sham+saline 301 2 2 2 0 1 0 
 302 1 1 1 1 1 1 
 303 2 3 2 1 2 2 
 304 0 0 1 0 0 2 
 305 0 3 0 0 2 0 
 306 2 1 2 2 2 2 
 313 3 1 2 2 0 0 
 314 4 2 2 3 1 1 
injury+saline 287 2 7 5 0 2 1 
 288 1 8 6 2 1 0 
 297 3 9 8 1 2 3 
 298 2 11 11 2 3 4 
 299 1 9 8 1 3 3 
 300 0 5 10 0 0 2 
2.
0g
f f
ila
m
en
t 
 307 2 7 6 0 1 1 
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   ipsilateral contralateral 
 group rat ID BL D1 D7 BL D1 D7 
injury+saline 308 3 7 8 2 1 3 
injury+10µg 285 1 7 2 1 2 1 
 286 2 6 2 2 1 0 
 290 0 7 1 1 2 2 
 293 2 8 4 1 0 1 
 294 0 7 1 1 1 2 
 296 1 8 0 1 1 0 
 311 0 8 1 0 2 2 
 312 1 6 2 2 0 1 
injury+150µg 283 2 5 4 1 1 1 
 284 2 6 2 2 0 1 
 289 1 8 4 1 0 3 
 291 1 5 5 2 1 0 
 292 2 7 2 1 1 0 
 295 1 6 3 0 0 1 
 309 0 5 3 1 1 1 
2.
0g
f f
ila
m
en
t (
co
nt
.) 
 310 1 9 1 2 2 1 
sham+saline 301 2 4 3 2 4 5 
 302 3 3 5 4 4 4 
 303 2 5 4 1 5 3 
 304 1 3 2 2 3 3 
 305 6 8 5 5 5 4 
 306 3 6 4 4 6 3 
 313 1 0 4 1 0 3 
 314 5 3 3 4 4 3 
injury+saline 287 2 8 7 2 4 4 
 288 3 11 7 2 5 3 
 297 5 11 9 4 3 4 
 298 3 13 11 4 7 5 
 299 2 15 11 2 8 4 
 300 1 11 11 1 5 5 
 307 4 11 9 1 2 2 
 308 3 7 10 4 1 4 
injury+10µg 285 3 9 2 3 5 0 
 286 3 9 3 3 3 2 
 290 2 10 2 3 3 2 
 293 3 12 6 3 6 3 
 294 1 8 5 2 3 3 
 296 3 8 1 4 2 1 
 311 1 11 3 2 5 2 
 312 3 9 4 4 2 2 
injury+150µg 283 3 8 8 3 4 4 
 284 3 5 4 2 2 3 
 289 2 10 5 4 4 2 
 291 3 7 6 2 3 3 
 292 3 8 4 2 3 2 
 295 3 11 2 2 4 0 
 309 2 7 4 3 2 3 
4.
0g
f f
ila
m
en
t 
 310 2 10 2 1 5 1 
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Table C.9 Mechanical allodynia (number of paw withdrawals) after a painful nerve root 
compression treated with Riluzole (injury+Riluzole) or the vehicle (injury+vehicle) or 
sham (sham+vehicle) (corresponding to studies in Chapter 7). 
   ipsilateral contralateral 
 group rat ID BL D1 D2 D3 D5 D7 BL D1 D2 D3 D5 D7 
sham+vehicle 162 0 1 1 1 0 1 0 0 0 0 0 1 
 193 1 1 1 0 1 1 0 0 2 1 0 1 
 195 0 1 0 0 1 1 1 0 0 0 1 0 
 196 1 1 0 1 0 0 0 1 1 0 0 0 
 200 1 0 0 1 0 1 0 1 1 0 1 1 
 211 0 1 0 0 0 0 0 0 0 1 0 1 
 212 1 1 1 1 2 1 0 1 0 1 2 0 
injury+vehicle 156 1 1 2 1 1 4 0 0 0 0 1 1 
 157 0 2 1 3 3 0 1 0 0 1 1 0 
 163 1 4 3 3 2 3 2 0 1 1 0 3 
 194 1 3 3 2 2 0 1 0 0 0 0 1 
 198 0 1 2 1 2 2 0 0 0 2 0 1 
 199 1 0 0 0 1 1 1 0 0 0 1 0 
 210 0 2 1 0 1 0 0 0 1 0 0 1 
injury+Riluzole 147 0 0 2 0 1 0 0 0 0 0 0 1 
 148 0 0 2 1 0 1 0 0 1 0 0 0 
 149 2 3 5 5 4 3 1 0 1 1 3 4 
 158 0 2 2 1 2 2 0 1 0 0 0 0 
 159 0 1 1 2 1 0 1 1 0 1 1 0 
 160 0 1 2 1 3 0 0 0 1 0 0 0 
1.
4g
f f
ila
m
en
t 
 161 1 2 2 2 3 2 2 1 2 2 3 1 
sham+vehicle 162 0 0 2 2 1 2 0 0 0 0 0 1 
 193 0 2 2 0 1 1 0 0 1 1 1 1 
 195 1 1 2 1 2 1 0 1 1 1 1 0 
 196 1 0 0 0 1 1 1 0 1 1 1 0 
 200 0 1 2 2 1 2 1 1 1 0 2 0 
 211 0 1 0 1 1 2 0 1 0 0 1 2 
 212 1 2 1 1 0 1 1 0 1 0 1 0 
injury+vehicle 156 0 4 3 2 5 7 0 0 0 0 2 0 
 157 0 6 4 6 4 4 1 0 1 2 1 1 
 163 1 5 3 6 5 4 0 3 0 3 0 3 
 194 0 4 3 5 5 1 0 0 1 2 0 0 
 198 1 1 6 7 9 6 1 0 1 1 2 1 
 199 0 2 3 3 7 5 1 0 1 1 1 0 
 210 0 2 2 1 0 1 0 1 0 0 1 1 
injury+Riluzole 147 0 2 1 2 2 3 1 1 0 0 0 1 
 148 0 2 2 1 1 1 0 1 1 0 0 1 
 149 2 5 4 6 4 4 1 2 1 2 2 2 
 158 0 5 4 2 3 3 0 0 0 0 2 1 
 159 0 4 2 3 0 2 1 1 1 0 0 0 
 160 0 4 4 4 4 2 0 0 2 1 1 0 
2.
0g
f f
ila
m
en
t 
 161 1 3 2 4 2 4 1 1 1 3 1 3 
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   ipsilateral contralateral 
 group rat ID BL D1 D2 D3 D5 D7 BL D1 D2 D3 D5 D7 
sham+vehicle 162 1 2 3 3 1 2 1 1 1 0 0 1 
 193 0 2 3 2 3 2 0 1 0 1 1 1 
 195 1 3 1 3 3 1 0 0 0 1 0 1 
 196 0 2 0 1 2 2 0 0 0 0 0 0 
 200 1 2 2 2 1 2 1 2 1 1 0 0 
 211 0 1 0 1 2 1 0 0 2 2 2 1 
 212 2 2 3 2 3 2 0 1 0 1 1 0 
injury+vehicle 156 0 4 4 6 7 8 0 0 0 1 1 1 
 157 0 7 5 8 6 4 1 0 0 2 1 0 
 163 2 2 5 8 7 8 1 0 2 3 1 4 
 194 0 6 7 7 8 8 1 0 2 2 2 0 
 198 1 4 9 8 8 6 1 0 1 1 2 2 
 199 1 7 5 4 6 5 0 2 0 1 0 1 
 210 1 5 5 4 4 5 0 1 0 0 1 1 
injury+Riluzole 147 0 6 2 3 2 3 1 1 0 0 0 0 
 148 0 7 3 2 4 2 0 1 0 0 0 2 
 149 1 9 6 6 4 4 1 2 2 2 3 4 
 158 1 6 3 1 4 4 1 0 0 0 0 0 
 159 0 7 2 3 2 1 1 0 0 1 1 0 
 160 0 5 4 3 4 3 0 0 1 0 0 2 
4.
0g
f f
ila
m
en
t 
 161 1 6 2 5 2 5 1 2 0 3 0 2 
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Table C.10 Thermal hyperalgesia (average withdrawal latency in seconds) after a painful 
nerve root compression treated with Riluzole (injury+Riluzole) or the vehicle 
(injury+vehicle), or sham (sham+vehicle) (corresponding to studies in Chapter 7). 
  ipsilateral contralateral 
 rat ID BL D1 D7 BL D1 D7 
sham+vehicle 162 8.80 8.24 8.79 11.30 8.88 9.03 
 193 10.17 7.80 10.14 10.06 11.32 10.37 
 195 11.24 9.55 11.59 9.34 9.87 11.39 
 196 11.25 9.42 9.20 10.62 9.17 10.57 
 200 8.46 8.56 8.25 9.60 9.45 7.96 
 211 11.21 8.74 8.60 10.87 10.46 9.13 
 212 10.41 7.52 8.81 9.24 7.31 8.84 
injury+vehicle 156 10.26 5.29 8.07 6.59 9.18 13.39 
 157 10.23 5.54 5.98 9.75 9.51 10.42 
 163 10.80 6.39 5.62 10.36 9.09 10.44 
 194 10.01 6.15 6.05 11.83 7.17 8.09 
 198 9.07 7.46 6.51 8.08 8.27 8.75 
 199 9.28 6.66 7.12 9.59 8.79 8.80 
 210 12.66 5.06 7.95 10.32 9.59 11.55 
injury+Riluzole 147 9.35 7.76 6.47 9.58 9.34 8.39 
 148 9.47 6.60 9.86 9.38 9.49 10.88 
 149 11.62 7.39 8.35 11.10 8.54 9.69 
 158 10.95 7.04 9.46 9.54 12.03 8.61 
 159 8.45 5.06 8.69 9.92 9.98 11.82 
 160 9.25 6.09 8.34 7.22 10.46 8.58 
 161 9.65 9.06 7.10 8.48 8.30 10.88 
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Table C.11 Mechanical allodynia (number of paw withdrawals) after a painful nerve root 
compression treated with Riluzole (injury+Riluzole) or the vehicle (injury+vehicle), or 
sham (sham+vehicle) (corresponding to studies in Chapter 7). 
   ipsilateral contralateral 
 group rat ID BL D1 D2 D7 BL D1 D2 D7 
sham+vehicle 259 1 0 1 1 1 0 1 0 
 261 0 2 3 0 0 1 0 1 
 263 1 0 2 2 0 0 0 1 
 265 0 0 1 1 0 0 1 0 
 268 1 0 0 0 0 0 0 0 
 269 1 1 0 0 1 1 2 0 
 271 0 0 2 2 0 0 1 1 
 274 1 1 1 0 1 1 0 0 
injury+vehicle 244 0 0 3 0 0 1 0 1 
 246 0 3 1 2 1 1 0 0 
 247 0 0 1 0 0 0 1 0 
 249 0 3 3 0 1 1 2 1 
 264 0 1 4 1 0 0 2 2 
 266 1 2 4 2 1 0 1 1 
 272 1 4 4 4 1 0 1 0 
 273 0 0 0 1 0 1 0 0 
injury+Riluzole 243 1 2 2 2 1 2 2 1 
 245 0 0 1 0 1 0 1 1 
 248 0 5 2 0 0 0 1 0 
 250 1 1 1 0 1 1 1 0 
 260 0 1 2 1 0 0 0 1 
 262 0 3 4 1 1 0 0 1 
 267 0 2 1 1 0 1 0 0 
1.
4g
f f
ila
m
en
t 
 270 0 0 1 2 1 0 0 1 
sham+vehicle 259 1 2 1 2 1 1 1 0 
 261 0 3 3 0 0 0 0 1 
 263 0 2 2 3 0 2 0 1 
 265 1 0 1 1 1 1 1 0 
 268 0 1 1 2 0 0 1 1 
 269 1 1 1 2 2 2 1 2 
 271 0 1 3 3 0 0 1 1 
 274 0 2 2 0 1 1 1 0 
injury+vehicle 244 0 6 6 9 1 0 2 1 
 246 1 5 8 8 0 0 1 3 
 247 0 8 7 2 1 2 2 0 
 249 1 7 5 6 1 4 1 1 
 264 2 5 4 4 2 1 2 2 
 266 0 3 4 7 0 1 1 1 
 272 2 9 10 7 3 2 4 0 
 273 2 2 5 7 2 0 0 1 
injury+Riluzole 243 0 10 7 4 1 4 4 4 
 245 0 5 3 0 0 1 1 0 
 248 1 8 4 5 0 3 0 2 
 250 1 8 3 2 1 2 0 0 
 260 0 3 2 2 1 0 0 1 
 262 1 5 4 2 1 0 0 1 
4.
0g
f f
ila
m
en
t 
 267 0 5 3 1 1 0 1 2 
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   ipsilateral contralateral 
 group rat ID BL D1 D2 D7 BL D1 D2 D7 
 270 2 6 3 2 0 1 2 0 
sham+vehicle 259 2 2 0 2 1 1 0 0 
 261 1 3 2 0 0 0 1 0 
 263 1 1 3 3 0 0 1 2 
 265 0 2 2 1 1 0 0 1 
 268 2 3 2 3 2 1 3 2 
 269 2 4 2 5 1 2 1 4 
 271 3 1 5 4 3 1 4 2 
 274 2 1 3 1 3 0 2 2 
injury+vehicle 244 0 5 8 8 0 2 2 5 
 246 2 6 10 9 1 2 2 4 
 247 1 7 9 1 0 2 4 0 
 249 0 10 10 7 1 2 4 4 
 264 2 4 5 4 1 0 1 0 
 266 1 5 4 8 1 1 0 3 
 272 3 10 9 10 2 6 4 4 
 273 2 5 6 10 2 2 3 3 
injury+Riluzole 243 3 11 7 6 2 4 6 5 
 245 0 5 5 3 0 0 1 2 
 248 1 9 6 8 0 1 3 4 
 250 2 8 5 3 2 2 2 0 
 260 1 5 3 2 1 1 1 0 
 262 2 7 4 3 2 1 0 2 
 267 1 7 4 5 1 3 1 2 
10
.0
gf
 fi
la
m
en
t 
 270 0 7 3 5 0 1 1 3 
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APPENDIX D 
 
Quantification of Spinal Protein Using 
Immunohistochemistry 
 
 
This appendix summarizes the immunolabeling of the dorsal horn of the spinal 
cord that was quantified in studies presented in Chapters 5-7. For all studies, 
densitometry was performed using Matlab to quantify the positively-labeled pixels in 
each image. The Matlab code is provided in Appendix F. Images are identified by the rat 
ID followed by the image number (ID-number). All data are expressed relative to the 
expression of each protein in normal tissue. The expression of each protein is quantified 
for the ipsilateral and contralateral dorsal horns separately, and is indicated in the “dorsal 
horn” column of each table. Spinal cord tissue was harvested at days 1 and 7, as indicated 
by each table.  
Tables D.1-D.3 summarize the spinal expression of the glutamate transporters, 
GLT-1, GLAST and EAAC1, at days 1 and 7 after a 3 or 15 minute compression, or 
sham procedures (Chapter 5). The spinal expression of GLT-1, GFAP, and GLAST at 
day 7 after a 15 minute compression treated with 10µg or 150µg ceftriaxone 
(injury+10µg, injury+150µg) or the saline vehicle (injury+saline) or sham procedures 
(sham+saline) is provided in Tables D.4-D.6 (Chapter 6). Table D.7 and Table D.8 list 
the spinal expression of CGRP at day 7 in the superficial and deep laminae, respectively 
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(Chapter 7). CGRP was quantified after a 15 minute nerve root compression treated with 
Riluzole (injury+Ril) and in a group of rats that received the matching vehicle treatment 
(10% β-cyclodextrin) after that same 15 minute compression (injury+veh) or sham 
procedures (sham+veh).  
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Table D.1 Quantification of GLT-1 in the superficial laminae at days 1 and 7 (Chapter 
5). 
 
dorsal horn group time-point image 
GLT-1 
(fold increase over 
normal) 
ipsilateral sham day 1 109-1 1.14 
   109-2 1.44 
   109-3 1.23 
   109-4 0.73 
   109-5 1.34 
   109-6 0.77 
   113-1 1.63 
   113-2 1.06 
   113-3 1.43 
   113-4 1.38 
   113-5 1.23 
   113-6 1.50 
   254-1 0.78 
   254-2 1.29 
   254-4 0.47 
   258-1 0.62 
   258-5 0.54 
   258-6 0.79 
   280-2 1.38 
   280-3 0.40 
   280-5 0.88 
   281-1 0.55 
   281-2 0.41 
   281-4 0.62 
   281-6 1.03 
   282-1 0.78 
   282-2 0.70 
   282-4 0.84 
   282-5 0.89 
   282-6 1.49 
  day 7 216-1 0.53 
   216-2 0.79 
   216-3 0.80 
   216-4 0.82 
   216-5 0.94 
   220-1 0.85 
   220-2 0.90 
   220-3 0.57 
   220-4 0.68 
   220-5 0.75 
   220-6 1.08 
   226-2 1.23 
   226-3 1.06 
   226-4 0.95 
   226-5 1.51 
   226-6 0.98 
   228-1 0.93 
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dorsal horn group time-point image 
GLT-1 
(fold increase over 
normal) 
ipsilateral sham day 7 228-2 1.01 
(cont.)   228-3 0.90 
   228-4 1.11 
   228-5 0.92 
   228-6 0.81 
   229-1 1.09 
   229-2 1.20 
   229-3 1.41 
   229-4 0.97 
   229-5 0.88 
   229-6 1.02 
   234-1 0.93 
   234-2 0.63 
   234-3 1.05 
   234-4 0.87 
   234-5 0.76 
   238-1 1.62 
   238-2 0.78 
   238-3 1.07 
   238-4 1.05 
   238-5 1.16 
   238-6 1.11 
 3 minute day 1 251-2 0.99 
   251-3 1.14 
   251-4 0.70 
   251-5 1.25 
   253-2 0.98 
   253-3 1.20 
   253-4 0.90 
   253-5 0.88 
   253-6 1.18 
   255-2 0.70 
   255-3 0.23 
   255-6 0.68 
   275-2 0.91 
   275-4 0.83 
   275-6 0.70 
   276-1 0.70 
   276-2 1.31 
   276-5 0.95 
   276-6 2.26 
   277-1 0.89 
   277-2 0.74 
   277-6 0.88 
   278-2 0.44 
   278-4 0.55 
   278-6 0.88 
  day 7 218-1 0.93 
   218-2 0.79 
   218-3 0.77 
 253 
dorsal horn group time-point image 
GLT-1 
(fold increase over 
normal) 
ipsilateral 3 minute day 7 218-5 0.80 
(cont.)   218-6 0.38 
   223-2 1.16 
   223-3 0.71 
   223-4 1.02 
   223-5 1.08 
   223-6 1.04 
   225-1 1.46 
   225-3 1.10 
   225-4 1.05 
   227-1 0.88 
   227-2 1.47 
   227-3 1.12 
   227-4 1.34 
   227-5 1.12 
   227-6 1.40 
   231-1 0.46 
   231-2 0.48 
   231-3 0.52 
   231-4 0.76 
   231-6 0.53 
   235-1 0.63 
   235-2 0.80 
   235-3 0.73 
   235-4 1.24 
   235-5 1.40 
   235-6 0.83 
   236-1 1.07 
   236-2 1.07 
   236-3 0.74 
   236-4 1.10 
   236-5 1.08 
   236-6 1.14 
 15 minute day 1 106-1 0.63 
   106-3 0.79 
   106-4 0.61 
   106-5 0.64 
   106-6 0.69 
   107-1 1.09 
   107-2 1.20 
   107-3 0.94 
   107-6 1.02 
   108-1 1.24 
   108-2 1.34 
   108-3 1.27 
   108-5 0.90 
   111-1 1.35 
   111-2 1.46 
   111-3 0.85 
   111-4 1.45 
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dorsal horn group time-point image 
GLT-1 
(fold increase over 
normal) 
ipsilateral 15 minute day 1 111-5 0.98 
(cont.)   111-6 0.96 
   112-1 1.13 
   112-3 1.14 
   112-5 1.04 
   112-6 0.88 
   252-2 1.12 
   252-3 0.70 
   252-5 1.16 
   256-1 0.18 
   256-2 0.60 
   256-5 0.23 
  day 7 213-1 0.92 
   213-2 0.91 
   213-3 0.97 
   213-5 0.64 
   214-1 0.43 
   214-2 0.38 
   214-4 0.61 
   214-5 0.83 
   214-6 1.01 
   217-1 1.24 
   217-3 0.93 
   217-4 1.01 
   217-5 0.89 
   217-6 0.73 
   224-1 1.36 
   224-2 1.09 
   224-4 0.94 
   224-5 1.23 
   224-6 1.03 
   230-1 0.39 
   230-2 0.69 
   230-3 0.70 
   230-4 0.22 
   230-5 1.00 
   230-6 0.96 
   233-1 1.07 
   233-2 0.93 
   233-3 1.09 
   233-4 0.54 
   233-5 0.96 
   233-6 0.78 
   237-1 0.86 
   237-2 0.95 
   237-3 0.49 
   237-4 0.64 
   237-5 0.83 
   237-6 0.98 
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dorsal horn group time-point image 
GLT-1 
(fold increase over 
normal) 
contralateral sham day 1 109-1 0.98 
   109-2 1.75 
   109-3 0.67 
   109-4 0.88 
   109-5 1.59 
   109-6 0.81 
   113-1 0.91 
   113-2 0.61 
   113-3 0.85 
   113-4 1.18 
   113-5 1.07 
   113-6 0.83 
   254-2 0.93 
   254-3 0.92 
   254-4 0.81 
   254-6 1.13 
   258-3 0.99 
   258-5 0.68 
   258-6 1.13 
   280-2 0.47 
   280-4 0.07 
   280-6 0.11 
   281-1 0.96 
   281-2 0.41 
   281-4 0.69 
   281-6 0.55 
   282-2 1.77 
   282-3 1.05 
   282-4 0.96 
   282-5 1.93 
  day 7 216-1 0.91 
   216-2 1.11 
   216-4 1.00 
   216-5 0.75 
   220-1 0.89 
   220-2 0.90 
   220-3 0.90 
   220-4 1.09 
   220-5 0.87 
   220-6 0.91 
   226-1 1.28 
   226-2 0.89 
   226-3 1.17 
   226-5 0.83 
   226-6 0.82 
   228-1 1.06 
   228-3 1.22 
   228-4 0.85 
   228-5 0.98 
   228-6 1.04 
 256 
dorsal horn group time-point image 
GLT-1 
(fold increase over 
normal) 
contralateral sham day 7 229-2 1.15 
(cont.)   229-3 0.84 
   229-5 0.73 
   229-6 1.82 
   234-1 0.91 
   234-2 0.64 
   234-4 0.66 
   234-5 0.71 
   234-6 0.88 
   238-2 0.87 
   238-4 0.67 
   238-5 0.94 
   238-6 0.83 
 3 minute day 1 251-2 1.29 
   251-3 1.04 
   251-4 0.71 
   253-2 1.58 
   253-3 1.20 
   253-4 1.35 
   253-5 1.44 
   253-6 1.32 
   255-1 0.33 
   255-2 0.54 
   255-3 0.41 
   255-4 0.41 
   255-6 0.73 
   275-1 0.47 
   275-2 1.06 
   275-4 1.11 
   276-1 1.58 
   276-2 0.88 
   276-4 1.50 
   276-6 0.19 
   277-3 1.71 
   277-4 2.06 
   277-5 1.05 
   278-1 0.32 
   278-2 0.26 
   278-3 0.23 
  day 7 218-1 0.95 
   218-2 1.47 
   218-3 1.05 
   218-4 1.50 
   218-5 0.75 
   218-6 0.95 
   223-1 1.06 
   223-2 1.92 
   223-3 0.58 
   223-4 0.45 
   223-5 1.01 
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dorsal horn group time-point image 
GLT-1 
(fold increase over 
normal) 
contralateral 3 minute day 7 223-6 0.94 
(cont.)   225-1 1.22 
   225-2 1.62 
   225-3 0.76 
   227-1 0.79 
   227-2 1.17 
   227-3 1.15 
   227-4 1.23 
   227-5 1.06 
   227-6 1.06 
   231-1 0.56 
   231-2 0.82 
   231-3 0.74 
   231-4 0.26 
   231-5 0.34 
   231-6 0.88 
   235-1 1.21 
   235-2 0.83 
   235-3 1.02 
   235-4 1.40 
   235-5 0.81 
   235-6 1.18 
   236-1 0.49 
   236-2 0.56 
   236-3 0.82 
   236-4 0.58 
   236-5 0.62 
   236-6 0.65 
 15 minute day 1 106-1 1.29 
   106-2 0.83 
   106-3 0.57 
   106-4 1.08 
   106-5 0.87 
   106-6 1.35 
   107-2 0.95 
   107-3 1.47 
   107-4 1.38 
   107-5 1.36 
   108-1 1.44 
   108-2 1.62 
   108-3 1.52 
   108-4 1.52 
   108-5 1.58 
   108-6 0.97 
   111-2 1.06 
   111-3 0.44 
   111-4 0.30 
   111-5 0.36 
   112-1 1.33 
   112-2 1.30 
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dorsal horn group time-point image 
GLT-1 
(fold increase over 
normal) 
contralateral 15 minute day 1 112-4 0.83 
(cont.)   112-5 1.77 
   112-6 0.60 
   252-2 1.82 
   252-3 0.51 
   252-5 0.62 
   256-3 0.43 
   256-5 0.67 
   256-6 1.17 
  day 7 213-1 0.79 
   213-2 1.06 
   213-3 0.89 
   213-4 1.10 
   213-5 1.16 
   213-6 0.33 
   214-1 1.12 
   214-2 0.53 
   214-3 1.43 
   214-4 1.29 
   214-5 0.61 
   214-6 1.25 
   217-1 1.22 
   217-2 0.71 
   217-3 0.72 
   217-4 0.85 
   217-5 0.88 
   217-6 0.88 
   224-3 1.57 
   224-4 1.15 
   224-5 1.52 
   224-6 1.53 
   224-7 1.51 
   230-1 0.95 
   230-2 1.31 
   230-3 1.12 
   230-5 0.86 
   230-6 1.41 
   233-1 0.73 
   233-2 0.68 
   233-3 0.95 
   233-4 0.86 
   233-5 0.77 
   233-6 0.70 
   237-1 0.31 
   237-2 0.38 
   237-3 0.54 
   237-4 0.96 
   237-5 0.69 
   237-6 0.82 
 259 
Table D.2 Quantification of GLAST in the superficial at days 1 and 7 (Chapter 5). 
dorsal horn group time-point image 
GLAST 
(fold increase 
over normal) 
ipsilateral sham day 1 109-1 1.71 
   109-3 1.82 
   109-4 1.39 
   109-5 1.22 
   109-6 1.52 
   113-1 1.97 
   113-3 1.74 
   113-4 1.46 
   113-5 0.85 
   113-6 0.96 
   254-1 1.50 
   254-2 1.28 
   254-3 0.56 
   254-4 0.84 
   258-1 0.84 
   258-2 1.01 
   258-3 1.31 
   258-4 1.12 
   258-5 1.19 
   258-6 0.92 
   280-1 1.11 
   280-3 1.22 
   280-5 1.11 
   280-6 1.44 
   281-1 1.41 
   281-2 1.17 
   281-3 1.76 
   281-4 1.41 
   281-5 1.42 
   281-6 1.53 
   282-2 1.44 
   282-4 1.39 
   282-5 1.43 
   282-6 1.33 
  day 7 216-1 0.46 
   216-2 0.72 
   216-3 1.18 
   216-4 0.74 
   216-5 1.47 
   216-6 1.09 
   220-1 0.87 
   220-2 1.06 
   220-3 0.62 
   220-4 0.93 
   220-5 0.58 
   220-6 1.05 
   226-2 0.52 
   226-4 0.51 
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dorsal horn group time-point image 
GLAST 
(fold increase 
over normal) 
ipsilateral sham day 7 226-5 1.07 
(cont.)   226-6 0.75 
   228-1 0.33 
   228-2 1.57 
   228-3 1.91 
   228-4 0.61 
   228-5 1.39 
   228-6 0.93 
   229-1 1.14 
   229-2 0.69 
   229-3 1.68 
   229-4 0.59 
   229-5 1.10 
   229-6 0.89 
   234-1 1.08 
   234-2 1.23 
   234-3 1.29 
   234-4 1.33 
   234-5 0.96 
   234-6 1.18 
   238-1 0.76 
   238-2 0.92 
   238-3 1.20 
   238-4 0.84 
   238-5 0.08 
   238-6 0.79 
 3 minute day 1 251-1 0.83 
   251-2 0.96 
   251-3 0.77 
   251-4 1.30 
   251-6 1.41 
   253-2 0.90 
   253-4 0.99 
   253-5 0.85 
   253-6 0.88 
   255-1 1.09 
   255-2 0.92 
   255-3 0.81 
   255-4 1.20 
   255-5 1.11 
   275-1 1.15 
   275-3 1.30 
   275-5 1.29 
   275-6 1.11 
   276-1 1.70 
   276-3 0.93 
   276-4 1.48 
   276-6 1.15 
   277-2 1.38 
   277-4 1.35 
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dorsal horn group time-point image 
GLAST 
(fold increase 
over normal) 
ipsilateral 3 minute day 1 277-5 0.97 
(cont.)   277-6 1.28 
   278-1 1.25 
   278-2 1.35 
   278-3 1.91 
   278-4 1.74 
   278-5 1.57 
   278-6 1.47 
  day 7 218-1 0.60 
   218-2 1.03 
   218-3 0.53 
   218-4 1.04 
   218-5 0.22 
   218-6 0.60 
   223-1 0.45 
   223-3 0.55 
   223-4 0.16 
   223-5 0.60 
   223-6 0.19 
   225-1 0.61 
   225-2 2.37 
   225-4 2.12 
   225-5 2.50 
   225-6 1.25 
   227-1 1.05 
   227-2 2.22 
   227-3 0.24 
   227-4 1.01 
   227-5 0.19 
   227-6 1.13 
   231-1 0.96 
   231-2 1.09 
   231-3 1.29 
   231-4 1.25 
   231-5 1.24 
   231-6 0.88 
   235-1 0.87 
   235-2 0.85 
   235-3 0.76 
   235-4 1.01 
   235-5 0.93 
   235-6 0.78 
   236-1 1.20 
   236-3 0.95 
   236-4 1.16 
   236-5 1.06 
   236-6 1.04 
 15 minute day 1 106-3 0.70 
   106-5 1.25 
   106-6 1.11 
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dorsal horn group time-point image 
GLAST 
(fold increase 
over normal) 
ipsilateral 15 minute day 1 107-1 1.34 
(cont.)   107-2 1.58 
   107-3 1.53 
   107-4 2.17 
   108-1 1.71 
   108-3 1.30 
   108-4 1.47 
   108-5 1.31 
   111-1 1.32 
   111-2 0.66 
   111-3 1.03 
   111-4 0.78 
   112-2 1.07 
   112-3 1.16 
   112-4 1.29 
   112-6 1.73 
   252-2 1.21 
   252-3 1.26 
   252-4 1.25 
   252-5 1.57 
   252-6 1.18 
   256-1 1.43 
   256-2 1.40 
   256-3 1.47 
   256-4 1.01 
   256-5 1.04 
   256-6 0.99 
  day 7 213-1 0.56 
   213-2 0.86 
   213-3 1.45 
   213-4 0.67 
   213-5 1.11 
   213-6 1.39 
   214-2 0.72 
   214-3 0.90 
   214-4 0.42 
   214-5 0.97 
   214-6 1.50 
   217-1 0.99 
   217-2 1.80 
   217-3 1.62 
   217-4 1.23 
   217-5 1.29 
   224-1 0.98 
   224-2 2.03 
   224-3 2.01 
   224-4 0.91 
   224-5 0.98 
   224-6 1.89 
   230-1 0.78 
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dorsal horn group time-point image 
GLAST 
(fold increase 
over normal) 
ipsilateral 15 minute day 7 230-2 1.94 
(cont.)   230-3 2.79 
   230-4 2.49 
   230-5 3.61 
   230-6 3.07 
   233-1 1.09 
   233-2 1.25 
   233-3 0.59 
   233-4 0.55 
   233-5 1.24 
   233-6 0.67 
   237-1 0.94 
   237-2 1.27 
   237-3 1.24 
   237-4 0.92 
   237-5 1.09 
   237-6 0.89 
contralateral sham day 1 109-2 1.15 
   109-3 1.37 
   109-4 1.17 
   113-1 0.90 
   113-3 0.82 
   113-4 0.82 
   113-5 0.99 
   254-1 0.96 
   254-2 1.37 
   258-1 0.96 
   258-2 0.84 
   258-3 0.68 
   258-4 0.71 
   258-5 0.99 
   258-6 0.69 
   280-1 0.94 
   280-3 1.06 
   280-5 1.15 
   280-6 1.02 
   281-1 1.57 
   281-3 1.55 
   281-4 1.25 
   281-5 1.65 
   282-2 1.28 
   282-3 0.81 
   282-4 0.88 
  day 7 216-1 0.53 
   216-2 1.16 
   216-3 1.30 
   216-4 0.91 
   216-5 1.13 
   216-6 0.67 
   220-1 1.19 
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dorsal horn group time-point image 
GLAST 
(fold increase 
over normal) 
contralateral sham day 7 220-2 1.61 
(cont.)   220-3 1.06 
   220-4 0.98 
   220-5 0.92 
   220-6 0.63 
   226-2 1.69 
   226-3 1.45 
   226-4 0.46 
   226-5 1.38 
   226-6 0.65 
   228-1 0.60 
   228-2 1.75 
   228-3 1.14 
   228-4 0.32 
   228-5 1.64 
   228-6 1.31 
   229-1 1.08 
   229-2 0.91 
   229-3 2.00 
   229-4 0.18 
   229-5 0.84 
   229-6 0.65 
   234-1 0.74 
   234-2 0.79 
   234-3 0.69 
   234-4 0.53 
   234-5 0.69 
   234-6 0.72 
   234-7 0.64 
   234-8 0.80 
   238-1 0.76 
   238-2 0.61 
   238-3 1.11 
   238-4 0.48 
   238-5 0.91 
 3 minute day 1 251-2 1.03 
   251-3 1.10 
   251-4 1.16 
   251-5 1.19 
   251-6 1.14 
   253-2 0.96 
   253-4 1.08 
   253-5 0.64 
   253-6 0.80 
   255-2 0.73 
   255-3 0.94 
   255-5 0.68 
   255-6 1.22 
   275-1 0.91 
   275-2 0.90 
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dorsal horn group time-point image 
GLAST 
(fold increase 
over normal) 
contralateral 3 minute day 1 275-3 0.81 
(cont.)   275-5 0.77 
   275-6 0.98 
   276-1 1.44 
   276-2 1.48 
   276-3 0.59 
   276-6 0.80 
   277-2 1.25 
   277-3 0.81 
   277-4 1.32 
   277-5 0.77 
   278-1 1.40 
   278-3 1.66 
   278-4 0.83 
   278-5 1.55 
   278-6 0.97 
  day 7 218-1 0.87 
   218-2 1.41 
   218-3 0.84 
   218-4 0.74 
   218-5 0.92 
   218-6 0.19 
   223-1 0.77 
   223-2 0.72 
   223-3 1.31 
   223-4 0.70 
   223-5 1.01 
   223-6 0.11 
   225-1 1.09 
   225-3 1.07 
   225-4 2.34 
   225-5 0.98 
   227-1 0.97 
   227-2 1.88 
   227-4 2.15 
   227-5 0.58 
   227-6 0.73 
   231-1 0.54 
   231-2 0.67 
   231-3 0.25 
   231-4 0.27 
   231-5 0.48 
   231-6 0.74 
   235-1 0.60 
   235-2 0.50 
   235-3 0.92 
   235-4 0.94 
   235-5 0.69 
   235-6 0.86 
   236-1 0.86 
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dorsal horn group time-point image 
GLAST 
(fold increase 
over normal) 
contralateral 3 minute day 7 236-2 0.62 
(cont.)   236-3 0.73 
   236-4 1.30 
   236-5 0.68 
   236-6 0.89 
 15 minute day 1 106-1 1.07 
   106-2 1.08 
   106-5 1.00 
   106-6 0.81 
   107-2 0.70 
   107-3 0.88 
   107-4 0.77 
   108-2 0.55 
   108-3 1.36 
   108-5 1.46 
   108-6 0.91 
   111-1 1.31 
   111-2 0.93 
   111-3 0.88 
   111-4 1.32 
   112-1 1.02 
   112-2 0.98 
   112-3 0.99 
   112-4 1.08 
   252-2 0.77 
   252-3 0.89 
   252-4 1.16 
   252-5 0.73 
   252-6 1.17 
   256-1 1.02 
   256-2 0.74 
   256-3 0.59 
   256-4 1.02 
   256-5 0.85 
   256-6 1.35 
  day 7 213-2 1.21 
   213-3 1.24 
   213-4 0.87 
   213-5 0.92 
   213-6 1.00 
   214-2 0.98 
   214-3 0.69 
   214-4 0.91 
   214-5 1.29 
   217-1 1.84 
   217-2 1.59 
   217-3 1.86 
   217-4 1.00 
   217-5 1.64 
   217-6 0.78 
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dorsal horn group time-point image 
GLAST 
(fold increase 
over normal) 
contralateral 15 minute day 7 224-2 0.94 
(cont.)   224-3 2.32 
   224-5 1.49 
   224-6 1.02 
   230-2 1.89 
   230-4 1.51 
   230-6 1.79 
   233-1 0.95 
   233-2 1.21 
   233-3 1.17 
   233-4 1.13 
   233-5 1.06 
   233-6 1.07 
   237-1 1.10 
   237-2 0.56 
   237-3 0.94 
   237-4 0.86 
   237-5 0.55 
   237-6 0.91 
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Table D.3 Quantification of EAAC1 in the superficial laminae at days 1 and 7 (Chapter 
5). 
 
dorsal horn group time-point image 
EAAC1 
(fold increase  
over normal) 
ipsilateral sham day 1 109-1 1.80 
   109-2 0.90 
   109-3 0.65 
   109-5 1.07 
   109-6 0.61 
   113-1 0.83 
   113-1 0.55 
   113-2 1.59 
   113-3 1.40 
   113-4 0.96 
   113-5 0.87 
   113-6 0.87 
   254-1 1.23 
   254-2 1.26 
   254-3 0.88 
   258-2 1.15 
   258-3 1.25 
   258-5 0.59 
   258-6 1.20 
   280-2 0.69 
   280-4 0.49 
   280-5 0.61 
   281-1 0.15 
   281-2 0.56 
   281-4 2.42 
   282-1 1.89 
   282-2 1.64 
   282-3 0.77 
   282-4 1.36 
  day 7 216-1 0.96 
   216-2 0.83 
   216-3 0.73 
   216-5 1.09 
   216-6 0.77 
   220-1 0.86 
   220-2 0.46 
   220-4 0.24 
   220-5 0.94 
   226-1 0.21 
   226-2 0.89 
   226-3 0.84 
   226-4 0.43 
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dorsal horn group time-point image 
EAAC1 
(fold increase  
over normal) 
ipsilateral sham day 7 226-5 0.16 
(cont.)   226-6 0.28 
   228-1 0.53 
   228-2 0.51 
   228-3 0.44 
   228-4 0.33 
   228-5 1.02 
   228-6 1.04 
   229-3 0.53 
   229-4 1.60 
   229-5 1.04 
   229-6 1.53 
   234-2 0.42 
   234-3 1.04 
   234-4 0.43 
   234-5 1.46 
   234-6 0.28 
   238-1 0.70 
   238-3 0.73 
   238-4 0.56 
   238-5 0.91 
   238-6 1.24 
 3 minute day 1 251-3 0.81 
   251-4 1.12 
   251-5 1.02 
   253-3 1.20 
   253-4 1.28 
   253-6 1.20 
   255-1 1.15 
   255-3 1.16 
   255-5 0.95 
   275-2 0.49 
   275-3 0.32 
   275-4 0.32 
   276-1 1.46 
   276-2 0.37 
   276-3 0.99 
   276-4 0.94 
   276-5 1.20 
   276-6 1.46 
   277-1 0.62 
   277-2 1.59 
   277-3 0.55 
   277-5 1.95 
   277-6 0.67 
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dorsal horn group time-point image 
EAAC1 
(fold increase  
over normal) 
ipsilateral 3 minute day 1 278-2 1.65 
(cont.)   278-3 0.77 
   278-4 0.63 
   278-5 0.62 
  day 7 218-1 0.11 
   218-2 0.23 
   218-3 0.38 
   218-4 0.68 
   218-5 0.85 
   218-6 0.22 
   223-1 0.31 
   223-2 0.28 
   223-3 0.23 
   223-4 0.23 
   225-1 0.97 
   225-2 2.48 
   225-4 1.88 
   227-1 0.54 
   227-2 0.71 
   227-4 2.04 
   231-1 1.18 
   231-2 0.76 
   231-3 0.57 
   231-4 0.71 
   231-5 1.51 
   235-1 1.29 
   235-2 0.53 
   235-3 0.68 
   235-4 0.36 
   235-6 0.77 
   236-1 0.73 
   236-2 0.81 
   236-3 0.38 
   236-4 0.48 
   236-6 0.46 
 15 minute day 1 106-1 1.21 
   106-2 0.94 
   106-3 1.08 
   106-4 1.26 
   106-5 0.81 
   106-6 0.84 
   107-2 1.43 
   107-3 1.74 
   107-4 1.20 
   108-1 1.18 
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dorsal horn group time-point image 
EAAC1 
(fold increase  
over normal) 
ipsilateral 15 minute day 1 108-2 1.38 
(cont.)   108-3 1.37 
   108-4 0.87 
   108-5 0.96 
   108-6 1.07 
   111-1 0.73 
   111-2 1.00 
   111-3 0.54 
   111-4 0.66 
   111-5 1.03 
   111-6 0.79 
   112-1 0.69 
   112-2 0.59 
   112-3 0.52 
   112-4 0.40 
   112-5 1.28 
   112-6 0.81 
   252-1 0.63 
   252-3 0.97 
   252-5 1.40 
   256-2 0.46 
   256-4 0.36 
   256-6 0.77 
  day 7 213-1 0.65 
   213-2 0.99 
   213-3 0.41 
   213-4 0.50 
   213-5 0.47 
   213-6 0.63 
   214-1 0.08 
   214-2 0.89 
   214-3 0.49 
   214-4 0.76 
   214-5 1.15 
   214-6 0.84 
   217-1 0.78 
   217-2 0.80 
   217-3 0.68 
   217-5 0.79 
   217-6 1.08 
   224-1 0.58 
   224-2 0.71 
   224-3 1.24 
   224-4 0.92 
   224-5 0.78 
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dorsal horn group time-point image 
EAAC1 
(fold increase  
over normal) 
ipsilateral 15 minute day 7 224-6 0.91 
(cont.)   230-1 0.61 
   230-2 0.72 
   230-4 0.82 
   230-5 0.72 
   233-1 0.74 
   233-2 1.04 
   233-3 0.96 
   233-4 0.63 
   233-5 0.46 
   233-6 0.59 
   237-1 0.68 
   237-2 0.62 
   237-3 0.95 
   237-4 0.41 
   237-5 0.42 
contralateral sham day 1 109-1 1.03 
   109-2 1.05 
   109-5 0.84 
   109-6 1.05 
   113-2 0.69 
   113-3 0.81 
   113-5 1.01 
   113-6 0.70 
   254-1 1.68 
   254-2 0.73 
   254-3 0.57 
   258-2 0.64 
   258-3 0.69 
   258-4 0.80 
   258-6 1.14 
   280-2 0.59 
   280-3 1.02 
   280-4 0.41 
   280-5 0.41 
   280-6 0.35 
   281-2 0.17 
   281-3 1.97 
   281-4 1.88 
   282-1 0.94 
   282-2 2.18 
   282-3 1.98 
   282-4 1.18 
   282-5 0.86 
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dorsal horn group time-point image 
EAAC1 
(fold increase  
over normal) 
contralateral sham day 7 216-1 0.35 
(cont.)   216-2 0.50 
   216-6 0.93 
   220-1 0.68 
   220-2 1.76 
   220-3 0.80 
   220-5 0.64 
   220-6 1.67 
   226-1 1.45 
   226-2 0.61 
   226-3 0.49 
   226-4 0.17 
   226-5 0.10 
   226-6 0.54 
   228-1 2.06 
   228-2 1.42 
   228-3 0.91 
   228-4 1.34 
   228-5 1.37 
   228-6 2.10 
   229-3 0.79 
   229-4 0.97 
   229-5 0.86 
   229-6 1.71 
   234-1 1.10 
   234-3 0.55 
   234-4 0.44 
   234-5 1.01 
   234-6 1.01 
   238-1 0.91 
   238-4 0.51 
   238-5 1.00 
   238-6 0.95 
 3 minute day 1 251-1 0.96 
   251-2 0.20 
   251-3 0.89 
   251-6 0.55 
   253-1 1.02 
   253-2 0.35 
   253-5 1.59 
   253-6 1.16 
   255-1 0.76 
   255-3 0.87 
   255-5 0.94 
   255-6 0.58 
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dorsal horn group time-point image 
EAAC1 
(fold increase  
over normal) 
contralateral 3 minute day 1 275-2 1.11 
(cont.)   275-4 1.20 
   275-5 0.39 
   276-1 0.51 
   276-2 1.18 
   276-3 0.37 
   276-5 1.56 
   277-1 0.68 
   277-2 0.74 
   277-3 0.57 
   277-4 1.14 
   277-5 1.97 
   277-6 0.77 
   278-2 2.02 
   278-3 0.65 
   278-4 2.08 
   278-5 1.49 
  day 7 218-2 0.37 
   218-3 0.53 
   218-4 1.10 
   218-5 0.82 
   218-6 0.82 
   223-1 0.85 
   223-2 1.59 
   223-3 0.32 
   223-4 1.13 
   225-1 0.68 
   225-2 0.89 
   225-4 1.34 
   227-1 0.93 
   227-3 1.45 
   227-4 1.74 
   231-1 0.68 
   231-4 0.54 
   231-5 0.67 
   231-6 0.70 
   235-1 0.53 
   235-3 0.96 
   235-4 0.99 
   235-5 0.80 
   235-6 0.75 
   236-1 1.60 
   236-2 1.74 
   236-3 0.39 
   236-4 0.87 
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dorsal horn group time-point image 
EAAC1 
(fold increase  
over normal) 
contralateral 3 minute day 7 236-5 1.06 
(cont.)   236-6 0.47 
 15 minute day 1 106-1 1.32 
   106-2 1.47 
   106-3 1.13 
   106-4 1.23 
   106-5 1.83 
   106-6 1.21 
   107-1 0.69 
   107-2 1.12 
   107-3 0.74 
   107-4 0.97 
   108-1 1.10 
   108-2 1.03 
   108-3 1.03 
   108-4 1.13 
   108-5 1.22 
   111-1 0.44 
   111-2 0.65 
   111-3 0.71 
   111-4 0.67 
   111-5 0.68 
   111-6 0.93 
   112-1 1.29 
   112-2 0.81 
   112-3 0.88 
   112-4 1.15 
   112-5 1.16 
   112-6 1.06 
   252-1 0.67 
   252-2 0.61 
   252-3 0.61 
   252-4 1.84 
   256-2 3.40 
   256-3 0.82 
   256-4 3.81 
   256-6 0.74 
  day 7 213-1 2.10 
   213-2 1.05 
   213-3 0.32 
   213-4 1.04 
   213-5 0.97 
   213-6 1.17 
   214-1 0.21 
   214-2 0.26 
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dorsal horn group time-point image 
EAAC1 
(fold increase  
over normal) 
contralateral 15 minute day 7 214-3 0.32 
(cont.)   214-4 0.56 
   214-5 0.13 
   214-6 0.82 
   217-1 0.59 
   217-3 0.73 
   217-4 0.97 
   217-6 0.50 
   224-1 0.51 
   224-2 1.02 
   224-3 1.21 
   224-4 2.58 
   224-5 0.80 
   224-6 1.98 
   230-1 0.63 
   230-3 1.08 
   230-4 1.09 
   230-5 0.83 
   230-6 0.50 
   232-1 1.80 
   233-1 1.14 
   233-2 0.61 
   233-3 1.34 
   233-4 1.28 
   233-5 1.28 
   237-1 0.45 
   237-2 0.85 
   237-3 0.77 
   237-4 0.46 
   237-5 1.16 
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Table D.4 Quantification of GLT-1 in the superficial laminae at day 7 after a painful 
compression treated with of ceftriaxone (injury+10µg, injury+150µg) or the saline 
vehicle (injury+saline), or sham treated with the saline  (sham+saline) (Chapter 6). 
dorsal horn group image 
GLT-1 
(fold increase  
over normal) 
ipsilateral sham+saline 131-1 1.44 
  131-2 0.39 
  131-4 0.97 
  131-6 1.39 
  171-2 2.02 
  171-4 1.43 
  171-6 1.32 
  175-1 0.27 
  175-2 0.22 
  175-5 0.20 
  178-2 1.06 
  178-3 1.06 
  178-5 0.65 
  178-6 1.43 
  179-4 1.02 
  179-5 0.75 
  179-6 1.64 
  183-2 0.97 
  183-4 0.80 
  183-5 0.82 
  183-6 1.10 
  184-2 2.07 
  184-3 1.96 
  184-4 1.51 
  184-5 2.14 
  184-6 1.83 
 injury+saline 128-2 0.12 
  128-3 0.06 
  128-4 0.03 
  128-5 0.02 
  128-6 0.18 
  129-1 1.04 
  129-2 0.84 
  129-4 0.94 
  129-5 0.69 
  129-6 0.93 
  130-1 1.04 
  130-2 0.48 
  130-3 0.84 
  130-4 0.67 
  164-1 0.80 
  164-2 1.14 
  164-3 1.11 
  164-4 1.01 
  164-5 0.86 
  164-6 1.04 
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dorsal horn group image 
GLT-1 
(fold increase  
over normal) 
ipsilateral injury+saline 165-1 0.84 
(cont.)  165-2 1.13 
  165-4 1.01 
  165-5 0.88 
  165-6 0.97 
  174-1 0.51 
  174-3 0.73 
  174-5 0.70 
  174-6 0.67 
  182-1 0.35 
  182-3 1.10 
  182-5 1.19 
 injury+10µg 138-1 1.83 
  138-2 0.46 
  138-3 0.59 
  138-4 1.03 
  139-2 0.48 
  139-3 1.86 
  139-5 0.50 
  140-1 0.31 
  140-2 0.30 
  140-3 0.33 
  141-1 1.74 
  141-2 1.06 
  141-4 1.65 
  141-6 1.57 
  168-1 1.36 
  168-2 1.03 
  168-4 1.02 
  168-6 0.75 
  169-2 1.44 
  169-3 1.00 
  169-4 1.37 
  169-5 0.73 
  169-6 1.67 
  176-2 1.23 
  176-3 1.28 
  176-4 1.19 
  176-5 1.11 
  176-6 1.01 
  177-3 0.87 
  177-4 1.19 
  177-5 1.23 
  177-6 1.13 
 injury+150µg 136-2 0.56 
  136-3 0.54 
  136-4 1.88 
  136-5 1.52 
  142-1 1.33 
  142-2 1.39 
  142-3 1.24 
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dorsal horn group image 
GLT-1 
(fold increase  
over normal) 
ipsilateral injury+150µg 142-5 1.03 
(cont.)  143-1 2.02 
  143-3 1.99 
  143-4 2.21 
  143-5 1.58 
  167-2 2.03 
  167-4 1.89 
  167-6 2.05 
  172-1 1.22 
  172-2 1.20 
  172-3 1.11 
  172-4 0.88 
  172-6 0.60 
  173-2 0.60 
  173-3 0.60 
  173-5 0.81 
  173-6 0.66 
  180-1 2.01 
  180-2 2.12 
  180-3 2.12 
  180-4 2.14 
  181-3 1.19 
  181-4 0.58 
  181-5 1.34 
  181-6 0.79 
contralateral sham+saline 131-1 0.72 
  131-2 0.67 
  131-4 1.75 
  131-6 1.01 
  171-2 1.64 
  171-3 0.49 
  171-4 0.92 
  175-1 0.70 
  175-2 0.71 
  175-6 0.11 
  178-2 1.64 
  178-4 1.31 
  178-5 0.44 
  179-4 1.20 
  179-5 0.35 
  179-6 1.43 
  183-1 0.98 
  183-2 1.78 
  183-3 1.47 
  183-4 1.59 
  184-1 2.24 
  184-2 2.22 
  184-3 2.44 
  184-4 2.27 
  184-5 2.43 
  184-6 2.24 
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dorsal horn group image 
GLT-1 
(fold increase  
over normal) 
contralateral injury+saline 128-1 0.34 
(cont.)  128-2 0.28 
  128-3 0.77 
  128-4 0.67 
  128-5 0.40 
  128-6 0.22 
  129-1 1.19 
  129-2 1.14 
  129-4 0.51 
  129-5 0.60 
  129-6 0.15 
  130-1 1.27 
  130-2 1.25 
  130-3 0.67 
  130-4 1.20 
  164-1 0.92 
  164-2 1.21 
  164-3 1.02 
  164-4 1.17 
  164-5 1.12 
  164-6 1.31 
  165-1 1.11 
  165-2 1.28 
  165-4 1.14 
  165-5 1.00 
  165-6 1.27 
  174-1 0.69 
  174-2 0.96 
  174-3 0.60 
  174-4 1.00 
  174-5 0.67 
  174-6 0.56 
  182-1 2.03 
  182-3 2.10 
  182-5 2.06 
  182-6 1.84 
 injury+10µg 138-1 2.26 
  138-3 2.53 
  138-4 1.49 
  138-5 0.88 
  139-2 1.34 
  139-3 1.81 
  139-5 0.91 
  140-1 0.23 
  140-2 0.15 
  140-3 0.19 
  140-6 0.16 
  141-1 1.27 
  141-4 1.01 
  141-6 0.81 
  168-1 1.96 
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dorsal horn group image 
GLT-1 
(fold increase  
over normal) 
contralateral injury+10µg 168-2 0.24 
(cont.)  168-3 0.70 
  169-1 0.92 
  169-2 1.45 
  169-3 1.80 
  169-4 1.38 
  169-6 1.08 
  176-1 1.00 
  176-2 1.70 
  176-3 1.24 
  176-4 1.55 
  177-3 1.35 
  177-4 1.39 
  177-5 1.40 
  177-6 1.28 
 injury+150µg 136-3 0.36 
  136-4 1.03 
  136-5 0.27 
  136-6 0.97 
  142-1 0.45 
  142-2 0.81 
  142-3 1.73 
  142-6 0.72 
  143-1 2.62 
  143-3 2.53 
  143-4 2.87 
  143-5 2.32 
  167-2 2.71 
  167-4 1.60 
  167-6 1.97 
  172-1 1.16 
  172-2 1.13 
  172-3 1.11 
  172-4 0.64 
  172-6 0.42 
  173-1 0.83 
  173-2 1.48 
  173-3 1.08 
  173-4 1.60 
  173-6 1.35 
  180-1 1.91 
  180-2 2.07 
  180-3 2.10 
  180-4 2.02 
  181-1 0.73 
  181-2 0.98 
  181-4 1.41 
  181-5 1.42 
  181-6 1.26 
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Table D.5 Quantification of GFAP in the superficial laminae at day 7 after a painful 
compression treated with ceftriaxone (injury+10µg, injury+150µg) or the saline vehicle 
(injury+saline), or sham treated with the saline  (sham+saline) (Chapter 6). 
dorsal horn group image 
GFAP 
(fold increase 
over normal) 
ipsilateral sham+saline 131-1 1.66 
  131-2 1.14 
  131-6 1.45 
  171-2 1.21 
  171-4 1.21 
  171-5 0.49 
  171-6 1.23 
  175-2 0.68 
  175-3 0.41 
  175-6 0.55 
  178-1 0.44 
  178-2 0.74 
  178-3 0.66 
  178-4 1.02 
  178-5 0.53 
  178-6 0.78 
  179-1 0.50 
  179-2 0.54 
  179-3 0.66 
  179-4 0.98 
  179-5 0.91 
  179-6 0.98 
  183-1 0.49 
  183-2 1.27 
  183-4 1.57 
  183-5 2.41 
  184-1 0.72 
  184-2 1.55 
  184-3 0.42 
  184-4 1.54 
  184-5 0.40 
  184-6 1.41 
 injury+saline 128-1 2.15 
  128-2 2.06 
  128-3 3.60 
  128-4 3.78 
  130-1 1.64 
  130-2 1.01 
  130-3 3.22 
  130-4 2.67 
  129-1 1.62 
  129-4 2.95 
  129-5 0.51 
  129-6 1.79 
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dorsal horn group image 
GFAP 
(fold increase 
over normal) 
ipsilateral injury+saline 164-1 0.48 
(cont.)  164-2 0.96 
  164-3 0.84 
  164-4 1.85 
  164-5 2.53 
  164-6 2.69 
  165-2 1.87 
  165-4 1.94 
  165-6 2.02 
  174-2 1.02 
  174-4 1.39 
  174-6 1.06 
  182-1 1.61 
  182-2 2.27 
  182-3 1.34 
  182-4 1.81 
  182-6 1.09 
 injury+10µg 138-1 3.06 
  138-2 2.46 
  138-3 2.82 
  138-4 1.52 
  140-1 0.82 
  140-2 0.85 
  140-3 0.91 
  140-6 1.27 
  139-2 1.56 
  139-3 0.57 
  139-5 1.73 
  141-2 1.37 
  141-4 1.33 
  141-6 1.41 
  168-2 0.63 
  168-3 1.17 
  168-4 1.74 
  168-5 1.35 
  168-6 1.13 
  169-1 0.88 
  169-2 1.62 
  169-4 2.17 
  169-5 0.92 
  169-6 2.19 
  176-2 1.17 
  176-4 1.04 
  176-6 0.99 
  177-1 0.80 
  177-2 1.08 
  177-3 0.77 
  177-4 0.87 
  177-5 1.02 
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dorsal horn group image 
GFAP 
(fold increase 
over normal) 
ipsilateral injury+10µg 177-6 0.77 
(cont.) injury+150µg 136-2 5.92 
  136-3 4.89 
  136-4 4.12 
  136-5 3.43 
  136-6 2.73 
  142-1 1.04 
  142-2 0.47 
  142-3 3.09 
  142-5 1.41 
  142-6 1.58 
  143-3 1.52 
  143-4 2.36 
  143-5 1.18 
  167-1 1.31 
  167-2 2.82 
  167-4 2.27 
  167-5 2.32 
  167-6 2.27 
  172-1 1.00 
  172-2 1.20 
  172-3 0.97 
  172-4 0.71 
  172-6 1.13 
  173-2 0.51 
  173-4 0.41 
  173-5 0.49 
  180-1 0.50 
  180-2 0.29 
  180-3 0.71 
  180-4 1.01 
  181-1 1.17 
  181-2 1.15 
  181-3 1.06 
  181-4 1.48 
  181-5 1.92 
  181-6 1.29 
contralateral sham+saline 131-1 0.79 
  131-2 1.34 
  131-4 1.24 
  131-6 1.19 
  171-3 1.98 
  171-4 0.55 
  171-5 1.88 
  175-1 0.19 
  175-2 0.51 
  175-6 0.51 
  178-1 0.47 
  178-2 1.17 
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dorsal horn group image 
GFAP 
(fold increase 
over normal) 
contralateral sham+saline 178-3 0.41 
(cont.)  178-4 0.71 
  178-5 0.58 
  179-1 0.43 
  179-2 0.57 
  179-3 0.77 
  179-4 1.22 
  179-5 0.93 
  179-6 1.15 
  183-1 1.27 
  183-2 2.40 
  183-4 2.30 
  183-5 2.59 
  184-1 1.57 
  184-2 2.13 
  184-3 0.52 
  184-4 1.49 
  184-5 0.54 
  184-6 1.87 
 injury+saline 128-1 3.80 
  128-2 1.63 
  128-3 2.32 
  128-6 3.02 
  130-1 2.01 
  130-2 2.78 
  130-3 2.05 
  130-4 3.84 
  129-1 1.69 
  129-2 1.92 
  129-4 0.71 
  129-5 0.72 
  129-6 1.17 
  164-2 2.41 
  164-3 1.24 
  164-4 2.15 
  164-5 1.76 
  164-6 2.54 
  165-2 3.08 
  165-4 2.38 
  165-6 1.56 
  174-2 1.37 
  174-4 0.98 
  174-5 0.98 
  174-6 1.00 
  182-1 2.13 
  182-2 2.62 
  182-3 1.29 
  182-4 2.30 
  182-6 0.69 
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dorsal horn group image 
GFAP 
(fold increase 
over normal) 
contralateral injury+10µg 138-1 1.97 
(cont.)  138-2 3.39 
  138-3 3.42 
  138-4 2.08 
  138-5 2.61 
  140-1 0.36 
  140-2 0.40 
  140-3 0.66 
  140-6 0.94 
  139-2 1.27 
  139-3 0.61 
  139-5 1.49 
  141-1 0.17 
  141-4 1.15 
  141-6 1.22 
  168-1 0.10 
  168-2 0.62 
  168-3 1.17 
  168-4 0.67 
  168-5 0.90 
  168-6 1.14 
  169-1 0.55 
  169-2 0.52 
  169-3 0.31 
  169-4 1.84 
  169-6 1.89 
  176-2 1.03 
  176-4 0.94 
  176-6 0.62 
  177-1 0.85 
  177-2 0.60 
  177-3 0.93 
  177-4 0.85 
  177-5 1.04 
  177-6 0.76 
 injury+150µg 136-2 2.22 
  136-3 2.33 
  136-4 4.99 
  136-5 1.93 
  136-6 3.65 
  142-1 0.34 
  142-2 0.43 
  142-3 2.04 
  142-5 1.11 
  142-6 1.55 
  143-3 1.74 
  143-4 3.11 
  143-5 2.13 
  167-1 1.15 
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dorsal horn group image 
GFAP 
(fold increase 
over normal) 
contralateral injury+150µg 167-2 3.30 
(cont.)  167-4 2.45 
  167-5 1.96 
  167-6 2.18 
  172-1 1.18 
  172-2 1.52 
  172-3 0.96 
  172-4 0.84 
  172-6 0.70 
  173-1 0.52 
  173-2 0.92 
  173-4 1.18 
  173-6 0.99 
  180-2 0.50 
  180-3 1.03 
  180-4 2.08 
  181-1 1.41 
  181-2 1.59 
  181-3 1.65 
  181-4 1.99 
  181-5 2.36 
  181-6 1.74 
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Table D.6 Quantification of GLAST in the superficial laminae at day 7 after a painful 
compression treated with ceftriaxone (injury+10µg, injury+150µg) or the saline vehicle 
(injury+saline), or sham treated with the saline  (sham+saline) (Chapter 6). 
dorsal horn group image 
GLAST 
(fold increase 
over normal) 
ipsilateral sham+saline 131-1 0.61 
  131-2 0.71 
  131-3 0.45 
  131-4 0.42 
  131-6 0.74 
  171-2 1.91 
  171-5 2.53 
  171-6 1.97 
  174-1 0.61 
  174-3 0.74 
  174-5 0.93 
  174-6 0.59 
  175-1 1.00 
  175-2 0.68 
  175-3 0.90 
  175-6 0.71 
  178-1 1.08 
  178-2 0.68 
  178-4 0.61 
  178-5 1.08 
  183-2 1.22 
  183-3 0.75 
  183-4 0.94 
  183-6 1.20 
  184-1 0.78 
  184-2 0.91 
  184-4 1.82 
  184-5 1.72 
 injury+saline 128-2 1.41 
  128-4 1.38 
  128-5 1.09 
  128-6 1.85 
  129-3 1.13 
  129-4 1.33 
  129-6 2.76 
  130-2 1.24 
  130-3 1.28 
  130-4 1.20 
  164-2 0.63 
  164-4 1.14 
  164-6 2.24 
  165-1 2.06 
  165-2 2.02 
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dorsal horn group image 
GLAST 
(fold increase 
over normal) 
ipsilateral injury+saline 165-4 2.20 
(cont.)  174-2 0.92 
  174-3 0.77 
  174-4 1.01 
  182-1 2.62 
  182-2 1.68 
  182-3 1.64 
  182-4 2.62 
  182-5 2.97 
 injury+10µg 138-1 0.64 
  138-2 0.54 
  138-3 0.67 
  138-6 1.14 
  139-1 0.71 
  139-2 1.00 
  139-4 0.67 
  139-6 1.42 
  140-2 0.40 
  140-4 0.28 
  140-6 0.54 
  141-2 0.90 
  141-3 1.57 
  141-4 0.64 
  168-1 0.53 
  168-2 0.75 
  168-4 1.75 
  168-6 1.64 
  169-1 1.11 
  169-2 1.04 
  169-3 1.40 
  169-4 0.84 
  169-5 0.78 
  176-1 0.95 
  176-3 0.73 
  176-4 0.40 
  176-5 0.66 
  176-6 0.98 
  177-1 1.05 
  177-3 1.21 
  177-4 1.38 
  177-5 1.38 
  177-6 1.94 
 injury+150µg 136-1 1.24 
  136-2 1.36 
  136-4 2.05 
  142-2 0.72 
  142-3 1.75 
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dorsal horn group image 
GLAST 
(fold increase 
over normal) 
ipsilateral injury+150µg 142-5 1.40 
(cont.)  143-1 1.66 
  143-2 0.21 
  143-3 0.53 
  143-4 1.20 
  167-1 0.27 
  167-3 0.79 
  167-4 0.28 
  167-5 0.57 
  172-1 1.23 
  172-2 0.31 
  172-3 0.64 
  172-5 0.69 
  173-2 0.10 
  173-3 0.54 
  173-4 1.51 
  180-1 1.06 
  180-2 0.61 
  180-3 1.64 
  180-4 1.85 
  180-5 0.63 
  181-1 0.35 
  181-2 1.20 
  181-3 0.91 
  181-4 0.62 
  181-5 1.12 
contralateral sham+saline 131-1 0.92 
  131-2 1.04 
  131-3 1.43 
  131-4 0.61 
  131-5 1.50 
  171-4 1.99 
  171-5 1.53 
  171-6 1.40 
  174-1 0.44 
  174-3 0.73 
  174-6 0.69 
  175-3 0.69 
  175-4 0.23 
  175-6 0.23 
  178-1 0.95 
  178-3 0.35 
  178-4 0.48 
  178-5 0.65 
  178-6 1.19 
  183-2 1.66 
  183-3 0.99 
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dorsal horn group image 
GLAST 
(fold increase 
over normal) 
contralateral sham+saline 183-4 0.71 
(cont.)  184-1 1.93 
  184-4 1.94 
  184-5 1.60 
 injury+saline 128-2 1.53 
  128-4 2.59 
  128-6 0.86 
  129-3 1.07 
  129-4 0.94 
  129-6 1.49 
  130-2 1.37 
  130-3 0.88 
  130-4 1.32 
  130-5 0.66 
  130-6 1.53 
  164-2 0.75 
  164-4 0.68 
  164-6 1.33 
  165-1 1.73 
  165-2 1.53 
  165-4 1.52 
  174-1 1.11 
  174-2 1.22 
  174-3 0.43 
  174-4 0.31 
  174-5 0.22 
  182-3 1.40 
  182-4 1.58 
  182-5 1.30 
 inj+10µg 138-1 1.36 
  138-2 0.74 
  138-6 0.63 
  139-1 1.99 
  139-2 2.14 
  139-4 0.73 
  139-6 1.26 
  140-2 0.21 
  140-4 0.37 
  140-6 0.27 
  141-2 0.27 
  141-3 0.20 
  141-4 0.70 
  168-1 1.68 
  168-2 1.69 
  168-4 0.40 
  168-6 0.42 
  169-1 1.80 
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dorsal horn group image 
GLAST 
(fold increase 
over normal) 
contralateral inj+10µg 169-2 1.38 
(cont.)  169-4 0.79 
  169-5 0.44 
  176-1 1.41 
  176-2 0.85 
  176-3 1.20 
  176-4 0.55 
  177-1 1.81 
  177-2 1.56 
  177-4 1.12 
 injury+150µg 136-1 0.29 
  136-2 1.63 
  136-3 0.37 
  136-4 1.63 
  142-1 1.10 
  142-2 1.34 
  142-3 0.32 
  142-4 0.42 
  142-5 1.29 
  143-1 1.34 
  143-3 2.23 
  143-4 0.88 
  167-1 2.51 
  167-2 0.98 
  167-3 0.78 
  172-1 2.55 
  172-2 1.97 
  172-3 0.44 
  172-5 1.01 
  173-2 1.12 
  173-3 0.40 
  173-4 1.79 
  180-1 1.28 
  180-3 0.71 
  180-4 0.86 
  180-5 0.84 
  181-1 1.92 
  181-3 1.28 
  181-4 0.65 
  181-5 0.81 
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Table D.7 Quantification of CGRP in the superficial dorsal horn at day 7 following a 15 
minute compression treated with Riluzole (inj+Ril) or the vehicle (inj+veh), or sham 
procedures treated with the vehicle (sham+veh) (Chapter 7). 
dorsal horn group image 
CGRP 
(fold increase 
over normal) 
ipsilateral sham+veh 162-3 1.07 
  162-4 0.96 
  162-5 0.73 
  162-6 0.68 
  193-2 1.13 
  193-3 0.86 
  193-4 1.24 
  195-2 0.77 
  195-3 0.83 
  195-5 1.04 
  195-6 1.15 
  196-1 1.02 
  196-2 0.82 
  196-3 1.04 
  196-4 0.86 
  196-6 1.11 
  200-1 1.06 
  200-3 1.04 
  200-4 0.96 
  200-6 1.22 
  211-1 0.72 
  211-2 1.00 
  211-3 0.90 
  211-4 1.20 
  211-5 0.73 
  211-6 0.94 
  212-1 0.57 
  212-2 0.83 
  212-3 0.76 
  212-4 0.79 
  212-5 0.81 
  212-6 0.93 
 inj+veh 156-1 0.41 
  156-2 0.85 
  156-5 1.00 
  156-6 1.08 
  157-1 0.42 
  157-2 0.55 
  157-4 0.65 
  163-1 0.53 
  163-3 0.84 
  163-5 0.70 
  163-6 0.82 
  194-1 0.49 
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dorsal horn group image 
CGRP 
(fold increase 
over normal) 
ipsilateral sham+veh 194-2 0.71 
(cont.)  194-4 0.62 
  194-5 0.72 
  198-2 1.30 
  198-3 1.03 
  198-4 1.12 
  198-5 0.67 
  198-6 0.92 
  199-1 0.66 
  199-2 1.01 
  199-3 0.54 
  199-4 0.82 
  199-5 0.36 
  199-6 0.50 
  210-1 0.73 
  210-2 0.79 
  210-3 0.64 
  210-4 0.69 
  210-5 0.59 
  210-6 0.70 
 inj+Ril 147-1 0.90 
  147-2 0.97 
  147-3 0.85 
  148-1 0.83 
  148-2 0.98 
  148-3 0.82 
  148-4 0.81 
  149-1 0.84 
  149-2 0.84 
  149-3 0.75 
  149-4 0.84 
  158-1 0.64 
  158-2 0.68 
  158-3 0.80 
  158-4 0.96 
  158-5 0.74 
  158-6 0.93 
  159-2 1.13 
  159-3 0.78 
  159-4 1.12 
  159-6 0.68 
  160-2 0.74 
  160-4 0.50 
  160-6 0.95 
  161-2 0.83 
  161-3 0.73 
  161-4 0.80 
  161-6 0.71 
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dorsal horn group image 
CGRP 
(fold increase 
over normal) 
contralateral sham+veh 162-1 1.03 
  162-2 1.10 
  162-3 1.06 
  193-2 1.39 
  193-3 0.71 
  193-4 0.68 
  195-2 1.05 
  195-4 1.27 
  195-5 0.82 
  195-6 1.17 
  196-1 0.77 
  196-2 0.84 
  196-6 0.85 
  200-1 0.92 
  200-2 0.73 
  200-3 0.84 
  200-4 0.95 
  211-1 1.18 
  211-2 1.30 
  211-3 1.25 
  211-4 1.25 
  211-5 1.10 
  211-6 1.17 
  212-1 1.18 
  212-2 1.19 
  212-3 1.21 
  212-4 1.21 
  212-5 1.04 
  212-6 1.16 
 inj+veh 156-2 0.72 
  156-3 0.57 
  156-4 1.06 
  156-5 1.27 
  156-6 1.20 
  157-1 0.65 
  157-2 0.67 
  157-3 0.99 
  157-4 0.65 
  163-1 0.58 
  163-2 1.23 
  163-3 0.76 
  163-4 1.23 
  163-5 0.89 
  163-6 1.07 
  194-4 0.61 
  194-5 0.78 
  194-6 1.15 
  198-2 1.17 
  198-3 0.97 
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dorsal horn group image 
CGRP 
(fold increase 
over normal) 
contralateral inj+veh 198-4 1.19 
(cont.)  198-5 1.01 
  198-6 1.28 
  199-1 0.70 
  199-2 1.23 
  199-3 0.89 
  199-4 1.02 
  199-5 0.73 
  199-6 1.07 
  210-1 0.87 
  210-2 0.96 
  210-3 1.03 
  210-4 0.97 
  210-5 1.19 
  210-6 1.15 
 inj+Ril 147-1 1.05 
  147-2 1.02 
  147-3 1.06 
  147-5 1.04 
  148-1 0.70 
  148-2 0.97 
  148-3 0.76 
  148-4 0.90 
  149-1 0.87 
  149-2 0.99 
  149-3 0.97 
  149-4 0.93 
  149-5 1.05 
  149-6 1.17 
  158-1 0.77 
  158-2 0.95 
  158-3 0.88 
  158-4 1.24 
  159-1 0.81 
  159-2 0.99 
  159-3 0.82 
  159-4 1.04 
  159-6 1.39 
  160-1 0.92 
  160-2 0.83 
  160-4 0.92 
  160-5 1.03 
  160-6 1.19 
  161-1 0.80 
  161-2 1.09 
  161-3 0.60 
  161-4 0.83 
  161-6 0.80 
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Table D.8 Quantification of CGRP in the deep dorsal horn at day 7 following a 15 
minute compression treated with Riluzole (inj+Ril) or the vehicle (inj+veh), or sham 
procedures treated with the vehicle (sham+veh) (Chapter 7). 
dorsal horn group image 
CGRP 
(fold increase 
over normal) 
ipsilateral sham+veh 162-2 0.69 
  162-3 1.07 
  162-4 0.52 
  162-5 0.59 
  193-1 1.62 
  193-4 1.31 
  193-5 0.69 
  195-1 1.03 
  195-3 0.66 
  195-4 0.78 
  195-5 1.82 
  196-4 1.02 
  200-1 0.77 
  200-2 0.16 
  200-3 0.78 
  200-4 0.34 
  200-5 0.20 
  211-1 0.74 
  211-2 0.91 
  211-3 0.72 
  211-4 0.34 
  211-5 0.62 
  211-6 0.54 
  212-1 0.37 
  212-2 0.52 
  212-3 0.78 
  212-4 0.37 
  212-6 0.59 
 inj+veh 156-1 2.34 
  156-2 2.33 
  156-4 2.54 
  156-5 1.53 
  156-6 2.22 
  157-1 1.59 
  157-3 1.06 
  157-4 0.78 
  163-1 1.21 
  163-2 0.57 
  163-4 0.78 
  163-5 0.53 
  163-6 0.75 
  194-1 2.84 
  194-3 1.28 
  194-5 1.69 
  198-1 1.56 
  198-3 1.54 
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dorsal horn group image 
CGRP 
(fold increase 
over normal) 
ipsilateral inj+veh 198-5 1.84 
(cont.)  199-1 2.54 
  199-4 2.38 
  199-6 1.10 
  210-2 0.60 
  210-4 0.31 
  210-5 0.50 
  210-6 0.78 
 inj+Ril 147-1 1.04 
  147-2 1.83 
  147-3 1.65 
  147-4 1.86 
  148-1 1.63 
  148-2 0.93 
  148-3 1.22 
  149-3 2.01 
  149-4 1.30 
  149-5 2.35 
  149-6 2.05 
  158-1 0.50 
  158-3 0.22 
  158-4 0.74 
  158-6 0.90 
  159-2 0.57 
  159-3 0.35 
  159-4 0.83 
  159-6 0.53 
  160-1 0.55 
  160-2 0.69 
  160-3 0.28 
  160-4 0.89 
  160-5 0.70 
  161-1 0.64 
  161-3 1.01 
  161-5 0.90 
contralateral sham+veh 162-1 0.50 
  162-3 0.61 
  162-4 0.39 
  162-5 0.95 
  162-6 0.81 
  193-1 2.41 
  193-2 2.48 
  193-4 1.17 
  193-5 1.73 
  195-1 0.58 
  195-2 0.38 
  195-3 0.77 
  195-4 0.73 
  195-5 1.09 
  195-6 0.83 
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dorsal horn group image 
CGRP 
(fold increase 
over normal) 
contralateral sham+veh 196-1 0.40 
(cont.)  196-4 1.00 
  196-5 0.92 
  200-1 0.75 
  200-2 0.95 
  200-3 0.42 
  200-4 0.39 
  200-6 0.32 
  211-1 0.51 
  211-2 0.39 
  211-3 0.45 
  211-4 0.66 
  211-5 0.58 
  211-6 0.54 
  212-1 0.63 
  212-2 0.75 
  212-3 0.35 
  212-4 0.62 
  212-5 0.36 
 inj+veh 156-1 1.73 
  156-2 1.69 
  156-3 2.05 
  156-4 1.44 
  156-5 1.51 
  156-6 2.54 
  157-1 0.26 
  157-2 0.34 
  157-3 0.16 
  157-4 0.37 
  163-3 0.36 
  163-4 0.70 
  163-5 0.53 
  163-6 0.71 
  194-1 1.80 
  194-3 1.18 
  194-4 0.60 
  198-2 0.50 
  198-3 2.82 
  198-5 2.39 
  199-2 1.13 
  199-3 0.74 
  199-4 0.46 
  210-2 0.85 
  210-3 0.87 
  210-4 0.48 
  210-5 0.83 
  210-6 0.98 
 inj+Ril 147-1 0.92 
  147-2 1.44 
  147-3 0.91 
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dorsal horn group image 
CGRP 
(fold increase 
over normal) 
contralateral inj+Ril 147-4 1.48 
(cont.)  147-5 1.11 
  147-6 0.93 
  148-3 0.87 
  148-4 1.19 
  148-5 1.46 
  148-6 1.05 
  149-1 1.14 
  149-2 1.21 
  149-3 1.85 
  149-4 1.25 
  158-1 0.67 
  158-2 0.36 
  158-3 0.37 
  158-4 0.45 
  158-5 0.69 
  158-6 0.47 
  159-3 0.24 
  159-5 0.14 
  159-6 0.33 
  160-2 0.58 
  160-3 0.62 
  160-4 0.86 
  160-5 0.36 
  160-6 0.27 
  161-1 0.55 
  161-4 0.22 
  161-5 0.61 
  161-6 0.67 
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APPENDIX E 
 
Quantification of Evoked Action  
Potentials in the Dorsal Horn 
 
 
This appendix provides a summary of the number of action potentials that were 
evoked during forepaw stimulation for individual neuron recordings in the dorsal horn on 
day 7 for studies in Chapters 5, 6 and 7. Specifically, recordings were made in the 
superficial (Table E.1) and deep (Table E.2) laminae at day 7 following compressions 
having durations of 3 minutes (deep laminae only), 15 minutes, or sham procedures for 
the studies presented in Chapter 5. Similarly, spinal recordings in the deep laminae were 
made at day 7 following ceftriaxone (Chapter 6; Table E.3) or Riluzole treatment 
(Chapter 7; Table E.4). For the ceftriaxone treatment study, rats underwent a painful 
compression (10gf, 15 minutes) that was treated with 10µg or 150µg ceftriaxone 
(injury+10µg, inuryj+150µg) or the saline vehicle (injury+saline) on days 1 through 6. A 
separate group of rats received the sham exposure and vehicle treatment (sham+saline), 
also on days 1 through 6. For the Riluzole treatment study, rats were either treated with 
Riluzole (injury+Ril) or the vehicle which was 10% β-cyclodextrin in saline 
(injury+veh), on day 1 after a painful nerve root compression (10gf, 15 minutes). In a 
control group for that study, rats underwent sham procedures and were treated with the 
vehicle (sham+veh).  
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In the tables of this appendix, the neuron ID identifies the rat in which the neuron 
was identified and the order that each neuron was found for that animal (rat#-neuron 
order). For each neuron, the table summarizes the depth (in µm) at which at which it was 
located from the pial surface and the number of action potentials that were evoked by 
application of each of four different von Frey filament strengths (1.4, 4.0, 10.0, 26.0gf). 
The phenotype of each neuron was identified as either wide dynamic range (WDR), low 
threshold mechanoreceptor (LTM) or nociceptive specific (NS), based on their response 
to the graded stimuli (Haines et al. 2003, Quinn et al. 2010, Saito et al. 2002). 
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Table E.1 Spinal neuronal firing in the superficial laminae at day 7. 
side group ID depth 1.4 4.0 10.0 26.0 phenotype
ipsilateral sham 125-1 400 0 31 25 69 WDR 
  125-2 360 12 24 43 41 LTM 
  125-3 200 2 15 15 92 WDR 
  125-4 430 108 116 108 99 LTM 
  125-5 380 13 39 46 88 WDR 
  154-1 160 1 42 46 118 WDR 
  154-2 240 0 12 15 20 WDR 
  154-3 180 0 8 10 18 WDR 
  186-1 150 11 9 11 22 LTM 
  186-2 200 19 15 28 35 LTM 
  186-3 300 0 1 36 30 NS 
  186-4 300 4 9 33 28 WDR 
  189-1 230 4 5 6 10 WDR 
  189-2 340 15 29 30 28 LTM 
  189-3 330 2 5 7 1 LTM 
  189-4 190 59 57 38 18 LTM 
  189-5 310 0 0 7 12 NS 
  189-6 290 1 0 2 15 NS 
  190-1 350 10 18 43 138 WDR 
  190-2 310 48 71 127 137 WDR 
  190-3 150 25 46 42 38 LTM 
  190-4 200 14 20 42 65 LTM 
  190-5 330 1 6 11 14 WDR 
  190-6 250 3 5 16 15 NS 
  201-2 370 0 7 35 50 WDR 
  201-3 250 12 16 15 8 LTM 
  201-4 140 0 0 19 25 NS 
  204-1 330 0 5 14 48 WDR 
  204-2 215 52 80 51 82 LTM 
  204-3 260 0 57 74 83 WDR 
  204-4 325 9 11 19 10 LTM 
  204-5 330 3 8 32 23 LTM 
  205-1 365 13 9 18 11 LTM 
  205-2 130 4 6 12 27 WDR 
  205-3 270 6 12 44 85 WDR 
  205-4 340 1 3 11 9 NS 
  205-5 115 2 0 5 12 NS 
 15 minute 122-1 60 30 45 55 116 WDR 
 compression 122-2 370 52 97 127 119 WDR 
  122-3 250 20 19 50 70 WDR 
  126-1 370 6 3 24 92 WDR 
  126-2 250 9 18 175 172 NS 
  126-3 350 5 28 48 59 LTM 
  126-4 110 1 1 8 53 WDR 
  126-5 340 11 10 28 65 WDR 
  127-1 350 27 66 59 99 WDR 
  127-2 400 61 78 78 112 LTM 
  127-3 310 2 6 2 4 LTM 
  127-4 310 6 10 27 28 WDR 
  127-5 410 8 15 30 112 WDR 
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side group ID depth 1.4 4.0 10.0 26.0 phenotype
ipsilateral 15 minute 153-1 300 5 12 47 61 WDR 
(cont.) compression 153-2 150 13 20 19 47 WDR 
 (cont.) 153-3 300 0 1 19 23 NS 
  153-4 270 3 6 19 21 WDR 
  188-1 50 1 5 60 103 NS 
  188-2 250 3 8 21 17 LTM 
  188-3 170 1 7 12 18 WDR 
  188-4 150 6 16 22 60 WDR 
  188-5 160 19 25 45 100 WDR 
  188-6 220 9 32 75 199 WDR 
  192-1 310 0 1 50 60 NS 
  192-2 240 1 8 22 33 WDR 
  192-3 250 0 1 25 46 NS 
  192-4 230 15 40 29 79 WDR 
  192-5 290 4 17 19 30 WDR 
  203-1 305 5 9 20 23 WDR 
  203-2 230 6 39 75 71 WDR 
  203-3 300 13 8 17 23 WDR 
  203-4 160 0 0 0 18 WDR 
  203-5 285 16 19 21 52 WDR 
  206-1 365 7 20 45 49 WDR 
  206-2 340 2 13 20 23 WDR 
  206-4 130 0 2 2 10 NS 
  206-5 325 22 35 39 55 WDR 
  206-6 85 10 11 18 24 WDR 
  206-7 315 5 11 19 19 WDR 
contralateral sham 125-6 110 21 19 28 17 WDR 
  125-7 280 2 3 6 7 LTM 
  125-8 270 20 15 63 69 LTM 
  125-9 400 5 6 26 42 WDR 
  125-10 330 7 6 9 16 WDR 
  154-4 260 8 2 5 11 LTM 
  154-5 150 3 2 15 17 NS 
  154-6 150 21 19 63 122 WDR 
  154-7 200 17 37 39 46 WDR 
  186-6 260 5 2 9 48 WDR 
  186-7 260 11 8 17 19 WDR 
  186-8 340 7 5 4 7 LTM 
  186-9 340 12 10 2 8 LTM 
  186-10 190 0 0 44 64 LTM 
  186-11 250 12 23 11 10 NS 
  186-12 360 14 28 51 48 LTM 
  189-7 320 5 3 4 12 WDR 
  189-8 340 16 11 16 20 WDR 
  189-10 300 1 6 14 18 LTM 
  189-12 290 9 11 24 35 LTM 
  190-7 160 53 26 57 24 NS 
  190-9 260 13 53 67 108 WDR 
  190-11 320 8 5 48 51 LTM 
  190-12 350 4 18 20 40 WDR 
  201-5 350 0 0 10 31 NS 
  201-6 340 4 8 15 22 WDR 
  204-6 220 2 8 25 22 NS 
 
 305 
side group ID depth 1.4 4.0 10.0 26.0 phenotype
contralateral sham 204-8 360 15 8 19 18 NS 
(cont.) (cont.) 204-9 345 10 12 16 21 LTM 
  204-10 310 0 0 8 8 LTM 
  205-7 155 3 6 4 10 LTM 
  205-9 350 18 44 84 56 WDR 
  205-10 180 13 25 38 36 LTM 
  205-11 235 2 5 10 33 WDR 
 15 minute 122-4 140 5 11 15 21 WDR 
 compression 122-5 350 68 134 26 33 LTM 
  122-6 340 9 24 21 31 LTM 
  126-6 400 18 39 42 79 WDR 
  126-7 200 8 23 13 54 WDR 
  126-8 380 31 28 49 77 LTM 
  127-6 320 0 28 32 65 LTM 
  127-7 200 16 69 51 28 LTM 
  127-8 280 14 26 49 81 LTM 
  127-9 200 1 10 48 52 LTM 
  127-10 110 5 0 12 25 WDR 
  127-11 370 25 21 30 13 WDR 
  153-5 250 0 8 23 53 WDR 
  153-6 310 5 4 9 23 WDR 
  188-7 270 13 35 55 72 NS 
  188-8 90 0 0 53 61 LTM 
  188-9 160 0 8 43 37 WDR 
  188-10 260 0 2 4 12 WDR 
  188-11 350 2 10 11 11 NS 
  188-12 165 5 6 27 132 NS 
  192-6 170 12 24 35 10 WDR 
  192-7 260 7 16 73 24 NS 
  192-8 60 11 13 15 14 WDR 
  192-9 290 23 30 0 24 WDR 
  192-10 290 10 17 34 71 WDR 
  192-11 270 0 9 4 34 LTM 
  192-12 170 2 7 69 52 LTM 
  192-13 340 0 12 20 63 WDR 
  203-6 290 5 16 21 56 WDR 
  203-8 210 0 0 64 102 WDR 
  206-8 365 0 7 7 8 WDR 
  206-9 310 63 48 41 55 LTM 
  206-10 295 53 59 122 125 WDR 
  206-11 320 29 30 35 30 LTM 
  206-12 340 2 10 8 15 LTM 
  206-13 310 3 4 4 4 LTM 
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Table E.2 Spinal neuron firing in the ipsilateral deep laminae at day 7. 
group ID depth 1.4g 4.0g 10.0g 26.0g phenotype 
sham 7-1 750 4 10 10 13 WDR 
 7-2 500 6 20 33 7 WDR 
 7-3 450 0 0 10 5 LTM 
 9-1 450 4 19 71 57 WDR 
 9-2 600 1 2 8 12 WDR 
 9-3 700 6 35 32 33 LTM 
 9-4 545 1 3 19 20 WDR 
 9-5 750 0 4 8 25 WDR 
 9-6 1000 14 11 35 46 WDR 
 9-9 500 10 0 17 41 LTM 
 11-2 955 13 36 46 48 WDR 
 11-3 645 5 14 16 13 WDR 
 11-4 925 9 15 28 42 WDR 
 11-5 555 0 6 10 21 WDR 
 11-6 740 3 1 28 23 WDR 
 11-7 450 0 0 4 7 WDR 
 11-8 825 10 6 12 12 LTM 
 11-9 575 6 8 8 6 LTM 
 42-1 600 1 3 9 5 WDR 
 42-2 800 3 27 9 10 LTM 
 42-3 550 4 3 0 3 LTM 
 42-4 525 4 4 4 4 LTM 
 42-5 550 14 6 10 19 LTM 
 42-6 525 38 98 115 117 WDR 
 42-7 500 55 74 17 130 WDR 
 42-8 600 4 23 90 151 WDR 
 43-1 575 3 5 11 94 WDR 
 43-2 600 2 9 13 23 WDR 
 43-3 625 3 1 8 0 LTM 
 43-4 600 6 10 11 4 LTM 
 43-5 650 3 1 2 19 WDR 
 43-6 725 0 13 21 46 WDR 
 43-7 525 3 2 0 24 WDR 
 43-8 550 3 10 0 28 WDR 
3 minute 315-1 625 0 44 30 48 WDR 
compression 315-2 525 6 5 3 8 LTM 
 315-3 600 8 7 9 10 WDR 
 315-4 550 11 43 65 50 WDR 
 315-5 525 4 7 11 6 LTM 
 315-6 650 11 25 41 52 WDR 
 315-7 700 4 10 14 16 WDR 
 316-1 550 4 4 8 6 LTM 
 316-2 600 1 16 15 20 WDR 
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group ID depth 1.4g 4.0g 10.0g 26.0g phenotype 
15 minute 8-2 850 0 10 25 40 WDR 
compression 10-3 450 1 17 14 36 WDR 
 10-4 650 0 15 19 31 WDR 
 10-6 750 19 78 156 130 WDR 
 10-7 700 17 19 13 23 LTM 
 10-8 800 6 18 63 55 WDR 
 10-9 500 31 33 36 36 LTM 
 10-7A 700 2 7 6 10 LTM 
 30-1 550 3 7 17 20 WDR 
 30-2 600 15 8 27 64 WDR 
 30-3 600 3 3 6 15 WDR 
 30-4 800 0 3 20 43 WDR 
 30-6 550 1 6 25 33 WDR 
 30-7 525 8 10 5 24 WDR 
 30-8 575 5 16 18 36 WDR 
 30-9 650 2 5 6 13 WDR 
 34-1 600 2 4 5 6 LTM 
 34-10 700 26 8 43 109 WDR 
 34-11 625 34 17 28 34 WDR 
 34-12 625 9 24 48 81 WDR 
 34-2 800 8 2 5 36 WDR 
 34-3 550 2 5 10 18 WDR 
 34-4 640 5 38 35 51 WDR 
 34-5 700 5 17 22 16 LTM 
 34-7 600 4 8 12 22 WDR 
 34-8 650 6 14 30 46 WDR 
 34-9 800 21 77 70 81 WDR 
 41-1 625 23 48 36 59 WDR 
 41-2 550 3 9 5 7 LTM 
 41-3 700 8 4 9 19 WDR 
 41-4 650 0 4 8 4 WDR 
 41-5 625 2 102 250 157 WDR 
 41-6 575 1 3 21 36 WDR 
 41-7 600 25 9 2 6 LTM 
 41-8 550 3 38 81 53 WDR 
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Table E.3 Spinal neuron firing after ceftriaxone treatment at day 7. 
side group ID depth 1.4 4.0 10.0 26.0 phenotype
ipsilateral sham+saline 301-1 470 1 10 1 9 WDR 
  301-2 780 3 0 6 13 WDR 
  301-3 840 4 5 15 26 WDR 
  301-4 740 1 4 0 25 LTM 
  301-5 550 15 11 79 183 WDR 
  302-1 570 2 1 2 11 LTM 
  302-2 890 2 2 2 5 LTM 
  302-3 700 2 12 12 12 LTM 
  302-4 580 3 12 23 16 WDR 
  302-5 810 3 13 33 67 WDR 
  303-1 420 0 2 10 21 WDR 
  303-2 870 0 6 5 0 WDR 
  303-3 470 1 2 15 5 WDR 
  303-5 770 4 10 13 12 LTM 
  304-11 430 2 20 8 10 LTM 
  304-12 550 0 12 19 18 WDR 
  304-14 770 5 10 12 15 LTM 
  306-1 420 4 4 16 11 WDR 
  306-2 670 10 23 16 20 LTM 
  306-3 560 1 1 8 2 LTM 
  306-4 560 5 16 7 0 LTM 
  306-5 840 3 11 35 62 LTM 
  313-1 420 6 6 4 4 WDR 
  313-2 630 8 11 22 14 WDR 
  313-4 870 0 11 52 79 WDR 
  314-1 430 9 6 61 101 WDR 
  314-2 820 6 7 6 5 LTM 
  314-3 820 3 10 8 20 WDR 
  314-4 490 0 2 16 36 WDR 
  314-5 910 0 0 19 35 WDR 
 injury+saline 287-1 420 18 22 26 38 WDR 
  287-2 730 55 13 21 44 WDR 
  287-3 530 4 12 9 43 WDR 
  288-1 790 9 0 13 71 WDR 
  288-2 530 2 3 3 24 WDR 
  288-3 670 12 44 68 118 WDR 
  297-1 420 7 12 17 13 WDR 
  297-2 540 2 8 14 16 WDR 
  298-1 610 26 63 190 243 WDR 
  298-2 810 8 25 45 39 WDR 
  299-2 430 5 22 19 75 WDR 
  299-3 710 24 75 127 85 WDR 
  299-4 850 10 20 52 64 WDR 
  299-5 560 32 18 45 37 WDR 
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side group ID depth 1.4 4.0 10.0 26.0 phenotype
ipsilateral injury+saline 299-6 700 4 17 50 34 WDR 
(cont.)  299-7 650 21 38 43 184 WDR 
  300-1 680 0 10 19 36 WDR 
  300-2 610 70 61 39 42 WDR 
  300-3 790 31 55 64 86 WDR 
  300-4 850 8 46 34 21 WDR 
  300-5 640 21 39 13 166 WDR 
  307-1 800 5 7 42 72 WDR 
  307-2 530 10 6 47 116 WDR 
  307-3 610 7 3 3 3 LTM 
  307-4 630 0 20 155 428 WDR 
  307-5 480 7 110 103 144 WDR 
  307-6 720 8 11 12 19 LTM 
  308-1 720 4 41 42 151 WDR 
  308-2 860 45 56 76 90 WDR 
  308-3 740 1 30 77 114 WDR 
  308-4 770 13 12 16 20 LTM 
  308-5 470 31 152 188 246 WDR 
  308-6 420 32 23 20 98 WDR 
 injury+10µg 285-1 420 6 14 28 27 WDR 
  285-2 530 0 4 7 29 WDR 
  285-3 590 3 17 14 16 LTM 
  285-5 430 9 12 41 46 LTM 
  286-1 600 0 4 8 4 WDR 
  286-2 690 4 1 6 10 WDR 
  286-3 800 1 3 15 35 WDR 
  286-4 510 0 5 6 2 LTM 
  290-1 620 13 48 54 81 LTM 
  290-2 800 3 2 17 13 WDR 
  290-3 520 4 2 13 33 WDR 
  290-4 680 22 19 36 33 WDR 
  290-5 850 0 23 24 77 WDR 
  290-6 800 10 7 17 14 WDR 
  293-1 480 4 5 13 9 LTM 
  293-2 550 26 22 25 68 WDR 
  293-3 500 0 11 69 143 WDR 
  293-4 690 6 3 10 9 LTM 
  293-5 650 19 27 26 27 LTM 
  294-1 550 16 8 15 11 LTM 
  294-2 730 6 6 19 32 WDR 
  294-3 860 16 16 38 26 LTM 
  294-4 540 6 20 32 75 WDR 
  294-5 650 22 15 19 18 WDR 
  296-1 480 8 15 32 25 LTM 
  296-2 540 0 0 20 63 WDR 
  296-3 550 6 3 3 14 WDR 
  296-4 650 9 11 32 24 WDR 
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side group ID depth 1.4 4.0 10.0 26.0 phenotype
ipsilateral injury+10µg 296-5 800 15 19 19 27 LTM 
(cont.)  311-1 430 0 5 30 55 WDR 
  311-2 600 2 8 10 24 WDR 
  311-3 510 7 5 6 5 LTM 
  311-4 740 8 20 78 120 WDR 
  311-5 890 2 14 39 46 WDR 
  312-1 660 1 15 54 61 WDR 
  312-2 730 3 0 9 10 LTM 
  312-3 820 5 26 41 79 WDR 
  312-4 630 17 9 14 26 LTM 
  312-5 560 1 0 6 11 WDR 
 injury+150µg 283-1 560 4 7 10 6 WDR 
  283-2 450 9 7 9 13 LTM 
  283-3 610 5 3 14 11 WDR 
  284-1 670 10 4 20 46 WDR 
  284-2 730 14 11 17 9 LTM 
  284-3 640 40 80 63 88 LTM 
  284-4 590 0 2 5 7 LTM 
  284-5 820 25 36 47 47 WDR 
  289-1 510 3 2 4 2 WDR 
  289-2 480 8 14 12 37 WDR 
  289-3 550 1 3 9 15 WDR 
  289-4 630 7 28 40 16 LTM 
  291-1 430 9 5 24 27 WDR 
  291-2 510 9 15 11 11 WDR 
  291-3 650 0 6 92 159 WDR 
  291-4 480 7 0 25 20 WDR 
  291-5 560 1 7 9 36 WDR 
  292-1 560 5 11 31 49 WDR 
  292-2 450 3 4 114 240 WDR 
  292-3 610 13 26 18 38 WDR 
  292-4 860 15 14 22 54 LTM 
  292-5 440 3 17 12 4 LTM 
  292-6 730 5 7 13 97 LTM 
  295-1 480 13 35 45 51 WDR 
  295-2 780 31 28 19 23 LTM 
  295-3 780 10 11 15 14 WDR 
  295-4 860 5 21 29 75 WDR 
  295-5 490 3 6 10 33 WDR 
  295-6 610 10 13 21 47 WDR 
  309-1 720 1 3 1 1 LTM 
  309-2 710 11 27 29 66 WDR 
  309-3 570 6 15 19 22 LTM 
  309-4 540 4 29 52 43 WDR 
  309-5 450 11 16 23 38 LTM 
  310-1 420 8 103 158 137 WDR 
  310-2 760 3 18 37 70 WDR 
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side group ID depth 1.4 4.0 10.0 26.0 phenotype
ipsilateral injury+150µg 310-3 880 2 3 14 39 WDR 
(cont.)  310-4 520 3 6 4 3 LTM 
  310-5 470 0 16 27 78 WDR 
contralateral sham+saline 301-10 590 13 14 59 56 WDR 
  301-6 540 0 10 14 26 WDR 
  301-7 900 7 22 14 9 LTM 
  301-8 410 2 10 8 32 LTM 
  301-9 680 1 29 78 121 WDR 
  302-10 670 8 15 34 26 WDR 
  302-6 540 2 11 19 23 WDR 
  302-7 650 0 1 13 58 LTM 
  302-8 720 1 2 2 5 WDR 
  302-9 550 3 2 10 23 LTM 
  303-10 850 1 3 5  LTM 
  303-6 890 5 7 4 0 LTM 
  303-7 670 1 36 32 76 WDR 
  303-8 500 0 20 18 28 WDR 
  303-9 580 4 1 27 17 WDR 
  304-15 550 2 5 17 51 WDR 
  304-16 500 9 10 37 34 WDR 
  304-17 690 1 25 29 53 WDR 
  304-18 850 1 2 84 105 WDR 
  305-1 640 0 18 70 48 WDR 
  305-2 900 6 40 26 24 LTM 
  305-3 740 5 5 29 24 WDR 
  305-4 870 4 12 7 23 WDR 
  305-5 750 0 4 27 40 LTM 
  306-6 820 4 22 18 22 LTM 
  306-7 530 23 16 50 57 WDR 
  306-8 620 15 14 16 19 LTM 
  313-5 670 8 10 6 3 LTM 
  313-6 740 0 6 6 5 LTM 
  313-7 820 7 10 9 27 WDR 
  313-8 610 8 4 9 6 LTM 
  314-6 720 0 1 3 9 WDR 
  314-7 740 6 8 5 5 WDR 
  314-8 850 0 3 6 13 WDR 
  314-9 800 0 2 10 14 WDR 
 injury+saline 287-4 570 6 19 40 68 WDR 
  288-5 740 17 53 86 88 WDR 
  288-6 600 1 3 5 37 WDR 
  288-7 430 7 8 4 10 LTM 
  288-8 630 22 14 22 7 WDR 
  288-9 540 13 10 21 15 LTM 
  298-3 440 6 12 31 94 WDR 
  298-4 750 5 15 9 59 WDR 
  298-5 870 7 18 27 32 WDR 
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side group ID depth 1.4 4.0 10.0 26.0 phenotype
contralateral injury+saline 299-10 690 2 5 9 60 WDR 
(cont.)  299-8 940 2 30 144 243 WDR 
  299-9 760 9 5 24 27 LTM 
  300-6 730 10 7 8 9 WDR 
  300-7 660 1 0 5 7 WDR 
  300-8 570 0 7 21 20 WDR 
  300-9 590 5 16 8 6 LTM 
  307-10 850 12 21 27 48 WDR 
  307-11 710 37 30 82 120 WDR 
  307-7 490 0 75 180 266 WDR 
  307-8 560 9 8 30 38 WDR 
  307-9 620 7 3 16 18 WDR 
  308-10 740 0 0 0 12 WDR 
  308-7 690 0 8 68 19 LTM 
  308-8 810 0 20 33 7 LTM 
  308-9 660 13 15 20 24 LTM 
 injury+10µg 285-6 760 19 21 22 26 LTM 
  285-7 600 7 3 2 13 LTM 
  285-8 440 1 11 23 9 WDR 
  285-9 540 8 18 29 15 WDR 
  286-10 470 15 8 45 39 WDR 
  286-6 470 0 0 6 8 WDR 
  286-7 510 4 8 17 37 WDR 
  286-8 650 1 16 24 13 LTM 
  286-9 830 12 78 166 219 WDR 
  290-10 470 13 27 70 96 WDR 
  290-7 630 2 5 14 19 WDR 
  290-8 850 12 11 13 29 LTM 
  290-9 650 0 0 17 45 WDR 
  293-10 800 10 1 26 34 WDR 
  293-11 680 15 4 29 25 LTM 
  293-6 800 12 19 32 45 WDR 
  293-7 450 0 18 123 118 WDR 
  293-8 450 27 27 28 38 WDR 
  293-9 750 7 4 43 81 WDR 
  294-6 800 2 1 6 6 LTM 
  294-7 800 11 24 26 26 WDR 
  296-10 620 2 16 15 17 WDR 
  296-6 720 12 30 93 106 WDR 
  296-7 840 10 19 25 34 LTM 
  296-8 800 0 5 6 10 LTM 
  296-9 740 46 31 19 27 WDR 
  311-6 720 3 3 4 2 LTM 
  311-7 430 0 0 5 21 WDR 
  311-8 620 1 2 11 23 WDR 
  311-9 780 6 6 35 32 WDR 
  312-10 460 4 6 4 3 LTM 
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side group ID depth 1.4 4.0 10.0 26.0 phenotype
contralateral injury+10µg 312-11 600 4 8 6 12 WDR 
(cont.)  312-12 620 11 11 14 17 WDR 
  312-6 560 0 6 14 6 WDR 
  312-7 490 10 3 5 12 WDR 
  312-8 730 8 11 8 12 LTM 
  312-9 730 3 12 17 17 LTM 
 injury+150µg 283-5 460 9 15  39 WDR 
  283-6 700 4 1 10 14 WDR 
  283-7 760 9 18 46 59 WDR 
  283-8 690 13 14 10 15 LTM 
  284-10 810 22 17 12 6 LTM 
  284-11 470 20 27 35 32 LTM 
  284-6 580 12 10 11 6 LTM 
  284-7 750 1 5 16 16 WDR 
  284-8 750 2 8 7 29 LTM 
  284-9 660 68 17 28 27 WDR 
  289-5 420 6 9 21 53 WDR 
  289-6 730 0 3 1 18 WDR 
  291-10 460 0 145 47 127 WDR 
  291-6 460 12 37 10 14 WDR 
  291-7 710 4 12 16 70 WDR 
  291-8 500 6 2 10 12 WDR 
  291-9 750 20 30 26 105 WDR 
  292-10 500 12 16 53 58 WDR 
  292-11 770 30 12 53 98 WDR 
  292-7 620 2 5 12 15 LTM 
  292-8 800 8 13 12 19 WDR 
  292-9 660 17 17 25 27 LTM 
  295-7 430 11 33 31 11 LTM 
  295-8 800 16 17 31 26 LTM 
  295-9 620 2 7 22 144 WDR 
  309-10 880 2 5 7 12 LTM 
  309-6 570 0 8 15 47 WDR 
  309-7 490 10 41 80 52 WDR 
  309-8 600 19 73  0 WDR 
  309-9 910 40 8 57 49 WDR 
  310-10 650 21 29 73 13 WDR 
  310-6 510 0 1 10 26 WDR 
  310-7 600 2 0 4 26 WDR 
  310-8 730 3 9 11 25 LTM 
  310-9 870 4 10 13 16 LTM 
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Table E.4 Spinal neuron firing after Riluzole treatment at day 7. 
side group ID depth 1.4 4.0 10.0 26.0 Type 
ipsilateral sham+veh 259-1 440 14 4 9 56 LTM 
  261-1 610 9 5 1 9 LTM 
  261-2 560 2 13 0 7 LTM 
  261-3 770 6 18 18 26 LTM 
  261-4 660 2 6 29 35 WDR 
  261-5 600 4 2 5 3 LTM 
  261-6 640 4 4 0 26 LTM 
  263-1 600 1 2 14 29 WDR 
  263-2 570 5 11 5 8 LTM 
  263-3 700 4 0 14 46 WDR 
  263-4 450 0 7 7 14 LTM 
  263-5 410 9 12 16 32 WDR 
  263-6 620 8 13 15 30 WDR 
  265-1 670 1 5 13 40 WDR 
  265-2 700 0 11 4 29 LTM 
  265-3 850 1 1 47 42 WDR 
  265-4 440 2 9 15 15 WDR 
  265-5 590 7 4 1 13 LTM 
  265-6 660 9 18 60 88 WDR 
  268-1 450 2 3 43 40 WDR 
  268-2 440 0 11 16 57 WDR 
  268-3 840 16 6 4 6 LTM 
  268-4 620 5 2 11 38 WDR 
  268-5 430 0 25 12 51 WDR 
  269-1 430 12 37 14 14 LTM 
  269-2 660 5 48 24 28 LTM 
  269-3 610 14 9 5 13 LTM 
  269-4 700 0 0 27 11 LTM 
  269-5 750 3 8 23 79 WDR 
  269-6 880 1 33 0 40 WDR 
  271-1 710 3 0 16 51 WDR 
  271-2 520 1 5 8 38 WDR 
  271-3 610 2 3 5 83 WDR 
  271-4 760 2 3 7 14 WDR 
  271-5 550 1 12 153 17 WDR 
  274-1 520 1 1 5 23 WDR 
  274-2 560 43 44 166 261 WDR 
  274-3 480 9 5 72 56 WDR 
 injury+veh 244-2 670 4 10 13 59 WDR 
  244-3 560 6 19 31 63 WDR 
  244-4 475 2 41 75 71 WDR 
  244-5 600 0 4 45 158 WDR 
  246-1 760 1 1 13 65 WDR 
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side group ID depth 1.4 4.0 10.0 26.0 Type 
ipsilateral injury+veh 246-2 720 16 44 33 84 WDR 
(cont.)  246-3 490 3 27 23 68 WDR 
  246-4 670 13 17 34 110 WDR 
  246-5 450 1 8 37 43 WDR 
  249-1 430 13 34 75 95 WDR 
  249-2 490 4 9 20 40 WDR 
  249-3 545 13 34 93 135 WDR 
  249-4 690 10 6 88 149 WDR 
  244-1 440 16 17 26 22 LTM 
  264-1 850 1 5 20 43 WDR 
  264-2 720 1 10 21 50 WDR 
  264-3 740 3 1 6 22 WDR 
  264-4 720 7 8 20 35 WDR 
  264-5 940 0 17 30 108 WDR 
  264-6 420 6 5 37 46 WDR 
  266-1 950 9 10 14 34 WDR 
  266-2 550 5 5 9 33 LTM 
  266-3 640 6 19 62 120 WDR 
  266-4 870 6 14 11 17 WDR 
  266-5 950 6 11 15 18 LTM 
  266-6 780 14 14 71 186 WDR 
  272-1 760 11 6 5 56 WDR 
  272-2 820 13 6 34 52 LTM 
  272-3 460 27 6 60 396 WDR 
  272-4 630 19 44 69 123 WDR 
  272-5 770 0 152 150 253 WDR 
  273-1 530 0 1 5 5 LTM 
  273-2 650 7 13 43 39 LTM 
  273-3 480 2 3 28 42 WDR 
  273-4 730 9 14 16 3 WDR 
  273-5 240 9 40 109 195 WDR 
 injury+Ril 243-1 650 9 15 38 185 WDR 
  243-2 830 8 21 36 54 WDR 
  243-3 580 8 32 40 44 WDR 
  243-4 810 5 6 10 43 WDR 
  243-5 710 1 8 39 77 WDR 
  245-1 490 0 7 18 37 WDR 
  248-3 530 0 3 4 41 WDR 
  248-4 690 5 21 74 80 WDR 
  248-5 840 5 13 17 56 WDR 
  248-6a 730 4 11 9 40 LTM 
  250-1 465 12 14 30 18 LTM 
  250-2 700 3 16 11 8 WDR 
  248-2b 490 2 13 20 30 LTM 
  248-1a 735 7 8 5 3 LTM 
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side group ID depth 1.4 4.0 10.0 26.0 Type 
ipsilateral injury+Ril 250-4 800 20 26 53 14 LTM 
(cont.)  260-1 660 0 7 10 42 WDR 
  260-2 910 1 9 41 35 WDR 
  260-3 800 0 0 18 18 WDR 
  260-4 550 12 17 27 57 WDR 
  260-5 650 8 5 28 36 WDR 
  260-6 610 0 10 48 48 WDR 
  262-1 720 2 0 2 7 LTM 
  262-2 600 5 4 5 29 LTM 
  262-3 540 0 42 58 43 WDR 
  262-5 420 0 8 13 47 WDR 
  262-6 680 24 9 6 10 LTM 
  267-2 630 1 8 60 32 WDR 
  267-3 440 1 8 2 7 WDR 
  267-3a 440 0 8 1 7 LTM 
  267-4 510 3 7 8 12 LTM 
  270-1 420 5 27 30 29 LTM 
  270-2 600 7 17 16 16 LTM 
  270-3 720 4 5 65 207 WDR 
  270-4 630 1 3 6 17 WDR 
  270-5 800 18 21 14 10 LTM 
  270-6 560 4 11 14 23 LTM 
contralateral sham+veh 261-7 440 3 2 12 22 WDR 
  261-8 820 4 13 42 143 LTM 
  261-9 430 16 14 29 38 LTM 
  261-10 450 8 10 32 46 WDR 
  261-11 470 0 5 29 86 WDR 
  263-7 730 3 6 32 48 WDR 
  263-8 790 3 35 35 37 LTM 
  263-9 680 4 19 24 43 WDR 
  263-10 780 27 60 50 86 WDR 
  263-11 860 3 4 21 36 WDR 
  263-12 840 27 14 7 6 LTM 
  265-7 640 4 14 20 36 WDR 
  265-8 590 9 4 9 9 LTM 
  265-9 480 10 12 46 88 WDR 
  265-10 560 0 12 22 84 WDR 
  265-11 550 11 4 49 83 WDR 
  265-12 630 2 0 3 57 WDR 
  268-7 460 0 6 21 24 WDR 
  268-8 760 6 17 25 31 LTM 
  268-9 520 7 9 3 8 LTM 
  268-10 610 1 23 32 48 WDR 
  268-11 680 0 0 12 10 WDR 
  268-12 810 12 16 47 120 WDR 
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side group ID depth 1.4 4.0 10.0 26.0 Type 
contralateral sham+veh 269-7 550 1 5 5 16 LTM 
(cont.)  269-8 720 0 6 26 17 WDR 
  269-9 810 0 18 22 16 LTM 
  269-10 540 2 11 24 74 WDR 
  271-6 660 11 8 8 12 LTM 
  271-7 470 1 1 9 30 WDR 
  271-8 490 6 6 33 29 WDR 
  271-9 580 16 17 23 24 LTM 
  271-10 760 2 3 7 19 WDR 
  274-4 570 2 5 4 5 LTM 
  274-6 580 6 2 27 21 WDR 
  274-7 440 1 9 35 44 WDR 
  274-8 560 0 7 26 32 WDR 
 injury+veh 244-6 860 7 5 31 58 WDR 
  244-7c 710 2 9 12 78 WDR 
  244-8a 780 3 0 11 53 WDR 
  244-9b 660 4 6 5 8 WDR 
  246-8 550 3 32 41 37 WDR 
  246-9 800 0 7 32 92 WDR 
  246-10 705 13 21 26 40 WDR 
  246-11 760 0 3 14 112 WDR 
  249-5 480 2 25 37 51 WDR 
  249-6 550 2 16 12 10 WDR 
  249-7 650 3 0 77 5 WDR 
  246-6 750 4 9 3 5 LTM 
  246-7 805 7 28 33 53 LTM 
  264-7 540 7 11 13 26 WDR 
  264-8 770 4 19 72 56 WDR 
  264-9 990 3 4 4 7 LTM 
  264-10 670 3 6 22 34 WDR 
  264-11 850 16 28 37 15 LTM 
  264-12 650 10 8 43 242 WDR 
  266-7 420 0 3 6 13 WDR 
  266-8 630 2 2 15 24 WDR 
  266-9 560 22 18 16 65 LTM 
  266-10 730 43 17 31 70 WDR 
  266-11 560 6 10 22 41 LTM 
  266-12 890 2 27 57 70 WDR 
  272-6 700 4 4 5 42 WDR 
  272-7 840 4 15 21 85 WDR 
  272-8 610 7 20 19 45 WDR 
  272-9 590 0 5 49 30 WDR 
  272-10 550 5 4 6 8 LTM 
  272-11 610 7 17 17 57 WDR 
  273-7 920 4 4 97 97 WDR 
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side group ID depth 1.4 4.0 10.0 26.0 Type 
contralateral injury+veh 273-8 650 22 37 63 57 LTM 
(cont.)  273-9 650 19 45 107 97 WDR 
  273-10 870 0 15 9 13 LTM 
 injury+Ril 243-6 470 9 22 18 64 WDR 
  243-7 670 0 2 28 116 WDR 
  243-9 850 9 29 45 42 WDR 
  245-2b 600 18 30 20 37 LTM 
  248-8 610 4 12 36 35 WDR 
  248-9 510 14 8 17 40 WDR 
  248-10 770 11 21 43 55 WDR 
  248-11 460 6 4 34 44 WDR 
  250-5 740 11 9 40 55 WDR 
  250-6 820 5 7 26 50 WDR 
  250-7 525 5 7 52 42 WDR 
  243-8 720 28 18 70 52 LTM 
  248-7 645 3 7 15 25 LTM 
  260-7 750 0 7 6 34 LTM 
  260-8 560 0 2 7 11 LTM 
  260-9 450 5 6 9 25 WDR 
  262-7 830 2 2 40 32 WDR 
  262-8 490 10 5 15 22 LTM 
  262-9 420 22 31 54 76 WDR 
  262-10 430 21 29 25 25 LTM 
  262-11 820 9 7 7 22 LTM 
  262-12 550 15 65 56 46 LTM 
  267-5 800 2 7 5 21 WDR 
  267-6 690 11 27 69 146 WDR 
  267-7 560 0 1 5 21 WDR 
  267-8 740 0 2 7 12 LTM 
  267-9 760 7 9 11 13 LTM 
  267-10 840 1 18 37 65 WDR 
  270-7 620 13 34 39 98 WDR 
  270-8 710 0 4 5 10 WDR 
  270-9 690 3 1 7 17 WDR 
  270-10 550 10 4 4 68 WDR 
  270-11 600 16 9 10 12 LTM 
  270-12 570 1 2 20 27 WDR 
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APPENDIX F 
 
Matlab Code for Quantifying 
Immunohistochemistry of Spinal Cord Sections 
 
 
The Matlab code that quantified the percent positive pixels in fluorescently 
labeled spinal cord sections throughout this thesis and summarized in Appendix D is 
provided in this Appendix. To run this script, the user must save the code and the images 
in the same file directory. Prior to running this script, the threshold (0-250) is defined and 
entered as pos_thresh in the code. Once the script is finished computing the percent 
positive pixels for all images, typing “D.name” into the command window will return a 
list of all the images that were processed. Entering “percpos” into the command window 
will return the percent positive pixels that were calculated for the corresponding images 
returned by the D.name command. 
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%% This script was written to calculate and visualize percent positive 
%% pixels per image.  
%% requires MATLAB 7.0 (or higher) and imaging toolbox. 
%% Written by Kristen Nicholson (modified from L. Dong and K. Quinn) 
%% December 2009 
  
clear all; 
close all; 
clf; 
  
D = dir('*.tif'); %specify which images in the current directory to  
                        %analyze (* = wildcard character) 
  
for k=1:length(D); 
  
    % Load the image  
    file=D(k).name; 
    imag_orig = imread(file);  
     
    %for colabeled images only, select which label to use, otherwise use 
    %the code to gray-scale the image 
    %imag = imag_orig(:,:,1);%grab the red labeled image 
    %imag = imag_orig(:,:,2);%grab the green labeled image 
    imag = rgb2gray(imag_orig);%gray-scale the image 
    invImag = 255-imag;%invert the image 
    imag = invImag; 
     
    %calc number of pixels 
    [a b]=size(imag); 
    tsize=a*b;     
    low=double(min(imag(:))); 
    high=double(max(imag(:))); 
    whiteSpace = 0.85*high;  
    pos_thresh = 200;%input based on normal run, higher value corresponds 
                       %to a higher +ive threshold. 
                       
  
    backg=sum(sum(imag>whiteSpace)); 
    posp=sum(sum(imag<pos_thresh)); 
    %calc percent of positive pixels in tissue 
    percpos(k)=  posp/(tsize-backg); 
    tpost(k) = posp; 
    Iname(k) = {file}; 
  
    %map out pos and neg pixels 
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    pmap=(imag<pos_thresh); 
    nmap=(imag>whiteSpace); 
  
    %   make figure for each image, if you are processing a bunch of images, you 
    %   may want to comment this part out  
  
    %make positive pixels more green, and background pixels less blue 
    imag1(:,:,1)=double(imag)/255; 
    imag1(:,:,2)=(1-pmap).*double(imag)/255+pmap; 
    imag1(:,:,3)=double(imag)/255.*(1-nmap); 
     
  
    h = figure(1); 
    subplot(3,1,3); 
    subimage(imag); 
    axis image 
    axis off 
    subplot(3,1,2); 
    subimage(imag1); 
    axis image 
    axis off 
    colormap gray 
    subplot(3,1,1); 
    subimage(imag_orig) 
    axis image 
    axis off 
    drawnow 
     
    clear imag imag1 
    clf 
end 
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